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ABSTRACT
The aim of this study was to develop improved diagnostic techniques for tropical
theileriosis caused by T. annulata. These were (i) stage specific indirect enzyme-linked
immunosorbent assays (ELISA) to distinguish animals vaccinated with high passage cell
lines from those naturally infected in the field and (ii) a highly sensitive and specific
polymerase chain reaction (PGR) methodology to detect low level infections in carrier
animals.
Material for this study was provided by experiments in which calves were
infected in different ways to simulate the field situation. Three groups of animals were
infected with different life cycle stages of T. annulata: sporozoites, a low passage
macroschizont-infected cell line or a high passage (attenuated) cell line, normally used
as a vaccine to control tropical theileriosis, and challenged with virulent heterologous
sporozoites. The challenge indicated that different parasite stages and levels of
attenuation used for primary infection stimulated different levels and duration of
immunity. The immunity stimulated by sporozoites and the low passage cell line was
solid throughout the study, in contrast to immunity induced by the high passage cell line
which fell by seven months post-infection. The carrier status of these animals was
determined by PCR using primers from small subunit ribosomal RNA (ssu rRNA) in
comparison to that illustrated by microscopic detection of piroplasms and cell culture
isolation of macroschizonts. The different patterns revealed that calves infected with
sporozoites or the low passage cell line were persistent carriers, while those inoculated
with the high passage cell line were intermittent or only transient carriers.
In order to obtain an antigen expressed by the macroschizont stage of the parasite
to use in ELISA an attempt was made to isolate a T. annulata gene, which was a
homologue of the QP rich protein of T. parva, from a T. annulata ZAP cDNA library.
Three T. annulata genes, NCI, NC2 and NC10, were isolated from the cDNA library by
screening with QP cDNA probe. Characterisation of these genes was carried out by
Southern, northern, western blot and sequence analyses. An immunogenic recombinant
protein, NC10-Sspl3, was obtained from the NC10 gene which was expressed by the
xi
macroschizont stage of the parasite. Antisera against the NC10-Sspl3 antigen detected
polypeptides both in macroschizonts and host nucleus.
Indirect ELISA using recombinant antigens, a merozoite rhoptry recombinant
antigen (Tamr-1), NC10-Sspl3 and an antigen expressed by both the macroschizont and
piroplasm stages of the parasite, Tash-2, were standardised following international
guidelines on data expression and quality assurance. The results were compared with
those obtained with indirect immunofluorescence antibody test (IFAT) using piroplasm
antigen. The recombinant antigens, Tamr-1, NC10-Sspl3 and Tash-2, were screened
against antisera produced by infection of cattle with different life cycle stages of T.
annulata in order to examine whether the combination of the Tamr-1 and NC10-Sspl3
ELISAs or Tamr-1 and Tash-2 ELISAs would distinguish vaccinated animals from those
that are naturally infected. The result showed that both Tamr-1 and Tash-2 antigens
sensitively detected the antibodies in animals infected with both sporozoites and the low
passage cell line. No antibody responses were detected against the Tamr-1 antigen, and
were very low against the Tash-2 antigen in animals immunised with the high passage
cell line. The antibody responses detected by the NC10-Sspl3 ELISA were lower than
those obtained for both Tamr-1 and Tash-2 ELISAs.
The results of this study show that, ELISAs using the Tamr-1, NC10-Sspl3 or
Tash-2 recombinant antigens did not reliably distinguish animals vaccinated with the
high passage cell line from those that were naturally infected. Both Tamr-1 and Tash-2
ELISAs, however, could serve as powerful diagnostic tools in epidemiological studies of
theileriosis, as ELISA systems permit processing of larger numbers of samples than
IFAT and give objective results.
The nested PCR using primers derived from the gene encoding the 30 kDa major
merozoite surface antigen (Tarns-1) of T. annulata amplified parasite DNA in blood
samples from animals exhibiting low piroplasm parasitaemia. The PCR distinguishes T.
annulata from T. buffeli in cattle and T. annulata from T. lestoquardi and B. equi in
vector ticks. Such sensitive and specific tests would complement the sero-




Tropical theileriosis is an important and frequently fatal disease of cattle
caused by the protozoon parasite T. annulata (Dschunkowsky and Luhs, 1904). It is
transmitted by ixodid ticks of the genus Hyalomma (Robinson, 1982). The disease
occurs in the Mediterranean littoral, North Africa, the Middle East, the Indian
subcontinent and Central Asia where an estimated 250 million cattle are at risk
(Purnell, 1978). In particular tropical theileriosis threatens exotic Bos taurus breeds
of European origin and their cross-bred progeny in which it may cause 40-60%
mortality (Brown, 1990). When cattle survive infection recovery is extended and
often incomplete resulting in loss of productivity and a carrier state (Uilenberg,
1981b). Therefore, bovine tropical theileriosis imposes serious constraints upon
breed improvement programmes and livestock production.
The control of tropical theileriosis is based primarily on vector control,
chemotherapy and, in many countries, vaccination using attenuated macroschizont
infected cell lines. The control of disease in Turkey other countries from North
Africa to China has been carried out by immunisation using an attenuated
macroschizont infected cell culture vaccine (Onar, 1989). 150,000 doses of vaccine
are produced each year at the State Veterinary Institute, Pendik, near Istanbul in
Turkey, This vaccine has been used to protect particularly valuable, highly
susceptible cattle in over 60 urban and peri-urban milk-producing areas in Turkey
(Onar, 1989). Despite the vaccine programme and the more recent development of
treatment with buparvaquone, theileriosis has become an increasing problem in
recent years due to the increase in cross-breeding and the demand for exotic cattle to
improve both dairy and beef production. Consequently the annual production of
vaccine is no longer sufficient to fulfill the requirement of Turkey. Not only is larger
scale production needed, on a sustainable, cost recoverable basis, but the vaccine
needs to be shown to be effective and to be targeted where it is most needed.
There are a number of factors that must be determined in the design of a
successful vaccination programme: (i) the proportion of hosts that must be
1
vaccinated, (ii) the age at which hosts should be first vaccinated, (iii) at what interval
hosts should be re-vaccinated (Woolhouse et al., 1997). All these require
comprehensive epidemiological knowledge of the disease that can only be obtained
using diagnostic tools that sensitively and specifically detect the presence of parasite
or antibodies which recognise parasite antigens.
In order to assess the impact of a T. annulata control programme, it is
necessary to assess whether an animal has been vaccinated effectively i.e. the
vaccine 'take', whether it has been challenged and whether it is immune to infection
by T. annulata. One way of measuring the effectiveness of attenuated cell line
vaccines is by monitoring the antibody response to the parasite as a consequence of
vaccination. To date the most common method used to monitor the response to
theilerial vaccines is the indirect immunofluorescent antibody test (IFAT) using both
macroschizont and piroplasm antigens (Pipano and Cahana, 1969; Anon, 1997).
However, IFAT fails to distinguish vaccinated/unchallenged animals from those
naturally infected because of the presence of common antigens in all stages of the
parasite (Knight et al., 1998).
The attenuated cell line vaccine used in Turkey has been reported not to
produce piroplasms in immunised cattle (Ozkoc and Pipano, 1981). Therefore, using
stage specific antigens might allow vaccinated animals to be distinguished from
those that are naturally infected. During natural infection with sporozoites, the host
immune system will be exposed to sporozoites, macroschizonts, merozoites and
piroplasms. In contrast, animals immunised with an attenuated high passage cell line
vaccine; which does not produce piroplasms, will be exposed only to the
macroschizont stage of the parasite. Thus, a macroschizont specific antigen could be
used to assess the vaccination status of cattle. Whereas a sporozoite or merozoite
/piroplasm stage specific antigen could be used to detect challenge or natural
infection in the field. These antigens would be of great value in investigating the true
prevalence of infection where the vaccine has already been used and in assessing
vaccination programmes.
In recent years, stage specific antigens of the different life cycle stage of T.
annulata have been expressed as recombinant proteins. These include the sporozoite
surface antigen, SPAG-1 (Hall et al., 1992; Williamson et al., 1994), the merozoite
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rhoptry antigen, Tamr-1 (Shiels et al., 1994), and the 30 kDa major merozoite and
piroplasm surface antigen, Tamsl (Shiels et al., 1995). Preliminary studies
demonstrated that antibodies against the Tamr-1 antigen were detected in animals
infected with sporozoites or with non-attenuated macroschizont infected cells,
whereas the antibody titres of animals immunised with high passage cell lines
remained close to the pre-immunisation levels (Ilhan, 1995). On commencement of
this study there were no recombinant antigens available which were expressed by the
macroschizont stage of T. annulata. Such an antigen was needed for the development
of a diagnostic test aimed at the measurement of efficacy of vaccination. Using such
antigens in an enzyme-linked immunosorbent assay (ELISA) systems would
hopefully provide a tool to distinguish vaccinated from naturally infected animals.
Additionally, an antibody ELISA has several advantages over IFAT including the
ability to test large numbers of samples rapidly and economically, thus making it
relevant to the conduct of large scale sero-epidemiological surveys.
Another important aspect of T. annulata infection is that a persistent
piroplasm parasitaemia occurs in the host following recovery from natural infection
(Sergent et al., 1945; Neitz, 1957). Vector ticks, which have fed on carrier cattle and
become infected, have the potential to transmit the parasite to a susceptible host.
Therefore, the carrier state is of great importance in the maintenance of the life cycle
of the parasite by alternate tick/cattle passage. The carrier state has, in the past, been
determined by microscopic examination of Romanowsky stained blood smears for
the presence of piroplasms. Nevertheless, piroplasm parasitaemia is often too low to
be detected in carriers and can be misdiagnosed where the distribution of other
Theileria species is sympatric with T. annulata (Norval et al., 1992; Uilenberg,
1981b). This results in underestimation or overestimation of the true prevalence of
the carrier state in a population. With advances in molecular biology, the detection
of very low number of parasites in the host and vector has become possible. One of
the most frequently used methods is the polymerase chain reaction (PCR) using
parasite specific oligonucleotide sequences. Recent studies showed that PCR using
primers from the small subunit ribosomal RNA (ssu rRNA) gene (Allsopp et al.,
1993; de Kok et al., 1993; Ilhan, 1995) or the gene encoding a 30 kDa merozoite
surface protein (Tamsl) (Shiels et al., 1995; d'Oliveira et al., 1995; 1997b) detected
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T. annulata sensitively and specifically in both the vertebrate host and tick vectors.
An effective PCR would permit simple, practical studies of the carrier state of
animals in the field. Such studies are needed for an accurate assessment of
theileriosis in risk areas, and as a prerequisite for effective targeting of vaccines for
the control of tropical theileriosis.
The primary objectives of this study were to develop improved diagnostic
techniques. These were: i) stage specific indirect ELISAs to distinguish animals
vaccinated with high passage cell lines from those naturally infected in the field and
ii) a highly sensitive and specific PCR methodology to detect low level infections in
carrier animals and in vector ticks. The work was carried out in the following stages:
1) Design controlled animal experiment that simulates the field situation in
order: a) to produce materials for development of stage specific ELISAs, b) to
evaluate, within the time available, duration of immunity, c) to examine the
relationship between the carrier state of cattle and immunity to challenge.
2) Clone a macroschizont gene of T. annulata and express it as a recombinant
protein for use in an ELISA.
3) Determine the immunogenicity of the Tamr-1 and macroschizont specific
antigens, and establish the diagnostic sensitivity and specificity of the Tamr-1 and
macroschizont ELISAs for detection of antibodies against T. annulata.
4) Assess the Tamr-1 and macroschizont ELISAs in the context of their
ability to distinguish vaccinated animals from those naturally infected and thus
determine their value as diagnostic tools for epidemiological studies.
5) Develop a highly sensitive and specific PCR methodology to detect low




The aim of this study was to develop improved diagnostic techniques for
tropical theileriosis. Thus, this review concentrates on the parasite, the disease it
causes, immune responses to disease, control measures and diagnostic techniques
that have been used. In addition, since this study is focused on the control
programme carried out using attenuated cell line vaccine in Turkey, epidemiology of
tropical theileriosis and studies on disease in Turkey are briefly described.
2.1. IDENTIFICATION AND CLASSIFICATION OF THEILERIA
ANNULATA
Dschunkowsky and Luhs (1904) encountered a fatal disease of cattle in
Transcaucasia, in the former Imperial Russia, which they named "Tropical
Piroplasmosis". Cattle infected with this disease had oval or round erythrocytic
parasite forms similar but not identical to the rod shaped parasites observed by Koch
(1898) in East Coast fever. This parasite was then named Piroplasmci annulata
(Dschunkowsky and Luhs, 1904). The presence of the schizont stage in the life-cycle
of P. annulata contributed to its removal from the genus Piroplasma and placement
in the genus Theileria (Bettencourt et al., 1907). In the following decades diseases
associated with T. annulata-like parasites were reported. Lack of knowledge and
defined reference stocks often resulted in their misdiagnosis as T. parva. In addition
many "new" Theileria species were reported such as T. dispar, T. turkestanica and T.
sergenti which were frequently confused with T. annulata. In his review, Neitz
(1957) stated that T. annulata and these species were synonyms. The former two
species were almost certainly T. annulata, but controversy still encompasses the
identity of T. sergenti.
The taxonomy of the Theileria genus at species level has been controversial















Theileria annulata (Dschunkowsky and Luhs,
1904).
T. parva (Theiler, 1904) and others
2.2. DISTRIBUTION OF TROPICAL THEILERIOSIS
T. annulata, associated with ixodid ticks of the genus Hyalomma is
widespread in cattle from Southern Europe, North Africa extending into Northern
Sudan, and the Near and Middle East, including India, Central Asia (Purnell, 1978)
and Northern China (Lu and Yin, 1994). Dolan (1989) suggested that where the
distribution has been described as extending eastward from India to the Pacific coast
including Southern China and Far Eastern countries south of China into Malaysia,
the disease probably incorporates the distribution of T. sergenti/T. orientalis. Figure
2.1 shows the probable distribution of tropical theileriosis.
The distribution and seasonal occurrence of T. annulata is restricted by the
geographical location and biology of its transmission vector, ixodid ticks of the
genus Hyalomma (reviewed by Robinson, 1982). In most endemic areas the majority
of cases occur between June and September (Sergent et al., 1945; Pipano, 1976)
although sporadic cases may be found throughout the year (Flach and Ouhelli, 1992).
Susceptible domestic cattle (Bos taurus and Bos indicus) in areas where the
tick vector occurs are, in principle, at risk of contracting tropical theilerosis. It is
thought that Asian buffaloes (Bubalus bubalis) may be the original hosts and cattle
secondary hosts (Uilenberg, 1981b). The disease is mild in buffalo, but highly
pathogenic to cattle, especially non-indigenous breeds. Steuber et al. (1986)
examined the host range of T. annulata in vitro and demonstrated that the sporozoites
neither entered nor attached to peripheral blood mononuclear cells (PBM) from
horse, rabbit, mouse, hamster or man. Recently, it was shown that T. annulata
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sporozoites infects PBM cells of goats and sheep both in vivo and in vitro (Brown et
al., 1998a; Leemans et al., 1998). In goat and sheep T. annulata sporozoites produce
macroschizonts in vivo, but do not produce piroplasms (Leemans et al., 1998). These
studies confirmed that the host range of T. annulata is limited to the bovid family.
T. annulata is maintained in nature by a cattle-tick-cattle cycle. T. annulata
may complete its life-cycle in ticks on pasture or in barns. Engorged nymphs of H.
detritum, one of the main vectors of T. annulata, hide in the cracks and crevices of
clay or barn walls and, after moulting, adults infect cattle introduced into these barns
(Pipano, 1994). The hypothetical synchrony between parasite, two-host H. detritum
tick and bovine host life-cycle in North Africa, for example, under seasonal
conditions is illustrated graphically in Figure 2.2 (Flach and Ouhelli, 1992). It
appears that the T. annulata cycle proceeds exclusively within cattle during the
summer but divides into two pathways in the autumn so that the parasite over-winters
either as piroplasms and possibly schizonts in carrier cattle, or as zygotes in
engorged nymphal ticks. This follows sexual replication in the gut of the engorged
nymph (Flach and Ouhelli, 1992). Subsequently, there is further development to the
kinete and then sporogony occurs with nymphs moult to adults. Attachment and
feeding of the adult in the spring and early summer ensures further transmission of
the parasite to the bovine host (Flach and Ouhelli, 1992).
2.3. THE VECTORS OF T. ANNULA TA AND ITS TRANSMISSION
Sergent et al. (1928) demonstrated for the first time that T. annulata in
Algeria^was transmitted by an lxodid tick, Hyalomma mauretanicum (II. detritum,
Schulze, 1919). The development stages undergone by the parasite within the tick
vector was shown by the same authors (Sergent et al., 1936). Several later studies
have shown that T. annulata is naturally or experimentally transmitted by 15 species
of the genus Hyalomma (Robinson, 1982). The major vectors appear to be the three
host tick H. anatolicum anatolicum and the two host tick H. detritum (Uilenberg,
1981a). The former is widely distributed in Northern Africa, the Near East, Asia
Minor and the Southern ex-Soviet Union States to the Indian Subcontinent whereas
H. detritum is found in warmer regions from Manchuria through China and India to
north-west Africa (Norval et al., 1992).
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Figure 2.2. Hypothetical synchronised life cycles of T. annulata and H. detritum and
their interaction with cattle (Flach and Ouhelli, 1992). Thin solid line: T. annulata;
thick broken line H. detritum, thin broken line cattle.
Abbreviation for T. annulata-. Le: leukocyte, T: trophozoite, Ma: macroschizont, Mi:
microschizont, Mc: Mcrozoite, Pi: piroplasm, Ga: gamate, Zy: zygote, Ki: Kinete, S:
salivary gland, Sb: sporoblast, Sp:sporozoites.










The parasite is transmitted transtadially by these vector ticks. In the two host
tick, in which larvae and nymphs feed on the same animal, only the adult can be
infective whereas in the three-host species, nymphal or adult stages may be infective
(Uilenberg, 1981a). Tick species whose immature form normally feed on non-
susceptible hosts such as small mammals and birds do not transmit the disease. For
example H. excavation transmits T. annulata experimentally, but in many areas its
immature forms normally feed on rodents and therefore the adults are unable to
transmit the disease (Barnett, 1977).
2.4. THE LIFE-CYCLE OF THEILERIA ANNULA TA
The basic features of the life cycle of the parasite in the bovine and tick hosts
are illustrated in Figure 2.3. The life cycle of the parasite can be divided into three
main stages; schizogony in the bovine host, gametogony and sporogony in the tick
host.
The life cycle of T. annulata starts when an infected tick takes a blood meal,
resulting in the introduction of sporozoites into the host blood stream. Recently, the
biology of Theileria sporozoite invasion of bovine cells was reviewed by Shaw
(1997). The sporozoites rapidly enter mononuclear cells (Fawcett et al., 1982; Jura et
al., 1983b). T. annulata sporozoites preferentially target cells displaying major
histocompatibility complex (MHC) class II molecules: the macrophage/monocyte
lineage and at a much lower efficiency, B cells (Glass et al., 1989; Spooner et al.,
1989; Campbell et al., 1994b). Sporozoites gain entry into lymphocytes within 5-60
minutes of inoculation by receptor mediated endocytosis, and as many as 15
sporozoites can be internalised within an individual cell. Sporozoite entry occurs
through a defined series of separate but contiguous events, namely initial binding,
zippering and internalization, and the escape of the parasite into the host cell
cytoplasm (Fawcett et al., 1982; Jura et al., 1983a; Jura et al., 1983b; Shaw et al.,
1991).
The sporozoite is nonmotile and initial binding to the lymphocyte occurs
through a passive process. However the subsequent entry into the cell is active (Shaw
et al., 1991). While sporozoite binding is a temperature independent and can occur at
0-2°C, all subsequent steps in invasion the process are temperature dependent (Jura,
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Figure 2.3. Life cycle of Theileria annulata. 1 .sporozoites entering bovine host tick
saliva, 2. trophozoites in mononuclear cells, 3. macroschizonts in transformed
mononuclear cells, 3. merozoites in transformed mononuclear cells, 4. piroplasms in
erythrocytes, 6. gamogony cycle in tick gut cells, 7. kinetes in haemolymph, 8. sporogony
cycle in tick salivary gland. (Figure prepared by Leslie Bell-Sakyi)
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1984; Shaw et al., 1991). Entry is accomplished by a progressive circumferential
zippering process characterised by the close apposition of the parasite and host cell
membrane. Subsequent to internalisation the parasite escapes rapidly from the
enclosing host cell membrane to lie free in the cytoplasm (Shaw, 1997). Escape into
the host cytoplasm occurs concomitantly with the discharge of the rhoptries and
microspheres (Fawcett et al., 1982; Shaw et al., 1991). A thick layer of fuzzy
material then appears on the surface of the parasite to which the host cell microtubule
arrays rapidly become associated (Fawcett et al., 1982; Fawcett et al., 1984; Shaw et
al., 1991).
Following entry, the sporozoite develops into a uninucleate trophozoite stage
(Jura et al., 1983a). The trophozoite undergoes a series of nuclear divisions and
forms a syncytial macroschizont with between 10-20 nuclei. The macroschizont lies
free within the host cell cytoplasm and is surrounded by a plasma membrane that has
no obvious outer surface coat (Shaw and Tilney, 1992). The nuclei are scattered
randomly throughout the cytoplasm and surrounded by a typical nuclear envelope
with nuclear pores. A unique event occurs following development of macroschizonts
as Theileria-mtected cells become immortalised and the infected cells can be
propagated indefinitely in vitro without requirement for exogenous growth factor
(Brown, 1987). The host cell and parasite divides synchronously (Hulliger et al.,
1964). The transformed host cells divide at regular intervals and at a rapid rate in
vitro, which often gives rise to a 10-fold increase in infected cells every three days or
less (Irvin et al., 1982). During host cell division, the schizonts also divide and
distribute to each daughter cells by a process which involves their attachment to the
spindle apparatus (Hulliger et al., 1964; Stagg et al., 1980; Mehlhom and Schein,
1984; Carrington et al., 1995). Infected cells can be detected in the lymph node
draining the site of the tick bite from about 5 days after infection.
During the course of infection, a proportion of the schizonts undergo
merogony to produce large numbers of merozoites (Shaw and Tilney, 1992).
Merogony is characterised by a series of structural and organisational changes. These
changes include development of smooth and rough endoplasmic reticulum, and the
formation of an external coat on the outer surface of the schizont plasma membrane,
which is also found on the surface of the mature merozoites. Nuclei migrate to the
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periphery of the schizont and uninucleate merozoites start to form. Rhoptries appear
in the schizont cytoplasm in small clusters associated with the nuclear spindle pore
bodies and fibrous structures beneath the plasma membrane. Mitochondria become
closely associated with the outer membrane of the nuclear envelope. Merozoites bud
from the syncytial schizont in a synchronous process. At the end of merogony the
host cell contains large numbers of mature merozoites that are liberated by the
breakdown of the host cell plasma membrane (Shaw and Tilney, 1992).
The merozoites become free and penetrate the erythrocytes to form
piroplasms. Merozoites can be detected 8-10 days after infection with T. annulata
and 13 days with T. parva. In extreme cases up to 90% of erythrocytes may become
infected with T. annulata (Mehlhorn and Schein, 1984). Merozoite entry into bovine
erythrocytes proceeds by a process morphologically similar to that described for
sporozoite entry into mononuclear cells (Shaw and Tilney, 1992). Following entry,
the parasite escapes from the surrounding host membrane into the host cytoplasm
and discharges the rhoptries and/or microspheres. The piroplasm lies free in the
cytoplasm of the erythrocyte but, unlike the macroschizont, host cell tubules do not
associate with the surface of the merozoite. Conrad et al. (1985; 1986) and Fawcett
et al. (1987) suggested that division of merozoite and piroplasm was by schizogony
of the spherical forms of piroplasm to produce maltese-cross forms similar to the
small Babesia spp (previously Nuttalia) such as B. microti and B. equi (Theileria
equi) (Schein et al., 1981; Moltman et al., 1983). The merozoites released from the
erythrocytes are identical to those released from schizont infected lymphocytes,
which has led to the suggestion that these forms could be responsible for the re-
invasion of erythrocytes (Conrad et al., 1985). When a tick feeds on an infected host,
infected erythrocytes are taken up and transmission of parasite between host and
vector occurs.
Infected erythrocytes ingested by the tick are lysed within the gut releasing
the piroplasms of which a variable proportion undergo development into sexual
stages (Norval et al., 1992). Spherical gamonts from the infected blood differentiate
into ray bodies. These bodies were first seen by Koch (1906) and rediscovered by
Schein (1975). Ray bodies develop into multinucleated microgamonts and then
uninucleated microgametes. These structures have up to four flagella-like projections
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and a slender posterior pole. Other gamonts transform directly into macrogamonts
(Gauer et al., 1995). The haploid microgametes fuse with haploid macrogametes to
form diploid zygotes (Gauer et al., 1995) which enter tick gut epithelial cells. This
stage and the succeeding kinete form are thought to be the only diploid forms during
the parasite life cycle. Sexual reproduction within the tick was shown by Morzaria et
al. (1992) who illustrated that recombinant parasites ofmixed parental genotypes can
be obtained from ticks fed on animals infected with two distinct parental stocks of T.
parva. Following zygote formation, there are differences in the further development
of T. parva and T. annulata life cycle (Gauer et al., 1995). The zygotes of T. parva
and T. annulata replicate and become tetraploid. The zygotes of T. parva then
undergo a two-step meiosis in the tick gut epithelium of their vector tick. Following
meiosis T. parva zygotes are reduced to a haploid set and kinetes developing from
this haploid zygotes initially show haploid DNA contents before they increase their
DNA to a polyploid level. Whereas T. annulata zygotes seems to be increase to
polyploid level during the process of differentiation into kinetes (Gauer et al., 1995).
The zygotes transform into club-shaped motile kinetes that penetrate the gut
epithelial cells of the tick and migrate to the salivary glands via haemolymph
(Mehlhorn and Schein, 1984). The formation of infectious sporozoites in the acinar
cells of the tick salivary gland are similar for T. annulata and T. par\>a. The single
kinete transforms into a sporoblast and undergoes multiple division. At this stage
maturation is delayed until sporogony is stimulated by tick feeding or high
temperature incubation (Samish, 1977). The parasitised type II and type III salivary
gland acini (Schein and Friedhoff, 1978) undergo marked enlargement due to the
parasite forming a multinucleate syncytium occupying most of the cell cytoplasm
(Fawcett et al., 1985). During tick feeding there is a rapid development of the
syncytium which gives rise to thousands of uninucleate sporozoites by cytoplasmic
fission (Mehlhorn and Schein, 1984). It is at this stage that the resulting sporozoites
are haploid (Gauer et al., 1995). t he formation of uninuclear sporozoites occurs
around day 3 of feeding or day 4 of heat stimulation (Reid and Bell, 1984).
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2.5. THE ECONOMIC IMPORTANCE OF TROPICAL THEILERIOSIS
It has been suggested that T. annulata is probably the most important of all
the tick borne disease agents of domesticated livestock (Purnell, 1978). The disease
is particularly important in breed improvement programmes (Rak, 1978) and the
development of intensive dairy and beef units in tropical and subtropical areas
infested with parasite (Robinson, 1982). It is estimated that around 250 million cattle
are at risk of the disease in endemic regions. The disease is highly pathogenic to
susceptible, exotic or improved cattle, causing 40-60% mortality (Brown, 1990).
Most indigenous cattle possess some natural resistance to theileriosis, due to
long associations between these cattle and the parasite, which helps to produce a
state of endemic stability (Anon, 1991). The devastation of the disease is seen
dramatically when exotic or 'improved' crossbred cattle are introduced to tick-
infected areas. Animals exposed to the parasite either die or become immune and
their immunity is maintained through their constant rechallenges. Furthermore, cattle
recovering from infection suffer weight loss, fertility problems and diminished milk
yields. The economic losses sustained include not only the price of expensive
imported breeding animals but also the potential contribution of those animals to the
genetic improvement of a national herd, with consequent loss in potential production
(Anon, 1991).
Flach (1991) carried out a study in Morocco to estimate economic losses due
to theileriosis including mortality, cost of treatment, reduced meat and milk
production. This figure was £3,500 per 100 cattle each year on farms in endemic
areas. The losses from T. annulata infection is estimated at US$ 800 million in India
which compromises direct loses from death of animals and loss of productivity, and
indirect losses due to the costs of control measures (Griffiths and McCosker, 1990;
Brown, 1997a)
2.6. CLINICAL SIGNS AND PATHOGENESIS
The severity of the disease in cattle infected with T. annulata is dependent
upon the susceptibility of an animal (Rafyi et al., 1965), the virulence of the parasite
strain (Sergent et al., 1945; Pipano, 1989b) and the number of sporozoites inoculated
(Preston et al., 1992). The disease caused by T. annulata may be classified according
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to its symptoms into mild, peracute, acute, subacute and chronic forms (Sergent et
al., 1945; Neitz, 1957).
In T. annulata infection, both the intracellular schizont stage and the
intraerythrocytic piroplasm contribute to the pathogenesis (Irvin and Morrison,
1987). The incubation period (time between tick attachment and onset of fever) of
disease is, on average, two weeks, with extremes of eight and thirty days (Sergent et
al., 1945; Neitz, 1957). One or two days before the febrile response, there is
enlargement of the local lymph node draining site where infected ticks have been
feeding, and biopsy smears of this node show hypertrophied lymphoid and
monocytic cells and the presence of schizonts. The most common clinical symptoms
of theileriosis are fever, inappetence, cessation of rumination, drooling from mouth,
serous nasal discharge, swelling of the eyelids, lachrymation, accelerated pulse, drop
in milk production and sometimes nervous symptoms (Khanna et al., 1980). At the
beginning of the pyrexial period the faeces are firm, but later there is diarrhoea often
containing blood and mucous cast (Barnett, 1977). The animal becomes markedly
emaciated.
The enlargement of the local drainage lymph node precedes the appearance of
clinical signs of disease. Parasitised cells are detected in the regional lymph node
from day 5 after inoculation of sporozoites in association with an increase in cell
output (Irvin and Morrison, 1987). After the first appearance of macroschizonts on
day 5 piroplasms can be detected in blood smears from day 9 after infection (C.G.D.
Brown pers. comm). During the disease there is development of severe leucopaenia
due to~a decline in the number of circulating lymphocytes and neutrophils (Prasad,
1946; Laiblin, 1978; Preston et al., 1992) and severe anaemia with a reduction of
erythrocyte numbers occurring during parasitaemia crises. Anaemia develops with
bilirubinaemia (Neitz, 1957). Anaemia becomes severe and animals develop
pronounced dyspnoea. It has been demonstrated that up to 90% of erythrocytes can
be infected by the parasites, and although direct lysis of infected cells by the parasite
adds to the anaemia, it is believed that the removal of infected erythrocytes by the
spleen and liver is the direct cause (Hooshmand-Rad, 1976; Barnett, 1977;
Uilenberg, 1981a). Autoimmune mechanisms have been suggested as playing a role
in pathogenesis of the anaemia in animals infected with T. annulata (Hooshmand-
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Rad, 1976). The mortality rate in susceptible adult cattle is related to the virulence of
the parasite stock and has been reported as between 40-60%. Death usually occurs
between one and two weeks after the onset of clinical signs (Uilenberg, 1981a).
Animals that recover from the infection become long-term carriers of the parasite
(Sergent et al., 1945).
The pathological lesions are mainly associated with lymphopoeitic and
vascular systems (Sergent et al., 1945; Neitz, 1957; Pipano, 1994). The severity of
lesions is primarily dependent on the course of disease. The main macroscopic
lesions are petechiae on subcutaneous tissues and serosa, hyperplasia of lymph nodes
both internal and superficial, splenomegaly, yellowish enlarged liver with distended
bladder, epi- and endocardial petechiae and ecchymoses, grey-white foci on the
cortex of the kidney. The abomasum usually shows characteristic ulcers consisting of
a central necrotic area surrounded by a haemorrhagic zone. Similar ulcers may be
observed along the entire length of the small and large intestine. The lungs are
frequently oedematous.
The schizont-infected cells rapidly disseminate from the lymph node draining
the site of inoculation to distant lymph nodes (e.g., precrural, mesenteric and
mediastinal) and to spleen and thymus through lymphoid tissues. The parasitized
cells also spread into non-lymphoid organs, i.e. liver, kidney, lung, abomasum,
adrenal glands and pituitary glands by day 7, in the brain by day 12 and in the heart
by day 14 after an acute infection with T. annulata (Forsyth et al., 1999). Metastasis
of infected cells may be due to their expression ofmatrix metalloproteinases (MMPs)
(BayliS" et al., 1992; Somerville et al., 1998a) and of adhesison molecules CD2,
CD1 lb, very late antigen-4 (VLA-4) and CD9 (Forsyth et al., 1999).
2.7. IMMUNITY TO TROPICAL THEILERIOSIS
Animals which have recovered from a primary infection with T. annulata or
which have been immunised by infection either with macroschizont-infected cell line
or sporozoites (with or without subsequent treatment) are solidly immune to
homologous challenge and frequently show good immunity to heterologous
challenge (Barnett, 1963; Irvin and Morrison, 1987; Hall, 1988). Protective
immunity to infection appears to be dependent upon a complex of immune responses
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to Theileria. Following each life cycle differentiation event within an infected
animal, the bovine immune system is exposed to different antigenic determinants. As
a result both humoral and cell mediated immune systems are generated during the T.
annulata infection (Tait and Hall, 1990; Boulter and Hall, 1999). Studies of the
immune mechanisms in T. annulata infection have recently been reviewed by
Preston et al. (1999), Boulter and Hall (1999) and Campbell and Spooner (1999).
2.7.1. Humoral Immune Response to T. annulata infection
Following recovery, animals exhibit antibodies that react with each of the
vertebrate stages of the parasite: sporozoites, macroschizonts, merozoite and
piroplasms. Two lines of evidence from experiments, however, suggest that
antibodies against the macroschizont and piroplasm stages of T. parva do not play a
role in protective immune response. First, animals immunised with extracted
schizont or piroplasm antigens had developed similar antibody responses to those
observed in animals immunised by sporozoite infection (Wagner et al., 1974). These
animals were fully susceptible to challenge. Second, antibodies from immune
animals do not react with the surface of either macroschizont infected cells (Shiels et
al., 1989) or the piroplasm infected erythrocytes (Ahmed et al., 1988).
However, humoral responses are effective against extracellular stages of the
parasite life-cycle, the sporozoite and merozoite. Gray and Brown (1981)
demonstrated that sera taken from calves after multiple infections with T. annulata
sporozoites inhibited entry of sporozoites into naive PBM in vitro. In the same study
it was 'also demonstrated that T. annulata immune serum raised against one stock of
T. annulata was able to neutralise the infectivity in vitro of heterologous sporozoite
stock (Gray and Brown, 1981). Further research showed that serum from calves
exposed repeatedly to sporozoite challenge also delayed the development of
trophozoites to macroschizonts in vitro (Preston and Brown, 1985). The blocking
effect of sporozoite invasion of host cells is only detectable after repeated sporozoite
challenge (Preston and Brown, 1985; Williamson et al., 1989). Since the sporozoites
invade the cells in a very short time (Brown et al., 1978b; Jura et al., 1983a), it was
inferred that high levels of circulating antibody will be needed to provide protection.
In the field this would require by repeated challenges by infected ticks.
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The observation that serum from hyperimmunised cattle neutralised the
infectivity of sporozoites in vitro prompted studies to determine the nature of the
target antigens. A series of monoclonal antibodies (mAbs) was raised against
purified sporozoites. Some of these mAbs showed effective inhibition of sporozoite
infectivity in vitro in both T. annulata (Williamson et al., 1989) and T. parva
(Dobbelaere et al., 1984; Musoke et al., 1984). One of the mAbs, 1A7, against T.
annulata sporozoites recognised a series of polypeptides in sporozoite extracts of T.
annulata which are thought to be the result of proteolytic processing of a single gene
product (Williamson, 1988; Williamson et al., 1989). Immunoelectron microscopical
studies indicated that the antigen (SPAG-1), recognised by mAb 1A7, is located on
the surface of the sporozoite (Knight et al., 1996). Studies were carried out to
characterise and assess the immunological significance of SPAG-1 of T. annulata,
(Knight, 1993; Knight et al., 1996; 1998; Boulter et al., 1994; 1995). The gene
encoding SPAG-1 was found to contain regions with a high degree of homology to a
bovine elastin repeat sequence (Hall et al., 1992). The presence of these repeats led
to the suggestion that sporozoites may be using mimicry to bind to the bovine elastin
receptors as means of invading cells and host recognition. However, this region was
demonstrated to be polymorphic (Katzer et al., 1994) and sporozoites were found to
invade cells lacking the elastin receptor (Campbell et al., 1994b). It has been shown
that there are several immunodominant sites on the SPAG-1 molecule (Knight et al.,
1996), and there are neutralising B-cell epitopes which lie towards the C-terminus
defined by immune calf serum (Boulter et al., 1994). This molecule is a candidate
for inclusion in a sub-unit vaccine and partial protection has been achieved in calves
immunised with recombinant SPAG-1 (Boulter et al., 1995; 1998; 1999).
Two different antigens, SPM1 and SPM2, both recognised by sporozoite-
neutralising mAb 4B11, have been characterised (Knight, 1993; Knight et al., 1998).
Unlike SPAG-1, these antigens are also expressed by the schizont and piroplasm
stages. However, their protective significance is not known.
Monoclonal antibodies neutralising sporozoite infectivity have also been
identified for T. par\>a (Dobbelaere et al., 1984; Musoke et al., 1984). These mAbs
recognise a 67 kDa protein expressed on the surface of the sporozoites (lams et al.,
1990a; Nene et al., 1992). Immunisation trials using recombinant p67 resulted in
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complete or partial protection in a proportion of animals (Musoke et al., 1992;
Musoke et al., 1993). The other fully characterised antigen from the sporozoite stage
of T. parva is a 104 kDa microneme-rhoptry protein (lams et al., 1990b). However,
antibodies to this molecule do not neutralise sporozoite invasion in vitro and
vaccination with this antigen does not produce any protection (Morzaria cited in
Boulter and Hall, 1999).
Limited studies have been conducted on the immune response against the
merozoite and piroplasm stage of T. annulata. Immune responses against the
merozoite and piroplasm are considered unlikely to protect animals from the disease,
since the schizont alone can cause death before the occurrence of piroplasms (Brown,
1990). On the other hand, immunity against piroplasms could play a valuable role,
since it might provide a way of preventing animals becoming carriers of infection
and block the transmission of the parasite and also may reduce the severity of disease
(Irvin and Gill, 1981; d'Oliveira et al., 1997a).
Immune serum from T. annulata infected animals has been shown to react
with free merozoites isolated from infected erythrocytes, but not with infected
erythrocytes (Ahmed et al., 1988), suggesting that humoral immunity to the
piroplasm stage is not effective. However, mAbs have been generated to piroplasms
and these have been shown to react with in vitro derived merozoites but not with
macroschizonts (Glascodine et al., 1990). One of these mAbs, (5E1), recognised an
antigen in merozoite and piroplasm stages of the parasite, which has a molecular
mass of 30 kDa. This antigen was also strongly recognised by immune bovine serum
and shown to exist in two forms, 30 kDa and 32 kDa, which are related to each other
(Dickson and Shiels, 1993). The genes encoding the 30/32 kDa molecule (Tarns 1)
have been isolated and characterised (Shiels et al., 1994; 1995). Sequence analyses
of Tamsl showed that there is significant variability within the coding sequence,
particularly within the region that contains the majority of N-linked putative
glycosylation sites (Katzer et al., 1998a). The level of diversity may indicate
selection of variable sites or amino-acid epitopes in order to evade the bovine
immune system (Shiels et al., 1995).
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2.7.2. Cellular Immune Response to T. anmilata infection
While the humoral response was shown to be important in Theileria infected
cattle against the sporozoites, the cellular response has been shown to be mainly
directed against the schizont-infected cells. Both the innate and adaptive immunity
are believed to be responsible for protective immunity to T. annulata (Preston et al.,
1999) and cytotoxic T cells, natural killer (NK) cells, macrophages and helper T cells
participate in these immune responses.
The first investigation of T. annulata cellular immunity was made by Preston
and Brown (1981). It was shown that irradiated T. annulata infected cells induced
proliferation of autologous peripheral mononuclear cells (PBM) whether or not the
cells came from an animal which was immune. Preston et al. (1983) later
demonstrated that recovery from primary T. annulata infection was accompanied by
the appearance of cytotoxic cells that were not manifest in animals undergoing a fatal
reaction. There were two peaks of cytotoxic cell activity following primary infection.
The first peak which occurred two weeks after the contact with the parasite was
bovine leukocyte antigen (BoLA = MHC class I) restricted. The second peak,
observed approximately four weeks after infection, was not BoLA restricted. The
same kinetics of responses occurred following challenge of immune cattle, but both
peaks were BoLA restricted. It was suggested that the non-restricted activity could be
due to the natural killer (NK) cells (Preston et al., 1983).
Innes et al. (1989) further analysed cytotoxic T lymphocyte (CTL) responses
in three groups of animals that were immunised with T. annulata sporozoites, or
autologous or allogenic macroschizont infected cells. All animals developed a CTL
response three weeks after the infection. However, animals infected with sporozoites
or with an autologous cell line showed a severe clinical reaction and a CTL response
which was not BoLA restricted. In contrast a mild clinical reaction was observed in
animals infected with allogeneic cell lines and the CTL response was directed against
the allogeneic MHC antigens. When animals were challenged with sporozoites, all
cattle were immune and developed a secondary CTL response 10 days after
challenge that was parasite specific and MHC restricted (Innes et al., 1989).
In addition to cytotoxic T cells responses, cytokines and macrophage-
mediated cytostasis of macroschizont-infected cells have been shown to be
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components of the immune response of cattle infected with T. annulata (Preston and
Brown, 1988; Preston et al., 1993). T. annulata infected macrophages activate
autologous T cells from naive cattle through a combination of cytokines and contact
between infected cells and T cells (Campbell et al., 1995). In vitro studies
demonstrated that the infected cells produce tumour necrosis factor alpha (TNF-a),
and stimulate TNF-a synthesis in uninfected macrophages (Preston et al., 1993),
interferon (IFN-y) synthesis in CD4+ T cells (Campbell et al., 1997) and nitric
oxide (NO) in macrophages and lymphocytes (Visser et al., 1995). The production of
NO by macrophages is stimulated by IFN-y. NO was assessed as a potential mediator
of macrophage anti-Theileria activity. It was shown that NO prevents T. annulata
sporozoites invading PBMs and also prevents trophozoite infected cells transforming
into macroschizont infected cell (Visser et al., 1995). Additionally, it was
demonstrated that enhanced production of NO inhibits the proliferation of schizont-
infected cells in vitro, causing macroschizonts to disappear and host cells to become
apoptotic, and to kill the cells containing differentiating merozoites (Richardson et
al., 1998). The cellular mechanisms that control intraerythrocytic piroplasms are not
known but it has been suggested that NO may also play a role to stop merozoites
invading erythrocytes (Preston et al., 1999).
NK cells may represent an important part in innate immunity to T. annulata
infection. NK cells lyse schizont-infected cells and produce IFN- y which activates
uninfected macrophages to produce TNF-a and NO. NK cells are found during the
healing stages of sporozoite-induced infections (Preston et al., 1983) and such cells
are activated by IFN- y, interleukin-12 (IL-12) and TNF-y which are all produced by
macroschizont infected cells (Preston et al., 1999).
2.8. DIAGNOSIS
2.8.1. Clinical Diagnosis
In areas where the disease is endemic the diagnosis of tropical theileriosis is
based on clinical signs and macroscopic lesions (section 2.7). For laboratory
confirmation, the most effective method is Giemsa's stained lymph node or liver
biopsy to demonstrate the presence ofmacroschizonts. Thin blood smears can also be
useful for clinical assessment of infection by detecting piroplasms (Sergent et al.,
22
1945; Pipano, 1994) though this may not per se distinguish current clinical infection
from past infection and the carrier state. The advantages of blood and lymph node
biopsy preparation are that the samples are easy to collect, transport and preserve,
and do not require sophisticated equipment. However, smears must be of good
quality and in searching for macroschizonts in smears care must be taken to
differentiate between the schizont and artefacts such as normal azurophilic granules
(Lawrence et al., 1994). Blood smears prepared during the early stages of the disease
show rare or no piroplasm infected red blood cells, a situation also observed in
recovered carrier animals.
In T. annulata infection, schizonts are rare in the peripheral blood and their
presence in blood smears indicates a poor prognosis. The number of piroplasm
infected red blood cells increases progressively during the course of disease,
parasitaemia reaching as high as 90%, but the severity of the disease does not
necessarily correspond to the percentage piroplasm parasitaemia. After recovery,
piroplasms persist for a long time but they are not always detectable by direct
microscopic examination (Pipano, 1994).
In all Theileria species, a variety of intraerythrocytic piroplasm forms is seen,
including rod, oval and comma shapes and rings (Uilenberg, 1981b). The distribution
of T. annulata overlaps with other Theileria spp, notably T. buffeli (Purnell, 1978)
and, in southern Sudan, with T. parva (Lomuro, 1992). The size and percentages of
different forms of piroplasms sometime can help to differentiate Theileria species
from each other where the distribution of the parasites overlaps. For example,
piroplasms of T. par\>a are predominantly rod-shaped and small whereas piroplasms
of T. annulata are predominantly round and oval, and are of moderate size.
Piroplasms of T. buffeli are predominantly rod-shaped and often exceptionally long
and associated with intra-erythrocytic structures, veil and bar. However, during the
course of infection piroplasm forms can vary, rendering them unreliable for
specification purposes (Uilenberg, 1981b; Norval et al., 1992).
The packed cell volume (PCV) can be an adjunct procedure for diagnosis of
T. annulata infection as the anaemia is an ;mportant symptom of the disease.
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2.8.2 Antibody and Antigen Detection
The most widely used serological antibody assay for theilerial antibodies
species is the indirect immunofluorescent antibody test (IFAT) using either
piroplasm or cultured schizonts as antigens (Pipano and Cahana, 1969; Pipano et al.,
1969; Burridge, 1971; Burridge and Kimber, 1972; Burridge et al., 1974). The
techniques for the performance of these tests has been standardised by (FAO, 1984).
The IFAT has been widely used in studies of the prevalence of T. annulata and for
monitoring antibody responses of vaccinated animals (Pipano, 1974).
However, the IFAT has some drawbacks, notably the subjective nature of the
test and a lack of specificity between Theileria species: T. parva, T. annulata, T.
mutans and T. taurotragi all cross-reacting to some degree (Burridge et al., 1974).
Cross-reactions also occur between other piroplasms {Babesia bigemina, B. bovis,
Anaplasma marginale and A. centrale) (FAO, 1984). Furthermore, IFAT requires
expensive equipment for it to be conducted. The complement fixation test and a
haemagglutination inhibition test have also been used to detect anti-theileria
antibodies but their value is limited due to lack of specificity (Norval et al., 1992).
Novel techniques have been developed to improve and complement the
IFAT. These have primarily involved replacing the fluorescein conjugate with
immunoperoxidase (Cowan, 1981; Cowan et al., 1984; Campbell et al., 1994a) or
alkaline phosphate anti-alkaline phosphatase (APAAP) (Ahmed et al., 1994).
Although the reagents for both techniques are expensive, these tests have some
practical advantages over IFAT as it easy and rapid to measure the antibody titres,
requires only an ordinary light microscope and allows indefinite storage of material
which can be examined over a number of weeks.
In the past 20 years the enzyme linked immuno-sorbent assay (ELISA) has
similarly replaced the radio-immunoassay and has been increasingly used in
veterinary medicine as a serological test for the diagnosis and epidemiological
assessment of disease (Voller et al., 1976). Wright et al., (1993) outlined the
development and application of these techniques in the diagnosis of infectious
diseases of veterinary importance.
ELISA has several advantages over the IFAT. For example, The ELISA
allows the processing of larger numbers of samples than the IFAT, it does not require
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expensive equipment yet can be fully automated, making it suitable for objective
screening. Thus, the technique offers the prospect of a more effective diagnostic and
survey tool (Kemeny and Chantler, 1988). In addition, the potential sensitivity of
ELISA is greater than IFAT. As a result, several attempts have been made to develop
an ELISA to detect antibodies specific to T. annulata (Gray et al., 1980; Kachani et
al., 1992; Sundar et al., 1993; Reddy et al., 1994; Beniwal et al., 1997; Prasanth et
al., 1995). In these studies, crude antigen extracts obtained from piroplasms (Gray et
al., 1980; Sundar et al., 1993), macroschizont (Reddy et al., 1994; Prasanth et al.,
1995) or both macroschizont and piroplasm (Kachani et al., 1992; Beniwal et al.,
1997) stages of the parasite were used. However, none of these tests were fully
evaluated regarding sensitivity and specificity.
The ELISA based on crude piroplasm antigens which was developed by
Kachani et al. (1992), based on the original method described by Gray et al. (1980),
using sera from immunised cattle exhibited low non-specific detection by normal
sera and high post-infection values. The same author also showed that the use of the
piroplasm crude antigen in ELISA was more efficient than the schizont antigen. The
assay has provided an opportunity for epidemiological studies of T. annulata
infection in Morocco (Kachani et al., 1994; Kachani et al., 1996). However, the
sensitivity and specificity of ELISA using either macroschizont or piroplasm extracts
were lower than that obtained for IFAT.
Recently, stage specific recombinant antigens from the sporozoite and the
merozoite/piroplasm stages of the parasite have been defined and used in ELISA
systems. These include the sporozoite surface antigen, SPAG-1 (Williamson et al.,
1989; Hall et al., 1992), merozoite rhoptry antigen, Tamr-1 (Shiels et al., 1994), and
the 32 kDa major merozoite and piroplasm surface antigen (Tamsl) (Shiels et al.,
1995). ELISAs using these recombinant antigens are described in details in Chapters
5 and 6.
To date, theileriai antigen detection ELISA has only reported for T. mutans
(Katende et al., 1990). This tests offers the prospect of a more effective diagnostic
and survey tool, being able detect antigens and immune complexes, allowing earlier
diagnostic confirmation than antibody detection. Two mAbs that recognise different
epitopes on the 32 kDa molecule of T. mutans piroplasms were used in a capture
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ELISA, while purified 32 kDa protein was used as antigen in an antibody ELISA
(Katende et al., 1990). By using this test it was possible to detect both circulating
antigens and antibodies successfully in serum of a reacting and/or immune cow.
There are presently two other methods to detect and identify Theileria
infection in the host. First, the presence of macroschizonts is detected by in vitro
isolation of peripheral blood mononuclear cells (PBM) which give any cells infected
with theilerial macroschizonts an opportunity to multiply in the culture to detectable
levels (Stagg et al., 1974; Sharma and Brown, 1981; Kariuki et al., 1995). Second,
the classical or traditional method is xenodiagnosis, by which tick application to
possibly infected animals and subsequent transmission of infection by the next life-
cycle stage of those ticks to susceptible hosts has been used to detect the true carrier
status of animals (Sergent et al., 1945; Dolan, 1986). Both of these tests are laborious
and time consuming and novel methods are being sought to improve and/or replace
them in the detection of carrier animals.
2.8.3. Detection of parasite DNA and RNA
Recombinant DNA techniques, the use of selected parasite-specific DNA
sequences cloned in plasmid vectors has allowed the presence of Theileria DNA in
an infected animal to be detected specifically and sensitively (Allsopp et al., 1993;
Conrad et al., 1987). This specific DNA can be detected during the prepatent, patent,
convalescent and carrier periods of haemoprotozoan disease by using specific DNA
probes (Figueroa and Buening, 1995). Using these techniques it has been possible to
distinguish species and stocks of parasite which are not possible to differentiate
solely on the basis of the morphology of the piroplasm and schizont stages (Norval et
al., 1992). There are several studies based on T. parva, the agent causing East Coast
fever in East and Central Africa. By using DNA probes on restriction enzyme
digested DNA from cloned Theileria-infected lymphoblastoid cell lines, a marked
polymorphism has been shown on antigenically different T. parva subclones (Conrad
et al., 1987) and among T. parva stocks from different areas using probes of different
specificity (Bishop et al., 1994). DNA probes have also been used to detect T.
annulata infection and have provided an opportunity to study genetic polymorphism
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of parasite populations within Tunisia by detection of restriction fragment length
polymorphism (RFLP) (Ben Miled et al., 1994).
In order to develop a rapid and species-specific diagnostic system, 6
oligonucleotide probes from small subunit ribosomal RNA (ssu rRNA),
corresponding to species-specific regions, were designed (Allsopp et al., 1993).
These probes were shown to provide unequivocal identification of each of the 6
species either by direct detection of parasite ssu rRNA or by hybridization to
amplified parasite ssu rRNA genes. The species specific oligonucleotides from this
gene was also used for development of polymerase chain reaction (PCR)
methodology for T. annulata (de Kok et al., 1993; Ilhan, 1995; Ilhan et al., 1998).
Later, Bishop et al. (1995) described the development of Theileria species-specific
oligonucleotides derived from large subunit (LSU) ribosomal RNA sequences. These
can be used for species discrimination and diagnosis of carrier animals under non-
stringent conditions. They reported that the sequence of the T. annulata variable
region was so different from that of the other four species tested that clear
discrimination was obtained among the five species using oligonucleotide probes
against PCR amplified LSU RNA gene sequences. Moreover, the sensitivity of DNA
detection by the LSU oligonucleotide was comparable to the oligonucleotide derived
from Theileria ssu rRNA gene sequences. This result has suggested that the multiple
oligonucleotides derived from LSU RNA genes will be useful for application in
detection of carrier state and identification of infected ticks.
With the advent of the polymerase chain reaction (PCR) technique (Saiki et
al., 19S8a) positive detection and identification of very small numbers of parasites in
the vertebrate host and tick vector has become possible. Bishop et al. (1992) has
developed a PCR method to detect carrier state of cattle infected with T. parva by
amplification of parasite DNA by using oligonucleotide primers for T. parva specific
a repetitive DNA sequence. The same primers were also used for identification and
quantification of T. parva in the vector tick Rhipicephalus appendiculatus (Watt et
al., 1997) and showed that the test sensitively detected the infection in ethanol
preserved, partially fed or unfed ticks.
In recent years, several different PCR methodologies have been reported for
the detection of T. annulata in either vector tick (de Kok et al., 1993; d'Oliveira et
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al., 1997b) or bovine host (d'Oliveira et al., 1995; Ilhan et al., 1998; Shayan et al.,
1998; Gubbels et al., 1999b; Leemans et al., 1999a; MartinSanchez et al., 1999).
These PCR methodologies were mainly based on primers from either ssu rRNA (de
Kok et al., 1993; Ilhan et al., 1998; Gubbels et al., 1999b) or the gene encoding the
major surface protein (Tamsl) (d'Oliveira et al., 1995; Leemans et al., 1999a;
MartinSanchez et al., 1999). The sensitivity of these tests differed widely. For
example, the PCR developed by d'Oliveira et al., (1995) for specific amplification of
T. annulata DNA from blood samples was able to amplify DNA at 0.00005%
parasitaemia. Another PCR developed using primers from ssu rRNA was able to
amplify T. annulata DNA at 0.0000025 % parasitaemia (20x more sensitive) (Ilhan
et al., 1998). However, the common feature of these tests was to be more sensitive
and specific than conventional tests used for detection of the parasite, i.e.
microscopic examination of Giemsa's stained thin blood smears and methyl green
pyronin or feulgen staining of tick salivary glands (Walker et al., 1979).
Recently, a reverse line blot (RLB) technique was developed for the
identification of Theileria and Babesia simultaneously where the mixed infections
occur (Gubbels et al., 1999b). The essence of this technique is the hybridisation of
PCR products to specific probes immobilised on a membrane in order to identify
differences in the amplified sequence. The sensitivity of the test was determined at
0.000001% parasitaemia and it specifically detected six bovine Theileria spp (T.
annulata, T. pan>a, T. mutans, T. taurotragi, T. velifera and T. orientalis) and three
Babesia spp (B. bovis, B. divergens and B. bigemina) tested. This assay gives the
opportunity to collect information concerning the epidemiology of pathogenic
parasites simultaneously and also non-pathogenic parasites that shows cross
reactivity with pathogenic ones. Additionally, the membrane with the covalently
linked species specific oligonucleotides can be used at least 20 times which reduces
the costs for screening animals.
2.9. CONTROL OF TROPICAL THEILERIOSIS
Four main approaches to control tropical theileriosis are available: vector
control, chemotherapy, breeding cattle resistant to theileriosis and vaccination. These
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measures in recent years have been reviewed by a number of authors including
Brown (1990), Dolan (1989) and Tait and Hall (1990).
2.9.1. Vector Control
Farm management and control of the vector ticks may play significant roles
in reducing the impact of tropical theileriosis in endemic areas. The main aims at
control of transmission of the disease is either to reduce the contact between the
animals and vector ticks to such an extent that transmission does not occur or
deliberately expose to cattle at a time when they are most likely to resist the impact
of the disease resulting in the development of endemic stability (Brown, 1990).
Control of the tick involves the use of acaricide application to the cattle and
cowsheds which ticks may reside in. Improvement in the construction of animal
accommodation to remove sites in which ticks can hide makes the acaricide use more
effective.
The use of acaricide for tick control is most commonly implemented by
dipping animals in tanks containing a solution of the acaricides. This method is more
effective than spraying in achieving satisfactory coverage of cattle by the acaricides
(Norval et al., 1992). Other methods of applying acaricides include spot or pour-on
application, slow release acaricide boluses and acaricide-impregnated ear tags
(Kocan, 1995). The use of the chemotherapeutic agent ivermectin has been shown to
be effective for tick control by acting on nervous system receptors of the ticks
(Wilson, 1993).
The use of acaricides in tick control has been reviewed (FAO, 1984), but
there are several problems with their use in the control of tick-borne diseases (Tait
and Hall, 1990): (i) The need for highly organised dipping programmes to ensure all
cattle are treated, (ii) Long term application can result in the development of
acaricide resistance in the ticks, (iii) Continual use of acaricides interferes with the
development of endemic stability that can exist in indigenous breeds when calves are
exposed to naturally transmitted tick borne diseases. These cattle populations are at
risk from disease outbreaks when acaricide treatment is interrupted for any reason.
Additional disadvantages of using acaricides are their increasing cost, toxic residues
in animal products and environmental pollution (Norval et al., 1992).
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The use of vaccines against ticks would be a potential measure to integrate
into control programmes. The immunology of tick-host interactions has recently been
reviewed (Willadsen and Jongejan, 1999). There is evidence that it is possible to
vaccinate livestock against ticks using gut extract. In recent years, commercial
vaccines have been produced against the one-host tick Boophilus microplus, the
vector of both anaplasmosis and babesiosis of cattle. The vaccines rely on an
artificially induced immune response to internal or 'concealed' antigens, for example
Bm86, in the gut or other tissue and this has been shown to be effective in field trials
in Australia (Willadsen et al., 1995), Cuba (Rodriguez et al., 1995b) and Brazil
(Rodriguez et al., 1995a). Vaccination of cattle leads to reduction in the number of
engorging female ticks and their weight and fecundity. Bm86, or its equivalent, is
present in other tick species. In H. anatolicum anatolicum, a 100 amino acid
sequence has 76% similarity to the B. microplus Bm86, but its significance as a
vaccine is not fully known (Willadsen and Jongejan, 1999).
2.9.2. Chemotherapy
In areas where a vaccine against tropical theileriosis is not yet widely
available disease control is based on acaricide use and chemotherapy. Early studies
reported a wide range of drugs, including antibacterial and antiprotozoal drugs that
have been tested, but none showed specific antitheilerial action (Neitz, 1957).
Tetracycline compounds, which have also been used (Neitz, 1957), but have little
effect once the clinical signs of tropical theileriosis are apparent (Hashemi-Fesharki,
1974)."
In the last 15-20 years novel, effective and specific drugs have been
developed to use against theileriosis. The first of these was menoctone (McHardy et
al., 1976), an anti-malarial naphthoquinone, which was highly effective but too
expensive. Another theilerial drug, halofuginone was identified as effective against
f. annulata infection (Schein and Voigt, 19 /9), but it is toxic tor the animals at near
therapeutic doses. Then, a second naphthoquinone, parvaquone, was found to be
effective against T. annulata (Gill et al., 1981). Parvaquone was followed by
buparvaquone which was several times more effective than parvaquone (McHardy et
al., 1985). Buparvaquone is now marketed widely as Butalex® (Shering). These
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drugs are safe and very effective against the disease but are still expensive (Brown,
1990). In addition, if treatment is to be effective it needs to be administered at an
early stage of clinical disease. Early diagnosis and an efficient veterinary service are
thus of great importance.
2.9.3. Resistance of Cattle to Tropical Theileriosis
In the long term, the use of breeds resistant to both theileriosis and the tick
vector will play a major role in the pragmatic control of theileriosis (Brown, 1990).
This may indeed prove to be the ultimate sustainable solution to this disease. It has
been stated in a review of the subject (Campbell, 1978) that Bos indicus cross cattle
may carry 10% to 40% fewer ticks than Bos taurus. The practical advantages of
using Bos indicus and Bos indicus cross cattle in northern Australia are widely
accepted due to the recognised tick resistance, improved weight gains, heat tolerance
and more efficient utilisation of feed. In a recent study in Burundi host resistance to
ticks on cross-bred cattle between higher producing exotic breeds and indigenous
Ankole cattle showed that the Ankole/Sahiwal cross-bred exhibited marked host
resistance to ticks, especially Rhipicephalus appendiculatus (Moran et al., 1996).
In the contexts of studies have shown that there is variation between animals
in their response to a low dose of parasite within Friesian and Ayrshire (Bos taurus)
calves examined, some being more resistant than others (Preston et al., 1992). The
current problem with the use of genetically resistant cattle is the difficulty in
simultaneously selecting and breeding for resistance and productivity. Therefore, if
the genes determining resistance could be identified, introducing these into highly
productive cattle is a possibility (Spooner and Brown, 1991). In the face of a
committed drive, in Turkey and elsewhere towards selective breeding of milk
producing cattle based on Friesian or Holstein genotypes, some interim means of
disease control will be necessary until such resistant cattle can be generated.
In the meantime until both productive and genetically resistant cattle have
been identified or constructed, alternative means of control need to be used. To date




2.10.4.1. Live vaccines- attenuated cell lines
The production and the use of schizont tissue culture vaccines have been
described by many authors including Pipano (1989b), Norval et al. (1992), Pipano
(1995) and Boulter and Hall (1999).
Vaccination with blood from cattle infected with field isolates of T. annulata
of naturally low virulence was used by the French investigators working in the 1920s
and 30s in Algeria and this method applied widely where the disease exerted an
important constraint. The result of these studies is summarised by Sergent et al.,
(1945).
Sergent et al. (1932) tested several isolates passaged mechanically between
cattle with the aim of detecting a naturally avirulent strain. They selected the Kouba
strain on this basis. Continuous mechanical passage of T. annulata Kouba strain in
cattle resulted in the loss of ability of the parasite to produce piroplasms, i.e.
infection in ticks but retain immunogenicity (Sergent et al., 1945). This strain was
used for vaccination from the 52nd to the 220th cattle passage, a period of over 10
years by inoculating 5-10 ml of blood from a donor calf. A mortality of 3.2% was
caused by this strain among the calves used for passage in the laboratory. In Israel,
Adler and Ellenbogen (1934) were unable to isolate an indigenous T. annulata strain
of low virulence and they used the Algerian (Kouba and Brunette) strains of low
virulence. These provided poor protection against the local virulent isolates. To
overcome this problem, a two step vaccination procedure was adopted: first
inoculating a mild exotic strain and then, 2 months later, inoculating a local virulent
strain in order to reinforce the partial immunity induced by the first inoculation.
The successful cultivation of T. annulata schizonts in vitro by Tsur (1945) led
to the development of a culture-derived vaccine against tropical theileriosis. This was
consolidated later when Tsur et al. (1964) achieved the mass propagation of the
parasite in tissue culture. Prolonged cultivation of a T. annulata infected cell line
results in attenuation of the virulence of the parasite (Pipano and Tsur, 1966).
Complete attenuation is achieved when the cultured schizonts no longer cause
parasitaemia or clinical and parasitological symptoms in inoculated cattle (Pipano,
1977). Despite this the antibody response against macroschizont antigens, as
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measured by IFAT, remains similar to that obtained after infection with virulent
schizonts (Pipano, 1989b). The cell culture vaccine protects most breeds of cattle
against homologous challenge and usually against heterologous challenge (Pipano,
1981).
T. annulata cell cultures were used in several countries following further
development by Pipano (1981), Hashemi-Fesharki (1988), Onar (1989), Ouhelli
(1991), Zablotsky (1991), Singh (1991). In many other countries, studies are under
way to produce their cell line vaccines such as Iraq (Khdier and Latif, 1991), Tunisia
(Darghouth et al., 1996a), Morocco (Ouhelli et al., 1997) and Spain (Viseras et al.,
1997; Viseras et al., 1998). The number of cells per vaccine dose varies between 104
- 107. The duration of immunity after cell line immunisation in the absence of
reinfection has not been fully investigated. However, it was reported that it ranges
between 1 year (Pipano, 1977) and 3.5 years (Zablotsky, 1991). Recently, Ouhelli et
al. (1994) showed that some animals immunised with 104 T. annulata infected cells
were not protected when challenged with sporozoites after seven months.
Following inoculation with T. annulata schizont infected cells, there is a
transfer of parasites from donor to recipient cells. This was demonstrated by having
donor and recipient of different sexes and karyotyping parasitised cells before and
after transfer (Brown et al., 1978a). The mechanisms by which the parasite transfers
are not known. However, a process involving opsonisation was suggested (Forsyth et
al., 1997). Schizont infected cells express CDllb, the membrane receptor for C3bi,
which is a component of the complement cascade and an opsonin. It is suggested that
schizonts freed from the donor cells by a rapid host response to inoculation with
allogenic cells and free schizonts would be obsonized by complement and/or
antibody, and then linked to cells bearing the C3bi receptors, i.e. macrophages.
Attachment of the parasite-complement complex would facilitate phagocytosis of the
parasite by the cell.
There are no indications that the time needed for attenuation is proportional
to initial virulence of schizonts. Different isolates however require different
cultivation times in order to become completely attenuated (Hooshmand-Rad, 1973;
Pipano, 1989b). Complete attenuation is accompanied by the loss of ability to
produce merozoites thus piroplasms (Pipano, 1977). The mechanism of attenuation
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or reduction of virulence of the parasite after prolonged cultivation is not fully
understood. It may be simply a clonal selection over a period of time (Brown, 1990).
This reduction of virulence of T. annulata infected cell lines would appear to be a
selection of a particular genotype (Sutherland et al., 1993). Studies have been carried
out to attempt to define the markers for attenuation. Immunofluorescence studies
using a mAb, EU106, which specifically recognizes virulent T. annulata cell lines
revealed alterations in antibody reactivity following in vitro culture (Sutherland et
al., 1996). The antigen recognised by the mAb EU106 is stage specific and is also
expressed on the surface of host cells infected with virulent cell lines (Preston et al.,
1998) and its expression diminishes upon attenuation. A number of genes have been
identified that are either upregulated or downregulated on attenuation (Somerville et
al., 1998b). Additionally, changes were observed in the host matrix
metalloproteinase profile of some of the attenuated T. annulata infected cell lines
(Baylis et al., 1992; Baylis et al., 1995; Adamson and Hall, 1997; Somerville et al.,
1998b). Additionally, it was demonstrated that the attenuation could be related to the
degree of T-cell stimulatory ability of infected cells and the levels of pro¬
inflammatory cytokines they produce (Brown, 1997b; Brown et al., 1998b). The low
levels of these two factor produced by the clonal cell lines induced less severe
reaction than those that the cell lines produced at high levels.
2.10.4.2. Inactivated vaccine- Subunit vaccine development
The application of an attenuated vaccine has a number of major drawbacks.
These include a short shelf life, approximately 1 week at 20°C or 1 month at 4°C, the
need for frozen transfer between laboratories and sites of immunisation, and the risk
of infection of immunised cattle with other pathogens. Preparation of a vaccine is
labour intensive and batch control is expensive (Brown, 1990; Tait and Hall, 1990).
Thus, while the attenuated cell culture vaccine is very effective, these drawbacks
have necessitated look for inactivated vaccine.
A number of potential antigens have been characterised including the
sporozoite specific antigens, SPAG-1 of T. annulata (Hall et al., 1992), and p67 from
T. par\>a (Nene et al., 1992), and the 30kDa major merozoite surface antigen of T.
annulata, Tamsl (Glascodine et al., 1990).
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The SPAG-1 antigen was identified by a monoclonal antibody which
inhibited sporozoite penetration of bovine peripheral blood mononuclear cells in
vitro (Williamson et al., 1989). The SPAG-1 gene was isolated and sequenced (Hall
et al., 1992), and has recently been demonstrated to have cross reactive epitopes with
the p67 T. parva sporozoite antigen (Knight et al., 1996). The neutralising
determinant on SPAG-1, recognised by the antibody which inhibited sporozoite
penetration of host cells, was mapped to 16 amino acids which implicated the C-
terminus of the protein as an immunologically relevant region that can be recognised
by the bovine immune response (Boulter et al., 1994). Several vaccination trials have
been performed using SPAG-1 recombinant antigens with various outcomes
(Williamson, 1988; Knight, 1993; Boulter et al., 1994; 1995; 1998; 1999). Some
protection against the disease was achieved in these trials, as assessed by a reduction
in the severity of the disease. Immunised animals had a significantly longer prepatent
period (length of time until schizonts were seen in the lymph node). The clinical
symptoms of the disease were delayed, macroschizont parasitosis was reduced and
there was a significant reduction in the level of macroschizonts and piroplasms.
Efficacy of the immunisation with SPAG-1 differed according to the different
delivery systems used (Boulter et al., 1999). SPAG-1 administered with SKBA
adjuvant RWL® gave a better protection against challenge by T. annulata sporozoites
than when combined with saponin, Freund's or ISCOMs.
The T. parva sporozoite antigen p67, a gene related to SPAG-1, has been
extensively used in vaccination trials. The p67 antigen has been expressed in a
number of systems including E. coli (Musoke et al., 1992; Nene et al., 1996),
baculovirus (Nene et al., 1995), vaccinia (Honda et al., 1998) and Salmonella clublin
(Gentschev et al., 1998; Heussler et al., 1998). Immunisation with five monthly
doses of recombinant p67 induced neutralising antibodies and protected six of the
nine animals challenged with T. parva sporozoites (Musoke et al., 1992). In another
vaccination trial 7 out of 12 calves were protected against homologous challenge and
6 out of 11 cattle against heterologous challenge (Nene et al., 1996). In order to
obtain native p67 protein a baculovirus expression system was used. Immunisation
with a baculovirus-derived p67 resulted in protection in four of six Boran cattle
(Nene et al., 1995). Recently, it was reported that 70% protection was obtained in
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trials using a total of 86 cattle (Morrison and McKeever, 1998). In all these
vaccination trials, multiple doses (3 to 5 doses) of vaccine were used and this is not a
practical delivery strategy. In order to reduce the number of vaccination doses two
live delivery systems have been evaluated, Salmonella and vaccinia. The p67
expressed in a secreted form by S. dublin produced better protection than the
internally located antigen (Gentschev et al., 1998). Honda et al. (1998) evaluated
vaccinia virus as a delivery system for p67 recombinant antigen. The p67 vaccinia
construct given alone to seven animals did not produce any protection. However, 5 of
7 animals receiving a combined p67-IL-2 vaccinia construct were immune to the
sporozoite challenge. To date the best protection level achieved by p67 recombinant
sporozoite antigen is 70%. To achieve a total protection probably requires a sub-unit
vaccine containing antigens from all parasite life-cycle stages.
The merozoite stage is, like the sporozoite, invasive and also a potential
target for a protective immune response. The most abundant and immunodominant
antigen on the surface of the merozoite of T. annulata is a 30kDa surface antigen
which is conserved throughout all species of Theileria analysed to date (Glascodine
et al., 1990; Dickson and Shiels, 1993). Recently, allelic forms of Tamsl (Tamsl-1
and Tamsl-2) which encode the 30- 32kDa major merozoite antigens of T. annulata
respectively, were expressed in a Salmonella typhimurium aroA vaccine strain and
Esherichia coli for inclusion in a sub-unit vaccine (d'Oliveira et al., 1996).
Preliminary immunisation trials with the recombinant antigens indicate that there
may be some protection against challenge (d'Oliveira et al., 1997a).
2.10. TROPICAL THEILERIOSIS IN TURKEY
Tropical theileriosis is the most important cattle disease in Turkey and occurs
throughout the country (Mimioglu et al., 1971; Mimioglu et al., 1972). The presence
of tropical theileriosis was reported for the first time early this century by Celebi
(1912; 1925) together with the presence of vector ticks of T. annulata. These reports
were followed by many others from every climatic region of Turkey, except the
mountainous areas where climatic conditions are not favourable for the vector tick
(Samuel and Raif, 1930; Tiizdil, 1954; Kurtpinar, 1954; Goksu, 1959; Mimioglu et
al., 1971; Tiizer, 1982; Dumanli and Ozer, 1987; Cakmak and Oz, 1993; Alp, 1996).
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T. annulata constitutes a major threat to European and crossbred cattle in particular
(Mimioglu et al., 1971). The mortality rate in such cattle was recorded as 53%
(Giiler, 1985) with figures of up to 100% and up to 43% in indigenous breeds
(Goksu, 1959; Mimioglu et al., 1971; 1972).
In Turkey, the most important Hyalomma spp. is three-host tick H.
anatolicum anatolicum and the two-host tick H. detritum (Dumanli, 1989). H.
excavation and H. marginatum are also frequently recorded (Kurtpinar, 1954;
Hoffman et al., 1971; Karaer, 1981; Sayin et al., 1991). Cases of tropical theileriosis
occur from May until September (this may change according to climatic zone
extending to between April and November), with the highest number occurring in
June and July, in parallel with the increase in numbers of adult Hyalomma ticks
(Goksu, 1959; Dumanli and Ozer, 1987).
The livestock industry plays a vital in the agricultural economy of Turkey and
provides 35% of the value of agricultural production. There are approximately 16
million cattle in Turkey of which 85% are local breed, 13% cross breeds and 2%
European breeds. Despite the high number of animals, the production level per
animal is not satisfactory. One of the main features of industry is the introduction of
European breeds (mainly Holstein-Friesian and Brown Swiss dairy cattle) into areas
with high agricultural potential to replace the local breeds. Theileriosis becomes
important when such fully susceptible exotic cattle are introduced to an endemic
area. Susceptibility to the disease was shown to be age dependent as clinical cases
were reported mainly in adult cattle (Goksu, 1959; Tiizer, 1982), possibly because
more ticks are found on adult cattle than on calves. Nevertheless, theileriosis cases
are reported in calves under one month old (Dumanli and Ozer, 1987).
The distribution of another species of Theileria T. mutans' in Turkey has
been reported as being widespread on the basis of microscopic examination
(Mimioglu et al., 1971; Giiler, 1978; Tiizer, 1982). It is now accepted that T. mutans
is mainly an African parasite occurring south of the Sahara (Norval et al., 1992).
Uilenberg et al. (1974) and Young et al. (1978) proved that T. mutans is transmitted
by ticks of Amblyomma species. There are no records of the presence of this tick in
Turkey (Kurtpinar, 1954; Merdivenci, 1969). However, T. buffeli/T. orientalis, which
is similar in appearance to T. mutans and of similar low pathogenicity is transmitted
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by Haemaphysalis spp. (Uilenberg, 1981b), which are widespread in Turkey
(Kurtpinar, 1954; Merdivenci, 1969). These observations lead to the conclusion that
the second theilerial species of cattle observed in Turkey may in fact be T. buffeli/T.
orientalis.
The control of theileriosis in Turkey has been carried out by vector control,
treatment and the use of an attenuated macroschizont-infected cell culture vaccine.
Tick control by acaricides is not always because excessive and frequent use leads to
acaricide resistant tick strains. Also the accumulation of drug residues in milk and
meat is unacceptable (Onar, 1989). Acaricidal control is only applicable in large-
scale animal holdings. For the small holder farms vector control is either very poor,
or not carried out effectively at all. Disease control was limited in Turkey until
buparvaquone (Butalex) was introduced into the Turkish market and used effectively
in the treatment of tropical theileriosis in the field (Unsiiren and Kurtdede, 1988).
In recent years the main control method for theileriosis has been vaccination
using an attenuated T. annulata macroschizont-infected cell line. This first became
available for use in 1982 (Ozkoc and Pipano, 1981; Onar, 1989). Preliminary studies
for preparation and application of this vaccine started with the isolation of stocks
from different regions of Turkey (Schein et al., 1975; Ozkoc et al., 1978) in co¬
operation with Israeli researchers (Pipano, 1989a). This isolation was followed by
pathogenicity tests of stocks isolated from different regions of Turkey, the Ankara,
Kirikkale, Hatay, Diyarbakir and Gebze 'strains'. Four out of these strains (excepting
Kirikkale) were found to be highly virulent (Ozkoc and Onar, 1980; Vural et al.,
1978). The strains of T. annulata isolated from different regions of Turkey have been
cultivated and passaged in vitro over various time periods for use in vaccination
trials. The strain designated 'Ankara' has been used for vaccine production and
passaged until complete attenuation was obtained at passage level 250 (Ozkoc and
Pipano, 1981). After this passage level, the cell line was used experimentally in the
laboratory (Ozkoc and Pipano, 1981) and field tested in different regions of Turkey,
(Onar, 1989). The conclusion was that this attenuated cell culture 'vaccine' was
effective enough to be produced for widespread use throughout Turkey. Vaccine
production was started with 9,500 doses (107 cell per dose), in 1982 and reached
150,000 doses of vaccine in 1988. In subsequent years the vaccine has been
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produced at approximately this level (Onar, 1989). The application of the cell line
vaccine in endemic areas was interrupted from 1992-1995 due to the contamination
of the vaccine with other pathogenic organisms (Sayin pers. comm.).
With the increasing numbers of European dairy cattle being imported into
Turkey and cross-breeding to improve productivity of indigenous cattle, 150,000
doses of vaccine scarcely meets the demand. There is thus, currently an initiative to
improve the viability of the vaccine and to reduce the cell dose required. Efficient
cost recovery will also lead to sustainable production and delivery. In the meantime
effective targeting and prioritising of vaccine delivery is important. This depends on
the provision of evidence that the vaccine works and is the current control method of
choice in Turkey. This study aims to develop tools to enable these points to be dealt
with, namely, to provide appropriate tests to study the epidemiology of the disease
and to help in determining the ability of vaccinated cattle to withstand challenge in
the field by unequivocally showing which animals have undergone a field challenge.
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CHAPTER THREE
IMMUNITY OF CALVES TO THEILERIA ANNULATA FOLLOWING
IMMUNISATION WITH SPOROZOITES AND MACROSCHIZONT
INFECTED CELL LINES
3.1. INTRODUCTION
Attenuated macroschizont infected cell lines have been used in several
countries to control tropical theileriosis and to protect exotic and improved cattle
(Brown, 1990). In Turkey, tropical theileriosis represents a major threat to improved
dairy and beef breeds. At present control of the disease is based on the use of
acaricides against the vector tick and on a live attenuated macroschizont vaccine.
However, only 150,000 doses of vaccine are produced each year and this is not
sufficient to meet the demand (Onar, 1989).
Successful deployment of a vaccine depends on the production of the vaccine
and on the design of the vaccination programme. This requires knowledge of the
vaccine's characteristics and the epidemiology of the target parasite or pathogen.
There are a number of factors that must be determined in the design of a successful
vaccination programme. These factors include: the proportion of hosts that must be
vaccinated, the age at which hosts should first be vaccinated and at what interval, if
at all, hosts should be re-vaccinated (Woolhouse and Bundy, 1997).
Regarding vaccine characteristics, experimental studies are needed not just to
determine vaccine take and the degree of protection afforded but also how this
protection wanes through time and how each of these might vary with host age and
vaccination history (Woolhouse et al., 1997). There is little information about the
duration of immunity engendered by vaccination against tropical theileriosis using
attenuated macroschizont infected cell lines. Available information suggests that the
length of protection ranges from less than 1 year to 3.5 years (Pipano, 1989b).
However, the requirement for the revaccination is not known.
The disease is distributed unevenly between the vector ticks and the
susceptible host populations. Understanding parasite population dynamics and
epidemiology helps in the design of immunisation programmes. It is particularly
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important that vaccination is given to the hosts most at risk of infection. Good
diagnostic tests are required to identify such populations. These diagnostic tests also
provide tools for evaluating vaccine efficacy in the field. Current diagnostic methods
for tropical theileriosis do not distinguish between animals that have only been
vaccinated and those that have been naturally infected or vaccinated/challenged. This
makes it impossible to determine the true prevalence of T. annulata in areas where
vaccination is practised. It is also not easy to study large-scale impact of vaccination
by using current diagnostic tests. Therefore, it is necessary to develop new diagnostic
methods to distinguish vaccinated animals from naturally infected animals, and so
obtain accurate epidemiological data.
The present study was carried out to extend a pilot study initiated by Ilhan
(1995) with the following aims: (i) provide materials for development of an ELISA
to distinguish vaccinated animals from naturally infected animals, (ii) evaluate,
within the time available, the duration of immune responses after infection (and
vaccination) of cattle with different life-cycle stages of the parasite, (iii) examine the
stage-specific immunity against T. annulata in cattle infected with different life-cycle
stages of the parasite, (iv) examine the relationship between the carrier state and
immunity of the cattle to challenge. The data obtained in the pilot study (Ilhan, 1995)
are presented along with results obtained in the current study for the purpose of
clarity.
The experimental design used in the current study was similar to that
described previously (Ilhan, 1995). Calves were infected in different ways to
simulate the field situation, i.e. natural infection and vaccination, in the laboratory.
Three main groups of animals were infected with T. annulata. The first group
received sporozoites to simulate natural tick infection; the second group was infected
with a low passage cell line to simulate calves vaccinated with a non-attenuated cell
line which gives 'carrier' state; and the third group was infected with high passage
attenuated cell lines to simulate vaccination with a fully attenuated non-piroplasm
producing vaccine cell line. The calves were then challenged 1 or 7 months after
primary infection with a heterologous sporozoite stabilate.
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3.2. MATERIALS AND METHODS
3.2.1. Experimental Animals
Twenty-five Friesian or Ayrshire castrated calves (2-3 month old, male) were
obtained from farms near Edinburgh. After arrival at the Centre for Tropical
Veterinary Medicine (CTVM) calves were kept in quarantine until confirmed
negative for Salmonella infection by faecal culture. Animals were kept indoors and
fed twice a day with commercial calf pellets and ad libitum with hay and water.
3.2.2. Parasite Material
A Turkish stock of T. annulata Ankara was used to infect or immunise calves
either in the form of cryopreserved, sporozoite stabilates or as macroschizont
infected cell cultures, viz. T. annulata Ankara low passage (p5) (Schein et al., 1975),
or T. annulata Ankara/Pendik high passage or 'vaccine' (p317) (Ozkoc and Pipano,
1981). Cryopreserved sporozoite stabilate of a Moroccan isolate, T. annulata Gharb
(Ouhelli, 1985) was used to challenge the calves.
T. annulata Ankara was isolated near Ankara and brought to Berlin (Schein et
al., 1975). A heavily infected batch of laboratory Hyalomma anatolicum excavatum
ticks was sent to the Centre for Tropical Veterinary Medicine (CTVM). The stock
was maintained at the CTVM by alternate tick/cattle passage. Sporozoites were
harvested and used to infect peripheral blood mononuclear cells (PBM) in culture
(Brown, 1983). T. annulata Ankara low passage cell line (p3) was established by in
vitro infection ofPBM of calf 279.
T. annulata Ankara isolated by Schein et al. (1975) was sent to Pendik
Veterinary Research Institute, near Istanbul and a cell line established ex vivo by
establishment of macroschizont infected cells. This cell line was attenuated by
prolonged in vitro passage and designated as T. annulata Ankara/Pendik. It is
currently used as a vaccine in Turkey (Ozkoc and Pipano, 1981).
Ground-up tick supernatant (GUTS) stabilates containing sporozoites were
stored at -180°C in liquid nitrogen at CTVM. The stabilates were prepared according
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to established procedures (Brown, 1983) and resuscitated for use as described in
section 3.2.3.2.
3.2.3. In vivo Experimental Design
3.2.3.1. Groups ofexperimental calves
Twenty-five calves were divided into four main groups numbered 1 to 4.
Each of these groups was challenged along with four control calves constituting the
fourth group at the same time. Table 3.1 shows details of the experimental Groups.
Table 3.1. Experimental design of calves for infection and immunisation
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T. annulata Ankara GUTS stabilate 54 was used to infect calves in Group 1.
The sporozoite stabilate, which had been cryopreserved in 7.5% glycerol at 2 tick
equivalent (t.e.)/ml, was resuscitated by thawing rapidly at 37°C and then allowed to
equilibrate at room temperature for 15-20 minutes, prior to ten fold dilution with
Minimum Essential Medium (MEM) (Gibco) containing 3.5% bovine plasma
albumin (BPA) (Sigma) with 7.5% glycerol (Analar, BDH). The diluted stabilate was
allowed to equilibrate at room temperature for a further 10 minutes. Then 1 ml of the
diluted sporozoite suspension containing 0.2 t.e. was inoculated subcutaneousiy in
front of the right shoulder of each calf in Group 1.
b) Schizont infected cells
On the day of infection, cells from 48 hour T. annulata schizont -infected
mononuclear cell cultures in the logarithmic phase of growth were counted and their
viability determined. Calves in Groups 2 and 3 were inoculated subcutaneousiy in
front of the right shoulder with a dose of 2 x 106 viable schizont infected cells in
tissue culture medium.
3.2.3.3. Challenge ofcalves
T. annulata Gharb sporozoite stabilates 63 for the first half of experiment
(Ilhan, 1995) and stabilate 63 and 67, which were pooled together, in the current
experiment were used to challenge all the calves (Groups 1-4) at a dose of 1 t.e. as
described in section 3.2.3.2. One ml, equivalent to 1 t.e. was inoculated
subcutaneousiy over the front of the left shoulder of each calf. The calves in the
control Group 4 were inoculated last. The sporozoite stabilate was inoculated into the
animals within 30 minutes after thawing.
3.2.3.4. Monitoring of infection and challenge reactions
Calves were routinely monitored from the day of infection (day 0) or
challenge for 35 day as follows:
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a) Clinical
Rectal temperatures were recorded daily. Animals with a temperature above
39.5°C were considered to be febrile. During the course of infection the clinical signs
of the disease including pyrexia, depression, inappetance, weakness, lachrymation,
petechial haemorrhages, lymph node enlargement, especially on the side of infection
and anaemia were assessed.
b) Haematological
Jugular blood was taken three times a week into vacutainer tubes (Becton
Dickinson) containing the di-sodium salt of ethylenediaminetetra-acetic acid (EDTA)
for preparation of blood smears and haematological examination. Total white blood
cell (WBC) counts and red blood cell (RBC) counts were measured using a Coulter
Counter (ZM, Coulter Electronics Ltd). The packed cell volume (PCV) was
determined using a haematocrit centrifuge (Heraeus).
c) Parasitological
Lymph nodes
The presence of schizonts, (macroschizonts/microschizonts) and hyperplastic
cells in the draining lymph node, right for first infection, left for challenge were
monitored by examination of Giemsa's stained needle biopsy smears which were
prepared three times a week starting on day 5 post-inoculation of sporozoite stabilate
or day 9 post-inoculation of cell lines. The biopsy sampling was continued until
schizonts were no longer detected in two consecutive biopsies or until day 28 post-
inoculation. Lymph node biopsy smears were air dried, fixed in absolute methanol
(BDE1) for 2-3 minutes and stained in 5% Giemsa's stain (Merck) in Giemsa's stain
buffer (pEl 7.2, BDH) for 40 minutes.
The smears were rinsed in Giemsa's stain buffer, air-dried and examined
under oil immersion at 500 x and 1000 x magnification using an Ortholux II
microscope (Leitz, Wetzlar, Germany). The degree of schizont parasitosis was
evaluated as, + (less than 1% of cells containing schizonts), ++ (1-5 % of
cells containing schizonts), +++ (more than 5% of cells containing schizonts).
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Blood smears
The presence and level of piroplasm parasitaemia were monitored by
examining thin blood smears taken three times a week during the first 35 days of
infection and challenge and daily during the clinical reaction. Blood smears were
prepared at 28-day intervals following infection. The blood smears were stained with
Giemsa's stain as described above. The degree of parasitaemia was recorded as the
percentage of infected red blood cells determined after counting 1000 cells. If the
parasitaemia was less than 0.1%, the number of piroplasms per 100 fields at 1000 x
magnification was assessed. The smear was recorded as negative if 200 fields
(approximately 100,000 RBC) were examined and no piroplasms were observed.
d) Cell culture
Jugular blood was taken into vacutainer tubes containing lithium-heparin
(Becton-Dickinson) in order to isolate T. anmdata infected cells from the calves
during patent infection and following recovery until challenge. Blood samples were
taken on days 9, 12, 14, 16, 28 and then 28-day intervals until challenge.
e) PCR
Blood was taken into EDTA containing vacutainer tubes for evaluation by
PCR. Blood samples were taken on days 0, 2, 5, 7, 9, 12, 14, 28 and then 28-day
intervals until challenge. Following challenge, samples were taken on days 7 and 14.
-f) Serology
Blood was taken into plain vacutainer tubes (Becton Dickinson) for IFAT and
ELISA at the following times: two hours before infection; days 7, 14, 21, 28 and then
28-day intervals until challenge; one day before challenge; days 7, 14, 28 and 42
following challenge. The serum samples were aliquoted and stored at -20°C until
use. Serum samples were tested in ELISA and IFAT as described in Chapter 6.
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3.2.3.5. Treatment
During the primary infection and challenge animals which underwent severe
reaction were treated with buparvaquone (Butalex, Shering) once or more at a dose
of 2.5 mg/kg, intramuscularly.
3.2.4. Cell Culture
3.2.4.1. Isolation ofT. annulata culturefrom peripheral blood mononuclear
cells
To detect the presence of macroschizonts in experimental calves, peripheral
blood mononuclear cells (PBM) were isolated from 10 ml aliquots of peripheral
blood using Ficoll-Paque (Pharmacia) as described previously by (Brown, 1987).
Ten ml of blood in lithium-heparin was mixed with 10 ml of sterile phosphate
buffered saline (PBS) pH 7.3 (BDH). The blood-PBS mixture was layered onto 8 ml
of Ficoll-Paque, and centrifuged at 1,000 x g for 30 minutes at 15°C. The PBM were
collected from the interface and washed in 20 ml PBS by centrifugation at 300 x g
for 10 minutes at 15°C. The supernatant, containing the platelets, was decanted and
the pellet was washed once more in 20 ml PBS and centrifuged as above but for 5
minutes. The cell pellet was resuspended in 10 ml cold complete medium, RPMI-
1640 (Gibco) supplemented with 20% heat inactivated foetal calf serum (FCS), 2
mM L-Glutamine, 100 pg/ml streptomycin, 100 iu/ml penicillin, 5 x 10"5 M 2-
mercapto-ethanol (2-ME). The suspension was put into a 25 cm2 tissue culture flask
and placed in a humidified incubator (LEEC) gassed with 5% CO2 at 37°C with the
cap loose. Giemsa's stained cytospin slides were prepared to check the quality of the
isolated cells and for the presence ofmacroschizont infected cells.
Following isolation of the PBM from blood, the medium was changed every
second or third day by centrifuging 8 ml cell suspension at 300 x g for 5 minutes at
room temperature and removing the medium before resuspending the cell pellet in 8
ml of fresh warmed medium as described above and then returning it to the original
flask. Each time a cytospin smear was prepared to assess whether infection had
established. When more than 50% of cells were infected, the cells were passaged into
a new flask. Once parasitosis reached 80% or more 2-ME was omitted from the
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medium. PBM cell cultures were kept for at least three weeks before discarding.
Figure 3.1 shows an established macroschizont infected cell line.
3.2.4.2. Maintenance ofcell cultures
Established cell lines were maintained by reducing the number of cells, which
increase by Logio every 48-72 hours, by appropriate dilution in fresh medium
(Brown, 1987). Cell growth was assessed using an inverted microscope and
cytospins, subculturing was carried out by diluting the cells 1:10 in order to start
cultures fresh at a cell density of 1-2 x 105 per ml in culture medium containing 10%
FCS. The PBM cell culture flasks were kept for at least three weeks before deciding
a cell line had not been established.
3.2.4.3. Cryopreservation ofcell lines
Cells from two day old cultures in logarithmic growth phase at a density of 1-
2 x 106 cells/ml were cryopreserved in 10% dimethyl sulphoxide (DMSO, Analar
BDFT) in culture medium containing 20% FCS (Brown, 1987). The culture was
centrifuged at 300 x g for 5 minutes, and then resuspended in cold complete medium
without 2-ME at 2 x 107 cells/ml. An equal volume of ice-cold 20% DMSO in
complete medium, was added dropwise, keeping the culture on ice. One ml aliquots
of cell suspension were aliquoted into cooled 1 ml cryovials (Nunc, Gibco). The
cryovials were kept at -80°C for 24 hours and then transferred into a liquid nitrogen
refrigerator (BOC) for long term storage.
~3.2.4.4. Resuscitation ofcell lines
Resuscitation of T. annulata infected cell lines was carried out by the method
described by Brown (1987). Cells were thawed rapidly in a 37°C water bath and
immediately pipetted into 8 ml of warm complete RPMI-1640 with 20% FCS. Cells
were then centrifuged at 300 x g for 5 minutes at room temperature, to dilute out the
DMSO. The cells were resuspended in 5 ml fresh complete medium and incubated at
37°C. The following day a further 5 ml medium was added and the cultures
maintained as described above.
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Figure 3.1. Macroschizont infected cells in a cytocentrifuge smear of T. annulata
infected cell culture (x 1000, Giemsa stain). Arrows show the macroschizonts in the
mononuclear cells.
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3.2.5. Polymerase Chain Reaction
3.2.5.1. DNA preparation from blood
Blood samples were collected into EDTA vacutainer tubes and one ml was
kept at -20°C until use. Blood samples were thawed at room temperature and
centrifuged at 13,000 x g for 5 minutes and the pellet recovered. Pellets were
resuspended in 1 ml saponin lysis buffer (0.22% NaCl, 0.015 % Saponin, (Sigma))
mixed on a vortex mixer and centrifuged as before. This was repeated twice and the
last pellet washed in PBS. The pellets were resuspended in 100 pi of 1 x PCR
reaction buffer (20 mM Tris-HCl pH 8.55, 16 mM (NH4)2 S04, 2.5 mM MgCl2, 150
pg/ml BSA) containing proteinase K at a concentration of 100 pg/ml, mixed gently
then incubated in a water bath at 56°C for one hour. Following heat inactivation at
95°C for 10 minutes the DNA samples were stored at -20°C until use.
3.2.5.2. PCR
Two primers, namely 989 and 1347, derived from the small subunit
ribosomal RNA (ssu rRNA) gene of T. annulata were used to detect the parasite in
the blood by PCR as described previously (Ilhan, 1995). The size of the expected
amplification product was 372 bp. Primer 989 (5' AGT TTC TGA CCT ATC AG 3')
is well conserved in the genus Theileria and primer 1347 (5' TGC ACA GAC CCC
AGA GG 3') is specific to T. annulata (Allsopp et al., 1993). PCR was performed in
a final reaction volume of 100 pi containing 20 mM Tris-HCl pH 8.55, 16 mM
(NH4)2S04, 4.0 mM MgCl2, 200 pM of each deoxynucleotide triphosphate (dNTP)
(Promega), 2.5 U of Taq polymerase (Thermometric), 0.4 pM primers and 5 pi of
DNA template. The PCR was performed using an automatic DNA thermal cycler
(Hybaid) operating on a regimen of 95°C for 4 minutes, then 94°C for 1 minute, 60°C
for 1 minute and 72°C for 1 minute for 40 cycles followed by 72°C for 10 minutes.
3.2.5.3. Detection ofPCR products
a) Agarose Gel Electrophoresis
Amplified products were detected on a Midi system (Bio-Rad) using 1.6%
agarose gel (Ultra pure DNA grade agarose, Sigma) in Tris-Borate EDTA buffer
(TBE) as described by Sambrook et al. (1989). Sixteen pi of each sample was mixed
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with 4 pi of 6x DNA loading buffer and loaded onto the gel. A 1 Kb DNA ladder
(Gibco) was used as a base-pair size marker. Electrophoresis was performed in 0.5 x
TBE at 80V for 1.5 hours. Gels were stained in 0.5 pg/ml ethidium bromide
(Amresco) for 30 minutes, de-stained in 80 mQ water produced with a Milli-Q
system (Millipore) for 30 minutes, amplification products were viewed under ultra¬
violet (UV) illumination and photographed using Polaroid black-and-white film, type
55 (Sigma).
b) Southern Blot Hybridisation
Southern blotting
The sensitivity of the amplification of the 372 bp T. annulata DNA fragment
was confirmed by Southern blot hybridisation. DNA from the agarose gel was
transferred to a nylon membrane (Hybond N+, Amersham) using the capillary
transfer method as described by Sambrook et al. (1989). Briefly, DNA was denatured
following electrophoresis by soaking the gel in three changes of alkali denaturing
solution (pH 8.0) over 45 minutes. The gel was rinsed briefly with 80 mQ water and
then neutralised in three changes of neutralisation solution. Transfer of DNA from
the gel to the nylon membrane was achieved by capillary movement of a high salt
buffer (20 x SSC, pH 7.0) overnight. The DNA was cross-linked to the membrane by
exposure to 150 Joules of short wave UV radiation using GS Gene Linker (Bio-Rad).
The membrane was kept at 4°C until use.
Purification ofprobefrom agarose gel
The "Gene Clean 2" kit (BIO 101) was used to recover the predicted 372 bp
PCR product of purified piroplasm DNA from agarose gels. The method is based on
the use of a powdered silica matrix to bind DNA, excess agarose is then washed
away (Vogelstein and Gillespie, 1979). The desired bands were visualised under UV
illumination, excised from the gel, and dissolved in three volumes of 3 M Nal at
50°C in the water bath. Five pi of silica matrix in water (glassmilk) was added, the
mixture was vortexed then incubated at room temperature for 5 minutes. Following
centrifugation at 9,000 x g for 5 seconds, the pellet was washed three times with
"NEW wash" (a solution of NaCl, Tris, EDTA and ethanol) (BIO 101). DNA was
then eluted in 5 pi sterile 80 mQ water at 50°C for 3 minutes and DNA in the
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supernatant was removed after centrifugation at 9,000 x g for 30 seconds. Elution
was carried out twice and the DNA obtained was kept at -20°C until use.
DIG DNA labelling and detection
The DNA fragments were labelled with digoxigenin-11-dUTP and visualised
with an immunological detection system using the DIG DNA Labelling and
Detection kit (Boehringer Mannheim) according to manufacturer's instructions.
DNA was denatured by heating at 95°C for 10 minutes in boiling water. The
labelling reaction consisted of 7 pi denatured DNA, 2 pi of hexanucleotide mix, 8 pi
80 mQ water, 2pl of dNTP mixture and lpl (2 units) of Klenow enzyme. The
mixture was incubated at 37°C in a water bath overnight. Labelled DNA was then
stored at -20°C for further use.
Hybridisation
Hybridisation was carried out according to manufacturer's instructions.
Nylon blots were prehybridised in hybridisation buffer at 42°C for 1 hour.
Hybridisation was carried out by incubating the blots at 42°C overnight in fresh
buffer containing the appropriate DIG labelled DNA probe. Before addition, labelled
probes were denatured by boiling for 10 minutes. Two pi of labelled probe was
added to 2-5 ml hybridisation buffer per 100 cm2 membrane. Standard DNA markers
(1 Kb ladder) which were DIG labelled as described were also added to some blots.
Blots were washed in two changes of 2 x SSC, 0.1% SDS at room
temperature (2x5 minutes), then 0.1 x SSC, 0.1% SDS at 68°C under constant
agitation (2x15 minutes).
Immunological detection
Immunological detection was carried out according to manufacturer's
instructions. Membranes were washed briefly in washing buffer (lOOmM maleic
acid, 150 mM NaCl pH 7.5, 0.3% Tween 20) for 5 minutes, then incubated for 30
minutes in 1% blocking buffer (1% blocking reagent in lOOmM maleic acid, 150
mM NaCl pH 7.5). The membrane was incubated for 30 minutes in anti-digoxigenin-
alkaline phosphatase conjugate at a dilution of 1:5,000 (150 mU/ml) in blocking
buffer. The antibody solution was decanted and the membrane was washed in
washing buffer (2x15 minutes), then equilibrated in detection buffer (100 mM Tris-
HC1, 100 mM NaCl pH 9.5) for 2-5 minutes. The membrane was incubated in
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chromogen-substrate solution (0.34 mg/ml NBT, 0.18 mg/ml BCIP in detection
buffer) until strong bands appeared without background staining. The reaction was
stopped by adding distilled water. The result was documented by photography using
Polaroid black-and-white film, type 55.
3.3. RESULTS
3.3.3. Clinical Reaction of Calves to Infection and Challenge
The haematological, parasitic and febrile reactions of calves are given
individually in Figures 3.2 to 3.7. The severity of reaction was determined using a
combination of clinical, parasitological and haematological parameters adapted from
the recommendation made for T. parva (Anon, 1989). Parameters assessed included
condition of the animal, duration of pyrexia occurring in the presence of
macroschizonts, percentage and duration of macroschizont parasitosis and piroplasm
parasitaemia, % reduction in PCV and white blood cell count. When the temperature
remained above 39.5°C for 6 days or more, macroschizont and piroplasms were
above 5% and 10% respectively and PCV was below 20%, the reaction was
classified as severe. Any animal requiring buparvaquone (Butalex) treatment was
considered to have been undergoing a severe reaction.
When macroschizont parasitosis and piroplasm parasitaemia were below 1 %
and 5% respectively, the duration of febrile period was less than 3 days and no
significant reduction in PCV occurred, the reaction was classified as mild. Between
these parameters for severe and mild reactions the reaction was called moderate.
Group 1 (infection with T. annulata Ankara sporozoites): All calves showed a
similar severe clinical reaction to infection with 7 to 12 days of pyrexia, a slight
decrease in WBC numbers. All calves showed reduction in PCV values (Figure 3.2).
Macroschizont parasitosis was observed for 9 to 13 days (data not shown). Calves
were treated either on day 12, 13 or 14 after infection at a single dose of 2.5 mg/kg of
buparvaquone (Figure 3.2).
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Figure 3.2. Clinical, parasitological and haematological reaction of calves (n=4)
infected with sporozoites (Group 1) to infection and challenge 7 months after
primary immunisation. T. annulata Ankara sporozoite stabilate 54 was used to
infect calves. One ml of the sporozoite suspension containing 0.2 tick equivalent was
inoculated subcutaneously in front of the right shoulder of each calf. T. annulata
Gharb sporozoite stabilate 63 and 67 were pooled and used to challenge the calves at
a dose of 1 tick-equivalent seven months after primary infection. During primary
infection all calves which underwent severe reaction were treated with buparvaquone













































































Following the challenge, all calves showed a mild reaction with body
temperature, PCV and WBC remaining around the pre-infection values except on
day 9 when calf 21A showed slight pyrexia. Increase in piroplasm parasitaemia was
not significant (Figure 3.2). Macroschizont parasitosis was detected for 1 to 6 days
(data not shown).
Groups 2A and 2B (immunisation with low passage 71 annulata Ankara cell
line!: Two peaks of temperature were observed. The first peak was thought to be the
reaction to the cells inoculated. The second peak was accepted as the reaction to the
parasite infection. Calves in these groups exhibited a wide range of reactions from
severe to mild. Two calves (32C, 892A) showed a severe reaction with 4 to 10 days
pyrexia and macroschizont parasitosis was observed 7 to 8 days. Both calves
required treatment. One calf (calf 22A) showed a mild reaction with one day of
pyrexia and no macroschizont in the lymph node smears. The remaining six calves
exhibited moderate reactions with 3 to 7 days of pyrexia (Figures 3.3 and 3.4). All
calves showed reduction in PCV and WBC. Macroschizont parasitosis was observed
for 1 to 7 days.
Following challenge, calves in Group 2A (low passage cell line for 7 months)
showed a mild reaction with 5 to 7 days of pyrexia, a slight decrease in WBC
numbers, no change in PCV and piroplasm levels (Figure 3.3) while macroschizont
parasitosis was detected for 7 or 8 days (data not shown). All calves in Group 2B
(low passage cell line for 1 month), except calf 15 exhibited a mild parasitic reaction
with a brief pyrexia and macroschizonts being detected for one day. Calf 15 showed
pyrexia for 12 days. There were no other obvious symptoms of T. annulata infection.
The PCV, WBC and piroplasm parasitaemia remained close to pre-immunisation
levels (Figure 3.4).
Groups 3A and 3B (high passage T. annulata Ankara/Pendik attenuated or
'vaccine' cell line): No calves in these groups showed any evidence of infection
except one or two day(s) of pyrexia which was recorded in calves 32A, 308A and
54C (Figure 3.5 and 3.6). Macroschizonts and piroplasms were not detected. PCV
and WBC remained around the pre-infection values.
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Figure 3.3. Clinical, parasitological and haematological reaction of calves (n=5)
immunised with the low passage cell line (passage 5) (Group 2A) and challenged
7 months after primary infection. A single dose of 2 x 106 live cells, which
obtained from two day-old mononuclear cell culture infected with T. annulata
Ankara (p5) schizonts, were inoculated subcutaneously in front of the right shoulder.
T. annulata Gharb sporozoite stabilate 63 and 67 were pooled and used to challenge
the calves at a dose of 1 tick-equivalent seven months after immunisation. Mean
values are given together with the standard deviation of the mean.
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Figure 3.4. Clinical, parasitological and haematological reaction of calves (n=4)
immunised with the low passage cell line (passage 5) (Group 2B) and challenged
one month after immunisation. A single dose of 2 x 106 live cells, which obtained
from two day-old mononuclear cell culture infected with T. annulata Ankara (p5)
schizonts, were inoculated subcutaneously in front of the right shoulder. T. annulata
Gharb sporozoite stabilate 63 and 67 were pooled and used to challenge the calves at
a dose of 1 tick-equivalent 35 days after immunisation. Mean values are given
together with the standard deviation of the mean.
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Figure 3.5. Clinical, parasitological and haematological reaction of calves (n=4)
immunised with the high passage cell line (passage 317) (Group 3A) and
challenged 7 months after immunisation. A single dose of 2 x 106 live cells, which
obtained from two day-old mononuclear cell culture infected with T. annulatci
Ankara/Pendik (p317) schizonts, were inoculated subcutaneously in front of the right
shoulder. T. annulata Gharb sporozoite stabilate 63 and 67 were pooled and used to
challenge the calves at a dose of 1 tick-equivalent seven months after immunisation.
During challenge infection calves (54C and 891A) which underwent severe reaction
were treated with buparvaquone at a dose of 2.5 mg/kg. Mean values are given
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Figure 3.6. Clinical, parasitological and haematological reaction of calves (n-4)
immunised with the high passage cell line (passage 317) (Group 3B) and
challenged one month after immunisation. A single dose of 2 x 106 live cells,
which obtained from two day-old mononuclear cell culture infected with T. annulata
Ankara/Pendik (p317) schizonts, were inoculated subcutaneously in front of the right
shoulder. T. annulata Gharb sporozoite stabilate 63 and 67 were pooled and used to
challenge the calves at a dose of 1 tick-equivalent one month after immunisation.
During challenge calf 308A which underwent severe reaction was treated with
buparvaquone at a dose of 2.5 mg/kg. Mean values are given together with the






























Following challenge, calves in Group 3A (attenuated cell line for 7 months)
showed moderate to severe clinical and parasitological reactions with pyrexia lasting
for 6 to 10 days (Figure 3.5). Macroschizont parasitosis was observed for 8 to 10
days. Maximum piroplasm parasitaemia was 39.4% in calf 54C, 11.8% in calf 891A,
7.2% in calf 26A and 2.7% 32A. PCV dropped to less than 20% in all calves.
Reduction in WBC numbers was observed in all calves. Calves 54C and 891A
required treatment on day 12 and 21 after challenge, respectively.
The responses to heterologous challenge of calves in Group 3B (attenuated
cell line for 1 month) were different. Calf 308A showed a severe reaction and
required treatment on day 14 after challenge at a dose of 5 mg/kg buparvaquone
(Figure 3.6). Pyrexia remained for 10 days, piroplasm parasitaemia reached to
26.4%, PCV fell to 12% and the WBC count was reduced. Whereas the remaining
three calves in this group underwent a moderate reaction with pyrexia lasting for 9 to
19 days, piroplasm parasitaemia was around 10% and a decrease in the WBC and
PCV. The calf recovered without treatment. Macroschizonts remained for 10 days in
both calves with a high percentage of infected lympoblasts in calf 308A (Figure 3.6).
Group 4 (susceptible controls): After infection all calves underwent a severe
clinical reaction. The decrease in PCV and WBC were notable and all calves
developed severe anaemia. The maximum level of piroplasm parasitaemia was
between 36.7 and 59.9%. Calves suffered a long period of pyrexia and macroschizont
parasitosis. Calves were treated three times with buparvaquone starting from day 12
(Figure 3.7). Two calves showing respiratory system disorders were treated with an
antibiotic (Synulox) applied intramuscularly for 5 days.
3.3.5. Parasitological Examination
The mean piroplasm parasitaemia of calves in each group is shown in Figures
3.2-3.7. The number of animals that were positive for piroplasms is shown in Figure
3.8. The data shown in Figure 3.8 are obtained on days during which PCR samples
were taken. Calves in Group 1 became positive on day 9 and remained positive until
and after challenge except following treatment between days 21 and 28 (Figure 3.2).
Calves in 2A and 2B became piroplasm positive on day 7 or 16 and remained
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Figure 3.7. Clinical, parasitological and haematological reaction of calves (n=4)
(Group 4) to challenge infection. T. annulata Gharb sporozoite stabilate 63 and 67
were pooled and used to infect the calves at a dose of 1 tick-equivalent. One ml of
pooled stabilate was inoculated subcutaneously over the front of the left shoulder of
each calf. Rectal temperatures were recorded daily. Animals with temperature above
39.5 were considered to be febrile. All calves, which underwent severe reaction,
were treated with buparvaquone at a dose of 2.5 mg/kg. Mean values are given





Figure 3.8. Detection of carrier state in immunised and infected calves by
microscopic examination of piroplasm parasitaemia. Solid bars indicate number
of animals that were piroplasm positive. Open bars indicate number of animals that
were piroplasm negative. A. Number of positive and negative animals that were
infected with sporozoites and challenged seven months after primary infection. B.
Number of positive and negative animals immunised with the low passage cell line
(Groups 2A and 2B). Blood samples were taken from animals for seven months in
Group 2A and for one month in Group 2B before challenge and 14 days after
challenge in both groups. Data for Groups 2A and 2B are combined for the first 28
days of immunisation and throughout challenge. C. Number of positive and negative
animals immunised with the high passage cell line (Groups 3A and 3B). Blood
samples were taken from animals for seven months in Group 3A and for one month
in Group 3B before challenge and 14 days after challenge in both groups. Data for
Groups 3A and 3B are combined for the first 28 days of immunisation and
throughout challenge.
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positive until and after challenge (Figure 3.3-3.4). Following treatment no piroplasms
were detected in calf 892A between day 28 and 35. In contrast, piroplasms were not
detected in any calves in Groups 3A and 3B following primary infection until
challenge. Following challenge all calves became piroplasm positive by day 10
(Figure 3.5-3.6).
3.3.6. Cell Culture Isolation
Results of attempts to establish infected cell cultures from PBM are given in
Figure 3.9. Cell lines could be cultured for up to day 56 after inoculation from calves
infected with sporozoites and for up to 28 days after inoculation from calves
immunised with the low and high passage cell lines.
3.3.7. Detection of T. annulata Infection in Calves by PCR
T. annulata DNA was detected in blood obtained from experimentally
infected and immunised calves by PCR, using primers 989 and 1347. PCR products
were analysed by both electrophoresis on agarose gels and Southern blot
hybridisation. Some blood samples gave positive results by hybridisation but were
negative on the agarose gels (data not shown). No products were obtained in PCR
reactions from negative control samples indicating that there was no contamination
with extraneous T. annulata DNA.
The number of positive animals in each group is given in Figure 3.10. Calves
in Group 1 infected with sporozoites became positive on day 7 or 12 and remained
positive up to and after challenge. Calves infected with the low passage cell line 7
out of 9 calves were positive on day 5, while the other calves in Groups 2 became
positive on day 12 and remained positive up to and after challenge. Calves in Groups
3A and 3B showed intermittently positive PCR reactions. Generally the PCR
products were weaker on agarose gel and were sometimes only positive on Southern
blot hybridisation (data not shown). Only two calves were consistently positive by
Southern blot hybridisation from days 12 to 35. Positive results did not always
correlate with the results of blood smear examination or tissue culture. Following
challenge all calves were positive on days 7 and 14.
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Figure 3.9. Detection of carrier state in immunised and infected calves by
isolation parasites in cell culture. Ten ml of jugular blood was taken into a
vacutainer tube containing Lithium-Heparin. Isolation of T. annulata-macroschizont
infected cells from peripheral blood mononuclear cells (PBM) was carried out as
described in Materials and Methods. Solid bars indicate number of animals from
which cell lines could be established. Open bars indicate number of animals from
which cell lines could not be established. A. Number of positive and negative
animals that were infected with sporozoites (Group 1) and tested for the
establishment of cell lines for seven months. B. Number of positive and negative
animals immunised with the low passage cell line (Groups 2A and 2B). Animals in
Groups 2A and 2B were tested for the establishment of cell lines for seven months
and one month, respectively. Data for Groups 2A and 2B are presented together for
the first 28 days following immunisation. C. Number of positive and negative
animals immunised with the high passage cell line (Groups 3A and 3B). Animals in
Groups 3A and 3B were tested for the establishment of cell lines for seven months
and one month, respectively. Data for Groups 3A and 3B are presented together for
the first 28 days following immunisation.
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Figure 3.10. Detection of carrier state in immunised and infected cattle by
polymerase chain reaction (PCR). DNA from blood samples was prepared using
saponin lysis buffer as described in Materials and Methods. PCR primers derived
from the small subunit ribosomal RNA gene of T. annulata were used to amplify a
372 bp fragment of T. annulata. PCR products were electrophoresed through a 1.6 %
agarose gel and the presence ofpositive signals were confirmed by Southern blotting
using the 372 bp amplification product. Solid bars indicate number of animals that
showed positive signal. Open bars indicate number of animals that showed negative
signal. A. Number of positive and negative animals that were infected with
sporozoites and challenged seven months after primary infection. B. Number of
positive and negative animals immunised with the low passage cell line (Groups 2A
and 2B). Blood samples were taken from animals for seven months in Group 2A and
for one month in Group 2B before challenge and 14 days after challenge in both
groups. Data for Groups 2A and 2B are combined for the first 28 days of
immunisation and throughout challenge. C. Number of positive and negative animals
immunised with the high passage cell line (Groups 3A and 3B). Blood samples were
taken from animals for seven months in Group 3A and for one month in Group 3B
before challenge and 14 days after challenge in both groups. Data for Groups 3A and
3B are combined for the first 28 days of immunisation and throughout challenge.
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The data presented here compare differences in the immune response and the
carrier state of animals infected with T. annulata sporozoites, low and high passage
macroschizont infected cell lines. Differences in the severity of reaction to infection
between groups indicated that sporozoite infection was most virulent, followed by
the low passage cell line. The T. annulata Ankara/Pendik high passage cell line
showed evidence of being highly attenuated, causing only very mild reactions. In
Group 1, calves were challenged only seven months after primary sporozoite
infection, but not one month after primary infection. All calves infected with
sporozoites, in the experiment, required treatment with buparvaquone between days
12 and 14. It was previously shown that buparvaquone remains in the serum of
calves at least 14 days following drug administration and reduces the severity of
reaction produced by sporozoite infection (Wilkie et al., 1998a). In addition, it was
shown that serum samples taken from animals 14 days after drug administration
reduced the infection rate of the cells by sporozoites in vitro (Wilkie et al., 1998b).
Therefore, challenging of calves one month after primary infection would not have
demonstrated the real immune status of animals. The carrier state of parasite is also
differed between the groups. Calves infected with sporozoites or immunised with the
low passage cell line became piroplasm carriers following infection or immunisation.
No piroplasms and macroschizonts were detected in Giemsa's stained blood and
lymph node biopsy smears, respectively, in calves immunised with the high passage
cell line.
■ The virulent heterologous sporozoite challenge indicated that different
immunising parasite stages and levels of attenuation resulted in different levels and
duration of immunity. The protective immunity that developed after inoculation of
sporozoites and the low passage cell line was solid throughout the study. In contrast,
the immunity induced by the high passage cell line was weaker. These results are in
agreement with two lines of evidence suggesting that the degree of protection is
controlled by the parasite stages and the level of attenuation. First, infection with
sporozoites may stimulate better protection than that obtained by immunisation with
cell lines (Preston and Brown, 1988). It is suggested that this is because cattle
infected with sporozoites respond to sporozoite challenge immediately, whereas
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those immunised with cell lines respond only after the development of schizonts
(Preston et al., 1999). Second, while macroschizonts provide optimal immunity to
homologous challenge, they provide a lesser degree of protection against
heterologous challenge (Sergent et al., 1945; Bamett, 1963; Gill et al., 1981;
Subramanian et al., 1986; Darghouth et al., 1996a).
The different levels of immunity induced by inoculating sporozoites, low and
high passage cell lines may be due to the exposure of animals to different stages of
the parasite. The host's immune system responds to various stages of the parasite in
different ways (Preston et al., 1999). There is evidence indicating that antibodies
against sporozoites and merozoites delays or prevents the invasion of mononuclear
cells (Gray and Brown, 1981; Preston and Brown, 1985) or erythrocytes (d'Oliveira
et al., 1997a). Nevertheless, a subunit vaccination with the sporozoite surface
antigen, SPAG-1, did not provide satisfactory protection alone, though it delayed the
onset of disease (Boulter et al., 1995; 1998). Similar results were obtained in
vaccination trials using two allelic forms of the major merozoite surface protein,
Tamsl-1 andTamsl-2, (d'Oliveira et al., 1997a).
The antigenic diversity between the parasites used to immunise and challenge
calves might also play a role in the differences observed between immunisation
regimes. Calves infected with sporozoites and the low passage cell line were exposed
to several parasite populations as confirmed by glucose phosphate isomerase (GPI)
polymorphism and by anti-macroschizont monoclonal antibodies (mAbs). In
contrast, GPI analysis demonstrated that animals immunised with the high passage
cell line had been infected with a single parasite population (Ilhan, 1995). Therefore,
the exposure of animals to several parasite populations, rather than one, could
provide better protection against a heterologous challenge. In the current study, the
challenge with T. annulata Gharb was heterologous to all calf groups infected with T.
annulata Ankara and resulted in effective protection of all calves infected with
sporozoitcs or with the non-attenuated cell line. These results are in accordance with
previous observations (Darghouth et al., 1996a). In most cases animals in the field
are exposed to a heterologous challenge by ticks. Therefore, vaccine cell lines that
contain only one parasite population might not provide adequate protection against
theileriosis.
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The low level of immunity obtained with the high passage cell line could be
due to the loss of immunogenicity and infectivity of the parasite through long term
culture in vitro. The aim of attenuation is to reduce the virulence of the parasite while
maintaining its immunogenicity and infectivity (Brown et al., 1978a). Long term
culture not only reduces the pathogenicity of cell lines, but also impairs their ability
to protect against heterologous challenge (Pipano, 1989b). Prolonged maintenance in
cell culture is also thought to result in altered gene expression, which might be
responsible for the loss of virulence (Sutherland et al., 1993). At present, however, it
is difficult to identify a single factor that explains the effect of attenuation by long-
term cell culture on immunogenicity.
The level of immunity obtained through the use attenuated cell lines depends
on several factors including the ability of the parasite to transfer, establish and
multiply within host cells (Brown et al., 1978a). Attenuation reduces the ability of
cell lines to produce detectable levels of macroschizont-infected cells in infected
calves (Pipano, 1977). In the current study, cell culture could be established from 6
out of 8 calves in the high passage cell line infected animals during the first 28 days
of immunisation. Additionally, the infected cells were shown to derive from the
recipient animals by BoLA typing (Ilhan, 1995, data not shown), indicating that
macroschizonts from the attenuated cell line transferred to the recipient host cells.
Thus it is unlikely that the lack of protection in animals vaccinated with the high
passage cell line is due to failure of the parasite to transfer into host cells.
It has been demonstrated that attenuated T. annulata Ode cells disseminate
very poorly compared to virulent parent cell lines in scid mice (Somerville et al.,
1998a). The degree of dissemination was correlated with a marked reduction in
matrix metalloproteinases (MMP), which are known to play an important role in
metastasis (Sier et al., 1996). Attenuation led to the loss of MMP activity in all
vaccine lines examined, including the Ankara/Pendik cell line (Somerville et al.,
1998b). It has been suggested that the loss of MMP could be related to the loss of
virulence of attenuated cell lines (Baylis et al., 1992; Adamson and Hall, 1997;
Somerville et al., 1998b). These results suggest that the decreased immunogenicity
of attenuated cell lines may be due to relatively low invasive ability of
macroschizonts leading to reduce priming of the immune system.
68
There is very little information on the establishment and maintenance of
macroschizonts in cattle after vaccination with attenuated macroschizont-infected
cells. Traditionally, the immunisation status of vaccinated animals has been
monitored using IFAT which does not reveal or necessarily imply the carrier state of
animals or the presence of macroschizont infected cells (Pipano, 1974; Pipano,
1977). In the current study, the carrier status of animals was investigated by
microscopic examination, cell culture isolation and PCR. During the current
experimental study, animals infected with sporozoites or the low passage cell line
were shown to be persistent carriers following infection by PCR and the presence of
piroplasms in blood smears. In addition, cell cultures were established more
frequently from these animals than animals immunised with the high passage cell
line. In the latter group cell cultures could not be established 28 days after
immunisation. Animals infected with the high passage cell line were rarely positive
by PCR, microscopic examination or cell culture and did not present a persistent
carrier state of piroplasms. However, it remains to be determined if the persistent
parasite form following vaccination is a tissue-dwelling macroschizont within the
reticulo-endothelial system. The classical definition of a carrier of T. annulcita is the
ability of an infected and recovered animal to serve as a reservoir of infection for
vector ticks which are able to transmit the parasite to susceptible host (Young et al.,
1986). Currently the carrier status is thought to be maintained by the persistent and
slow division of macroschizonts giving rise to piroplasms (Norval et al., 1992). In
addition, early studies described by Pipano (1972) indicate that infection could be
established in splenectomised calves by inoculating red blood cells infected with
piroplasms from animals 167 to 432 days after recovery. In the same study,
macroschizonts were later detected in the recipient calves, implying the long-term
persistence ofmacroschizonts developing to piroplasms.
It is interesting to note that in the current study animals that possessed solid
immunity to challenge were also consistent piroplasm carriers throughout the
experimental period up to challenge, while those that showed only sporadic or no
evidence of being carriers were poorly protected from challenge. These observations
suggest that there is a causal relationship between the level of immunity obtained and
the carrier status of animals and that persistence of the parasite in animals are
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necessary for the maintenance of immunity. The continued presence of the parasite
might be necessary to reinforce immunological memory and to ensure an adequate
and appropriate cellular immune response (Bunce and Bell, 1997). These findings
support the notion of 'premunition' for Theileria and other protozoa as defined
previously (Sergent, 1963).
Challenge with sporozoites under laboratory conditions may result in more
severe reactions than challenge under natural conditions in the field (Pipano, 1995).
For example, animals immunised with the vaccine cell line used in the current study,
viz. Ankara/Pendik, at passage level 250, showed various reactions to laboratory
challenge ranging from mild to severe/lethal (Ozkoc and Pipano, 1981). However, in
a field study, the same vaccine cell line at passage level 252 to 325, was adequate for
protection against field challenge (Onar, 1989). It is apparent that for most vaccine
cell lines a slight loss in immunogenicity may not be very significant, unless animals
are challenged with an unusually high dose or remain unchallenged for a long time
following vaccination.
Previous studies indicated that there is no direct relationship between the
severity of clinical reaction following immunisation with macroschizont infected cell
lines and the level of protection (Innes, 1988). Brown et al. (1998b) demonstrated
that the degree of clinical reactions following immunisation with cell lines may be
related to the T-cell stimulatory ability of infected cells and the levels of pro¬
inflammatory cytokines they produce. In contrast to these observations, in the current
study, calves that developed moderate or severe reactions to infection and
immunisation were better protected against challenge than animals which exhibited
only a mild reaction. These observations would suggest that a high level of
parasitosis/parasitaemia during primary infection might stimulate a higher level of
immunity.
Attenuated macroschizont infected cell lines have been used in many
countries to control tropical theileriosis (Brown, 1990). However, the duration of
protection, a key parameter in the design of vaccination programmes (Woolhouse
and Bundy, 1997), remains largely unknown. In the current study, immunity
stimulated by the Ankara/Pendik cell line (passage 317) protected three out of four
animals one month following vaccination and two out of four 7 months following
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vaccination. For vaccines with low impact and especially for those with relatively
low duration of protection, repeated vaccination may be required according to the
level of endemic stability in the region. However, re-immunisation with the same cell
line may not boost immunity because of a graft rejection type response (Nichani et
al., 1997a; Nichani et al., 1997b).
In subsequent chapters, the development and evaluation of ELISAs to detect
T. annulata stage-specific antibodies will be discussed. The establishment of such
ELISAs is essential to distinguish vaccinated animals from naturally infected animals
and to detect which vaccinated animals have been challenged i.e. true prevalence of
disease. Chapter 7 describes a nested PCR, which distinguishes T. annulata from T.
buffeli in cattle and T. annulata from T. lestoquardi and B. equi in vector ticks. Such
sensitive and specific tests are essential to target the limited amount of vaccine
produced each year (150,000 doses in Turkey) to the areas of highest impact.
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CHAPTER FOUR
EXPRESSION AND PURIFICATION OF MACROSCHIZONT STAGE
SPECIFIC ANTIGENS
4.1. INTRODUCTION
At present the control of tropical theileriosis, in many countries where the
disease is endemic, is by administration of attenuated live parasites to vaccinate
cattle (Brown, 1990). In order to assess the impact of the control programs, it is
necessary to be able to assess whether an animal has been vaccinated, whether it has
been challenged in the field and whether it is immune to infection by T. annulata.
One way of detecting vaccinated animals and monitoring a parasite challenge is the
measurement and characteristics of their antibody responses against the parasite.
Monitoring antibody responses before and after vaccination would provide
information about the effectiveness of attenuated cell line vaccines, which have been
used in defined areas. To date, the most commonly used system to monitor the
efficacy of vaccines is by serological testing using the piroplasm and macroschizont
IFAT (Pipano, 1974). However, IFAT fails to distinguish vaccinated/unchallenged
animals from those that are either vaccinated/challenged or those that are simply
naturally infected by ticks because of the presence of common antigens in all stages
of the parasite (Knight et al., 1998).
It has been shown for other parasite systems that stage specific antigens could
be used to detect different stages of the infection. For example, a major surface
glycoprotein of Leishmania parasites, gp63, seems to distinguish an ongoing
infection from a previous one (Okong'o-Odera et al., 1993). Similarly, a stage
specific enzyme of Schistosoma mansoni, cercarial elastase, has been used as a sero-
diagnostic marker for cercarial exposures during post-treatment follow-up and
epidemiological studies (Ramzy et al., 1997). Therefore, stage specific antigens of T.
annulata might provide reagents that would allow vaccinated animals to be
distinguished from naturally infected ones.
During a natural infection with T. annulata sporozoites, the host immune
system will be exposed to sporozoites, macroschizonts, merozoites and piroplasms.
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In contrast, animals immunised with high passage cell lines, which are believed not
to produce piroplasms (Pipano, 1977), will be exposed only to the macroschizont
stage of the parasite. Serological tests employing proteins specific to the sporozoite
or piroplasm stages of the parasite could only detect animals infected with
sporozoites, and thereby distinguish these animals from cattle vaccinated with these
attenuated high passage schizont infected cell lines. To complement these antigens
and further develop the assay, a recombinant protein specific to the macroschizont
stage of the parasite could be used to detect both animals infected with sporozoites
and animals that were vaccinated with an attenuated, high-passage cell line. In
combination, these antigens would provide a portfolio of tests that could be used to
measure the vaccination status of the cattle (using a macroschizont antigen), whether
it had been recently challenged (using a sporozoite antigen) and the outcome of
challenge (using a piroplasm antigen). The use of stage specific antigens would,
therefore, be of great use to epidemiological studies investigating the true prevalence
of the disease in areas where vaccine has been used as well as the assessment of the
efficacy of the vaccination programme.
Recently, stage specific recombinant antigens from the sporozoite and the
merozoite/piroplasm stages of the parasite have been defined. These include the
sporozoite surface antigen, SPAG-1 (Williamson et al., 1989; Hall et al., 1992), the
merozoite rhoptry antigen, Tamr-1 (Shiels et al., 1994), and the 32 kDa major
merozoite and piroplasm surface antigen, Tarns 1 (Shiels et al., 1995). Preliminary,
indirect ELISA studies were carried out using recombinant SPAG-1 and Tamr-1. The
ELISA using SPAG-1 was not sensitive enough to detect antibodies in calves that
had been exposed to sporozoites once (Matita, 1994; Williamson et al., 1994). This
indicated that the recombinant SPAG-1 protein would not be reliable in diagnostic
tests aimed at detecting animals as positive after a single infection. In contrast,
studies using recombinant Tamr-1 in an ELISA demonstrated that this protein was
suitable as a reagent for a diagnostic test (Matita, 1994), as the Tamr-1 antigen was
detected by the serum of the majority of infected animals. It was also demonstrated
that antibodies against the Tamr-1 antigen were detected in animals infected with
sporozoites or non-attenuated macroschizont infected cells; whereas the antibody
titre of animals immunised with attenuated high passage cell lines remained close to
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the pre-immunisation levels, or only increased slightly (Ilhan, 1995). The results of
these experiments supported the plan of using stage specific recombinant antigens to
distinguish vaccinated animals from naturally infected animals.
On commencement of this study, there were no recombinant antigens
available that were expressed by the macroschizont stage of T. annulata. Such an
antigen was needed for the development of a diagnostic system aimed at testing the
efficacy of vaccination using attenuated cell lines. In order to clone a gene encoding
a macroschizont antigen, gene expression libraries were screened with antisera raised
against vaccine cell lines, following verification that the antisera detected an
immunodominant macroschizont antigen. In addition, a subtractive screening
procedure was employed using immune bovine sera whose antibodies that react with
piroplasm antigens were blocked by immunoabsorption to increase the probability of
isolating a macroschizont antigen gene. An alternative strategy was to identify
homologues of macroschizont genes already cloned in related species of Theileria.
As it is known that T. annulata and T. parva are closely related, the gene encoding
the QP protein of T. parva (Baylis et al., 1993) was considered to be a good
candidate for this strategy. The QP antigen is synonymous with polymorphic
immunodominant molecule (PIM) described by Toye et al. (1991; 1995b; 1996). The
QP/PIM protein is expressed in the sporozoite, macroschizont and piroplasm stages
of the parasite (Baylis et al., 1993; Toye et al., 1995b). PIM is one of the most
immunogenic antigens of T. parva inducing strong antibody responses. It was
demonstrated that a PIM-based ELISA for T. parva provided a high degree of
sensitivity and specificity (99% and 94-98%, respectively) in detecting antibodies in
cattle infected with T. parva (Katende et al., 1998). Since PIM is expressed at all
stages of the parasite, the T. annulata homologue of this antigen should detect
antibodies in both naturally infected and vaccinated animals. Therefore, when used in
combination with the Tamr-1 antigen, an ELISA using the T. annulata homologue of
QP/PIM would allow one to distinguish vaccinated animals from those that were
naturally infected or challenged following vaccination.
The primary aim of the work presented in this chapter was to isolate a gene(s)
encoding an immunogenic protein that is expressed in the macroschizont stage of the
parasite. Several approaches were considered to obtain such an antigen: i)
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identification of the immunodominant molecules recognised by antibodies induced
by vaccination using attenuated high passage cell lines; ii) screening of parasite
genomic expression libraries with immune bovine sera whose antibodies against
piroplasm antigens were blocked by immunoabsorption; iii) screening of cDNA and
genomic DNA libraries with the gene encoding the QP protein of T. parva. These
approaches were followed by expressing recombinant proteins encoded by the
isolated genes in order to determine their immunogenicity.
4.2. MATERIALS AND METHODS
4.2.1. Parasite Material
The details of parasite material for the preparation ofDNA, RNA and protein
extracts analysed by Southern, northern or western blots are given in Table 4.1.
Cells from infected or uninfected cultures maintained as described in section
3.2.4.2 were centrifuged at 300 x g for 10 minutes at 4°C and the cell pellet was
washed in PBS three times as above. Cells then were used to prepare DNA, RNA or
protein.
The method described by Ben Miled (1993) was used to purify piroplasm
from infected blood. Briefly, approximately 100 ml jugular blood from a T. annulata
Ankara infected calf with a parasitaemia of 45% was taken into a sterile bottle
containing 2000 IU sodium heparin. The blood was centrifuged at 2,500 x g for 15
minutes at 4°C. The plasma and buffy coat were removed and cells were washed
three times in cold PBS while removing the buffy coat each time. The red cells were
lysed at 37°C by addition of three volumes prewarmed 0.9 % ammonium chloride.
After 10 minutes, when the colour of blood changed to deep red, the lysed
erythrocytes were centrifuged at 800 x g for 5 minutes. The supernatant was
centrifuged at 3,000 x g for 20 minutes at 4°C. The pellet containing free piroplasms
was washed three times in cold PBS and used to prepare protein extract, DNA and
RNA.
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Table 4.1. Details of parasite material used in Southern, northern and western blot
analyses.
Species Stock Stage Country origin/reference
T. annulata Ankara Sporozoite Turkey (Schein et al., 1975)
T. annulata Ankara piroplasm Turkey (Schein et al., 1975)
T. annulata Ankara/
D7 clone
Schizont Turkey (Shiels et al., 1992)
T. annulata Gharb Schizont Morocco (Ouhelli, 1985)
T. annulata Hissar Schizont India (Gill et al., 1976)
T. anriulala Tova Schizont Israel (Pipano et al., 1974)
T. annulata Beja Schizont Tunisia (Ben Miled, 1993)
T. annulata Razi Schizont Iran (Hooshmand-Rad and
Hashemi-Fesharki, 1968)
T. annulata Soba Schizont Sudan (Melrose et al., 1984)
T. annulata Caceres Schizont Spain (de Kok et al., 1993)
T. parva Muguga Schizont Kenya (Brocklesby et al., 1961)
T. lestoquardi Lahr Schizont Iran (Hooshmand-Rad et al.,
1993)
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4.2.2. SDS-Polyacrylamide Gel Electrophoresis (PAGE) and Preparation of
Protein Extracts
SDS-PAGE was carried out according to the method of Laemmli (1970),
using the Biorad Protean II and mini Protean II gel electrophoresis systems. The
acrylamide concentration of resolving gels varied from 8% to 10%, depending on the
molecular mass range of the polypeptides analysed. For the mini Protean II
apparatus, 5 ml of a 10% resolving gel was used routinely. The gel was composed of:
2 ml dH20, 1.7 ml acrylamide mix (30% acrylamide, 0.8 N-N Bis-methylene
acrylamide, Sigma), 1.3 ml of 1.5 M Tris.HCl, pH 8.8 and 50 jul 10% SDS.
Polymerisation was initiated by the addition of 50 pi freshly prepared 10%
ammonium persulphate (APS, Sigma) and 2 pi tetra-methyl-l,2-diaminoethane
(TEMED, Sigma). A 5% stack gel was poured on the top of the resolving gel, 2 ml
for each gel, and an appropriate sample comb placed in the stacking gel. The 2 ml
stack gel was composed of: 1.4 ml dH20, 0.33 ml 30% acrylamide mix, 0.25 ml 1M
Tris.HCl pH 6.8 and 20 pi 10% SDS. When large Protean II gels were used the
volumes of resolving and stacking gels were increased to approximately 30 ml and 5
ml respectively.
10 or 20 pi of protein extracts was loaded per lane. Molecular masses of
proteins were estimated by reference to molecular markers of the high mass range
(29-205 kDa, Sigma) or broad mass range (7-206 kDa, Biorad). Protean II gels were
electrophoresed overnight in electrophoresis buffer (50 mM Tris base, 384 mM
glycine, 2 mM EDTA and 0.1% SDS) at 50 V, while mini Protean II gels were run
for approximately 2 hours at 120 V. Following electrophoresis, gels were stained and
fixed in a solution of 30% methanol, 10% acetic acid and 0.5% Coomassie Brilliant
Blue R-250 (Sigma) in dH20 for approximately one hour and destained in the same
solution lacking the Coomassie dye.
Piroplasms (100 pi pellet), macroschizont infected cells and BL-20 cells (5 x
10' cells) were lysed by adding 1 ml of 1 x sample buffer (diluted from 4x stock:
0.25M Tris-HCl, pH 6.8, 4% SDS, 20% glycerol, 10% P-mercaptoethanol, 0.001%
bromophenol blue). Protein samples were passed through a needle twice, boiled for 5
minutes and centrifuged at 14,000 x g for 5 minutes.
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4.2.3. Western Blotting
Immunoblotting of polyacrylamide gels was adapted from (Towbin et al.,
1990). Following electrophoresis, proteins were transferred onto nitrocellulose filters
(Schleicher and Schuel, BA 85, 0.45 pm or Hybond C, Amersham) in transfer buffer
using either a Bio-Rad Trans blot cell wet system (25 mM Tris base, 192 mM
glycine, 20% methanol) or semi-dry system (50 mM Tris base, 380 mM glycine,
0.1% SDS, 20% methanol). Transfer was carried out with a current of 300 mA for 1
or 3 hours for wet gels and for 30 or 60 minutes at 15-20V for the semi-dry system.
The efficiency of transfer was determined by staining the filters for 5 minutes with
0.2% Ponceau-S (Sigma) in 3% trichloroacetic acid, followed by destaining in
distilled water. Filters were washed with Tris-saline buffer (10 mM Tris.FlCl, pH 7.4,
150mM NaCl, 0.1% Tween 20). Filters were then incubated in blocking buffer (Tris-
saline buffer plus 5% nonfat dried milk (Marvel)) at room temperature on a rocking
platform for one hour. Following blocking, filters were incubated overnight, or for 2
hours, at room temperature in primary antibody; bovine sera were diluted at 1:500 -
1:800 and rabbit sera were diluted 1:200 - 1:500 in block buffer. The filters were
then washed three times for 5 minutes in Tris-saline buffer, to remove unbound
antibodies, and incubated for one hour with anti-bovine (raised in rabbit) or anti-
rabbit (raised in goat) alkaline phosphatase conjugated secondary antibody (IgG
whole molecule, Sigma), diluted 1:20,000 in blocking buffer. The filters were
washed as above and developed by incubation with 5-bromo-4-chloro-3-indolyl-
phosphate (BCIP) and nitroblue tetrazolium (NBT) (Kirkegaard and Perry
Laboratories Inc.). The reaction was stopped by washing the filters in tap water.
4.2.4. Blocking the Detection of Piroplasm Antigens by a Rabbit Antiserum
(C9m) Raised Against Merozoites
Western blots containing extracts from uninfected BL-20, the T. annulata
Ankara D7 cell line and T. annulata piroplasms were pre-incubated with rabbit
antiserum (C9m) raised against merozoites at different dilutions (1:10-1:500) and
incubation times of 2-16 hours to block reactivity to non-schizont specific antigens
before incubation with bovine sera N57, N58 and 155 (at a dilution of 1:800)
infected with either low passage cell lines or sporozoites.
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4.2.5. Immunoabsorption ofAnti-piroplasm Antibodies from Immune Sera
Immunoabsorption was carried out to block anti-piroplasm antibodies from
an immune serum by a method described previously (Dickson and Shiels, 1993).
Proteins were extracted from a 0.5 ml piroplasm pellet using 2% SDS in 50mM
Tris.HCl, pH 8.0. Following the shearing of the DNA, the extract was diluted 1:5
with NET buffer (0.5% Nonidet 40, 5mM EDTA, 150 mM NaCl, lOmM Sodium
Azide, 50 mM Tris.HCl pH 8.0). 500 jal of the piroplasm extract was incubated
overnight with immune bovine serum (1:800 dilution in 10 ml immunoblot blocking
buffer). The following morning, a further 500 pi of the piroplasm extract was added
to the serum sample which was incubated at room temperature for a further two
hours. The serum and piroplasm extract mixture was used for western blot analyses
and for screening a T. annulata genomic expression library.
4.2.6. Screening of T. annulata Genomic Expression Library
A genomic DNA expression library previously constructed in the Lgtll
vector using DNA isolated from purified T. annulata Ankara (D7) merozoites was
donated by Dr. J. Kinnaird (Department of Veterinary Parasitology, University of
Glasgow). Eschericia coli strain Y1090 R" (Stratagene) was used as host bacterium to
plate out the Agtl 1 genomic expression library. Y1090 R" was streaked out onto L-
Broth (LB) plates (1% bactotryptone, 0.5% yeast extract, 1% sodium chloride, 10
mM magnesium sulfate, 1.5% bactoagar) containing 100 pg/ml ampicillin and 0.2%
maltose and incubated overnight at 37°C. Overnight cultures were prepared the
following day by picking single colonies into 5 ml of LB-media (as LB plates
without bactoagar) containing ampicillin and maltose and incubated overnight on an
orbital shaker at 37°C. A 50 ml culture was generated by inoculation with 0.5 ml of
overnight culture and incubation in an orbital shaker at 37°C until an absorbance of
0.3-0.5 at 600 nm was reached. The cells were centrifuged at 800 x g for 10 minutes
at 4°C, and the pellet was re-suspended in 5 ml of 10 mM MgSCU
The A.gtl 1 genomic expression library was diluted to 7.5 x 104 pfu/ml (Plaque
forming units) in SM buffer (50 mM Tris.HCl pH 7.5, 10 mM MgSCL, 100 mM
sodium chloride, 0.01% w/v gelatin). 1 ml of diluted library was mixed with 0.8 ml
ofY1090 R" in 10 mM MgS04 and incubated at room temperature for 15 minutes. 50
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ml of top agarose [LB media containing 0.7% low EEO agarose (Sigma)] was then
added and the mixture poured onto a large LB-plate (20 cm2) containing 10 pg/ml
ampicillin. Plates were incubated at 42°C for 3-4 hours until plaques just began to be
visible. Nitrocellulose membranes, pre-soaked in 10 mM isopropythio-[3-D
galactosidase (IPTG, Gibco BRL), were laid onto the plates. The plates were
transferred immediately to 37°C and incubated for a further 4 hours. Following
incubation, filters were marked for orientation, lifted into immunoblot blocking
buffer (5% Marvel, 10% Horse serum, 0.1 % Tween-20 in Tris-saline pH 7.4) and
kept at 4°C overnight. The filters were then incubated with immune serum diluted at
1:800 in blocking buffer plus piroplasm lysates (see section 4.2.5) for 2 hours at
room temperature, washed 3 times in Tris-saline buffer with 0.1% Tween-20 for 10
minutes each and incubated with alkaline phosphatase-conjugated anti-bovine IgG,
diluted 1:20,000, for 2 hours. Washed filters were developed using BCIP/NBT.
4.2.7. cDNA Library Screening
A A, ZAP cDNA library, constructed by Dr. J. Kinnaird, representing RNA of
a cloned T. annulata Ankara macroschizont infected cell line (D7), was used to
screen for a gene homologous to the QP / PIM gene of T. parva. The XL1 Blue
MRF' Eschericia coli strain (Stratagene) was the host bacterium used to plate out the
library using overnight cultures as detailed by the supplier.
To screen the A. ZAP D7/37 library, 2.5 x 104 plaque forming units in SM
buffer were absorbed onto 0.6 ml of XL1 Blue MRF' cells by incubation at room
temperature for 15 minutes. 8 ml of top agarose [LB-media containing 0.7% low
EEO agarose (Sigma)], that was kept at approximately 55°C, was added to the cells
and poured onto 14 cm diameter LB- plates. Once set, plates were incubated at 37°C
overnight and then chilled at 4°C for 1 hour. Plaque lifts were taken from three plates
by laying nylon membranes (Colony/Plaque Screen Membranes, NEN-Life Science)
on top of the plates tor two minutes and the orientation of the filter was marked with
a needle. Lifted membranes were placed (phage side up) onto Whatman 3MM filter
paper that was previously soaked in denaturing solution (0.5 M NaOH, 1.5 M NaCl)
for 7 minutes followed by immersion for 2 x 3 minutes in neutralising solution (1.5
M NaCl, 0.5 M Tris.HCl, pH 7.4), and rinsing in 2 x SSC (150 mM NaCl, 15 mM
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sodium citrate, pH 7.0), 0.1% SDS. The DNA was fixed to the filter by exposure to
150 Joules short wave ultra-violet radiation using a GS Gene Linker (Bio-Rad).
Following UV cross-linking the filters were prehybridised with 15 ml Church
and Gilbert hybridisation buffer (Church and Gilbert, 1984) at 55°C for two hours
using the Hybaid cylinder and hybridisation oven system (Hybaid). Approximately
25 ng of a denatured DNA probe was radiolabelled using a Random Priming DNA
Labelling Kit (Boehringer-Mannheim Pharmaceuticals) according to the
manufacturer's instructions. The labelled probe denatured by boiling for 3 minutes
was added to the 15 ml of Church and Gilbert hybridisation solution. Hybridisation
was performed overnight at 55°C. The nylon membranes were then washed three
times with 1 x SSC, 5% SDS at 55°C for 15 minutes, before being expose to
autoradiography film (Kodak X-0 MAT) overnight in a X-ray film cassette at -70°C.
Positive plaques were identified, picked into 1 ml SM buffer containing 20 pi
of chloroform and stored at 4°C. One negative plaque was also picked to serve as a
negative control in subsequent rounds of screening. To re-screen putative positive
plaques, 3,000 pfu were absorbed onto 500 pi of XL1 Blue MRF' bacteria, mixed
with 2.5 ml top agarose and plated onto 90 mm diameter LB plates.
4.2.8. In Vivo Excision
Single plaques were picked from agar plates, transferred to sterile microfuge
tubes containing 500 pi SM buffer and 20 pi chloroform and incubated overnight at
4°C. Overnight cultures ofE. coli XL1 Blue MRF' and SOLR (Stratagene) cells were
grown up in LB/maltose medium. 500 pi of each overnight culture was used to
inoculate 50 ml LB-medium containing maltose (1:100 dilution) and incubated in an
orbital shaker at 37°C. XL-1 Blue MRF' cells were grown until an OD6oo of 0.5 was
obtained, spun down at 1,000 x g and resuspended to give an OD6oo of 1.0 in 10 mM
MgSCL. The SOLR cells were allowed to grow to an OD60o of 0.5-1.0, then were
kept at room temperature until used.
200 pi ofXL 1-Blue MRF' cells were combined with 250 pi (approximately 1
x 106 pfu) of ZZAP phage stock isolated as described in section 4.2.7 and 1 pi
(approximately 1 x 106 pfu/pl) ExAssist helper phage (Stratagene). The mixture was
incubated at 37°C for 15 minutes, after which 3 ml LB medium was added and the
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samples were incubated in an orbital shaker for a further 2.5 hours at 37°C. The tubes
were then heated to 70°C for 20 minutes and centrifuged for 15 minutes at 2,000 x g.
The resulting supernatant containing rescued phage was decanted into sterile tubes
and stored at 4°C for up to 2 months. 10 pi and 100 pi of rescued phage stocks were
mixed with 200 pi of SOLR cells (OD6oo= 1-0) and incubated at 37°C for 15 minutes.
300 pi of LB was added and the samples were incubated for a further 45 minutes at
37°C. 200 pi from each mixture was then plated out onto LB/ampicillin plates and
incubated overnight at 37°C. Colonies (3-5) were selected the next day, grown up
overnight and glycerol stocks and plasmid DNA prepared. The presence of DNA
inserts was examined by restriction enzyme analysis as described in section 4.2.9.
4.2.9. Plasmid DNA Preparation, Restriction Enzyme Analysis and
Purification of DNA Fragments
Bacteria from 1.5 ml of an overnight culture were pelleted by centrifugation
at 15,800 x g for 30 seconds. The pellet was resuspended in 150 pi of 50 mM
Tris.HCl pH 7.5, 10 mM EDTA, 100 pg/ml RNAse A, lysed by the addition of 150
pi 200 mM NaOH, 1% SDS and neutralised by the addition of 150 pi 1.32 M
potassium acetate, pH 4.8. Samples were then centrifuged for 30 minutes at 15,800 x
g and supernatants collected. DNA was precipitated from the supernatants by the
addition of 2 sample volumes of ice-cold ethanol, and the precipitate pelleted by
centrifugation for 30 minutes. After washing the pellets in 70% ethanol and air-
drying, DNA samples were resuspended in 30 pi sterile distilled water and stored at
-20°C.
0.2 to 1 pi of plasmid DNA was mixed with 2 pi of appropriate lOx React
buffer (Gibco BRL) and 5-10 u of restriction enzyme (Gibco BRL), and the final
volume of the reaction was brought to 20 pi with sterile dFLO. The mixture was
incubated at 37°C for 1 - 2 hours. In multiple digests, if all the restriction enzymes
required the same reaction buffer, digests were carried out at the same time.
Otherwise, each digest was sequentially performed using appropriate buffers. 5 x
Ficoll-loading dye (100 mM EDTA pH 7.5, 22% Ficoll, 0.05% Bromophenol blue)
was then added to a final concentration of Ix and samples were run on agarose
electrophoresis gels according to standard protocols (Sambrook et al., 1989). 0.7 -1%
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agarose gels were prepared by melting agarose (Sigma) in an appropriate volume of
either TBE or TAE. When cooled to hand temperature, ethidium bromide (Sigma)
was added to a final concentration of 0.5 pg/ml. The agarose was poured into a
casting frame and the gel was allowed to set at room temperature. Gels were
electrophoresed at 50-100 V in either TBE or TAE buffer and the size of the DNA
fragments estimated by comparison to a 1 kb marker ladder (Gibco BRL). Bands
were visualised by exposure to short wave ultraviolet light (366nm). When DNA
fragments were to be excised from gels for random prime labelling (section 4.2.7),
low melting agarose (Sigma) was used and the gels run at a maximum of 60 Volts.
Otherwise bands of interest were excised and purified either by using the QIAquick
Gel Extraction Kit (Qiagen) or the "Gene Clean 2" kit (BIO 101), according to the
manufacturer's instructions.
4.2.10. Ligation ofDNA Fragments and Transformation of Competent Cells
To ligate purified DNA restriction fragments into restriction digested vector
DNA, ratios of insert to vector of 3:1 and 1:1 were used. Insert and vector DNA was
taken up to a total volume of 17 pi with dEBO and 2 pi of 10 x T4 DNA ligation
buffer (500 mM Tris.ElCl, pH 7.8, 100 mM dithiothreitol, 1 mM ATP, 25 pg/ml
bovine serum albumin) and 1-2 units of T4 DNA ligase (Gibco BRL) were added.
The ligation mixture was incubated overnight at 16°C and used to transform
competent E. coli cells. To prepare competent cells, 500 pi of overnight culture of E.
coli XL 1-Blue (Stratagene) was used to inoculate 50 ml LB medium and the culture
incubated at 37°C, with shaking, until an absorbance of 0.2-0.5 at 600 nm was
obtained. Cells were centrifuged at 1,000 x g for 10 minutes, resuspended in half the
pellet volume using pre-chilled 50 mM calcium chloride and incubated for 20
minutes on ice. Cells were centrifuged as before, resuspended in a 10th of the original
volume of 50 mM calcium chloride and left on ice for several hours before use.
For transformations, 10 pi of the ligation reaction or 10 ng of plasmid DNA
were mixed with 50 pi of competent cells, left on ice for 45 minutes and heat
shocked for 2 minutes at 42°C followed by very brief cooling on ice. 200 pi of LB
was added and the cells were incubated at 37°C for 30-45 minutes. Cells were then
plated onto LB/ampicillin plates that were pre-streaked with 2.5 pi of 1 M IPTG and
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50 pi 5-bromo-4 chloro 3 indolyl (3-D galactoside, (X-gal, lOmg/ml in
dimethylformamide, Gibco BRL). Plates were incubated overnight at 37°C, white
recombinant colonies picked and overnight cultures prepared in LB/ampicillin
medium the next day. The presence of inserts was checked by restriction enzyme
digestion as described in section 4.2.9.
4.2.11. Automated DNA Sequencing
Samples for sequence analysis were generated by combining approximately
500 ng of DNA, 2 pmol of infrared fluorophore (laser dye IRD 800) labelled T7,
M13 or SP6 primers, 2.5 pi of 10 x sequencing buffer (0.5 M Tris.HCl pH 9.3, 25
mM magnesium chloride), 1 pi of BioPro thermostable DNA polymerase (Bioline)
and dH20 to final volume of 17 pi. 2 pi of the dideoxy termination mix (180 pM 7-
deaze-dGTP, 50 mM NaCl; 180 pM dCTP, 50 mM NaCl; 180 pM dATP, 50 mM
NaCl; 180 pM dTTP, 50 mM NaCl) was placed into one of 4 corresponding
thermocycler tubes together with 4 pi of the template/primer/enzyme mix. The top of
each reaction mixture was covered with 30 pi mineral oil and the tubes were placed
onto a thermocycler (Hybaid) for the following cycles: initially 95°C for 5 minutes;
followed by 30 cycles of: 95°C for 30 seconds (denaturing step), 60°C for 30 seconds
(annealing step) and 70°C for 1 minute (elongation step). After the cycling program
was completed, 4 pi of stop buffer (95% formamide, 20 mM EDTA pH 7.6, 0.1%
bromophenol blue, 0.1% xylene cyanol FF) was added to each reaction mix and
stored at -20°C until use. Samples were denatured by heating to 95°C for 5 minutes
prior to loading onto 6 % acrylamide gels. Gels were prepared by dissolving 21.0 g
of urea in 6 ml of LongRangerIM gel mix, 6 ml of 10 x TBE (890 mM Tris.HCl, 890
mM boric acid, 20 mM EDTA) and 23 ml dH20, giving a total volume of 50 ml. The
acrylamide solution was degassed before polymerisation was initiated by the addition
of 25 pi TEMED and 250 pi freshly made 10% APS. The gel was then cast using 41
cm x 25 cm x 0.5 cm LI-COR gel plates and was left for approximately 60 minutes
to set. Assembly of the LI-COR 4000 DNA sequencer apparatus was carried out
according to the manufacturer's instructions (LI-COR). The gel was pre-run with 1 x
TBE until a running temperature of 50°C was reached. 0.8 pi of each sample was
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loaded and electrophoresis was carried out for approximately 12 hours. Sequence
information was collected using computer software Base Imager™, LI-COR.
4.2.12. Exonuclease III Deletions
Promega's Erase-a-Base System was used to generate deletions allowing
derivation of the complete sequence of the Theileria gene inserts isolated from the A
ZAP cDNA library. Plasmid DNA was prepared as described in section 4.2.9, except
before the alcohol precipitation, a phenol/chloroform extraction step was carried out.
50 pi of closed circular DNA, in either pBluescript or pGEM 7zf+ vectors, was
linearized with two different restriction enzymes that cut within the multiple cloning
site, between the end of the insert to be deleted and the sequencing primer binding
site. The first enzyme generated a 4-base 3' overhanging end, close to the sequencing
primer binding site that was resistant to exonuclease III digestion. The second
enzyme digestion generated a blunt end or 5' overhanging adjacent to the insert that
was susceptible to Exo III. After the first digestion, a 2 pi sample was taken and run
on a 0.8% agarose gel to check that the DNA was cut to completion. Following the
second digestion, the plasmid DNA was precipitated with 2.5 volumes of ethanol and
1/10 volume of 3 M NaAc pH 5.3 and the pellet resuspended in 52 pi sterile dfEO.
6pl lOx EXO III Buffer and 4pl dH20 were added to 50 pi DNA and the sample
heated to 36°C. 350 units of Exo III were mixed with the DNA and, at one minute
intervals, 4 pi samples were removed into Eppendorf tubes on ice that contained 12.0
pi SI nuclease mix (40mM potassium acetate, pH 4.6, 338mM NaCl, 1.35mM
ZnS04, 6.8% glycerol, 60 units of SI nuclease). The tubes were then incubated at
room temperature for 30 minutes. 1.4 pi of SI nuclease stop buffer was added to
each tube, followed by incubation at 70°C for 10 minutes and a brief centrifugation.
5 pi samples from each time point were run onto a 1% agarose gel for size analysis.
2.6 pi Klenow mix (20mM Tris.HCl, pH 8.0, lOOmM MgCh, 4 units of Klenow
DNA polymerase) was then added to samples containing DNA fragments that
exceeded the size of the vector alone, followed by incubation at 37°C for 10 minutes.
Re-ligation of the deletions was carried out in a total volume of 20 pi containing 1 x
T4 Ligase buffer and 1 unit of T4 Ligase at 16°C overnight. 10 pi of the ligation
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products were then transformed into XL-1 Blue cells, and 5-10 colonies from each
time point screened to select those containing deletions of appropriate sizes for
sequence analysis.
4.2.13. Southern Blotting
4.2.13.1. Preparation ofGenomic DNA
Genomic DNA was prepared from purified macroschizont infected cell
cultures and piroplasms using a method described previously (Ben Miled et al.,
1994). 100 ml of macroschizont infected cell culture was grown to a density of 106
cells/ml and centrifuged at 1,500 x g for 10 minutes. The cell pellet, or 0.5 ml of a
purified piroplasm pellet, was resuspended in 5 ml of 1 x SSC. 5 ml of 100 mM
Tris.HCl pH 7.5, 100 mM NaCl, lOmM EDTA, 1% Sarkosyl was then added to the
cell suspension and mixed carefully for 2-3 minutes to lyse the cells. Proteinase K
was added to a final concentration of 100 pg/ml and the lysate incubated at 55°C for
2 hours. An equal volume of phenol saturated with TE was added and mixed for 30
min on a rotator. The sample was centrifuged at 2,000 x g for 10 minutes, the
aqueous phase recovered and a further extraction carried out with an equal volume of
phenol-chloroform (1:1). Finally, the DNA was extracted once with an equal volume
of chloroform alone. The aqueous top phase was transferred to a fresh tube and this
1/10 volume of 3M sodium acetate pH 5.4 and 2.5 volumes of ethanol were added.
DNA was precipitated at -70°C for 2 hours, pelleted by centrifugation for 10 min and
washed with 70% ethanol. Excess ethanol was removed and the pellet was allowed to
dry before resuspension in 600pl of TE.
4.2.13.2. Southern Blotting andHybridisation
20 pg of cell line DNA or 10 pg of piroplasm DNA were digested with 20-40
U of an appropriate restriction enzyme. After adding 2 pi RNAse A, the final volume
was made up to 40 pi with dH20 and was incubated at 37°C overnight. 10 pi of 5x
Ficoll-loading buffer was added, and the samples along with the 1 kb marker ladder
were loaded onto a 0.8% agarose gel containing 0.5 pg/ml ethidium bromide and run
at 35 Volts overnight. The gel was visualised under UV light.
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Capillary transfer of DNA from agarose gel to nylon membrane was carried
out according to standard protocols (Sambrook et al., 1989). DNA in gels was
denatured by immersion in 1.5M NaCl, 0.5M NaOH for 45 minutes on a shaker, then
neutralised in 2 M NaCl 0.5 M Tris HC1, pH 7.4 for 30 minutes. The gel was then
equilibrated in 25 mM phosphate transfer buffer, pH 5.5, for 30 minutes and the
DNA was transferred onto nylon membrane (Gene Screen Hybridisation Transfer
Membrane NEN™, Life Science Products, or Hybond N, Amersham) by capillary
action for at least 18 hours. DNA was cross-linked to the membrane and
hybridisation performed as described in section 4.2.7.
4.2.14. Northern Blotting
4.2.14.1. RNA extraction
Total RNA was prepared from macroschizont infected cell cultures or
piroplasms using Tri-Reagent (Sigma). All solutions and equipment were treated
with diethylpyrocarbonate (DEPC, Sigma) prior to use. 109 macroschizont infected
cells or 500pl pellets of purified piroplasms were mixed with 4 ml of Tri-Reagent
with a pipette until the lysate was fairly homogenous. After homogenisation, the
suspension was centrifuged at 12,000 x g for 10 minutes at 4°C (Beckman, Model J2-
21). The supernatant, containing RNA and protein, was transferred to a fresh tube
and left to stand for 5 minutes at room temperature. 0.2 ml of chloroform was added
per ml of Tri-reagent used. The samples were vortexed and allowed to stand for a
further 10 minutes at room temperature. The samples were then centrifuged at 12,000
x g for 15 min at 4°C to separate the mixture into 3 phases. The colourless upper
aqueous phase, containing RNA, was collected and 0.5 ml isopropanol added per ml
of Tri-Reagent. After 10 minutes at room temperature, the RNA precipitate was
pelleted by centrifugation at 12,000 x g for 10 min at 4°C and washed by adding 1 ml
of 75% ethanol per ml of Tri-Reagent, followed by vortexing and centrifugation at
7,500 x g for 5 minutes at 4°C. The final pellets were dried for 5-10 minutes at 37°C,
resuspended in 200 pi of 0.5% SDS and incubated at 55°C for 10 minutes. The
concentration of each RNA sample was then measured by spectroscopy.
Total RNA was extracted from the salivary glands of approximately 200 T.
annulata Ankara infected Hyalomma anatolicum nymphs, fed on rabbits for two
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days (Williamson et al., 1989; Hall et al., 1992). The salivary glands were dissected
under sterile conditions as described by Walker et al. (1979), put into 10 ml of Tri-
Reagent (Sigma) and kept at -70°C. When the mixture was thawed, the tick salivary
glands were homogenised using a Griffiths tube. After homogenisation, RNA was
isolated as described for cell lines and piroplasms.
4.2.14.2. Northern blotting and hybridisation
RNA samples were loaded onto 1.2% agarose gel to assess the integrity of
RNA. The gel tank (Pharmacia), combs and tray were thoroughly cleaned by
washing with dH20 and wiping with 70% ethanol. 195 ml dH20 were mixed with 3.0
g of agarose low EEO (Sigma) and boiled in a microwave until the agarose was in
solution. After cooling to hand temperature, 50 ml of 5x MOPS buffer (0.2M 3-[N-
morpholino]-2-hydroxy-propanesulfonic acid (MOPS), pH 7.0, 50mM NaOAC,
5mM EDTA) and 5 ml of formaldehyde were added and the gel was allowed to set
for 30 min. RNA samples (10 pg total RNA) were mixed with 4.5pl 5xMOPS buffer,
7.9pl 37% formaldehyde, 22.5pl formamide and RNAase free water (DEPC treated
water) to a final volume of 45pl. Samples were denatured by heating to 55°C for 15
min and 5pl of dye mixture (95% formamide, 20 mM EDTA pH 7.6, 0.1%
bromophenol blue, 0.1% xylene cyanol) were added after the samples were chilled
on ice. The samples were loaded onto the gel together with a 0.24-9.5 kb RNA
Ladder (Gibco BRL) and run at 100 Volts for 30 minutes followed by 35 Volts
overnight in lx MOPS buffer.
The gel was stained in 300 ml of dH20 containing ethidium bromide
(10p.g/ml) for 30 minutes and then washed in two changes of d^O for 15 minutes
each. Bands were visualised by exposure to short wave ultraviolet light (366nm).
Nucleic acids were transferred from gels to nylon membrane by capillary
blotting using 25 mM phosphate transfer buffer. Gels were not stained with ethidium
bromide in most cases except for the marker tract as ethidium bromide may interfere
with transfer efficiency. Gels were washed with distilled water while the nylon
membrane was soaked in transfer buffer (25mM phosphate buffer, pH 5.5) for 15
minutes. UV cross-linking and hybridisation were carried out as described in 4.2.
13.2.
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4.2.15. Preparation of Expression Constructs
Both the pQE (QIAexpress, Qiagen Ltd,) and the pGex (Promega) vector
systems were used to generate the expression constructs. In pQE vectors, the
recombinant protein is tagged with six histidine residues (His6) and in pGex it is
tagged with the glutathione S-transferase (GST). Where appropriate restriction sites
were available, subcloning was carried out directly into the correct reading frames of
the vectors. Where there were no appropriate restriction sites in the DNA fragment to
be cloned, oligonucleotide primers with suitable restriction enzyme sites were
designed to flank the region to be expressed.
PCR was carried out at 94°C for 5 minutes (1 cycle); 94°C for 1 minute, 55°C
for 1 minute, 72°C for 1 minute (30 cycle) and 72°C for 10 minutes (1 cycle). PCR
products were analysed on 1% agarose gels. The PCR products were ligated into the
pGEM®-T Easy vector (Promega) using a 3:1 ratio of insert to vector DNA
according to the manufacturer's instructions. Overnight cultures and plasmid DNA
were prepared from 18 white colonies. In order to confirm the presence of the correct
inserts, EcoPl digestions were carried out and examined by agarose gel
electrophoresis. Positive inserts were confirmed by sequence analysis using T7 and
SP6 universal primers. The inserts of the plasmid DNA were then released with
restriction enzymes specific for the sites created by the primers and purified from
agarose gels as described in section 4.2.9. Purified DNA was then ligated into either
pQE vectors (-30, -31, -32) (QIAexpress) or pGex vectors (5x-l, 5x-2) (Promega).
4.2.15.1. Production of soluble purified recombinant antigen using pQE
Expression Vectors
Ligations were transformed into Ml5 (pRep4) (Qiagen) competent cells
which were plated out onto LB agar plates containing 100 pg/ml ampicillin and 25
pg/ml kanamycin. The presence of inserts was tested either by restriction digestion
of DNA or by colony screening. Colonies were streaked out onto LB agar plates
containing ampicillin and kanamycin and incubated for 8 hours at 37°C. Nylon
membranes (Colony/Plaque Screen membranes, NEN-Life Science) were carefully
placed onto the plates, left for two minutes and the orientation of the membranes
marked with a needle. Once the membranes were lifted, plates were returned to the
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37°C incubator and left overnight. Denaturation, neutralisation and fixation of the
DNA on the filters were achieved as described in section 4.2.7. Hybridisation with a
radiolabeled probe (section 4.2.7) was carried out at 65°C. Overnight cultures and
plasmid DNA were prepared as described in sections 4.2.6 and 4.2.9. The cloning
junctions and the open reading frame of each construct were confirmed by sequence
analysis using vector specific primers. Screening of transformants for polypeptide
expression was then carried out using small-scale cultures.
Single colonies of transformants were grown for 16 hours at 37°C in LB
containing ampicillin and kanamycin.100 pi of each overnight culture was used to
inoculate 3 ml LB with antibiotics, and the cells were allowed to grow at 37°C until
they reached an OD6oo of 0.7. A 500 pi aliquot was then removed as an 'uninduced'
control sample and IPTG added (2mM) to the remaining culture to induce protein
expression over a 5 hour period. 500 pi of cells were removed as "induced" sample.
Control and induced cells were harvested by centrifugation at 15,000 x g for 20
seconds and resuspended in 200 pi of lx SDS-PAGE sample buffer. All samples
were boiled for 5 minutes and 20 pi aliquots analysed by 10% SDS-PAGE (see
section 4.2.2.).
To analyse the solubility of the expressed protein, 2 ml of overnight culture
were used to inoculate 100 ml of culture media and the cells were grown at 37°C,
while shaking, until an absorbance of 0.7-0.9 at 600nm was reached. Induction was
carried out as described above and cells were harvested by centrifugation at 4,000 x g
for 10 minutes, followed by storage at -70°C. Pellets were thawed on ice,
resuspended in 5 ml sonication buffer (50 mM Na-phosphate pH 8.0, 300 mM NaCl)
and subjected to freeze thawing in dry-ice/ethanol and cold water to assist cell lysis.
The suspension then was sonicated on ice for 5 cycles (20 second burst at maximum
amplitude/20 second cooling periods) and centrifuged (10,000 x g, 20 minutes, 4°C).
The supernatant was collected and the pellet was resuspended in 5 ml sonication
buffer. Samples collected before induction, after induction and following sonication
(supernatant and pellet) were analysed by 10% SDS-PAGE.
To purify recombinant protein under native conditions, a 500 ml culture
OD6oo=0.7 was generated and induced for 5 hours at 37°C by adding IPTG to 1 mM.
90
Cells were harvested by centrifugation (4,000 x g, 20 minutes, 4°C) and pellets
stored at -70°C.
Thawed cells were resuspended in sonication buffer at 5 volumes per gram of
wet weight and sonicated. DNAse I (0.5 pg/ml), phenylmethylsulfonyl fluoride
(PMSF, 0.1 mM) and MgCE (8 mM) were added and the lysate incubated for 10
minutes on ice. Following centrifugation at 10,000 x g for 20 minutes at 4°C, the
supernatant was collected and mixed with 3 ml of a 50 % slurry of Ni-NTA resin
(Qiagen), previously equilibrated in sonication buffer. The mixture was stirred at
room temperature for 45 minutes and loaded into a 1.6 cm diameter column. The
column was then washed with 100 ml sonication buffer and 100 ml wash buffer (50
mM Na-phospate pFI 8.0, 300 mM NaCl, 10% glycerol, pH 6.0) and the protein
eluted with 10 ml 0.1-0.5 M imidazole in Wash Buffer. 1 ml fractions were collected
and analysed on 10% SDS-PAGE. The fractions containing the purified protein were
then dialysed in several changes of PBS pH 7.4. The concentration of proteins was
estimated using the BCA Protein Assay kit (Pierce) according to the manufacturer 's
instructions. The protein concentration was calculated by spectrophotometric
absorbance at 562 nm against a standard curve, established using bovine serum
albumin standards ranging between 100 pg/ml and 2,000 pg/ml. The eluted proteins
were divided into small aliquots (50 pl-1 ml) and kept at -70°C. For western blot
analysis (see section 4.2.3), 1-10 pg protein was loaded per track.
If a recombinant protein was not soluble under the above extraction method
the bacterial pellet was resuspended in the EGTA solution (0.25% Tween-20, 0.1
mM EGTA) and sonication carried out three times as described above. The
supernatant was collected after each sonication and the pellet resuspended in fresh
EGTA solution. SDS-PAGE and western blot analysis of supernatants and the final
pellet was carried out using mouse anti-His-tag monoclonal antibody (Sigma). The
primary anti- His -tag monoclonal antibody was used at a dilution of 1:3,000 and the
secondary anti-mouse alkaline phosphatase conjugate (Sigma) at 1:10,000.
The methods described above were not always successful in generating
soluble protein. Therefore, the method of Frangioni and Neel (1993) was also used.
Following induction, cells from a 250 ml culture were pelleted and resuspended in 5
ml STE buffer (100 mM NaCl, 1 mM EDTA, 50 mM Tris.HCl pH 8.0) containing 1
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mg/ml of lysozyme. PMSF was then added to a final concentration of 0.1 mM and
the lysate was incubated at room temperature for 20 minutes with occasional stirring.
MgCb and DNAse I were added to a final concentration of 8 mM and lOpg/ml,
respectively. The lysate was incubated for a further 30 minutes on ice and then
sonicated. Triton X-100 was added to a final concentration of 2%, followed by
centrifugation (15,000 x g for 20 minutes at 4°C). The supernatant was collected and
fractionated on a Ni-NTA resin column as described above.
As a final method to obtain soluble recombinant antigen, purification of
proteins under denaturing conditions was utilised. The bacteria were grown and
induced as described above. Frozen bacterial pellets were thawed for 15 minutes at
room temperature and resuspended in Buffer A (6 M GuHCl, 0.1 M Na-phosphate,
0.01 M Tris.FICl, pH 8.0) at 5 ml per gram wet weight. Cells were stirred for 11
hours at room temperature and the resulting lysates centrifuged at 10,000 g for 20
minutes at 4°C. The supernatant was then mixed with 3 ml of a 50 % slurry of Ni-
NTA resin, previously equilibrated in Buffer A, stirred at room temperature for 45
minutes and loaded into a 1.6 cm diameter column. The column was washed with 10
column volumes of Buffer A, 5 column volumes of Buffer B (8 M Urea, 0.1 M Na-
phosphate, 0.01 M Tris.HCl, pFI 8.0), and 20 column volumes of Buffer C (8 M
Urea, 0.1 M Na-Phosphate, 0.01 M Tris.HCl, pH 6.3). Protein was then eluted with
20 ml of Buffer F (6 M GuHCl, 0.2 M Acetic Acid). 3 ml fractions were collected
and analysed by SDS-PAGE. Fractions containing the purified protein were then
placed into dialysing tubing and the protein refolded by sequential dialysis against
buffer with gradual dilution of Urea (6 M- 1M Urea, 0.05 M Tris.HCl, 0.005%
Tween-80, 2 mM reduced glutathione, 0.02 mM oxidized glutathione, pH 8.0)
(Jaenicke and Rudolph, 1990). The protein was dialysed overnight for each step.
After the concentration of urea was reduced to 1 M, it was completely removed from
the buffer. This was followed by the removal of glutathione and Tween-80 from the
solution. The protein was finally dialysed against with two changes of 0.05 M
Tris.HCl, pH 8.0. Protein concentrations were estimated as described above.
Two New Zealand White rabbits were inoculated with purified protein NC10-
Sspl3 by Prof. A. Tait (Department of Veterinary Parasitology, University of
Glasgow) to raise polyclonal sera against this recombinant antigen. The rabbit anti-
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sera were then used in western blot analysis and IFAT as described in sections 4.2.3
and 4.2.16, respectively.
4.2.15.2. Preparation and purification of recombinant antigen from pGex
Expression Vectors
Ligations were transformed into XL1-Blue competent cells, plated onto LB
agar plates containing 100 pg/ml ampicillin and incubated overnight at 37°C. The
presence of inserts was analysed by either restriction digestion of purified plasmid
DNA or by hybridisation to colony lifts as described in section 4.2.15.1.
To analyse expression from the pGex constructs, the small scale culture
method described in section 4.2.15.1 was adapted by altering the incubation period
following protein induction. Thus, for pGex expression, cells were grown for 2 hours
at 37°C after induction and the samples then processed for SDS-PAGE. The pGex
5x-l or the pGex 5x-2 vector in XL1-Blue cells was used as a positive control.
Fusion proteins were purified on Glutathione-Sepharose 4B columns
(Pharmacia) from lysates of E. coli by modifying the method of Smith and Johnson
(1988). Overnight cultures of pGex transformed E. coli were used to inoculate 500
ml pre-warmed 2xYT (Sigma) medium supplemented with 0.2% glucose and 100
pg/ml ampicillin. This was incubated for 2-3 hours at 37°C. Induction with 2 mM
IPTG was followed by incubation for a further 2-3 hours. Cultures were then
harvested by centrifugation at 4,000 x g for 20 minutes at 4°C. Pellets were
resuspended in 10 ml of cold PBS, 1% Triton X-100 (Sigma) containing protease
inhibitors (10 pM 1,10 phenanthroline, 0.1 mM PMSF). The suspension was
sonicated 9 times for 30 seconds on ice, at maximum amplitude of 6 microns, with a
30 second interval between each burst. The lysate was then centrifuged at 10,000 x g
for 20 minutes at 4°C. The resulting supernatant was added to 2 ml Glutathione-
Sepharose 4B, previously equilibrated in PBS, %1 Triton X-100. The mixture was
stirred at room temperature for 45 minutes and loaded into a 1.6 cm diameter
column. The column was washed with 50 ml PBS, 1% Triton X-100 and then with
50 ml PBS. Purified protein was eluted with 10 ml elution buffer (10 mM reduced
glutathione, 50 mM Tris.HCl pH 8.0) in 1 ml fractions and analysed by 10% SDS-
PAGE. The fractions containing purified protein were then dialysed against several
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changes of PBS, pH 7.4, at 4°C. Concentrations of the eluted fusion proteins were
estimated as described in section 4.2.15.1.
4.2.16. Indirect Fluorescent Antibody Test
An indirect immunofluorescent antibody test (IFAT) based on the method of
Minami et al. (1983) was performed using isolated T. annulata infected cells as
antigen. Cells in RPMI medium were harvested onto cytospin slides by spinning 100
pi of culture in a Shandon Cytospin at 240 x g for 5 minutes. When necessary, the
density was adjusted by dilution of cells in RPMI medium. Slides were then air
dried, and fixed by immersion in acetone at -20°C for 15 minutes. 20 pi of the first
antibody, diluted in RPMI medium at dilution of 1 in 100-400, was spotted onto the
fixed cells and the slides placed in a humidified box for 30 minutes at room
temperature. Unbound antibodies were removed by 2 x 5 minute washes in PBS. The
slides were then air dried before the addition of 20 pi fluorescein isothiocyanate
(FITC) conjugated anti-rabbit IgG raised in goat (Sigma; F-0511), at a dilution of
1:100 in complete RPMI culture medium. The slide was again incubated in a
humidified box for 30 minutes at room temperature, washed in PBS and counter-
stained with Evans Blue (0.1% in PBS) for 5 minutes. The slide was mounted with a
few drops of 50% glycerol/FFO containing 2.5% w/v 1,4 diazabicycloctane
(DABCO), pH 8.0. A Leitz Ortholux II fluorescence microscope and an Orthomat-W
Camera attachment were used to record the results.
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4.3. RESULTS
4.3.1. Identification ofMacroschizont Antigens by Western Blot Analysis
In order to define macroschizont antigens that could be candidates for use in a
diagnostic ELISA western blot analysis was carried out using antisera from animals
immunised with attenuated cell lines. Serum samples tested against protein extracts
from T. annulata Ankara D7 macroschizont infected cells and T. annulata Ankara
piroplasms are indicated in Table 4.2. BL20 extracts were used as negative controls.
Western blot conditions were optimised on the basis of serum, antigen and conjugate
concentrations (see section 4.2.3). However, non-specific background staining
observed with some of the pre-infection serum samples and with the uninfected
BL20 control could not be totally eliminated (Figure 4.1).
Serum samples obtained from animals immunised with attenuated cell lines,
except T. annulata Razi, strongly recognised piroplasm antigens, especially those of
estimated molecular masses of 30-37 kDa and 80 kDa. Figure 4.1 represents typical
results of the western blot analysis performed with sera indicated in Table 4.2. In
general, there was no strong recognition of schizont antigens by these serum
samples. However, a specific set of schizont antigens as well as piroplasm antigens
was recognised using sera from animals immunised either with non-attenuated cell
lines or sporozoites (data not shown). Sera from calves N57, N58 and 155 recognised
three major schizont specific antigens. Molecular masses of these polypeptides were
estimated to be approximately 130 kDa and 40 kDa (Figure 4.1 blot 11). These
polypeptides were absent in piroplasm extracts and were not detected with pre-
immune bovine sera.
Since there were no serum samples from calves infected with high passage
attenuated cell lines that specifically recognised macroschizont antigens, a second
approach was chosen to define macroschizont specific antigens. This approach,
which was based on a strategy of blocking the recognition of piroplasm antigens, was
initially tested on western blots using a rabbit antiserum (C9m) raised against T.
annulata merozoites. Thus, as merozoites and piroplasms are antigenically very
similar (Glascodine et al., 1990), preincubation of blots with the rabbit antiserum,
followed by incubation with bovine immune serum and an anti-bovine immune
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Table 4.2. Details of serum samples used to probe western blots using the T. annulata
Ankara D7 macroschizont infected cell line, T. annulata Ankara piroplasms and the
uninfected BL20 cell line as antigens. All these sera were obtained from calves
































































Figure 4.1. Western blot analysis of serum samples from animals immunised
with low and high passage cell lines. Calves 26A, 32A and 891A were immunised
with the T. annulata Ankara/Pendik (passage 317) cell line, calf 58 was immunised
with T. annulata Gharb (passage 5). Blots 1-3: calf 26A days 0, 28, 56; blots 4-6:
calf 32A days 0, 28, 56; blots 7-9 calf 891A days 0, 28, 56; blots 10-11: calf N58
days 0, 28.
B: BL20 cell line; D: the clonal T. annulata Ankara D7 cell line; P: T. annulata
Ankara piroplasm. 20 pi of BL20 and D7 and 5 pi of piroplasm protein extracts






























conjugate, would result in a reduction of piroplasm antigens detected but allow
recognition of antigens specific to the schizont stage. If successful, this method could
then be used to screen a genomic expression library. Serum samples from calves
N57, N58 and 155 were tested using western blots of BL-20, T. annulata Ankara D7
and piroplasm extracts. While the pre-incubation of these blots with several different
dilutions (1:10 — 1:500) of C9m rabbit serum eliminated only some of the piroplasm
bands or reduced to intensity of their reaction (Figure 4.2), the immune bovine serum
still reacted with several piroplasm antigens.
Another approach used to eliminate the recognition of piroplasm antigens
was blocking of antibodies against piroplasms in immune sera using piroplasm
lysate. After incubations of serum samples with piroplasm lysate, only a limited
number of piroplasm antigens were detected at high molecular mass (around 120
kDa in size) (Figure 4.3). Most of the reactions with macroschizont antigens were
also reduced by this methodology. Only one macroschizont antigen at about 40 kDa
was recognised strongly (Figure 4.3). This polypeptide was previously observed and
shown to exhibit size polymorphisms (Shiels et al., 1994; Shiels per. comm.). On the
basis of these results, the iinmunoabsorption technique using piroplasm lysate was
used to screen a genomic expression library in order to isolate the gene encoding the
40 kDa macroschizont specific antigen.
4.3.2. Attempted Cloning of the Gene Encoding the 40 kDa Macroschizont
Antigen
-An available kgtl 1 T. annulata genomic expression library was screened with
bovine serum-155 following blocking of piroplasm antibodies in the serum by
immunoabsorption with piroplasm lysate (see section 4.2.5). No positive plaques
were identified with this bovine serum (data not shown). The screening experiment
was not repeated with additional antisera or altered incubation times because of time
constraints. Since the 40 kDa protein shows size polymorphism and it is
immunodominant, it is possible that this protein could be related to the QP/PIM gene
of T. parva. If this were the case, isolating the homologue of this gene by screening a
cDNA or genomic DNA library with a QP gene probe would provide an alternative
cloning strategy.
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Figure 4.2. Western blot analysis of immune bovine serum after blots were
blocked with rabbit anti-merozoite serum. Blots 1 and 2: CalfN58 day 0 and day
58, incubated with rabbit anti-merozoite serum; blots 3 and 4: Calf N58 day 0 and
day 58, control blots. B: BL20 cell line; D: T. annulata Ankara D7 clonal cell line; P:
T. annulata Ankara piroplasm. 20 pi of BL20 and D7 and 5 pi of piroplasm protein
extracts loaded onto each lane. The numbers on the left indicate the molecular
weights of the marker proteins.
Figure 4.3. Western blot analysis of serum samples after immunoprecipitation
of piroplasm antibodies using piroplasm extract. Blot 1 was probed with immune
bovine serum (calf 155) after elimination of piroplasm antigens by
immunoprecipitation. Blot 2 was probed with immune bovine serum (calf 155) as a
control. B: BL20 cell line; D: T. annulata Ankara D7 clonal cell line; P: T. annulata
Ankara piroplasm. 20 pi of BL20 and D7 and 5 pi of piroplasm protein extracts
loaded onto each lane. The numbers on the left indicate the molecular weights of the
marker proteins.
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4.3.3. Establishing the Existence of a QP Homologue in T. annulata
4.3.3.1. Southern blotprofile ofQP/PIM
Southern blot analysis was carried out to test for the presence of a T. parva
QP protein gene homologue in the T. annulata genome. The genomic DNA from the
T. annulata Ankara D7 cell line, T. annulata Ankara piroplasms and T. pan>a
Muguga piroplasms was digested with Bamlil, EcoRl, Hindlll and Xbal.
Hybridisation of the Southern blot was carried out at 55°C using the QP cDNA
probe. The blot was washed with 1 x SSC, 5% SDS at 55°C and exposed to an X-ray
film for 2.5 hour and overnight. The blot was then washed at 60°C and 65°C and
exposed to film as above.
At low stringency (55°C), many DNA restriction fragments were detected on
T. parva genomic DNA (Figure 4.4 lanes 1-4) indicating the presence of many QP
related genes in the T. parva Muguga genome. Following high stringency washes,
there was only one band visible in all the digests, except for Hindlll as reported
previously (Baylis et al., 1993; Toye et al., 1995a) (Figure 4.4C). However, longer
exposure revealed several bands ranging from 0.5 kb to >12 kb (Figure 4.4D).
The QP cDNA probe identified several restriction DNA fragments ranging
from 0.5 kb to >12 kb in T. annulata Ankara, using both DNA from macroschizont
infected cells (representing a single parasite genotype) and piroplasms (Figure 4.4A
and B, lanes 5-12) at low stringency. Following high stringency washes, many of the
bands disappeared on T. annulata DNA. However, some of the bands between 3 kb
and >T2 kb were still visible on T. annulata Ankara piroplasm DNA following
overnight exposure (Figure 4.4C and D, lanes 9-12). The bands in lanes representing
the macroschizont DNA (lanes 5-8) were much fainter. This result is to be expected,
since the relative amount of parasite DNA loaded was significantly less in
macroschizont infected cell DNA than piroplasm DNA. These results indicated that
there are likely to be at least several genes in the T. annulata genome with homology
to the QP probe.
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Figure 4.4. Southern blot analysis of the gene encoding the QP protein.
Genomic DNA was prepared from T. annulata Ankara piroplasms (lanes 1-4), T.
annulata Ankara D7 macroschizont infected cell line (lanes 5-8) and T. parva
Muguga piroplasms (lanes 9-12). Genomic DNA was digested with BamHl (lanes 1,
5, 9), EcoKL (lane 2, 6, 10), Hindlll (lanes 3,7, 11) and Xbal (lane 4, 8, 12). The blot
was hybridised with the 32P labelled QP probe at low stringency. Washes were
performed first at 55°C (A and B) and then at 65°C (C and D). The blot was exposed
either for 3 hours (A and C) or overnight (B and D). Sizes of the DNA markers are
shown in kilobase pairs (kb).
123456789 10 11 12 123456789 10 11 12
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4.3.3.2. Analysis of the copy number ofQP related genes in T. annulata
The gene that encodes the QP protein has been reported to be single copy in
the T. parva genome (Baylis et al., 1993). Since Southern blot analysis of the T.
parva Muguga piroplasm DNA revealed many bands at low stringency, the
hybridisation pattern of the QP probe of T. annulata genomic DNA was compared
with that of a single copy gene, Tarns-1. This gene encodes the 30 kDa
merozoite/piroplasm surface antigen and was shown to be a single copy gene in T.
annulata (Shiels et al., 1995). DNA from T. annulata Gharb piroplasms and the
macroschizont infected cloned cell line (D7) were digested with several restriction
enzymes (BamYil, EcoRl, Hindlll, Xbal and PstT). The hybridisation of the Southern
blot was carried out at 55°C for both probes. The blots were washed first at 55°C,
then 60°C and finally 65°C. The QP probe detected several restriction fragments with
piroplasm DNA at low stringency as described above, although there was a decrease
in the number of bands with increasing stringency using the QP probe. In contrast,
the Tarns-1 probe hybridised to a single restriction fragment for each of the digests
(Figure 4.5) under low, medium and high stringency conditions. It was previously
demonstrated that Tarns-1 probe detects a single band with DNA of D7 cell line
indicating that the Tarns-1 is a single copy gene (Shiels et al., 1995). Figure 4.5D
shows the results of Southern blotting after the 60°C washes using DNA from the D7
cell line. Two strong bands were detected for each restriction enzyme digestion
indicating that the T. annulata genome may contain more than one gene that is
closely related to the QP probe.
4.3.4. Cloning and Characterization of the QP Homologue of T. annulata
A X ZAP cDNA library of the T. annulata Ankara macroschizont infected
cell line D7 was screened in order to isolate the T. annulata homologue of the
QP/PIM gene using a cDNA probe. Hybridisation of the library with a 1.7 kb EcoBl
gel-purified QP gene fragment was performed at 55UC and the filters were washed 3
times at 55°C with 1 x SSC, 5% SDS for 20 minutes. A total of 64 positive plaques
were picked from the first round of library screening. 24 positive plaques, randomly
selected, were taken to subsequent rounds of screening. Of these, 14 consistently
hybridised with the probe and were purified to homogeneity.
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Figure 4.5. Analysis of the copy number of QP related genes in T. annulata.
A-C) Genomic DNA was prepared from T. annulata Gharp piroplasms. DNA was
digested with BamBl (lanes 1, 6), EcoBl (lanes 2, 7), Hindlll (lanes 3, 8) and Xbal
(lane 4, 9) and Pstl (lanes 5, 10). The blots were hybridised with the 32P labelled QP
probe (lanes 1-5) and Tams-1 probe (lane 6-10) at low stringency. Washes were
performed first at 55°C (A), then at 60°C (B) and 65°C (C).
D) Genomic DNA from the clonal T. annulata Ankara D7 cell line was digested with
BamYll (lane 1), EcoBl (lane 2) and Hindlll (lane 3). The blot was hybridised with
the 32P labelled QP probe (lanes 1-5) at 55°C and washed at 60°C. Sizes of the DNA
markers are shown in kilobase pairs (kb).
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The inserts of X ZAP phage clones were then excised into the pBluescript
plasmid (see section 4.2.8) and the size of the inserts was estimated by restriction
digestion with Smal and Kpnl and agarose gel electrophoresis. Southern blot
analysis of the gel with the QP probe confirmed that the inserts were related to the
QP gene (data not shown).
Initial characterization of the 14 clones was carried out by sequence analysis
of the 5' and 3' ends of each insert. The X ZAP cDNA library was constructed so
that the 5' end of the Theileria cDNA inserts were ligated into the EcoBl site and the
3' end ligated into the Xhol site of the vector. This orientation of the cloned cDNA
inserts was confirmed as tracks of poly A sequence were seen at the 3' end of each
clone. Comparison of the 14 nucleotide sequence with each other resulted in the
establishment of four distinct groups of cDNA clones (Table 4.3).
Group 1 (called NCI) consisted of 9 clones. One of the clones in this group
(NCI 1) has an additional 33 bp insert at the position of 1804 on the NCI consensus
sequence that did not align with the sequences of the other clones in this group. The
nucleotides 5' [GT AG] 3', flanking this insertion, suggested that it represents
an unspliced intron.
Group 2 (called NC10) consisted of three clones, which were identical at the
3' end. Although the size of the insert of clone "NC5" was smaller than the remaining
two clones in this group, the 5' end of the sequence did not align with that of the
other two clones.
Group 3 (called NC2) and Group 4 (called NC9) consisted of only one clone
each.
The sequence obtained for the 5' and 3' end of each clone was compared with
the sequences in the EMBL database. The sequences from groups 1, 2 and 3 did not
have any significant homology to any known gene. However, the sequence of NC9
had a high homology score with a bovine ribosomal protein gene (97.2% identity
over 686 bp).
4.3.5. Genomic Arrangement of Genes Isolated from the cDNA Library
To determine the organization of the genes isolated from the X ZAP cDNA
library, Southern blot analysis was carried out using genomic DNA from both
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Table 4.3. Groups of cDNA clones isolated using QP protein probe from X ZAP cDNA
library of the T. annulata Ankara D7 macroschizont infected cell line. The sequence
analysis of the 5' and 3' end of each clone was carried out using T7 andMl 3 primers.
Group cDNA clone Size/Kb
NCI, NC6, NCI6, NC19,
NC21, NC22, NC23
3.4







Group 3 NC2 3.0
Group 4 NC9 2.2
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piroplasms and the D7 cell line. Bovine DNA from the uninfected cell line BL20 was
used as a control. The DNA inserts of plasmid clones, NCI, NC10 and NC2, were
released with Smal and Kpnl and used to probe Southern blots at 55°C followed by
washing at 55°C (low stringency) and then at 65°C (high stringency).
4.3.5.1. Group 1 (Clone NCI)
The cDNA clone NCI hybridised to several restriction fragments in each of
the digests of both macroschizont and piroplasm DNA at low stringency. The
molecular sizes of these fragments ranged between 0.7 kb and >12 kb (Figure 4.6A).
However, one of the bands in each digest was stronger than the other bands, except
in the Bamlil digest where two strong bands were observed. A single band remained
with digests of the macroschizont DNA following washing at 65°C, except for the
Bamlil digest (Figure 4.6B).
The hybridisation pattern detected by clone NCI differed between the Bamlil
digestion of macroschizont and piroplasm DNA. Four DNA fragments were detected
in the piroplasm DNA, i.e. a 0.7 kb fragment, a doublet at approximately 1.6 kb and
a large fragment (>12 kb). The 0.7 kb band was not present in the digest of
macroschizont infected cell DNA and there was only a strong single band at 1.6 kb
as well as a large band (>12 kb) which was slightly smaller than the equivalent band
observed in the piroplasm track. Sequence analysis of NCI clone revealed the
presence of an internal Bamlil site in the cDNA clone, indicating that the gene
represented by clone NCI is likely to be single copy gene. Differences in the
hybridisation pattern between macroschizont and piroplasm DNA is likely to be due
to restriction fragment length polymorphism (RFLP) between different genotypes of
the parasite population. The results indicated that the major genotype present in the
piroplasms differs from the D7 cell line with regard to the Bamlil RFLP while the
other restriction sites are conserved between D7 and major piroplasm genotypes. No
hybridisation was detected with bovine DNA under low or high stringency
conditions, indicating that the cloned insert represents a parasite gene and that it is
not of bovine origin.
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Figure 4.6. Southern blot analysis of the T. annulata NCI clone. Genomic DNA
was prepared from the uninfected BL20 cell line, the clonal T. annulata Ankara D7
cell line and T. annulata Ankara piroplasms. DNA was digested with BamUl (lane
1), £coRI (lane 2), Hindlll (lane 3) and Xbal (lane 4). The blot was hybridised with
the 32P labelled NCI cDNA probe under low stringency condition. Washes were
performed first at 55°C (A) and then at 65°C (B). Sizes of the DNA markers are



































4.3.5.2. Group 2 (Clone NC10)
The cDNA clone NC10 hybridised to several restriction fragments in digests
of both macroschizont and piroplasm DNA at low stringency. The sizes of these
fragments ranged from 0.2 kb to >12 kb (Figure 4.7A). For DNA of the
macroschizont cell line, a single restriction fragment remained visible following
washes at 65°C, except for the Xbal digest (Figure 4.7B). Three strong and two weak
bands were observed with the Xbal digest. Sizes of these fragments were
approximately 0.2 kb, 0.55 kb, 2.5 kb, 3.1 kb and 4.1 kb. Sequence analysis
demonstrated that there are three internal Xbal sites within the region covered by the
cDNA probe. These Xbal sites were located at nucleotides 2424, 4142 and 4349 of
the NC10 consensus sequence (data not shown). Data obtained from the genomic
sequence showed that there was another Xbal site located at nucleotide 1910. On the
basis of this information, four restriction fragments, 207 bp, 514 bp, 1718 bp in size
and another fragment with a minimum size of 1 kb, would be expected. Therefore,
the 0.2, 0.55 and 4.1 kb fragments detected by Southern blotting matched the
estimated sizes of the fragments determined by sequence analysis. However, a strong
band at about 2.5 kb and a faint band at about 3.1 kb were larger than expected. The
PGR amplification and preliminary sequence analysis of part of the 1.7 kb fragment
revealed an intron of approximately 750 bp (data not shown), thus increasing the size
of this Xbal RFLP fragment from 1718 bp about 2.5 kb. Therefore, the 3.1 kb faint
band could be the result of a partial digest of the 2.5 kb and the adjacent 514 bp
fragments. These results would suggest that the NC10 gene is a single copy gene.
Alternatively, the 3.1 kb band could be due to the presence of another NC10 gene in
the T. annulata genome or a gene that is closely related to NC10.
The analysis of the piroplasm DNA also detected several bands under high
stringency conditions in all digests except Hindlll. One of the bands in each digest of
piroplasm DNA was at the same size as that observed in macroschizont DNA. This
indicates that it is likely that for these enzymes RFLPs exist in the major parasite
populations represented in the piroplasm DNA with BamYll, EcoRl and Xbal. No
bands were detected with bovine DNA under both low and high stringency
conditions indicating that the gene is of parasite origin.
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Figure 4.7. Southern blot analysis of the T. annulata NC10 clone. Genomic DNA
was prepared from the uninfected BL20 cell line, the clonal T. annulata Ankara D7
cell line and T. annulata Ankara piroplasms. DNA was digested with BamHl (lane
1), EcoRl (lane 2), Hindlll (lane 3) and Xbal (lane 4). The blot was hybridised with
the j2P labelled NC10 cDNA probe under low stringency condition. Washes were
performed first at 55°C (A) and then at 65°C (B). Sizes of the DNA markers are



















4.3.5.3. Group 3 (Clone NC2)
At low stringency the cDNA clone NC2 hybridised to many restriction
fragments in digests of both macroschizont and piroplasm DNA (Figure 4.8A). The
size of these bands ranged from 1.2 kb to >12 kb. Following high stringency washes
at 65°C, many of the bands were removed leaving only a single restriction fragment
for the BamHI digest (Figure 4.8B). The presence of internal restriction enzyme sites
for EcoRI, Hindlll and Xbal was confirmed by digesting the NC2 plasmid DNA with
these enzymes. On the basis of the BamRl digest and the presence of internal sites in
clone NC2 it is likely to be a single copy gene with related DNA sequences in the
genome. On the other hand several bands observed with each digestion could be due
to the presence ofmore than one NC2 gene in the genome.
4.3.6. Full Length Nucleotide Sequences
One representative clone, with the largest insert, from each group was chosen
and fully sequenced on both strands. Clone NCI was chosen from Group 1 and clone
NC10 from Group 2. It was not possible to sequence the clone in Group 3 because of
time constraints.
4.3.6.1. Nucleotide sequence determination ofclone NCI
The cDNA clone NCI had an insert of about 3.2-3.4 kb. Exo III deletions of
this insert were generated using the methodology outlined in section 4.2.12. For the
reverse orientation of the insert, there were no appropriate restriction enzymes to
generate the deletions. In order to create appropriate sites, the insert was released
from the pBluescript vector, ligated into pGem 7zf(+) and Exo III deletions were
made.
Sequence analysis demonstrated that the insert is 3192 bp long, has a single
open reading frame (ORF) of 2280 bp that starts from nucleotide 691 and extends to
a stop codon ending at nucleotide 2970 (Figure 4.9A). The cDNA encodes a protein
of 760 amino acids (Figure 4.9B). The ATG start codon at the beginning of the ORF
(at the position 691) is the 17th 'ATG' in the cDNA.
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Figure 4.8. Southern blot analysis of the T. annulata NC2 clone. Genomic DNA
was prepared from the uninfected BL20 cell line, the clonal T. annulata Ankara D7
cell line and T. annulata Ankara piroplasms. The DNA was digested with BamHl
(lane 1), EcoBl (lane 2), Hindlll (lane 3) and Xbal (lane 4). The blot was hybridised
with the 32P labelled NC2 cDNA probe under low stringency condition at 55°C.
Washes were performed first at 55°C (A) and then at 65°C (B). Sizes of the DNA






















Figure 4.9A. The nucleotide sequence of the NCI gene. The numbers represent the


































































GGCACGAGTA TTGTTACTGT CGATTGTTCT ATTATCTATC CTAAAAATAT
CGCATGCTTC CGATAAAGAT CCACAGAAGG ATCCACAAAA AAAGGATGTT
GATCCTTTAC ACCATGTAAA TGTTCATTTA AGACTTGTGC AAAGGTTATT
TTCAAGGGAC TCTACTCAAT TACCTGATCA ACCTCAGCCT GAGCCTATTG
GTGAACCTGA ATATGAGGAA TATGAGGAGG AATCGGACGA TGAAGAACTT
GCAAGAAGTA TACTCGAAGA AAATGAGGAA CGGAGCAAGG AAATACAAAA
ATGCAAGATC CAAAGTCTTG ACTTTTCAGA ACAAGATCTT GTAATGATGG
TTATAGAAGA AATGGAATCT AAATCAGATG ATGAAGGGGA AGAAGGAAGT
GATGAAGGTC ATCATGAGCC AGATCAACAG GAGAAAGAGG GAAAAAAGGA
AGAAACAAAG AAACGAAAGA AAGTAGACGA TACTGATGAT GAAGAACAAA
AGGAAACCGA AAAAAAGAAG AAACCTAAAC ATCAAGATAA ACCTGAGGGG
TACCCCAAAG ACCTACACCG AAACCTAGAA CTAAACCAGA TACCAAGCCG
AAACCATCAC CAATACCTAA GCCTAGAACT AAACCAGTTA CGATTGAAAA
ACCATCACCT ACACCCAAAC CTAGAACTAA ACCAGGTACG ATGGAAACCC
CGTCACCTAA GGCTGTGCCA CCTCCAAAAC CTAAACGCAC GAAAAAACCA
TTAGCTCAAA CTGCACCTGT GGGATCTGAG GAAAAAGAAG ATAAGAAGGT
TGAGGATACT GAACCAAAAC CTCAGGAACC TATAACTGAA ACAAAACCTG
AACCAGAGCC ACAACAACCG CAACCGATAA CTGAACCAAT AACTGAACCA
CAACCAAAGG AACCTGAACC TGAAGAACCT AAAGAACAAT CAATGCCAGA
ATCTGGACCT GAAGGACCTA AGGAGACAGA AGATAAAGAT GCAACGGGAC
CAGAAGAGCC TAAGCAGACA GAGCCTGAAC ATGAAAAACC AAAGGAACAA
GATGATACTG AACCAAAACC TGATACAGAG CATGAACATG AAAAACATGA
CTCACAAGAA GATAAAGATA CCAAGGAACG TCAGGAACAA GAGGATTCTG
ATAAGAAAGA TGATTCTGTT CCAGAACCAG AACCAGAAGA ACCCAAGGAT
ATTGACCATG TAGATGTGGA TGAACCAGAA CAAGAGGAAC AAGAGGATTC
TGATAAGAAA GAAGATGAAA CTGAGGATAA ACATGAACCT CCAAAGGAAC
AAGAAGATAT GGAGGCTGGG GATACTGAAC AAGAACCACA ACCACAACCA
GAAGGACAGG AGGAAACTGA ACCTGAAGTA TCAAAGGATA CTGAACCAAA
ATCAGAACCT ATACAAGATC CTATACCTGA CACAAAACAT GAAGATGAAC
AGGAACAAGA GGATTCTGAT AAAGAAAAAC CTGATGCTGT CCCAGAAGAG
CCTAAGGATA CTGACCATAA ACAAGAATCA GAAGAAGACA AAGATACCAA
GGAACCAGAA GAGCCTACTC AACCTACTGA ACCTGAACCT GAACCTCAAC
CTCAACAAGA GGTACAACCT GAGGAACCGA CGAAACCTCA GCCCCAGGAG
ACTAAGGATC CTGATGATAA GCAGGAAGAA GAAAAGAAGC CTGATCCTGG
GGAAGAAGAT CGAACTGATT TGGATAAAGA TGGACAAATG AAAACACCTG
AGAAAATGAA ACCAGAGGAT ATTGGGGGAC CTGAATTTCC AGAGCCAGTA
GATCAATCCA CGCCAAATAC TGTTAAACCC CCTATATTCG ATAAAGATCG
CATAAAAACA CCTAGATTAG TCTTTTTGAC TGATGATGAT GACGGCGAAG
GATCTGAACC TACTAAAAGA AGAAAGCCAT TCTTAATCTA TGATAGGCCT
GGAAAAACTC CAAGAAGACC TAAGAAGAAA AAGATTAAAC AGCTTTTTGA
GCATGATGAT GATGGTGACG GTGATGATGA AGATGAAGAT GAAGATGAAG
AAAGTGATGA AGCTGAAGCT GAAATTCATA CAAGTGGAAC AAAAGATAGA
AAAGATGACG GTGGAGATAA AGATGACGGA AGTGGAGGTT CAGGGGGTGC
AGGCCCAACT CCTTCAACAG ATGAAAACAA CCAGGCTGGT GGTAGTGGAA
GTGGAGAGGC AAAACATGAT GATAATGGGG ATTCAAATAC AGGAGGGTCC
AAACAATCAG ACACGGGAAA TGGAGATGAT AGTAAAGATA AGGATGAAAA
ACAGCAAGGT GAGGATGAAA AAGAAAAAGA AAAGGAGAAA AAGGAAGTTG
AGCAAAAACT TCCTGTAACT GAAACACCCA GTACACCAGC AATATCAAAC
CCAGTAACTA AAACACCTAA AACACCAAAA AAACGAAGAC GACCATCTAA
GATACCTATT AAACAAACAA AAGTGAAACC AGCATCAAGA CCATCAACGA
CGCCTGGTAA AGGACCATTT AAAAAGCCAA TAGTAACACC TGGTGGACCA
TCAATAGTGA AACCAGTATC AAGACCATCA ACTTCAAGGC CATCATCTAC
CACACCACCA ACTACAACAT CCGGAAGACA ACCTCCTAAA AGTGATGATC
GAAGATCATC TCAACCACCA AGACCCCCGT TTGTTGTACC ATGGGCAACT
AAAGAAATAC TCACTAAGGG TGCAACAAAA ACGCCACAAC AAGAACAAGG
GACACAATTC TCTACAGAGG ATAGAACAAG AGAACAAGGA AAAAGGGCAG
GAGGTGAAAC AAGGCCTGAT ACATCAAAAG GAGCAGTAGG TGAAGGAAGA
TCTAGAAGAT CACAAAGGTT ATCAGCTAGA GGAACACAAA ATACTTCATC
TTCGGCAACA AGAGAAACTA GAGGAGCTAG ATCCGAGAGC ACATCGCGAA
ATAGAAGGAA TAGCAAATAA TCAGTCAAAT TAAAAATGTT AATTATAACA
AAACCATTGA AACTAATGGA TAATAATGCA GTATGTGGAT TCCAAAAGAA
AAAAGTCGAA GAATATAGGT GTAATTTATT TCTTAAAACA TTGTTTTGGA
GTTTAAATTA ATAGTTAAAA AGTTAATGAG ATTAATTAAT CGTATCACAC
TAGATGTATG TAATTTATTA GAGAATAAAA AAAAAAAAAA AA
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Sequence homology searches with the NCI sequence in the EMBL
database showed that the NCI sequence had low homology to the cell surface
glycoprotein 1 precursor of Clostridium thermocellum (26.4% identity in a 732
amino acid overlap), the glutamic acid-rich protein procursor of P. falciparum
(21.9% identity in a 565 amino acid overlap) and the sporozoite surface protein 2
precursor ofP. berghei yoelii (23.0% identity in a 534 amino acid overlap). There is
also some homology to the circumsporozoite of Plasmodium spp.
4.3.6.2. Nucleotide sequence determination ofclone NC10
The cDNA clone NC10 had an insert of approximately 3.5 kb in size. ExoIII
deletion series were generated to allow sequencing of both strands. For the reverse
strand a 1 kb Kpnl and Xhol fragment was subcloned into pBluescript. ExoIII
deletions of this subclone and the remaining 2.5 kb insert were then carried out as
described in section 4.2.12.
Analysis of the sequence data demonstrated that the insert of clone NC10 is
3.4 kb in length and an ORF extends from the first base through to nucleotide 3100
where a TAA stop codon exists. The insert of the NC10 lacked a start codon and to
obtain the full ORF it was decided to clone an upstream genomic DNA fragment. For
this purpose, a 600 bp BamlAl / Stul fragment derived from the 5' end of clone NC10
was used to probe a Southern blot. The BamlAl site was located within the polylinker.
In order to increase the amount of parasite DNA isolated from macroschizont
infected cells, T. annulata Ankara D7 macroschizont infected cells were incubated at
42°C for 5 days, a procedure which greatly increases the number of parasite nuclei
per infected cell. The parasite enriched DNA was digested with restriction enzymes
that cut near to the 5' end of the NC10 insert clone but not within its first 600 bp or
very close to the Stul site (Apal, Dral, EcoRN, Stul, Xbal). Digests were separated
on duplicate agarose gels. One gel was used for Southern blotting and probed with
the 5' BamlAl / Stul fragment. Hybridisation and washes were carried out at 65°C.
Southern blot analysis identified a 2.5 kb fragment for both Dral and EcoRN
digestion, a 0.5 kb fragment and a 10 kb fragment for Xbal and Stul digestion,
respectively. A very faint and fairly large DNA fragment, about 14 kb, was identified
for the Apal digestion (data not shown). From the duplicate agarose gel, DNA
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fragments of sizes identified for Dral, EcoRV and Stul were excised and purified
using the "Gene Clean 2" kit. The purified DNA fragments were ligated into pGem
7zf (+) cut with Smal. Following transformation, colony lifts were taken (see section
4.2.15.1) and probed with the 600 bp Stul/BamHl fragment. Two positive colonies
were obtained; one from the Dral and one from the EcoRV digest. Sequence analysis
showed that both had an insert of about 2.6 kb.
Nested deletions were created with Exo III digestion for both strands of the
insert derived by Dral digestion. The genomic clone was 2.6 kb of which 600 bp
were identical to the cDNA clone. The sequence of the genomic DNA revealed an
ORF beginning at 442 bp. The combination of the genomic DNA sequence and the
cDNA sequence generated a 5,400 bp sequence that contains a substantial ORF
located between nucleotides 480 and 5,063 (Figure 4.1OA) and it encodes a protein
of 1,540 amino acids (Figure 4.10B).
The predicted NC10 protein sequence consists of interspersed tandem repeats
of amino acids within the central region of the polypeptide. These repeats, underlined
in Figure 4.10B, overlap in some instances. Tetrapeptide sequences similar to those
observed in the QP protein /PIM (Baylis et al., 1993; Toye et al., 1995a) were also
present. The sequence QPXP (X being F, Q or P) is found three times. The sequence
QPXQ (X being G, P, Q, F, S, T, N, L) occurs 19 times; QQXQ (X being P, T, G, S,
Q or N) occurs 12 times; and QGQX (X being F, P, G, Y or I) is found 11 times.
There is also an eight-amino acid repeat, q/tGYYq/gPXq/p (X being S, P, G, T or N)
which occurred eight times.
- A search of the amino acid sequence databases with the predicted NC10
polypeptide revealed that the best similarity is to wheat glutenin (31.1% identity in a
679 amino acid overlap AC P08489), then to the calcium binding protein of
Dictyostelium discoideumi (37.6% identity in a 388 amino acid overlap AC: P35085)
and to human procollagen alpha 1 (V) chain precursor (24.8 % identity in a 706
overlap AC: P20908). There are also some small regions of homology to the
circumsporozoite surface antigen of Plasmodium knowlesi, P.berghei yoelii and P.
simium.
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Figure 4.10A. The nucleotide sequence of the NC10 gene. The numbers represent
the sequence position with reference to the most 5' base. ATG start and TAA stop

































































GAATTCGGTA CCCCAAATTC ATCATTTAAT CTTGTGTAAA TTAGGATTAT
TGTAATCAGT GTCAGTGAAT AAAATATAAC GTATAATGGT ATATAAATTG
TTTTATTTGA ATATTAAGAT CATTTGATTG TATTTTATAA AATAATTCAC
GAATGCGTTT TATCTAAAAC TGCATTCGGA AAAATCGACA AGATTTAGAT
TAAATCAAAA GAAAAAATTC TGAAATAACA AATTGATTTA TTTTTATATA
TAATGAAAAA GTTAGTTAAT CGAGGACAGA TTAAGTAATT AATTACACAC
AATTGGCAGT A'i'AAGTGATA TAAGGTCGAG AGTGGTTAAG AAAAGTTCGA
GACTATTTCA GCATATTATA CAGAGGTTAT GTGATTCAAT AACGTAACAG
AGCAAAATAC CCTCAAATTG TTTTTTATTG GTATATGAAG AAATGAAATC
GTTAATAATT TATATTTACA TAATTAAAGT CTTAGTTTAT TGCGGAAGAT
TTGCTATCTT TGATGTAAAG GGCATTTATA ACACAGTTCA ATATATATTG
AGGAAAAAAT CCGACAACTC TCTCCTGTGC ACTATTCTTA ATGTTAAAAA
GAATAATGAG TTGTATGGAG TAGTGAGCAA TGATGAAATA TTGTGGATTA
AGCAATCAAA AAAGGAAGAG TGTCAAGATG TGTTGGTTAC AAAACATCAG
GGGAAGGCTA AGCTGGCGCT GCTTCAGATC CAACACTTCA AGAGCTTTTA
TACTGTAAAA AGATTAAGGT ACTTTTTAGG TATATGGGTA CCAGTAAGCA
AAGAATTATA TAATAAAATA GATAAAATTA TATCTTGGAA GTTTGATTAT
AAAGAATCTG AAATCAGTGT GGAATTAACA GAAGAATTTG ATACAGCTGG
ACTTATGGTG AACAATTTCT TTATCAATGA AGAAAATAAA ACAAGGTTGT
ATCCACGACC AGGGTTCAAA ATAACTTTAG TTAACTATAG AAATAATGAG
TTATGGTCAA AAAATGATTA TCAAGAGGAG GCCATTCAAA TCGAAATTGT
AAAAACAGAT TCAAAAATAC AACGTCTTTA CGTAAGATAC GAGACTTATT
ACGGAACAGC AGATACTATT TATTATAAAT GTTATCCGGA ACTAAGAAGG
GTGGATAGAA AAGAGTATTT CATGGATGAT GATGACGACG ATGACGATGG
AGATGATGAT TATTTACCAG ATGGAATTGA TAGGTATAGA AGAATAGGAA
CAAGAGACGT GGATTCAAGT CACGGAACTC AACCTGGTGG ATCAAGTCAA
ACCGGAACTA CCGATCAAGG TACAGAGGAT CAAGATCAGA GAGCAAGTAG
TCCTGTTTAT TATGGAGTAT CAGAGCTTGT TCCACTACCA CTTGGCACAA
GGCCGGCCAC ACCCTTACCT ACCCCGTCAA AACTGGTGGC TCCAACTCCA
ATTAAACATT TCCCTGAGGG TATTATTCGT TGTTTTCATG TCGAAACTTT
TAGTGAAATT GGATTGGTCC CCCAAAAAAC TGCTAAACAA AGAGAAGCTG
CTAAACAAGT AACTATTCGA GTAGGTGGTA CAGATGATTC TCAAGGACAA
TCTGAGCCAA CTCATTATAT ACCACAACAT ACTGAGGCTG TGTCACATGG
TACACATTAT ACCCCAGGTC AAGTTACAAG ACATCCTACT CAGCCAATTC
TAAGAATGCC GCAGCAGACT GCTCCTAGGC CAACAGGGCG GCCAAGACAT
GCTCCCCCAG TTCCACATGT TCCAACACAA CCATTTCCGA CTACTTTAAT
ACAACCGCCG CCGCCAAGAC CATCCGGAAT TACACCTTAT AATATAATTC
AGGGGATTGG GCAACAACGA TTTCCAACTT CCCAGACAGA CAATAGAGCA
GAGCAAGGCT CTAGAACAGG ATCAACTACT TCAAGTTCAA CACCTACTAA
CAAAGACAAT AGTAAAAAAA CAACTGATGA CAGCGATTCA GATGGCTCAG
ATCTTTTTGA TATTCAAGAG ACTGATGTTG TTACAGAAGT TCCCGAAAGT
GACACTCGTA TAGATGAATT TCTTAATATG ATAACAAAAA CAGTTACGAG
TTCGACTACA AGTGTAACCA CCACATCCAG ACAAACGGGT CAAGCATCGA
AGGCCATTGT TGCGATAACA TCAAGTACTC CACAACCAGG CACTCAATTT
GGAGATGCTT CAGGGTTAAG TCTATTTTCA TCAGGTGAAC TCACTAGGGC
AAGAGAATCT GGAGGATCAG GAGGAATGCA TGCCATTAGT GACTCCACAG
TGAGTAGTAC GGTATCTTCG TGGGATTATT CAAATGCAAA TCCGTTTCAG
GATTATATAG ATATAGGGCA AATCCCAGAG GTTGTAACAT CTGACTTTAG
CCAGGAAGAA ATTGAACTGG CTTCTAGATC ATTAACAAGT TCAATTGAAA
GTGGTAGAAC TGGGAGCAGT GGTGATCAAA CTCCAACTCC GGGTCAAACG
TTTTCACCGG CCATTATGGG TGATGGCAGA ACCCCCAGAT ATCCTAGCGC
CCCCAGTGTA AGGCCTCAAT TTGGAGTTGA AGGTGGTTTA AAGAACGTTA
TTGTTAGACC AAGCTCTCTA ACTGGTACAC AAACGGTTAG GGCCCCAGTG
GTTAGAGCCC CAGTGTTCAT GCCACGTGAT CCTGAAACTA GATCCGAGTA
CGAGGRACCA CCACGTAAGA GACCAAATAC AGGACAAACG GTTCAACCAT
TTCCACAACC TCAACCTCAA CCTGGGCAAT TTCAATATCA GCCTCCTCAA
GCTCAACAAC CTCAAGGACA ATTTGGGCAG GGGCAATTTC AACCTTCACA
AACTCAATTT TCCCAAGGTT ATTATCAACC AAGTCAGCAA ACTCAACAAA
ATCTTGGGCA GTATGGGCCG AGTCAAGGTT TTCAACCTCA ACAAGGTACA
GGTTATTATG GGCCTAATCA ACCTTTCCAA CCTCAACAAC AAGGACAATT
TACTCAAGGA CAACCATTCC AAGGACAAGG TGATCAAGGT CAGGGTTATT
TTCTATCTAT GTTACAAGAA CAAGATCCAT ATAACTCAGG CCAACAATCA

















































ACCAAATCAG GGCCAATATT CTCAAGGTTA TTATGGACCC AATCAACCTT
TGCAACCTCA GCAATCCCAA CCTGGGCAGG GTTATTATCA GCCTCCTCCT
CCTCAACAAC AACAACCTCA AAATCAATAT CATCAGGGGT ACTATGGACC
TAATCAGCCT CAACAAAATC AGGCTCAACA GGGACAAATT CCATATTCTC
AGGGACAACC TACTCAACAA CCTCAAGGTT ATTATGGTCC TCCTCAACAA
CAGCAAACTC AAGGTTACTA TCAACCTACT CAACAACAAC CAACTCAACC
TCAATTTTCA CAGGGTTATT ATGGACCTAA TCAAAATCAA CCACCTCAAG
GACAATTTGG ACATGGACAA CGTCAACAAC CTCAAACAGG ATATTCTCAA
GGTTATTATC AACCTGGCCA AAATACAGGA ACACCAAATA CACAGACTCA
GAATATTGGT TCAACTCAGC AACAAGGCAG ATATGGTGAT AATTCAAATG
GAGAAGATAA TCAGAGTAGT GATGATGAAG ATGGTGATAA TTTTTTGGTA
ACAGAACAAA CTGAGAAAAC AACTGGAGGA CCAGATACCG GCGCAGGTTC
CACCCCTCCA GTTCAGCAAA GACCAGTTGG TTCCCAACGA CCTTTAGTTC
GTGCGCCAAT TTACAGACCA CCAACAACTC CAGTAGGACC AATAAGCCAA
CAACCACCAG TAAGCGGTGT TGGAGGGAAA AGGAGATTAC AAACCGCTCC
GACCCATTAT ATTCCAGAAA ATGCACGTGG TGATCGGACA GGGTTAGGGC
CTGAAAATTC AGGTAGAACT CGGCCAACCG CTCACGGTAA TAATTATGTT
CCAGTATATA AACGACCGCG CCAATCTCAA GGTTTAGATT TTCCTGAAGA
AGATCCTGAA TATGAAGATG ACAATGACGA CGCAGAATCT TTTATACTGA
ATGTCAACTC CGATGTTGAA GAAACAGAAG ATACAGAGCG ATCTAGAGAT
AAAACTGCAC AACCTAGGCC ACAAGTGAAT CCAGAACAAT CATCTGTTGT
CAGAAGCATT CTTAGAAAAT CTTTACTGGG ACAAGCAAGA GGAACTCAAG
GGGATTCCGC TTCAAAGACA ACTCCAGCAG GAACAAGACA TTCTGGTGGT
CAAAGTGATG GAAGTCAAGC TAGTGGAGGG GGTTCAGGAG GTGCAGATTC
TAGAAGACCA GATAGTTCTC AATCGTCACA GTTTGATGGA GGATATCGGT
CTGCACTTCA ACATGTTGAT TCCAGAGACG TTAGAAATGA TGACGATCCA
AATGGTGAGT TTAGGAAAGA AGGATTTCCA CTAGACGTAC TCGAGTTGGA
TGACAGTACG AAACATTACA CCGTGTTGGT TGACAAGCTA CTGAAAGTTC
CCGTGGTTAT TATAATTCCA GCAGATGAAT CGTTCGTTGA GGAGATAACT
TTAGGAAGTT TAATGATATG GAGGAGCGAA ACTGTAAAGT GTGTTAGAGT
AAGATTAGTA GTTTCAGAGG GTAACTTCAT TGCTATTGAA TTGACCTTGG
TTACTCCAAG GAGGAAAAAG TTCCATTTGT TCTTTAGATA CCATGACGGT
TATTACAAAG GTGTGGCAAG ACCAAGGTTT AACGAAGCTA TTTACGAACA
GGCTACAAAA GTTCAAAACA TTAAAAGATT AAGTAAAAGG ATCGACAAGG
AAATTATGGA GGAAGAAAAG GCTAAAAAAG ATGAAAAGGG AAACAAAAAA
GCGTTCAGTA GATGGGAAAG TGCAACATAC AGGGAGTCAG ATGAAACTGA
AGATGAAACT GAATATGAAA ACAGGAGGTG GGATATACAA GAAATAATAA
CAAGAGAGAA TGGCAATCAC ACGAACATCA TCAGGGGACC AAAGAACATA
ACCCAGAGGA GATAATTGAA TAAATAAAAT AAACAAAGAA ACAGATCAAA
ACAAATATAA CAGTCTCACT CAATTAAAAC AAATTAAAAA ATTAAAAACA
GTGGTTTGTA ATGGCATTAG TGGAAAATTT TCAATGTAAA TTAGAATTTT
TTAAAAATCG AGTTTTTTTA CCAAAAAATT AGCTGGAGAT TTTTTGAAAA
TAATAAAAAT GAATCAAGAG TATAAATTTA TACATCTAAA TGGTTCCAAA
AATAATCACG ATTCCCCATC GGATTCTAAT CGCAATAAAA TCTGAAAGGC
AGCACACATT TAAAATGTGT CAGCTCAACT AATTTCTGTA GACTATGAAA
AAAAA
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Figure 4.10B. The predicted amino acid sequence of the NC10 gene. Lined
arrows show repeated tetrapeptide sequences, QPXP, QPXQ, QQXQ and QGQX.
Straight lines show the repeat of eight amino acids. The 'X' in the amino acid
sequence ofNCI 0 indicates a sequence ambiguity.
1 MKSLIIYIYI IKVLVYCGRF AIFDVKGIYN TVQYILRKKS DNSLLCTILN
51 VKKNNELYGV VSNDEILWIK QSKKEECQDV LVTKHQGKAK LALLQIQHFK
101 SFYTVKRLRY FLGIWVPVSK ELYNKIDKII SWKFDYKESE ISVELTEEFD
151 TAGLMVNNFF INEENKTRLY PRPGFKITLV NYRNNELWSK NDYQEEAIQI
201 EIVKTDSKIQ RLYVRYETYY GTADTIYYKC YPELRRVDRK EYFMDDDDDD
251 DDGDDDYLPD GIDRYRRIGT RDVDSSHGTQ PGGSSQTGTT DQGTEDQDQR
301 ASSPVYYGVS ELVPLPLGTR PATPLPTPSK LVAPTPIKHF PEGIIRCFHV
351 ETFSEIGLVP QKTAKQREAA KQVTIRVGGT DDSQGQSEPT HYIPQHTEAV
401 SHGTHYTPGQ VTRHPTQPIL RMPQQTAPRP TGRPRHAPPV PHVPTQPFPT
451 TLIQPPPPRP SGITPYNIIQ GIGQQRFPTS QTDNRAEQGS RTGSTTSSST
501 PTNKDNSKKT TDDSDSDGSD LFDIQETDW TEVPESDTRI DEFLNMITKT
551 VTSSTTSVTT TSRQTGQASK AIVAITSSTP QPGTQFGDAS GLSLFSSGEL
601 TRARESGGSG GMHAISDSTV SSTVSSWDYS NANPFQDYID IGQIPEWTS
651 DFSQEEIELA SRSLTSSIES GRTGSSGDQT PTPGQTFSPA IMGDGRTPRY
701 PSAPSVRPQF GVEGGLKNVI VRPSSLTGTQ TVRAPWRAP VFMPRDPETR
751 SEYEXPPRKR PNTGQTVQPF PQPQPQPGQF QYQPPQAQQP QGQFGQGQFQ
' ' ^








901 PTQPNQGQYS QGYYGPNQPL QPQQSQPGQG YYQPPPPQQQ QPQNQYHQGY
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951 YGPNQPQQNQ AQQGQIPYSQ GOPTOOPOGY YGPPQQQQTQ GYYQPTQQQP




> •> > > >
1051 QTQNIGSTQQ QGRYGDNSNG EDNQSSDDED GDNFLVTEQT EKTTGGPDTG
1101 AGSTPPVQQR PVGSQRPLVR APIYRPPTTP VGPISQQPPV SGVGGKRRLQ
1151 TAPTHYIPEN ARGDRTGLGP ENSGRTRPTA HGNNYVPVYK RPRQSQGLDF
1201 PEEDPEYEDD NDDAESFILN VNSDVEETED TERSRDKTAQ PRPQVNPEQS
1251 SWRSILRKS LLGQARGTQG DSASKTTPAG TRHSGGQSDG SQASGGGSGG
1301 ADSRRPDSSQ SSQFDGGYRS ALQHVDSRDV RNDDDPNGEF RKEGFPLDVL
1351 ELDDSTKHYT VLVDKLLKVP WIIIPADES FVEEITLGSL MIWRSETVKC
1401 VRVRLWSEG NFIAIELTLV TPRRKKFHLF FRYHDGYYKG VARPRFNEAI
1451 YEQATKVQNI KRLSKRIDKE IMEEEKAKKD EKGNKKAFSR WESATYRESD
1501 ETEDETEYEN RRWDIQEIIT RENGNHTNII RGPKNITQRR ★
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When the sequences of the clones NCI, NC10 and the QP protein were
compared, low homologies to each other were observed. The predicted amino acid
sequence of NCI shared a 26.6 % identity (57.5% similarity) over 240 amino acids
and 18.9 % identity (46.8% similarity) over 598 amino acids with those of the QP
protein and the NC10 polypeptide, respectively. The nucleotide sequence of NCI
showed a 54% identity over 610 bp and 54% identity over 310 bp with the QP and
NC10, genes respectively.
The predicted amino acid and nucleotide sequences of clone NC10 showed
29.9% identity (50.5% similarity) over 239 amino acids and 59.6% identity over 141
bp with the QP gene. The region of similarity covered the Q/P rich region ofPIM.
4.3.7. Northern Blot Analysis
4.3.7.1. Expression level ofcDNA clones throughout the life cycle stages
In order to study the expression of the clones isolated from the X ZAP cDNA
library and to show if indeed they are expressed by the macroschizont stage of the
parasite, northern blot analyses were performed. Total RNA was isolated from
different life cycle stages of the parasite; sporozoites, the macroschizont infected D7
cell line cultured at 37°C, the D7 cell line during differentiation towards the
merozoites at 41°C and piroplasms (section 4.2.14.1). RNA from the bovine
lymphoid cell line, BL20, was used as a negative control.
a) Group 1 (Clone NCI)
"The mRNA profile of the gene represented by the cDNA clone NCI is shown
in Figure 4.11A. Although a single band of about 3.6 kb was detected in all life cycle
stages, the results suggest that the gene represented by the NCI clone was
differentially expressed during the life cycle. The detected mRNA was found to be
present at a high level in sporozoites and followed by a reduction upon
differentiation to merozoites, and was detected at much lower levels in piroplasms
and no signal was detected in BL20 RNA (Figure 4.11A). It can be concluded that
transcription of the NCI gene is downregulated following differentiation to the
merozoite and is most likely expressed at high levels during sporozoite formation
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Figure 4.11. Analysis of RNA levels during life cycle stages of T. annulata by
northern blotting. Total RNA was isolated from the uninfected bovine cell line
BL20 (BL), T. annulata Ankara sporozoites (S), clonal cell line D7 at 37°C (Sc), D7
cells under-going merogony at 41°C at day 6 (M), piroplasms (P) and T. parva
Muguga macroschizonts (TpM). Ten pg of total RNA was loaded in each lane. (A)
Hybridisation with the T. annulata NCI cDNA probe, (B) hybridisation with the T.
annulata NC10 cDNA probe, (C) Hybridisation with the T. annulata cDNA NC2
probe, (D) hybridisation with the QP cDNA probe and (E) hybridisation with the 2P3
probe. Northern blots of A, B, C and E were hybridised at 65°C and blot D was
hybridised at 55°C. The sizes of mRNA species detected by cDNA probes are
indicated in kilobase pairs (kb).
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and during the macroschizont stage. The size of the transcript is in slightly larger
than the cDNA clone which was shown to be 3172 bp long by sequence analysis.
b) Group 2 (Clone NC10)
Figure 4.1 IB shows the results of the northern blot analysis using the clone
NC10. This gene, like NCI, is differentially expressed during different life cycle
stages. The gene represented by NC10 is expressed at high levels in the
macroschizont stage and at low levels in the sporozoite stage of the parasite. No
signals were detected in the RNA of the piroplasm stage of the parasite nor in the
uninfected bovine BL20 cell line (Figure 4.1 IB). Two transcripts were visible in
macroschizont RNA: the approximate sizes of the two mRNA species were around
6.2 kb and 7.4 kb. The 6.2 kb transcript was most prominent. Both mRNA species
were larger than the size of the longest cDNA clone isolated. As indicated in section
4.3.6.2, sequence analysis of clone NC10 generated a 5400 bp sequence with an ORF
beginning at 480 bp. This implies that there are about 800 bp missing to generate a
6.2 kb transcript and that there is about 1 kb of untranslated sequence before the
ATG start codon. During the course of differentiation from macroschizonts to
merozoites the messenger RNA species at 7.4 kb was down regulated while the
mRNA species at 6.2 kb remained at approximately the same level. There was no
signal detected by the NC10 cDNA probe with piroplasm RNA after an exposure
period of two weeks. To confirm equal loading of total RNA, the same membrane
was probed with a constitutively expressed gene, the large subunit ribosomal 2P3
probe-(Swan et al., 1996) (Figure 4.1 IE). As expected, although the 2P3 probe
indicated that RNA levels from the macroschizont and macroschizont/merozoite
stages were relatively less than those of the sporozoite and piroplasm stages, this did
not effect the overall results with respect to the assessment of the relative expression
pattern of the NC10 gene.
c) Group 3 (Clone NC2)
Figure 4.11C shows the result of the northern blot analysis with clone NC2.
The expression pattern and the size of the signal were similar, but not identical, to
that obtained for clone NCI. The mRNA detected by the NC2 probe was about 3.3
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kb and was found to be differentially expressed throughout the parasite life cycle.
Thus, the NC2 gene is highly expressed by the sporozoite stage and at a lower level
by the macroschizont. The expression level stays possibly about the same during
differentiation from macroschizonts to merozoites. The level of expression was very
low but could be detected in the piroplasm stage.
d) QP protein
To determine the expression profile of the QP gene, RNA from different life
cycle stages of T. annulata was hybridised with the QP cDNA probe at 55°C. RNA
from T. parva Muguga macroschizonts was used as a positive control. Three major
signals were detected in T. annulata RNA (Figure 4.1 ID) and the approximate sizes
of these signals were 1.3 kb, 2.1 kb and 3.3 kb. There was also low level detection of
a RNA species at 4.0 kb in the macroschizont, macroschizont/merozoite and
piroplasm RNA samples and an additional 0.7 kb signal in piroplasm RNA. The
expression level of these transcripts varied between life cycle stages. The expression
profile and the size of the 3.3 kb fragment was very similar to the profile established
for NCI and NC2. Both the 2.1 and 1.3 kb signals were strongly expressed by both
sporozoites and piroplasms. The expression level detected was low in the
macroschizont and macroschizont/merozoite tracks. However, this could be due to
lower amounts of RNA loaded for the macroschizont and macroschizont/merozoite
stages than for the sporozoite and piroplasm stages (Figure 4.1 IE). The QP protein
gene was found to be expressed in macroschizonts of T. parva at very high levels and
encodes an mRNA species of 1.7 kb, as reported previously (Baylis et al., 1993). In
addition, a minor mRNA species of approximately 4.0 kb was also detected.
4.3.7.2. Different Parasite Stocks
In order to determine the expression profile detected by the cDNA clones in
RNA from different Theileria stocks, total RNA was isolated from eight
geographically discrete T. annulata macroschizont infected cell lines (Table 4.1).
Three of these stocks (Ankara, Hissar and Gharb) were previously shown to be
different on the basis of isoenzyme analysis (Melrose et al., 1980) and by their
reactivity to a panel of anti-macroschizont mAbs (Shiels et al., 1986). Additionally,
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RNA was isolated from macroschizont infected cell lines representing T. parva
Muguga and T. lestoquardi Lahr in order to examine the relatedness of the genes
across other Theileria species. RNA from BL20 was used as negative RNA control
and RNA from the D7 cell line was used as a positive control. As a further control
for T. lestoquardi, RNA isolated from sheep lymphocytes infected with T. annulata
macroschizonts was also included.
Figure 4.12 shows the results of the northern blot analysis using plasmid
DNA from clones NCI and NC10 as probes. All hybridisations were carried out at
65°C. Hybridisation using the NCI and NC10 probe was carried out simultaneously
to the same northern blot. The different stocks of T. annulata demonstrated a similar
hybridisation pattern with NCI, with the exception of minor differences in size and
expression levels in some RNA samples (Figure 4.12A). In order to confirm that the
RNA was loaded equally, the blot, was stripped and re-hybridised with the heat
shock protein 70 (Hsp70) probe (Mason et al., 1989). The Hsp70 probe detected a
2.5 kb signal in the three Theileria species and all T. annulata stocks. An additional
signal larger than 2.5 kb was detected in BL20 and T. annulata Ankara RNA. The
results also showed that the amounts of RNA loaded was slightly different between
stocks (Figure 4.12B) and coincided with the expression levels of cDNA clone NCI.
An obvious size difference of the major detected mRNA transcript was observed
only for the T. annulata Tova cell line. No hybridisation was detected in T. parva
Muguga lane, whereas the probe clearly reacted with T. lestoquardi Lahr. The band
intensity in T. lestoquardi Lahr is relatively lower than that observed for T. annulata
which-might be due to sequence differences between the genes of these two species.
The size of the T. lestoquardi transcript is also slightly smaller. Considering that the
hybridisation was carried out at high stringency conditions, T. lestoquardi is likely to
possess good homology to the NCI gene of T. annulata.
The NC10 gene was also shown to be expressed by all the T. anmdata cell
lines tested. In contrast to NCI, the size of the detected bands did not differ between
the parasite stocks. The level ofRNA loaded from T. annulata Gharb was lower than
the other RNA samples and is likely to account for the reduced signal detected in this
sample (Figure 4.12A). As with the NCI, there was no hybridisation signal detected
in T. parva Muguga RNA. However, both bands at 6.2 kb and 7.4 kb were detected
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Figure 4.12. Expression of NCI and NC10 in geographically different T.
annulata stocks and cross reactivity to T. parva and T. lestoquardi by northern
blotting. The northern blot was prepared with 10pg of total RNA each from
uninfected BL20 cells and macroschizonl infected cells. (A) The blot was
simultaneously probed with the NCI cDNA probe and the NC10 cDNA probe. (B)













in T. lestoqucirdi Lahr RNA. The intensity of the band at 6.2 kb was very low while
the band at 7.4 kb was similar in intensity to that obtained with the other cell lines.
4.3.8. Protein Expression of cDNA Clones NCI and NC10
Previous work indicated that the NCI and NC10 genes are expressed at
reasonable levels in the macroschizont stage of the parasite. To characterise the
potential of these genes in the development of diagnostic ELISAs utilising
recombinant antigens, it was necessary to obtain the corresponding recombinant
proteins using prokaryotic expression systems.
4.3.8.1. Expression strategy
Different strategies were undertaken to express the cDNA clones NCI and
NC10 as recombinant polypeptides. The expression strategies will be explained for
each clone separately.
a) Clone NCI
The approach chosen to express NCI was based on PCR amplification of
parts of the gene and subcloning these, as no appropriate restriction sites were found
in the gene sequence. The primers used are given in Table 4.4 along with the
restriction sites incorporated into the primers for subcloning purposes. The fragments
generated by PCR amplification are diagrammatically illustrated in Figure 4.13. The
PCR primers A and C amplified 2.2 kb of the NCI gene excluding the first 94
nucleotides and last 22 nucleotides of the coding sequence. The second primer
combination used (B-C) amplifies 1,186 bp from the C terminus of the gene, starting
at nucleotide 1762 and finishing at nucleotide 2948 of the cDNA clone. The pQE
vector systems used to produce recombinant proteins are described in section 4.2.15.
Table 4.4. Primers used for creating a cDNA clone NCI expression construct.
Primer Sequence Adaptor Length
A CCC GGG CTG ACC TGT TGG GAT CTG AGG Smal 27
B GGA TCC CAG AGG ATA TTG GGG GAC CTG BamYLI 27
C GTC GAC GCG ATG TGC TCT CGG ATC TAG CTC C Sail 31
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Figure 4.13. Construction of expression cassettes of the NCI gene for the pQE
vector systems. PCR amplification of NCI DNA using primer combinations A/C
and B/C resulted in DNA fragments of 2,164 bp and 1,186 bp respectively. These
PCR products were ligated first into the pGem T Easy vector system and then
subcloned into the pQE-31 vector digested with Smal + Sail or BamRl + Sail
respectively. The resulting plasmids were trasnformed into E. coli M15[pREP4],
B
ATG 690 2970 TAA
NCI cDNA
bp 784 1762 2948
1) ligation into pQE-31





Ten positive 2.2 kb-pQE-31 colonies were selected and analysed for protein
expression. Upon induction of protein expression by adding of IPTG, cell growth
was significantly reduced in comparison to the control cells containing the pQE-31
vector. Total cell extracts of uninduced and induced cells containing the 2.2 kb-pQE-
31 construct were resolved on SDS-PAGE and visualized by Coomassie staining. A
representative gel is shown in Figure 4.14. There was no evidence of an expressed
fusion protein following induction. To increase the chance of expressing NCI, a
smaller fragment (1.2 kb) was subcloned, avoiding internal start codons. The result
of protein expression was very similar to that obtained for the 2.2 kb size fragment.
The cell growth was hindered following IPTG induction and no obvious expression
of a fusion protein was detected on SDS-PAGE (data not shown).
To overcome the lack of expression, two bacterial cultures containing the 1.2
kb- pQE-32 construct were grown until an ODeoo of 2.4, rather than 1, was reached in
5 ml LB medium. The cells were then induced by adding IPTG to a final
concentration of 4, rather than 2, mM. Total cell extracts were taken before and 2, 3
and 5 hours after induction and were separated by SDS-PAGE. No expressed protein
was detected on the gels (Figure 4.15A). However, western blot analysis using anti-
His-tag monoclonal antibody revealed that there was a very low level expression of a
His-tag fusion protein at about 66 kDa (Figure 4.15B). In order to increase the
expression level of the fusion protein two approaches were tested:
i) Cells were grown with a high concentration of ampicillin (200pg/ml), and
supplemented with 2% glucose to reduce the level of fusion protein expression, as it
might be toxic to the bacteria. Cells were grown until an OD6oo of 0.9 was reached
and were then induced. Samples were taken at the same time intervals as in (i).
ii) Cells were grown at a lower temperature, 30°C, and were then processed
as above.
None of these methods led to an increase of fusion protein expression (data
not shown). Although the level of protein expression was very low, recombinant
fusion protein was purified from a large-scale culture using column chromatography
as described in section 4.2.15. The amount of purified protein was low but levels
increased with higher imidazole concentration in the elution buffer.
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Figure 4.14. Coomassie stained SDS-PAGE gel of bacterial cell lysates
containing the NCI expression construct 2.2 kb-pQE-31. Total cell extracts of
un-induced and induced bacterial cultures were separated by 10% SDS-PAGE gel.
Lanes 1: un-induced cell extract; lanes 2,4-7: induced cell extract; lane 8: un-induced
negative control; lane 9: induced positive control, which a part of T. annulata gene
encoding the cdc2-related kinase and was kindly provided by Dr. Kinnard; lane 3:
molecular size markers (kDa) as indicated on the left.
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Figure 4.15. SDS-PAGE and western blot of protein extracts from bacteria
expressing the NC1-1.2 Kb-pQE-32 construct using 4mM IPTG for induction.
(A) Bacterial extracts were resolved on a 10% SDS-PAGE gel and visualised by
Coomassie staining. (B) The resolved proteins were transferred onto a nitrocellulose
membrane and probed with an anti-His-tag monoclonal antibody. Lane 1: molecular
size markers (kDa) as indicated on the left; lanes 2 and 9: uninduced colony 1 and 2;
lanes 3-5: colony 1 after 2 hours, 3 hours and 5 hours of induction; lanes 5-8 colony
2 after 2 hours, 3 hours and 5 hours of induction.
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Figure 4.16 shows the His-tagged protein at 66 kDa molecular mass. A large number
of non-specific bacterial proteins were co-purified from the column with the NCI
fusion-protein (Figure 4.16). A possible reason for the high concentration of bacterial
protein contamination may have been due to the amount of Ni-Agarose used and as
the amount of expressed fusion protein was low, excess Ni-Agarose can bind non-
specifically to bacterial proteins.
To examine whether the purified protein was immunoreactive western blot
analysis was carried out using three immune bovine sera. None of the immune sera
reacted with the recombinant protein (data not shown) indicating that the protein
isolated was not an immunodominant molecule.
b) Clone CIO (NC10)
The strategies undertaken to express a fragment of the NC10 gene as a
recombinant protein are summarised in Figure 4.17. First, a 2.7 kb fragment of the
NC10 cDNA was amplified by PCR using the primers listed in Table 4.5. A 2.7 kb
amplification product was initially ligated into the pGEM T-Easy vector and then it
was subcloned into the BamWHSall sites of both the pGex 5x-l and the pQE-32
expression vectors (see section 4.2.15). Only a few positive transformed colonies
were obtained with either plasmid construct. Sequence analysis confirmed that the
ORE was maintained for both constructs.
Table 4.5. Primers used for creating a cDNA clone NC10 expression construct.
Primer Sequence Adaptor Length
A GGA TCC CGG GTC AAG CAT CGA AGG CC BamYLl 26
B GTC GAC GCT TCG TTA AAC CTT GGT CTT GCC ACA CC Sail 35
Following growth and induction of positive colonies, it was evident that the
expression levels were so low that they could not be detected on Coomassie stained
SDS-PAGE gels. However, western blot analysis of the total cell extracts determined
low level expression, from both systems, of immunoreactive bands at around 100
kDa, which were detected by immune bovine sera (data not shown). Attempts were
then made to purify these proteins and while this was successful for the GST-fusion
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Figure 4.16. Purification of the recombinant pQE-NCl-1.2 protein. (A) 1 ml
fractions were collected from the column and 20 pi of each fraction were resolved on
a 10% SDS-PAGE gel and visualised by Coomassie staining. (B) The resolved
proteins were transferred onto a nitrocellulose membrane and probed with an anti-
his-tag monoclonal antibody. Lane 1: molecular size markers (kDa) as indicated on
the left; lanes 2-5, 1 ml fractions of protein eluted using 0.3 M imidazole; lanes 6-9,
1 ml fractions of protein eluted using 0.5 M imidazole.
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Figure 4.17. Construction of expression cassettes of the NC10 gene for the pQE
and the pGex vector systems.
Design 1: PCR of the NC10 gene using primers A and B resulted in a 2,652 bp
product. The PCR product was first ligated into the pGem T Easy vector, and then
subcloned into the pQE-32 and pGex 5x-l digested with BamHl + Sail. The resulting
plasmids were used to transform E. coli M15[pREP4] and XL1 blue, respectively.
Design 2: The fragment obtained in design 1 was digested with Stul + Xhol which
resulted in a 2 kb fragment which was ligated into pQE-32 and pGex 5x-l digested
with Smal + Sail. The resulting plasmids were used to transform E. coli M15[pREP4]
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Figure 4.17. continued
Design 3: The Kpnl-Pstl fragment of the NC10 eDNA was isolated by gel extraction
and then digested with EcoRV, Hincll, Sspl, Styl and Xbal. The resulting DNA
fragments were blunt ended and ligated into the pGEX 5x-l and pGex 5x-2 digested
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protein, the His-tag protein could not be purified following standard methodology.
SDS-PAGE analysis of the purified GST-NC10 fusion protein revealed a band of
around 100 kDa and many smaller products which all reacted with immune bovine
sera, indicating that the polypeptide encoded by NC10 is immunogenic (data not
shown).
Since expression of the large fragment of the protein resulted in very low
yields, it was decided to sub-clone and express smaller immunogenic fragments of
NC10. The NC10 cDNA clone was digested with Still / Xhol releasing a 2 kb
fragment spanning the QP repeat region of the gene which was ligated into the pGEX
5x-l and pQE-32 vectors. Protein expression levels of these constructs were
examined using 10 positive colonies for each system. Although sequence analysis
confirmed that the ORE for the fragment was maintained, there was no visible
expression on SDS-PAGE gels. Several approaches described in section 4.3.9.l-(a)
failed to improve the levels of protein expression.
Another methodology used to generate an NC10 expression clone was based
on isolating the Kpnl-Pstl fragment of the NC10 cDNA clone followed by restriction
digestion with EcoRSl, Hincll, Sspl, Styl and Xbal (Figure 5.17 Design 3). These
enzymes recognise multiple sites in the sequence of the gene. The resulting DNA
fragments were blunt ended and cloned into pGex 5x-l and pGex 5x-2. Colony lifts
were taken and probed with the KpnUPstl fragment (see section 4.2.15). Positive
clones were tested their ability to express recombinant NC10 protein. 8 colonies
derived from the pGex 5x-l EcoRY ligation, 1 from the pGex 5x-l Hindi ligation, 6
from the pGex 5x-l Sspl ligation, 3 from the pGex 5x-2 EcoRY ligation, 1 from the
pGex 5x-2 Hindi ligation, 7 from the pGex 5x-2 Sspl ligation and 1 from the pGex
5x-2 Styl ligation expressed proteins which were visible by Coomassie staining.
Figure 5.18A shows seven of these proteins on a Coomassie stained SDS-PAGE gel.
Western blot analysis, however, demonstrated that only two of these recombinant
proteins were specifically detected by immune bovine sera: Sspl (13) and Sspl (24)
(Figure 4.18B). Because of time constraints work was concentrated on the pGex 5x1-
NC10 - Sspl (13) construct, since it produced a larger protein and reacted more
intensely with immune bovine serum.
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Figure 4.18. Expression of NC10 gene fragments following digestion with
several restriction enzymes. (A) Coomassie stained 10% SDS-PAGE gel. Lanes 1-4
and 6: total lysates of induced bacterial cultures containing expression constructs:
pGex-5xl-NC10-Ssp4, pGex-5xl-NC10-Sspl3, pGex-5x2-NC10-Sspl6, pGex-5x2-
NC10-Ssp24 and pGex-5x2-NC10-Sty40 fragments; lane 7 and 8: uninduced and
induced pGex 5x-l controls, lane 5: The molecular weight marker (kDa) as indicated
on the left side of the gel. (B) Western blot analysis of the expressed NC10 fragment.
Lanes 1-2: the pGex-5xl-NC10-Ssp4 lysates before and after induction; lanes 3-4:
the purified pGex-5xl-NC10-Sspl3 protein and induced whole cell lysates; lane 5:
induced pGex-5x2-NC10-Sspl6 lysate; lane 6: induced pGex-5x2-NC10-Ssp24
lysate; lane 7: induced pGex-5x2-NC10-Sty40 lysate; lane 8: induced pGex-5xl
lysate for control of GST fusion protein. The size of the molecular weight markers is
shown on the left of the gel in kDa.
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To reduce possible non-specific immune responses against the GST-fusion
protein fragment generated by GST, a 1.2 kb BamRl - Sail fragment (NC10-Sspl3)
was ligated into the pQE vector system. The NC10-Sspl3 DNA fragment was
purified from an agarose gel, ligated into a BamHl-SaB cut pQE-32 vector and
transformed into M15[pREP4] cells (construct called pQE-NC10-Sspl3). Six positive
colonies were selected and analyzed for fusion protein expression. All six colonies
produced a fusion protein of approximately 60 kf)a, which was larger than the
expected size of 45 kDa (Figure 4.19). The sequence of the cloning junctions
indicated that the His-tag was in frame with the ORF of the NC10 gene fragment.
The sequence analysis also revealed that the expression fragment was located
between 1,966 bp and 3,168 bp of NCI0 consensus sequence and contained the first
half of the repeat region of the gene.
Before large-scale production of the fusion protein was performed, the
solubility of the protein was examined as described in section 4.2.15.1. The result
revealed that the protein expressed in M15[pREP4] cells was not soluble.
An attempt was made to solubilize the protein first by using an EGTA
solution, then by using lysozyme (section 4.2.15.1). Both techniques failed to
solubilize the recombinant protein. Although low levels of solubilized protein was
seen in the supernatant after lysozyme treatment, the amount was too low to justify
this approach. Therefore, protein purification was carried out under denaturing
conditions as described in section 4.2.15.1. Purification under denaturing conditions
with Ni-NTA resin allowed the purification of a single polypeptide migrating at
approximately 60 kDa as determined by SDS-PAGE (Figure 4.19). The protein was
refolded by gradually reducing the concentration of urea. The protein remained
soluble in 50 mM Tris.HCl pH 8.0 but came out of solution in PBS 7.4 and in 50 mM
Tris-HCl pH 7.4.
4.3.9. Western Blot Analysis Using Antisera Raised Against the Recombinant
His-tagged NC10-Sspl3 Protein
To characterise antigens that are recognized by an anti-NC10-Sspl3 rabbit
serum, western blotting was conducted using protein extracts from macroschizont
infected cell lines: eight geographically different T. annulata stocks, the
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Figure 4.19. Coomassie stained SDS-PAGE gel showing the expression,
purification and refolding of recombinant NC10-Sspl3 protein. Protein samples
were resolved on a 10% SDS-PAGE and visualised by Coomassie staining. Lanes 2
and 3: uninduced and induced bacterial lysate containing the pQE-NC10-Sspl3
construct; lane 4: purified protein using the denaturation method; lane 5: recombinant
protein following refolding by gradually reducing the urea concentration. The size of
the molecular weight markers (lane 1) is shown on the left of the gel in kDa.
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T. lestoquardi Lahr and the T. parva Muguga infected cell line (Table 4.1). Figure
4.20 shows the result of an immunoblot of total cell extracts from Theileria infected
cell lines. All T. annulata cell lines reacted with the immune rabbit serum, except T.
annulata Caceres from Spain. The experiment with the Caceres cell line was
repeated two more times and identical results were obtained. The antiserum detected
3-6 bands in seven T. annulata stocks, whose molecular weight ranged between 150
kDa to above 205 kDa. The polypeptide just above 205 kDa was the most prominent
polypeptide recognised by the serum and other bands were less intense. They may
represent processed forms of the NC10 protein or a group of related proteins, which
share the same/similar epitopes. Alternatively, the lower bands may be the result of
proteolytic degradation during the preparation of the samples. It is unclear why the
Caceres cell line did not react with the immune serum. It could be due protein
degradation during lysate preparation or it might be due to antigenic variations.
The immune rabbit serum did not react with any polypeptides from T. parva
Muguga cell extract. However, cross reactivity with T. lestoquardi was observed
(Figure 4.20). The polypeptide detected in T. lestoquardi was slightly bigger than the
prominent band of T. annulata but the bands detected were very faint (It is not
possible to see them in the Figure 4.20). The immune serum did not react with BL20
(Figure 4.20) confirming specific recognition of a parasite polypeptide.
4.3.10. IFAT
The location of the NC10 protein within the macroschizont-infected cell was
identified by IFAT using antisera raised against the His-tagged NC10-Sspl3 fusion
protein in two rabbits. For this purpose, macroschizont infected cells of three stocks
of T. annulata (Ankara, Gharb and Hissar) stocks and two T. annulata Ankara clonal
cell lines (D7 and D7B12) were used. An uninfected lymphosarcoma cell line BL20
and the same lymphosarcoma cell line infected with T. annulata Ankara were used as
negative and positive controls, respectively.
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Figure 4.20. Western blot analysis of Theileria infected cell lines using rabbit
serum raised against NC10-Sspl3 recombinant protein. Lane 1: uninfected BL20
cell line; lane 2: T. annulata Ankara infected BL20 cell line; lanes 3-10: T. annulata
Ankara D7, Beja, Caceres, Gharb, Hissar, Razi, Soba, Tova cell lines; lane 11: T.
parva Muguga, lane 12: T. lestoquardi Lahr, lane 13: recombinant protein NC10-
Sspl3.
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IFAT revealed that all T. annulata infected cells tested in the current study
were recognised by both of the rabbit sera. Interestingly, the sera reacted with the
nucleus of the infected host cell as well as the macroschizont within the cell (Figure
4.21). Immunofluorescence appeared to be distributed over the area of nuclear
envelope but was excluded from the nucleoli (Figure 4.21). Although the general
pattern of the reactivity was the same for all T. annulata cell lines, there were
differences in the level of staining of the host nucleus between cell lines (Figure
4.21). Thus, the strongest reaction was obtained with the D7B12 cell line, while the
weakest reaction was detected with the Gharb cell line. Variability in the level of
staining was also observed within the cell lines. The host nuclei of some of the
infected cells stained very strongly, whereas in other cells of the same cell line less
intense staining was observed. Furthermore, the reactivity against the host nucleus
was not observed in cells with condensed chromosomes, although the
macroschizonts in these cells showed immunoreactivity and general staining could
be observed throughout the host cytoplasm (see Figure 4.21). Recognition of the host
cell, therefore, may be confined to cells that are in the interphase of the cell cycle.
No staining of either macroschizonts or the host nucleus was observed with
the pre-immune rabbit serum (data not shown). In addition, the antisera did not react
with the uninfected BL20 cells. Results demonstrating that the nuclei of T. annulata
Ankara infected BL20 cells, but not the nuclei of uninfected BL20 cells, reacted with
the antisera suggest that the expression of the detected antigen is related to infection
of the host cells by the parasite.
-In order to determine if the pattern of reactivity obtained with anti-NClO-
Sspl3 sera was species specific, IFAT was performed with macroschizont-infected
cells of T. par\>a Muguga and T. lestaquardi Lahr. The NC10-Sspl3 antisera strongly
reacted with macroschizonts of T. par\>a Muguga. However, no reactivity was
detected against the nuclei of the host cells (Figure 4.21). In contrast, both
macroschizonts and host nuclei of the T. lestoquardi Lahr infected sheep cells were
stained with the antisera, although the staining was faint in both macroschizonts and
nuclei (Figure 4.21). It should be noted, however, that the nuclei of occassional cells
were strongly stained in the T. lestoquardi Lahr cell line.
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Figure 4.21. IFAT analysis of macroschizont infected cell lines using the
antiserum raised against NC10-Sspl3 recombinant protein. T. annulata Ankara
infected BL20, T. annnlata Ankara D7B12, T. annulata Hissar, T. annulata Gharb,
T. parva Muguga and T. lestoquardi Lahr cell lines were tested. The uninfected
BL20 cell line was used as negative control. Ta. denotes T. annulata; Tp. denotes T.









4.4.1. Screening of cDNA and Genomic DNA Libraries of T. annulata
The purpose of the current study was to define an immunogenic antigen from
the macroschizont stage of T. annulata that could be used in enzyme linked
immunoassays to detect stage-specific antibody responses against this parasite,
especially in animals vaccinated with attenuated cell lines. Such an antigen could
then be used in conjunction with the Tamr-1 antigen to distinguish vaccinated
animals from those naturally infected in the field, since the Tamr-1 antigen has been
shown to be detected by serum from animals infected with sporozoites and a low
passage cell line but not animals vaccinated with a high passage cell line (Ilhan,
1995).
Initially, it was considered that the best approach would be to screen a
genomic DNA expression library of T. annulata with sera from animals immunised
with high passage cell lines. The basis of this approach was that such sera would
recognise mainly macroschizont antigens, as it is generally accepted that the
attenuated-high passage lines used for immunisation lose the ability to differentiate
from macroschizonts to piroplasms (Pipano, 1977). However, most of the serum
samples tested recognised not only macroschizont antigens but also piroplasm
antigens including the 30/32 kDa major merozoite surface antigen (Tarns 1). Many of
these proteins have not been shown to be present in the macroschizont stage, or are
expressed at very low levels. Therefore, it is most likely that generation of
merozoites has taken place in the animals vaccinated with the attenuated cell lines.
Since -neither merozoites nor piroplasms were observed in these animals, it is
possible that macroschizonts of attenuated vaccine cell lines start to undergo
differentiation, but are arrested during this process before viable merozoites are
formed. An example of such a cell line is the Tova line which was maintained in the
laboratory by serial passage through susceptible calves before isolated by cell culture
and lost the capacity for the schizonts to develop into piroplasms but it was fully
virulent (Pipano et al., 1974). This cell line generates high levels of merozoite
antigens in vitro, yet no morphologically-intact merozoites are observed (Shiels,
unpublished observations). It is known that merozoite antigens can be produced
relatively early during the differentiation process. For example the 30/32 kDa antigen
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appears before free merozoites are produced in vitro (Shiels et al., 1994). The other
possibility is that macroschizont infected high passage cell lines produce merozoites
and piroplasms at such low levels that they cannot be detected by blood smear
examination, but are able to stimulate the immune system to produce anti-piroplasm
antibodies. Taken together, the results precluded the use of sera from animals
immunised with attenuated cell lines in screening a genomic DNA expression library
of T. annulata.
The recognition of macroschizont antigens with serum samples from animals
infected either with sporozoites or non-attenuated low passage cell lines was more
prominent than that obtained using sera from animals immunised with attenuated cell
lines. Serum samples from animals infected either with non-attenuated cell lines or
sporozoites detected three major proteins, around 130 kDa, and 40 kDa that were
specific to macroschizont extracts in western blot analysis. However, the use of these
sera in screening a genomic DNA expression library of T. annulata was complicated
since several piroplasm antigens were also recognised. When an anti-merozoite
rabbit serum (C9m) was used to eliminate the detection of piroplasm antigens by
immune bovine serum, only very few piroplasm antigens were eliminated,
suggesting that the antiserum C9m did not react against all the piroplasm antigens
within the extract. However, incubation of the immune bovine sera with crude
piroplasm extracts effectively blocked the detection of most of the piroplasm and
macroschizont antigens including the major 130 kDa macroschizont antigen. The 40
kDa macroschizont antigen could, however, still be detected strongly. This protein is
likelyto be the same antigen that was shown to be a polymorphic immunodominant
molecule of T. annulata, which displayed variable mobility when examined from
different isolates (Shiels et al., 1994; Shiels per. comm.).
Initial screens of a genomic expression library using the immune bovine sera
treated with piroplasm extracts were not successful in identifying a positive plaque.
The reasons for this negative result are unclear. Screening expression libraries with
an antibody can be difficult, as one has to rely on the assumption that the epitopes
recognised by the serum will be replicated by the Agtl 1 expression system. Thus, it
is possible that epitopes were not represented by the library due to either
conformational changes or modification of the primary amino acid sequence
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(Sambrook et al., 1989), generating a false negative result. The immune bovine sera
used in the current study recognised the 40 kDa antigen in western blot analysis.
Therefore, it is unlikely that the failure to detect this protein was due to
conformational changes (Sambrook et al., 1989). Another possibility is that the
antigen or the detected epitopes were not represented by the library before or after
the induction of the gene expression.
Since attempts to clone the gene encoding the 40 kDa macroschizont antigen
by immunoscreening the genomic expression library failed, an alternative strategy
based on screening a cDNA library with a possible homologue of this gene was
sought. The QP/PIM gene of T. parva was a good candidate for this purpose, for
several reasons. First, both the 40 kDa protein (current study) and PIM (Toye et al.,
1991; Raylis et al., 1993) are expressed by the macroschizont stage of the parasite.
Second, both proteins are immunodominant. Third, both the 40 kDa protein (Shiels,
pers.comm.) and PIM (Toye et al., 1991; Toye et al., 1995a) show size
polymorphism when tested with different stocks of the parasite. Therefore, it is
possible that the 40 kDa protein could be the T. annulata homologue of the QP/PIM
antigen. In order to test if the T. annulata genome has a gene(s) homologue of the
QP/PIM gene of T. parva, Southern blot analysis was performed. It was
demonstrated that there are genes in the T. annulata genome that hybridised to the
QP/PIM probe. These results were supported by northern blot analysis where the QP
cDNA probe detected at least three mRNA species of T. annulata. On the basis of the
preliminary data the QP probe was used to screen a cDNA library representing T.
annulata macroschizont infected cells. Three main groups of clones, NCI, NC2, and
NC10 were obtained.
4.4.2. Characterisation of Genes Isolated from the cDNA Library
In order to characterise cDNA clones NCI, NC2 and NC10, Southern blot,
sequence and northern blot analyses were performed. Southern blot analysis of T.
annulata genomic DNA using clones NCI, NC2 and NC10 as probes at low
stringency revealed that the T. annulata genome contains several genes related to
each of these clones (see Figures 4.6-4.8). Under high stringency conditions, a single
restriction fragment was detected with digests of DNA from cloned macroschizont
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infected cell lines probed with cDNA clones NCI and NC10, but not with NC2. In
some cases, however, multiple restriction fragments were obtained. Sequence
analysis of clones NCI and NC10, and restriction analysis of NC2 indicated that for
certain enzymes there are multiple restriction sites within the corresponding genes.
Multiple restriction fragments could also be due to partial digestion of genomic
DNA. Based on detailed analysis of the obtain Southern profiles it was concluded
that it is most likely that clones NCI, NC2 and NC10 represent single copy genes.
Southern blotting in conjunction with sequence analysis revealed that there is
at least one intron in the NC10 gene with an estimated size of around 750 bp. The
presence and size of this intron was confirmed by PCR (data not shown).
Interestingly, this intron is much longer in length than introns of other genes of
Theileria characterized to date. So far, only a total of 22 introns have been identified
and their sizes varied between 29 and 159 bases in length (Nene et al., 1998).
Therefore, to the best of my knowledge, the intron in the NC10 gene is the longest
intron found in Theileria to date. In addition, sequence analysis demonstrated that
one of the cDNA clones in Group 1 (clone NCI 1) has an additional 33 bp insert that
did not align with the consensus sequence of the NCI gene. It is likely that this 33 bp
insert is an unspliced intron as it contains splice site sequences (Shapiro and
Senapathy, 1987).
The sequence analysis of the cDNA clone NCI revealed an insert of 3.2 kb,
which is smaller than the size of the mRNA species detected by northern blot
analysis (around 3.6 kb). The longest ORF starts from nucleotide 691, making it an
unusually long 5' untranslated region for Theileria (Katzer per. comm.). In addition,
the ATG start codon at the beginning of this ORF is the 17th 'ATG' within the NCI
cDNA. It is unusual for the coding sequences of eukaryotic genes to be initiated with
an ATG codon that does not correspond to the first ATG sequence in the transcript
(Kozak, 1985). Since there is another ORF extending from nucleotide 1 to nucleotide
750, there could be a sequencing error between nucleotides 691 and 750 resulting in
a frame shift in the ORF. If indeed there was a sequencing error, it is most likely that
the sequence of the 5' end of the gene represented by clone NCI is not complete, as
the estimated size of the mRNA was larger than the insert. However, this possibility
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could not be investigated due to time constraints and the sequence obtained will be
verified by further studies.
As in the case of NCI, the size of the NC10 gene obtained by sequence
analysis (5.4 kb) was smaller than the size of two mRNA species detected by
northern blot analysis (6.2 and 7.4 kb). An ORF starts from nucleotide 480,
indicating the presence of over 1 kb untranslated region at the 5' end. Since the
sequence of the 5' end was obtained from genomic DNA, it is possibly that the ORF
started downstream from the 3' end of an intron. If this is the case, then there is
evidence for at least two introns in the NC10 gene, including the 750 bp intron.
Additional studies are needed to obtain the complete cDNA sequence to verify the
presence of introns, define the initiation ATG codon and determine which mRNA
species is representative of the NC10 gene.
Both nucleotide and amino acid sequences of cDNA clones NCI, NC2 and
NC10 were compared with the corresponding sequence of the gene encoding the
QP/PIM protein. The region of similarity between the predicted amino acid
sequences of the cDNA clones and the QP/PIM gene was found to be over the Gin-
Pro and Glu-Pro regions. The sequence similarity between PIM and clones NCI,
NC2 and NC10 was low. However, the NC10 gene shows tetrapeptide repeats with
QP motifs in its central region. These repeats, in particular, are similar to the repeats
observed in the PIM gene sequence (Baylis et al., 1993; Toye et al., 1995b). It has
been demonstrated recently that similar motifs are also present in the pi50 gene of T.
parva, which immunologically cross reacts with PIM (Skilton et al., 1998). In
addition, like PIM, the pl50 gene was also shown to be polymorphic (Skilton et al.,
1998). It was suggested that these motifs and sequence homologies may represent a
common function or reflect a common ancestry for the pi50 and PIM antigens
(Skilton et al., 1998). It is tempting to speculate that NC10 also shares a common
ancestor with the pi50 and PIM genes at some point in the past.
Northern blot analyses were performed to reveal the expression patterns of
the cDNA clones. It was demonstrated that genes represented by clones NCI, NC2,
and NC10 were differentially expressed by different life cycle stages of the parasite.
The NCI and NC2 genes were expressed mainly by the sporozoite stage and were
clearly down-regulated at the piroplasm stage. However, it is difficult to conclude
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that the down-regulation occurs during the macroschizont stage, since the amount of
macroschizont RNA loaded was less than the sporozoite and piroplasm RNA due to
the presence of bovine RNA in the samples obtained from infected cell lines.
In contrast, the NC10 gene was expressed mainly at the macroschizont stage
of the parasite life cycle. Two mRNA species of 6.2 and 7.4 kb, were detected by the
NC10 probe in northern blot analysis. Two hypotheses can be put forward for the
presence of these two mRNA species. Firstly, ifNCI0 represent a single copy gene,
two transcripts could be generated by the presence of different transcription
initiation/termination sites, differential 3' processing and polyA addition, or by
alternative RNA splicing as seen in other systems (Ranson et al., 1998; Kitayama et
al., 1999). Complete sequence information and mapping of the 5' and 3' termini of
the mRNA species by RACE analysis are needed to test this hypothesis. Secondly,
although Southern blot analysis suggested that the NC10 is a single copy gene, these
results are not conclusive as only a small number of restriction enzymes were tested.
Therefore, additional related genes may be present in the genome as indicated by
northern and western blot analyses and the results of IFAT with anti-NC10-Sspl3
sera.
The QP probe detected at least three T. annulata mRNA species. The size
and the expression pattern of the mRNA species at about 3.3 kb obtained by the QP
probe was similar to that obtained by NCI gene. However, nucleotide sequence
homology between the NC2 gene and the QP/PIM gene is low. At the stringency
used a higher level of homology would be expected for detection of the same RNA
species by these probes. Additionally, both QP and NC2 probes do not detect the
same RFLP's on Southern blots at 60°C stringency. Therefore, either Southern or
northern are different in terms of stringency or probes detect different mRNA species
of approximately same size.
Taken together, none of the genes isolated from the T. annulata cDNA library
appears to be the real homologue of the QP/PIM gene. However, it is possible that
there is a gene(s) in the T. annulata genome with a higher homology to the QP/PIM
gene, since Southern blot analysis of T. annulata Ankara piroplasm DNA with the
QP probe showed that there are restriction fragments that are detected by QP probe
following a high stringency wash (60°C). None of these restriction fragments were
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detected by the NCI, NC2 or NC10 gene probes. Thus, these cDNAs may only have
limited sequence relatedness to the QP probe. On the other hand, the NC10 gene is
QP-like in terms of the tetrapeptide repeats with QP motifs and the encoded
polypeptide could be a structurally related to and act as a functional homologue of
the QP/PIM. Furthermore, as the QP/PIM gene is highly polymorphic among T.
parva stocks (Toye et al., 1995a; Toye et al., 1995b), it is possible that the selection
for diversity in this antigen in one or both species has resulted in the low level of
homology displayed between PIM and the T. annulata genes cloned in this study.
4.4.3. Expression and Characterization of Proteins
Since both NCI and NC10 genes were expressed by the macroschizont stage
of the parasite, attempts were made to produce recombinant proteins from these
genes. These proteins could then be used in a combination ELISA involving Tamrl
in an attempt to distinguish animals vaccinated with high passage cell lines from
those naturally infected with T. annulata.
In order to express two fragments of the NCI gene (1.2 and 2.2 kb in length),
two expression constructs were designed using both pQE and pGex vector systems. It
was demonstrated that expression products of both fragments were toxic to the
strains of E. coli used, XL1 Blue and M15[pRep4], It is possible that expression
products of both fragments of the NCI gene interfered with bacterial gene expression
or other essential cellular processes (Spector et al., 1998). Although various methods
were used to overcome the lack of expression due to toxicity, the purified expression
product obtained from the 1.2 kb fragment of the NCI gene in the pQE system was
not sufficient enough for further studies. In addition, the His-tagged fusion protein
did not react with the immune bovine serum. This indicated that the fusion protein
was not immunogenic and, therefore, could not be used in an ELISA.
In order to express a fragment of the NC10 gene, three different strategies
were followed. Expression of the whole cDNA fragment using the pGex vector
resulted in very low levels of expression product, and no expression products were
obtained from a fragment spanning the QP repeat region of the NC10 gene. To
overcome the lack of expression, smaller fragments were obtained using several
restriction enzymes that recognised multiple sites in the cDNA sequence. The
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expression of these fragments resulted in several GST fusion proteins. The
expression product of the NC10-Sspl3 fragment was more immunogenic than the
other GST fusion proteins, making it a good candidate to use in ELISA. The use of a
GST fusion protein in ELISA, however, could be complicated since GST antigens
are present in Schistosoma bovis and Fasciola hepatica (Hillyer et al., 1992), and
infections with these parasites occur in areas where tropical theileriosis is endemic
(Kaplan, 1994; Gargili et al., 1999). Although previous studies indicated that serum
samples from animals infected with S. bovis and F. hepatica did not cross react with
PIM GST fusion protein in an ELISA (Katende et al., 1998), it was necessary to rule
out the possibility of false-positive findings due to the GST. For this purpose, the
Sspl3 fragment of the NC10 gene was expressed in a pQE vector as His-tagged
fusion protein.
For the NC10-Sspl3 His-tagged fusion protein, the molecular mass predicted
from the protein sequence is less than that estimated from polyacrylamide gel
electrophoresis. This discrepancy may be due to the presence of sequences of
alternating proline residues, particularly Glu-Pro and Gin-Pro, which is thought to
confer an elongated conformation on proteins (Brewer et al., 1990). This
conformation would retard the migration of the NC10-Sspl3 fusion protein in a
polyacrylamide gel, as in the case of other proline-rich proteins (Carroll and
Laughon, 1987).
As indicated above, the expression product of the NC10-Sspl3 fragment
appeared to be more immunogenic than the other GST fusion proteins. This region of
the gene included approximately a third of the repeated amino acid sequence. It has
been demonstrated in many other organisms that repeated regions of amino acid
sequences are immunogenic (Schofield, 1991). For example, in Plasmodium spp,
antibodies to sporozoites appear to be directed almost entirely towards the repetitive
domain of the circumsporozoite (CS) protein (Zavala et al., 1985). Similarly, studies
carried out with monoclonal antibodies against the PIM protein indicated that the
repeat region of this molecule contains immunogenic epitopes (Toye et al., 1996).
Therefore, it is likely that the repeats within the NC10-Sspl3 fragment are
responsible for a major proportion of its immunogenicity.
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In order to confirm the antigenicity of the recombinant NC10-Sspl3 protein
and to obtain more information about the native protein, western blot analyses were
performed using an antiserum raised against the His-tagged NC10-Sspl3 fusion
protein. Results of western blotting demonstrated that several polypeptides from
macroschizont infected cells of different T. annulata stocks reacted with the rabbit
anti-NC10-Sspl3 serum. Two explanations can be put forward for this observation.
First, since the NC10-Sspl3 protein contains repeated amino acid motifs, it is
possible that some of the bands were due to the cross reactivity of the anti-serum
with similar repeats within different proteins. This possibility was shown previously
for malaria antigens where cross-reactions occurs between epitopes in repeats of
different proteins such as circumsporozoite (CS) proteins and asexual blood-stage
membrane antigen (CRA) (Anders, 1986). Furthermore, it was shown that anti-PIM
mAb 8 reacted with both recombinant PIM and recombinant pi50 of T. parva. A
sequence that occurs twice in the repeated region of the pi 50 has homology with the
PIM peptide sequence that contains the mAb 8 epitope (Skilton et al., 1998). There
were no other regions of sequence with comparable homology between pi50 and
PIM. It is entirely possible therefore that the repeated epitopes in NC10-Sspl3 are
present in other T. annulata macroschizont antigens. The detection of several related
genes in Southern blotting, at reduced stringency, of the T. annulata genome using
the NC10 cDNA probe supports of this hypothesis. The second possibility is that the
detection of several polypeptides is due to the presence ofmore than one related gene
for NC10 in the T. annulata genome. This is supported by two observations: (i) Two
mRNA species were detected by the NC10 cDNA probe in northern blot analysis at
high stringency which could suggest that there are two genes for NC10. Therefore, it
is possible that the two large polypeptides detected in western blot analysis are
derived from these two mRNA species and that the remaining polypeptide bands
could be due to breakdown or processing products of these proteins; (ii) IFAT results
showed that the anti-NCIO sera detected protein(s) on both macroschizonts and
nucleus of the host cells. Clearly, further Southern blot analysis carried out at high
stringency is necessary to distinguish between these two possibilities as the current
data indicating the existence of a single copy NCI 0 gene requires confirmation.
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On analysis by immunofluorescence microscopy, reactivity of NC10-Sspl3
anti-serum was detected against both macroschizonts and the host cell nucleus. Host
nuclear reactivity was scattered over the region of the nuclear envelope and appeared
to be absent from the nucleoli. A similar pattern of reactivity was observed among
different stocks of T. annulata including the BL20 cell line infected with T. annulata
Ankara, while the uninfected lymphoblastoid BL20 cell line was negative. These
results indicate that the protein detected on the host nucleus may be related to
infection and immortalisation of the host cell by the parasite. However, with the data
available, cross recognition of a host polypeptide cannot be discounted. It is also
possible that a parasite protein transported to the nucleus is not encoded by the NC10
gene as Southern, northern and western blotting suggest there may be related genes
in the T. annulata genome and/or cross recognition of polypeptides with related
repeat epitopes.
Variations were observed in the level of reactivity against the host nucleus
both between and within the macroschizont infected cell lines that were tested. This
could be due to the presence of different parasite populations in the in vitro
established cell lines as it is known that they can represent a number of distinct
parasite genotypes. It is possible, therefore, that one polypeptide or different forms of
the same polypeptide could be polymorphic across different parasite populations.
However, variations were also obtained within cell lines (D7 and D7B12), which are
thought to represent the same genotype, suggesting that the intensity of staining
could be related to the expression level of the same protein(s) and it is known that
alterations to gene expression that result from adaptation to in vitro cultivation might
also lead to variation in the intensity of staining (Baylis et al., 1992; Shiels et ai,
1994; Sutherland et al., 1996).
The staining of the host cell nucleus appeared to be specific to cells in
interphase as no staining was observed in cells visibly undergoing mitotic division.
In contrast, macroschizonts weie detected during all cell cycle stages. Detection of
reactivity on the host nucleus during interphase and its absence during mitosis would
suggest that loss of reactivity could be related to the disintegration of the nuclear
envelope, i.e. the protein could be attached or inserted into the nuclear membrane,
and this possibility is supported by the observation of fluorescence in the cytoplasm
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ofmitotic cells. Nevertheless, it is not possible to reach a definitive conclusion from
the IFAT pattern alone.
A molecule that may be of parasite origin and is located to the host cell
nucleus is clearly of interest with respect to the parasite induced immortalisation of
the host cell. At present, identification of mechanisms related to induction of host
cell proliferation by Theileria is limited and not fully understood (reviewed by
Chaussepied and Langsley, 1996; Dobbelaere and Heussler, 1999). It has been
demonstrated that host cell division depends on the presence of the macroschizont, as
drug-induced death of the parasite results in termination of proliferation and
induction of apoptotic host cell death (McHardy and Morgan, 1985; Dobbelaere et
al., 1988; Fich et al., 1998). Several studies have demonstrated changes in important
host cell regulatory molecules in Theileria-infected cells; such as the transcription
factors NFkK (Ivanov et al., 1989); AP-1 (Baylis et al., 1995); interleukin 2 (IL-2)
and the IL-2 receptor (IL-2R) (Dobbelaere et al., 1988; Heussler et al., 1992) and
Casein kinase II (Ole Moiyoi et al., 1993). However, it is not known how the
infection of the host cell by the parasite initiates these changes associated with
immortalisation infection. The first candidate for a parasite molecule that is
transported to the host cell nucleus and could be involved in regulating proliferation
and/or host cell gene expression was reported recently (Swan et al., 1999). This
molecule (TashAT) has homology over a small motif (the AT hook) which is known
to bind to A.T rich DNA and is present in molecules with known oncogenic potential
(Tkachuk et al., 1992; Ashar et al., 1995; Slany et al., 1998). Although the pattern of
staining detected by anti TashAT sera and anti NC10-Sspl3 sera are related, they are
not identical. Staining with anti TashAT antibody, for example, has been observed
in cells during mitosis (Shiels, Stem and Swan, unpublished). Thus while the
TashAT genes and NC10 may both be involved in the control of host cell
division/gene expression it is possible they perform distinct complementary functions
related to a location either within or on the surface of the host nucleus.
The pattern of reactivity in actively dividing cells with anti NC10-Sspl3
antibody is interesting as it mimics the pattern observed for nuclear envelope
polypeptides especially the lamina protein, (LAP) 2a (Dechat et al., 1998). The
nuclear envelope forms the boundary of the nucleus in eukaryotic cells and separates
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nuclear and cytoplasmic activities. It consists of a double membrane, an underlying
filamentous meshwork (the nuclear lamina) and nuclear pore complexes that mediate
nucleo-cytoplasmic transport. The structural integrity of the nuclear envelope is
essential for nuclear functions such as DNA replication, RNA transcription and RNA
processing (Dechat et al., 1998). In higher eukaryotes the nuclear envelope breaks
down during mitosis (open mitosis) and the nuclear lamina is transiently
disassembled, most probably through phosphorylation of lamina proteins by protein
kinases which are key regulators of the cell cycle (Kendrew and Lawrence, 1994).
By altering the nuclear envelope structure or nuclear pore complexes, essential
replication factors may be enabled to cross the nuclear envelope to enter the nucleus
and to start DNA replication (Coverley et al., 1993). Thus, it is possible that a
parasite polypeptide associated with host nuclear envelope may function to alter the
envelope structure or nuclear pore facilitating the transport of molecules involved in
regulating host nuclear function, as proposed for the TashAT polypeptides (Swan et
al., 1999).
Evidence for a putative transport structure has been described previously in T.
annulata infected cells. Thus, Musisi et al. (1981) and Jura et al. (1983a)
demonstrated the possibility of a connection between the host cell nucleus and the
macroschizont via annulate lamellae at interphase of the cell cycle by
electronmicroscopy, but no conclusion could be made as to the precise nature of this
connection. These membranes are often observed in rapidly dividing cells, germ
cells, and cells at the onset of differentiation (Kessel, 1992). The function of this
membTane system in these cells is yet to be elucidated. Recently, studies on
lymphoid cells infected by human herpesvirus 6 using anti-endoplasmic reticulum
antibodies showed a close relationship between annulate lamellae and the
endoplasmic reticulum and nuclear membranes (Cardinali et al., 1998). In addition,
at least some of the proteins involved in the nuclear pore complex formation have
common binding properties with proteins of the annulate lamellae (Cordes et al.,
1995). From these findings it is conceivable that annulate lamellae are involved in
the transport of molecules to the nucleus of proliferating cells and may contain the
NC10 polypeptide in Theileria infected cells.
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In order to determine whether the NC10 antigen has a structural role, a
number of studies need to be performed. These include immunoelectron microscopy
during different phases of the cell cycle. Such studies could provide further
information on the fate of the antigen during mitosis. Is it processed, for example, or
could it be associated with the microtubule network involved in nuclear assembly? A
role for these functions has been described for lamin B proteins (Ellenberg et al.,
1997). Is the molecule associated with the schizont present on the parasite surface
and does it allow attachment to the host mitotic spindle? Transfection studies, as
described for the TashAT gene (Swan et al., 1999), should also be performed.
Importantly, they will confirm whether the NC10 antigen is responsible for the
fluorescence pattern described in this study or whether this is due to a related parasite
antigen or cross recognition of a host polypeptide, although the lack of reactivity in a
range of host nuclei including BL20 and T. parva infected cells suggests this is
unlikely.
The aim of the current study was to define an immunogenic antigen from the
macroschizont stage of T. annulata that could be used in ELISA to detect antibodies
against this parasite in both animals vaccinated with high passage cell lines and those
that are naturally infected. To facilitate this goal, recombinant proteins encoded by
genes expressed at the macroschizont stage of the parasite were obtained. Among
these, the NC10-Sspl3 fusion protein was found to be immunogenic, making it a
good candidate for ELISA. Results of experiments aimed at development of an
indirect ELISA using recombinant NC10-Sspl3 protein in combination with the
recombinant merozoite rhoptry antigen (Tamr-1) and a second macroschizont antigen
(Tash-2) are described in Chapters 5 and 6.
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CHAPTER FIVE
DEVELOPMENT OF INDIRECT ENZYME LINKED IMMUNOSORBENT
ASSAYS USING RHOPTRY AND MACROSCHIZONT ANTIGENS
5.1. INTRODUCTION
The collection of serum samples and production of the macroschizont stage
specific recombinant antigen for the enzyme linked immunosorbent assay (ELISA)
were described in Chapters 3 and 4, respectively. This chapter focuses on the use of
the stage specific recombinant antigens in serological tests.
Detection of antibodies specific to T. annulata is necessary not only to assess
the prevalence of tropical theileriosis in epidemiological studies but also to measure
the impact of control programmes for T. annulata in endemic areas. To date, the
indirect fluorescent antibody test (IFAT) using both macroschizont and piroplasm
antigens has been extensively used for the detection of antibodies against T. annulata
in cattle following infection (Pipano and Cahana, 1969) and vaccination with
attenuated cell lines using macroschizont antigen (Pipano et al., 1969). However, the
IFAT fails to distinguish vaccinated/unchallenged animals from those that are either
vaccinated/challenged or those that are naturally infected by ticks due to the presence
of common antigens in all stages of the parasite (Knight et al., 1998). Such
distinction is important to assess the efficacy of a vaccine against possible
challenge(s) in the field.
ELISA has several advantages over the IFAT. For example, IFAT relies on
subjective observation of degree of fluorescence whereas ELISA provides objective
results. ELISA systems allow large numbers of samples to be assayed. In addition,
the potential sensitivity of ELISA is greater than IFAT. As a result, several attempts
have been made to develop an ELISA to detect antibodies specific to T. annulata
(Gray et al., 1980; Kachani et al., 1992; Sundar et al., 1993; Reddy et al., 1994;
Beniwal et al., 1997). In these studies, crude antigen extracts obtained from
piroplasms (Gray et al., 1980; Sundar et al., 1993), macroschizont (Reddy et al.,
1994; Prasanth et al., 1995) or both macroschizont and piroplasm (Kachani et al.,
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1992; Beniwal et al., 1997) stages of the parasite were used. However, none of these
tests were fully evaluated for sensitivity and specificity. In addition, it has been
demonstrated that ELISAs performed with crude antigen extract from the piroplasm
stage of the parasite cannot distinguish between vaccinated and naturally infected
animals (Kachani et al., 1996; Beniwal et al., 1997).
One approach to increase sensitivity and specificity of the test would be to
use recombinant antigens rather than crude piroplasm antigen preparation.
Furthermore, if the recombinant antigen used is expressed in a specific stage of the
parasite, it would be possible to identify the stage of the parasite that an animal has
been exposed to. Such a test could then be used to distinguish vaccinated animals
from those that are naturally infected. Following a natural infection with T. annulata
sporozoites, antibodies would be detected against sporozoites, macroschzionts,
merozoites and piroplasms. In contrast, animals immunised with attenuated high
passage cell lines, which do not produce piroplasms, will be exposed only to the
macroschizont stage of the parasite. Therefore, serological tests using antigens
specific to the sporozoite or piroplasm stages of the parasite could only detect
animals infected with sporozoites, and thereby distinguish these animals from
vaccinated cattle. On the other hand, tests performed with macroschizont-specific
antigens would detect both naturally infected and vaccinated animals.
It is evident from the above discussion that identification of recombinant
antigens specific to sporozoites of T. annulata would be of pivotal importance in
distinguishing vaccinated animals from naturally infected ones. Previous studies
performed with a sporozoite stage specific recombinant antigen, SPAG-1, showed
that the SPAG-1 ELISA is not sensitive enough to detect animals exposed to
sporozoites only once (Matita, 1994; Williamson et al., 1994) as this is a regular
occurrence in the field only once or twice in a year (Flach and Ouhelli, 1992). This
could be due to the fact that the immune system is exposed to sporozoites for a very
short time period before sporozoites enter the host lymphocytes and differentiate to
macroschizonts (Jura et al., 1983a).
An ELISA based on an antigen specific to the merozoite / piroplasm stage of
T. annulata would detect naturally-infected but not vaccinated animals, provided that
attenuated cell line vaccines do not produce piroplasms. An indirect ELISA using a
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merozoite surface antigen, Tamsl-1, was recently developed by Gubbels et al.
(1999a). Their study demonstrated that the Tamsl-1 ELISA is not sufficiently
sensitive to detect animals infected with sporozoites, when the test is performed
earlier than three months post infection (Gubbels et al., 1999a). In addition, a 30-32
kDa merozoite surface antigen (Tarns 1) was detected in Western-blot analyses using
serum samples from animals immunised with the T. annulata Ankara/Pendik
attenuated cell line (Chapter 4). Thus, it is possible that the Tamsl-1 ELISA would
detect not only naturally infected animals but also those that are vaccinated with
attenuated cell lines.
A recombinant merozoite rhoptry protein, Tamr-1, is another antigen specific
to the piroplasm stage of T. annulata. Preliminary studies carried out by Matita
(1994) demonstrated that Tamr-1 is antigenic. In a further preliminary study, it was
found that when animals are infected with sporozoites or a low passage cell line they
showed antibody responses in the Tamr-1 ELISA (Ilhan, 1995). In contrast, animals
immunised with attenuated high passage cell lines showed no or only a slight
increase in antibody levels (Ilhan, 1995). These studies suggested that Tamr-1 could
be used in an ELISA designed to distinguish between naturally infected and
vaccinated animals. However, the diagnostic sensitivity and specificity of the Tamr-1
ELISA remain to be evaluated.
While Tamr-1 ELISA could be used to detect naturally infected animals, an
ELISA that could detect antibodies in vaccinated animals is also needed to verify that
macroschizonts are established in the recipient animal. This could be accomplished
using an antigen expressed in the macroschizont stage of the parasite, such as NC10-
Sspl3 (see Chapter 4). An antigen that is expressed in both the macroschizont and
piroplasm stages of the parasite such as Tash-2, which was shown to be
immunogenic (D. Swan, pers. comm.), could also be used for the same purpose.
In the current study, the three recombinant antigens, Tamr-1, NC10-Sspl3
and Tash-2 were evaluated by ELISA using guidelines tor the international
standardisation of antibody-detection ELISA protocols (Wright et al., 1993). The
objectives of this chapter were: (i) to determine the immunogenicity of Tamr-1,
NC10-Sspl3 and Tash-2 against immune bovine sera using Western blot analysis; ii)
to standardise working protocols for indirect IgG and IgM ELISA using Tamr-1,
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NC10-Sspl3 and Tash-2; iii) to establish the diagnostic sensitivity and specificity of
these ELISAs. In the following chapter (Chapter 6), these antigens will be further
analysed for the purpose of distinguishing vaccinated animals from those that are
infected by ticks in the field.
5.2. MATERIALS AND METHODS
5.2.1. Purification of Recombinant Antigens
5.2.1.1. Merozoite rhoptry antigen (Tamr-1)
The merozoite rhoptry (Tamr-1) recombinant protein was expressed as a
GST-E21X fusion protein using the pGex-lN gene fusion vector (Pharmacia). The
clone containing two-thirds of the rhoptry gene was kindly provided by Dr. Brian
Shiels (Department of Veterinary Parasitology, University of Glasgow). The
recombinant protein was purified as described in section 4.2.20.2 and the quality of
the protein was assessed by 10% SDS-PAGE (see section 4.2.2). The protein was
reconstituted in PBS at a concentration of 3.5 mg/ml. The fusion protein was divided
into 50 pi aliquots and stored at -70°C.
5.2.1.2. NClO-Ssp13 antigen
The macroschizont NC10-Sspl3 recombinant antigen was expressed in pQE-
32 vector as a His6-tagged protein. The recombinant protein was purified as
described in section 4.2.20.1 and was reconstituted in Tris-HCl, pH 8.0, at a
concentration of 160 pg/ml.
5.2.1.3. Tash-2 antigen
The recombinant Tash-2 protein was kindly provided by Dr. David Swan
(Department of Veterinary Parasitology, University of Glasgow) as a GST fusion
protein. The concentration of recombinant protein was 130 pg/ml in PBS.
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5.2.2. Western Blot Analysis of Recombinant Proteins
Western blot analysis was carried out using serum samples from animals
infected with either sporozoites or low or high passage cell lines as described in
section 4.2.3. The standardisation of protein concentrations, serum and conjugate
dilutions was carried out by serial dilution of each recombinant protein. For Western
blot analysis, 100 ng of recombinant protein was loaded to each lane in SDS-PAGE
loading buffer. Bovine sera were diluted at 1:500 and alkaline phosphatase
conjugated secondary antibody raised in rabbit (IgG whole molecule, Sigma, A-
0705) was diluted at 1:20,000 in blocking buffer. Since both Tamr-1 and Tash-2
antigens were expressed as GST- fusion protein, serum samples were also tested
against glutathione-S-transferase (GST), at 29 kDa. For this purpose, 100 ng of the
GST protein was loaded on respective lanes.
5.2.3. ELISA
5.2.3.1. Theileria annulata antibody ELISA reagents andprotocol
The indirect-ELISA protocol was used to detect both IgG and IgM antibody
responses of animals using Tamr-1, NC10-Sspl3 and Tash-2 recombinant antigens.
i) Reference control sera
A set of pre- and post infection serum samples was tested to choose the
negative control (C-), low positive (C+) and high positive (C++) reference control
sera to be included as standard control sera in future tests. For IgG ELISAs, serum
samples were tested using 1:25-1:3,200 antigen dilution, 1:50 serum dilution and
1:5,000 conjugate dilution. Dilutions for IgM biotin conjugate (immunoglobulin
(r)fraction ofmouse ascites fluid, clone BM-23) (Sigma; B-0774) and the ExtrAvidin
(Sigma; E2886) were 1:10,000 and 1:1,000, respectively. Where applicable, pre-
infection serum samples with an optical density (OD) reading of around 0.1-0.2 were
used as negative (C-) control sera. Serum samples with OD readings of 0.5-0.7 and
1.0-1.5 were used as low positive (C+) and high positive (C++) control sera,
respectively. Selected negative (C-), low positive (C+) and high-positive (C++)




Affinity purified, rabbit anti-bovine IgG horseradish peroxidase-labelled
conjugate (HRPO) developed in rabbit (Sigma; A-5295) was used for IgG ELISAs.
The conjugate was stored at -20°C in 50 pi aliquots. Once thawed, the conjugate was
kept at + 4°C. An anti-bovine IgM biotin conjugate (immunoglobulin fraction of
mouse ascites fluid, clone BM-23) (Sigma; B-0774) was used with ExtrAvidin®-
peroxidase (Sigma; E2886) for IgM ELISAs.
iii) Coating buffer
Carbonate-bicarbonate buffer, pH 9.6, 0.05M, (Sigma) was prepared by
dissolving one capsule in 100 ml deionised water. The buffer was kept at 4°C and
used within one week.
iv) Washing buffer
Phosphate-buffered saline (PBS, 144 mM Sodium chloride, 1.47 mM
Potassium dihydrogen orthophosphate, 8.1 mM di-Sodium hydrogen orthophosphate
dodecahydrate, 2.68 mM Potassium chloride, pH 7.4), with 0.05%
polyoxyxyethylene sorbitan monolaurate (Tween 20) (PBST/0.05T), was prepared
and kept at room temperature for up to four weeks.
v) Serum and conjugate diluents
-Phosphate-buffered saline, pH 7.4, with 0.5% Tween 20 was used as diluent
for all the ELISAs. It was kept at room temperature for up to two weeks.
vi) Substrate buffer
One component Tetramethylbenzidine dihydrochloride (TMB) Microwell
Peroxidase Substrate (Kiikegaard and Perry Laboratories) was used according to the
manufacturer's directions.
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5.2.3.2. Basic ELISA protocol
i) Detection of immunoglobulin G antibodies
All ELISAs were performed using 96 well polystyrene micro-ELISA plates
(Dynatech, Immulon, Type I). Antigen prepared in carbonate-bicarbonate buffer was
added at 100 pi per well and plates were covered with plate sealers (ICN
Biomedicals). Plates were put on a microplate incubator/shaker (Dynatech
Laboratories Ltd) for 30 seconds at room temperature to obtain an even distribution
of the solution at the bottom of each well. Plates were then kept overnight at 4°C.
Each well was washed five times with 300 pi PBS/0.05%T using a Multichannel
Dispenser Pipette (Finnpipette). The content of each well was removed by shaking
out, and plates were blotted upside down on paper towels to remove excess buffer.
Test samples and control sera were diluted in PBS/ 0.5%T and added, 100 pi per
well, in duplicate and quadruplicate wells, respectively. Four controls were included
on each plate: the conjugate control (Cc) which was serum diluent only, high positive
(C++), low positive (C+), and negative (C-) controls. The plates were covered with
plate lids and incubated at 37°C for 1 hour on the microplate shaker. Following the
incubation, plates were washed with PBS/0.05%T as described above. The
horseradish peroxidase conjugate diluted with PBS/0.5%T was added at 100 pi into
each well. Plates were covered, incubated for a further one-hour period in the
microplate shaker and washed with PBS/ 0.05%T. One hundred microlitres of the
TMB substrate solution was added into each well and plates were incubated at room
temperature for 10 minutes while shaking. The enzymatic reaction was stopped by
adding 100 pi of 0.2 M sulphuric acid per well. The ODs of individual wells were
read immediately using a Labsystems Multiskan Plus II ELISA plate reader (Life
Sciences International, UK, Ltd.) with a 450 nm filter. Before reading the test results,
the plate reader was blanked against an empty ELISA plate of the same type used for
the test.
ii) Detection of immunoglobulin M antibodies
ELISA for detecting IgM was performed as described in section 5.2.3.2(i)
with slight modifications. Incubation periods for coating plates, diluents, washing
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buffer, incubation times, temperatures, and volumes of the samples were the same as
for IgG ELISAs. Biotin labelled anti-bovine IgM monoclonal antibody was diluted
with PBS/0.5%T and 100 pi of antibody solution was added into each well following
the incubation serum samples. Following incubation and washing steps, lOOpl
ExtrAvidin®-peroxidase conjugate diluted in PBS/0.5%T was added into each well.
Plates were incubated at 37°C for 45 minutes. The colour development and
measurement was as described above for IgG ELISAs.
5.2.3.3. Standardisation and optimisation of indirect ELISAsfor the detection
of7. annulata specific antibodies
Chequerboard titrations were conducted to determine which antigen, serum
and conjugate dilutions gave optimal differentiation between OD readings of positive
(C++) and negative sera (C-). For this purpose, the ratio of positive and negative
control ODs (ODc++/ ODc.) was calculated as described previously (Voller et al.,
1976).
5.2.3.4. Data expression and quality controlparameters
The data obtained from the IgG Tamr-1 ELISA assays were expressed
according to the guidelines for the international standardisation of antibody detection
ELISA protocols and reagents (Wright et al., 1993). The data were expressed as
percentage positivity (PP) as described by Wright et al. (1993). The PP value of the
OD of each well was calculated using the following equation:
Single well OD
PP = x 100
Median ODc++
where the median ODc++ equals the median of at least three high positive control
ODs which were within the upper (UCL) and lower (LCL) control limits.
The OD and PP values of the high-positive control (C++), and the PP values
of the low-positive (C+), negative (C-) and conjugate (Cc) controls were used to
determine whether each test plate was within acceptable limits of variability, as
defined by the upper (UCL) and lower (LCL) control limits. UCL and LCL were
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determined for the reference control serum samples (C++, C+, C- and Cc) of the IgG
Tamr-1 ELISA. In order to establish these limits, four plates with multiple replicate
wells for each control were assayed on different days by the IgG Tamr-1 ELISA,
under as near to ideal condition as possible. New plasticware and exact incubation
times were used for each assay. The high-positive control (C++) was added to
column 1-3, the low-positive control to columns 4-6, the negative control (C-) to
column 7-9, and the conjugate control (Cc) to column 10-12.
The lower and upper control limits for the Tamr-1 ELISA controls (C++, C+,
C-, Cc) were determined by the 90th and 10th percentiles of the replicate well OD
and PP values, respectively (A.G. Luckins, per. comm.). Because the data did not
have a Normal distribution when measured by the correlation coefficient using
Minitab software (version 12), the percentile was obtained by sorting the data in
descending order.
Individual test plates were accepted or rejected using three criteria. First, at
least three of the four replicate high-positive control (C++) ODs had to be within the
established UCL and LCL. Second, at least three of the four replicate PP values for
each control (C+, C- and Cc) had to be within their respective upper and lower
control limits. Third, the difference between ODs of replica test samples had to be
less than 15%.
Data for IgM Tamr-1, NC10-Sspl3 and Tash-2 ELISAs were expressed as
optical densities (OD). LCL and UCL were not determined for these ELISAs due to
time constraints. In these ELISAs the antibody response to infection with T. annulata
was monitored in each individual animal. In order to avoid plate to plate variations,
sequential serum samples obtained from each animal were tested on the same ELISA
plate. Antibody responses were correlated with the corresponding pre-infection
values.
5.2.3.5. Estimation ofsensitivity and specificity and cut-offanalysis
Known positive serum samples from British cattle (n=209) experimentally
infected with eight different stocks of T. annulata (Ankara, Diyarbakir, Gharb,
Hissar, Ode, Tova, Tunisia, Razi) were used to determine the sensitivity of the IgG
Tamr-1 ELISA. These sera were generated at the CTVM over the past 15-20 years.
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Serum samples were taken from animals 28 to 58 days after a single infection with
sporozoites or macroschizont- infected low and high passage cell lines of T.
annulata. All samples have been tested by IFAT using both the schizont and
piroplasm antigens. All the serum samples chosen for the sensitivity test were
positive in the piroplasm IFAT at a 1:160 cut-off value. Known negative senim
samples (n= 188) from pre-infection experimental calves were tested to determine
specificity of the IgG Tamr-1 ELISA.
Cross reactions with other blood protozoans were tested by sera from cattle
experimentally infected with T. parva (n=9 from CTVM; Muguga, Marikebuni,
Lanet and Boleni stocks), T. buffeli (n=13; 2 from Australia, 11 from Sicily - serum
samples from Sicily were collected from cattle infected in the field), T. sergenti (n=2
from Japan; Ikeda and Chitose stocks), Babesia bovis (n=12 from CTVM and ILRI,
Mexico stocks), B. bigemina (n=9 from CTVM and ILRI, Muguga and Zaria stocks),
Anaplasma marginale (n=8 from ILRI) and Trypanosoma evansi (n=2 from CTVM,
Indonesian isolate TREU 1994, kindly provided by Dr. Tony Luckins). Serum
samples from three Scottish cattle infected with the nematode Ostertagia ostertagi
were also tested to see if anti-GST antibodies in these animals would cross react with
the Tamr-1 antigen.
Optical density (OD) values were transformed to PP values as described in
section 5.2.1.5. In order to choose optimal ELISA cut-off values, two-graph response
operating characteristic curves (TG-ROC), which are equivalent to cumulative
frequency distribution of negative (CFDneg) and the inverse positive (CFDpos) sample
(Greiner et al., 1995), were established using cut-off values of 0 - 100 PP at 1 PP
intervals for the IgG Tamr-1 ELISA.
Positive and negative threshold PP values were chosen arbitrarily to obtain
the optimal sensitivity and specificity for the IgG Tamr-1 ELISA. Test sensitivity
was calculated as the number of the test positive animals divided by the total number
of T. annulata-infected animals tested, and was expressed as percentage. Test
specificity was calculated as the number of test-negative animals divided by the total
number of non-exposed animals tested, and was expressed as percentage.
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5.2.3.6. Blind test
A set of 240 serum samples (re-coded) selected by Dr. Susanna Williamson
from experimentally infected animals served as "Gold Standard" samples according
to the international standardisation and validation of different ELISAs for bovine
tropical theileriosis. There were 86 negative serum samples from Scottish calves
(pre-infection), 144 positive (post infection and post challenge) and 10 serum
samples from animals which were infected with various blood protozoa (n= 6 T.
parva, n=l T. buffeli, n= 1 B. bigemina, n=l B. bovis). Results from the IFAT using
the piroplasm antigen were available for most of these samples. The presence of
fluorescence at a dilution of 1:160 and above was accepted as positive. These serum
samples were aliquoted in 250 pi volumes and distributed to a laboratory in Utrecht
and to another laboratory in Morocco. The blind test that was performed at the
CTVM was conducted using the IgG Tamr-1 ELISA, whereas the one at the Utrecht
laboratory was conducted using a 32 kDa merozoite surface antigen (Tarns 1) ELISA.
A blind test is yet to be performed in Morocco. Although exchange of antigens used
in ELISAs between the two laboratories, viz. CTVM and Utrecht Laboratory, was
planned, this could not be achieved due to time constraints.
5.2.4. Statistical Analysis
For each control serum sample, the edge-effect factor between inner and
outer wells in the repeated quality control limits was analysed by Mann-Whitney test
using Minitab (version 10.2). Confidence intervals (CI) for sensitivity and specificity
of the IgG Tamr-1 ELISA were calculated as described by Thrusfield (1995).
Differences between estimates of sensitivity were assessed by the Chi-square
distribution using Minitab (version 10.2). When expected counts were less than five,
the Fisher's correct test was employed instead of the Chi-square test using Instat
statistic. The data were analysed for significance at the 5% level. The kappa statistic




5.3.1. Western Blot Analysis of the Recombinant Antigens
Results of Western blot analysis of a set of serum samples from animals
infected with different stocks (Ankara, Hissar, Gharb) and life cycle stages
(sporozoite or macroschizont) of T. annulata are given in Table 5.1. Figures 5.2A, B
and C show results of representative Western blots of the Tamr-1, NC10-Sspl3 and
Tash-2 antigens tested with these sera.
Table 5.1. Western blot analysis of a set of serum samples from animals infected
with different stocks (Ankara, Hissar, Gharb) and life cycle stages (sporozoite or









Pre-infection 0/12 2/16 1/16















Figure 5.1 A shows a Coomassie stained SDS-PAGE gel of purified Tamr-1
(lane 3) and GST (lane 4) recombinant proteins. A distinct band at 116 kDa and
several low molecular weight breakdown products were detected with the Tamr-1
fusion protein (Figure 5.1A, lane 3). Pre-infection serum did not react with either the
Tamr-1 fusion protein or the GST protein by Western blot analysis (Figure 5.IB).
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Figure 5.1. Western blot analysis of purified merozoite rhoptry fusion protein,
Tamr-1. A) Coomassie stained 10% SDS-PAGE gel, lane 1: molecular marker, lane 2:
Total cell extracts of un-induced bacterial culture; lane 3: Tamr-1 fusion protein, lane 4:
GST fusion protein. B) Western blot analysis, lane 1 and 3: Tamr-1 fusion protein, lane 2
and 4: GST fusion protein. Lane 1 and 2: probed with pre-infection bovine serum (calf
892A day 0); lane 3 and 4: probed with post-infected bovine serum (calf 892A infected
with T. annulata Ankara low passage cell line 84 day after infection). The numbers on
the left indicate the molecular weights of the marker proteins.
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Post-infection bovine serum (day 84) reacted distinctly with the 116 kDa protein
band and a range of lower molecular weight proteins between 66 and 100 kDa.
Neither pre- nor post-infection bovine serum reacted with the GST protein.
Pre-infection serum samples (n=12) did not react with the Tamr-1 antigen
(Table 5.1 Figure 5.2A). Serum samples from two calves immunised with the high
passage cell line (T. anniilata Ankara/Pendik) were negative (Figure 5.2A). Both
calves showed positive reaction with the Tamr-1 antigen following challenge (Table
5.1). Four out of 12 serum samples from calves infected either with low passage cell
lines or with sporozoites were negative. Antibodies against the Tamr-1 antigen were
also detected in the remaining sera.
5.3.1.2. NCI 0-Sspl3 antigen
Pre-infection sera with two exceptions did not react with the NC10-Sspl3
recombinant antigen (Figure 5.2B; Table 5.1). 13 out of 20 post-infection sera gave
positive reactions of varying intensities to the NC10-Sspl3 antigen. Calves
immunised with the high passage cell line gave weak bands on Western blots.
Following challenge the bands became intense.
5.3.1.3. Task-2 antigen
All pre-infection serum samples were negative against the recombinant Tash-
2 antigen (Figure 5.2C; Table 5.1). 10 out of 20 post-infection sera gave positive
signals of different intensities. One of the calves immunised with the high passage
cell line gave no reaction after immunisation and challenge.
5.3.4. Standardisation and Optimisation of ELISAs
5.3.4.1. Optimisation of reagent dilutions
Figures 5.3 to 5.8 show the titrations of the Tamr-1, NC10-Sspl3 and Tash2
recombinant antigens, the reference bovine sera and conjugates. The optimal
dilutions determined for the antigens, control sera and conjugates are given in Table
5.2, as are the ratio of positive and negative sera samples (ODc++/ODc-) at the
optimal conditions. The same control reference serum samples were used in the IgG
Tamr-1, NC10-Sspl3 and Tash-2 ELISAs. The ratio of the positive to negative sera
169
Figure 5.2. Western blot analysis of three recombinant antigens, Tamr-1, NC10-
Sspl3 and Tash-2 using a set of serum samples. A) Tamr-1 fusion protein, B) NC10-
Sspl3 fusion protein C) Tash-2 fusion protein. Lane 1: calf 48C pre-infection, lane 2-3:
calf 48C 35 and 112 days after infection with 71 annulata Ankara sporozoites, lane 4:
calf 48C 42 days after challenge with 71 anmilata Gharb sporozoites, lane 5: calf 32C
pre-infection, lane 6: calf 32C 35 days after infection with 71 annulata Ankara low
passage cell line, lane 7: calf 32C 42 days after challenge with 71 annulata Gharb
sporozoites, lane 8: calf 891A pre-infection, lane 9: calf 891A 28 days after
immunisation with 71 annulata Ankara/Pendik low passage cell line. 100 ng of protein
was loaded into each lane. Molecular size markers (kDa) are indicated on the left.
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obtained with the IgG Tamr-1 ELISA was greater than those obtained for both IgG
NC10-Sspl3 and Tash-2 ELISAs (Table 5.2). The results showed that with
increasing serum dilutions, the OD readings decreased more rapidly in the Tamr-1
ELISA than in the NC10-Sspl3 and Tash-2 ELISAs (Figure 5.3, 5.4, 5.5).
IgG NC10-Sspl3 ELISA gave higher background binding OD levels with
negative serum samples compared to the Tamr-1 and Tash-2 antigens (Figure 5.4).
Because of time constraints, different dilutions of blocking agents (Skimmed milk,
Tween 20 etc.) could not be tested in order to reduce the non-specific background
binding.
The high positive control serum (C++) used at 1:500 and 1:100 for the Tamr-
1 and NC10-Sspl3 respectively gave very high OD values in the Tash-2 ELISA
(Figure 5.5) at 1:400 dilution. Similar results were obtained with other C++ sera
(data not shown).
The control serum samples (C++ and C+) used in IgG ELISAs were not
suitable for the IgM ELISAs. High positive control serum (C++) gave a very high
OD value (around 2.5 OD) at optimal conditions (data not shown). Therefore, new
control serum samples with acceptable positive/negative OD ratios were chosen
(Table 5.2).
The Tamr-1 antigen gave higher background binding OD values in IgM
ELISA in comparison the IgG ELISA. With increasing serum dilutions, the OD
reading decreased more rapidly in the Tamr-1 ELISA than in the NC10-Sspl3 and
Tash-2 ELISAs (Figure 5.6, 5.7, 5.8).
-High antigen dilutions were required for both NC10-Sspl3 and Tash-2
antigens in order to detect T. annulata specific IgM antibodies in C+ control serum
sample (Figures 5.7A, 5.8A). When low antigen concentrations were used lower
background binding OD levels were obtained. The ratios of the positive to negative
sera obtained with the IgM NC10-Sspl3 and Tash-2 ELISAs were greater than that
obtained for the Tamr-1 ELISA (Table 5.2). The antibody titres obtained in C+ with
IgM NC10-Sspl3 and Tash-2 ELISAs control serum sample gave low OD readings
such that C+ and C- sera could not be distinguished from each other unequivocally
(Figures 5.7, 5.8).
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Table 5.2. Optimal reagent dilutions of standardised Theileria annulata antibody
ELISAs for testing bovine sera and the ratio of positive to negative control optical









Serum 1:500 1:100 1:400**
Conjugate (HRPO) 1:10,000 1:5,000 1:8,000











Serum 1:400 1:200 1:200
IgM 1:20,000 1:10,000 1:10,000
ExtrAvidin* 1:1,000 1:1,000 1:1,000
Ratio of positive to
negative sera
4.1 13.1 15.4
*Dilution recommended by supplier
**C++ control serum used at 1/800 dilution due to high OD values.
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Figure 5.3. Titration of the antigen, control serum samples and conjugates in the
standardisation of IgG Tamr-1 ELISA.
A) Tamr-1 antigen dilutions (1.4 mg/ml-0.54 pg/ml, i.e. 1:25-1:6,400) using
control serum samples at the dilution as shown in brackets (1:50-1:200) and a 1:5,000
conjugate dilution.
B) Titration of control semm samples (C-, C++) using dilutions of Tamr-1
(1:800-l :3,200) and conjugate (1:5,000).
C) Titration of the conjugate using the optimal dilution of Tamr-1 (1:1,600, i.e.
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Figure 5.4. Titration of the antigen, control serum samples and conjugates in the
standardisation of IgG NC10-Sspl3 ELISA.
A) NC10-Sspl3 antigen dilutions (16 pg/ml-0.13 pg/ml, i.e. 1:10-1:1280) using
control serum samples (C-, C+, C++) and conjugate at dilutions 1:50 and 1:5,000
respectively.
B) Titration of control serum samples (C-, C+, C++) using the optimal dilution
ofNC10-Sspl3 (1.6 pg/ml, i.e. 1:100) and conjugate dilution at 1:5,000.
C) Titration of the conjugate using optimal dilution of NC10-Sspl3 (1.6 pg/ml)
and control serum samples (C-, C+, C++) at dilution 1:100.
I I I I
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Figure 5.5. Titration of the antigen, control serum samples and conjugates in the
standardisation of IgG Tash-2 ELISA.
A) Tash-2 antigen dilutions (1.3 pg/ml-0.01 pg/ml, i.e. 1:100-1:12,800) using
control serum samples (C-, C++) at 1:100-1:400 dilutions and conjugate at 1:5,000
dilution.
B) Titration of control serum samples (C-, C+, C++) using the optimal dilution
of Tash-2 (80 ng/ml, i.e. 1:1,600) and conjugate dilution at 1:5,000.
C) Titration of the conjugate using the optimal dilution of Tash-2 (80 ng/ml) and






Figure 5.6. Titration of the antigen, control serum samples and conjugates in the
standardisation of IgM Tamr-1 ELISA.
A) Tamr-1 antigen dilutions (1.4 mg/ml-0.54 pg/ml, i.e. 1:25-1:6400) using
control serum samples (C-, C++) at 1:50 and 1:100 dilutions. The dilutions of IgM
monoclonal antibody and ExtrAvidin conjugate were 1:10,000 and a 1:1,000,
respectively.
B) Titration of control serum samples (C-, C++) using the optimal dilution of
Tamr-1 (1.0 pg/ml, i.e. 1:1,600). The dilutions of IgM monoclonal antibody and
ExtrAvidin conjugate were 1:10,000 and a 1:1,000, respectively.
C) Titration of the conjugate using the optimal dilutions of Tamr-1 (1.0 pg/ml),
control serum samples (C-, C++) at 1:200-1:400 and ExtrAvidin conjugate at 1:1,000.
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Figure 5.7. Titration of the antigen, control serum samples and conjugates in the
standardisation of IgM NC10-Sspl3 ELISA.
A) NC10-Sspl3 antigen dilutions (6.4 pg/ml-50 ng/ml, i.e. 1:25-1:3,200) using
control serum samples (C-, C+, C++) at 1:50 and 1:100 dilutions. The dilutions of IgM
monoclonal antibody and ExtrAvidin conjugate were 1:10,000 and a 1:1,000,
respectively.
B) Titration of control serum samples (C-, C+, C++) using the optimal dilution
ofNC10-Sspl3 (50 ng/ml, i.e. 1:3,200). The dilutions of IgM monoclonal antibody and
ExtrAvidin conjugate were 1:10,000 and a 1:1,000, respectively.
C) Titration of the conjugate using optimal dilutions of NC10-Sspl3 (50 ng/ml),
control serum samples (C-, C+, C++) at 1:200 and ExtrAvidin conjugate at 1:1,000.
Reciprocal antigen dilution
3.5 n




Figure 5.8. Titration of the antigen, control serum samples and conjugates in the
standardisation of IgM Tash-2 ELISA.
A) Tash-2 antigen dilutions (5.2 pg/ml- 40 ng/ml, i.e. 1:25-1:3,200) using control
serum samples (C-, C+, C++) at 1:50 and 1:100 dilutions. The dilutions of IgM
monoclonal antibody and ExtrAvidin conjugate were 1:10,000 and a 1:1,000,
respectively.
B) Titration of control serum samples (C-, C+, C++) using optimal dilution of
Tash-2 (40 ng/ml, i.e. 1:3,200). The dilutions of IgM monoclonal antibody and
ExtrAvidin conjugate were 1:10,000 and a 1:1,000, respectively.
C) Titration of the conjugate using optimal dilutions of Tash-2 (40 ng/ml),
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5.3.4.2. Establishment ofupper and lower control limits
Upper and lower control limits (LCL and UCL) established for the IgG Tamr-
1 ELISA are given in Table 5.3. PP values were calculated using median ODc++
value of 1.264. In the IgG Tamr-1 ELISA, there was no significant difference
between inner and outer replicate wells in the repeated quality control plates
(p<0.001). Therefore, results of all wells were accepted as consistent.
Table 5.3. Upper (UCL) and lower (LCL) control limits for IgG Tamr-1 ELISA
given as optical densities. Percent positivity (PP) values are given in brackets.
Control UCL LCL
C++ 1.536(121.5%) 1.045 (82.7%)
C+ 0.499 (39.5%) 0.341 (27.0%)
c- 0.072 (5.7%) 0.050 (4.0%)
Cc 0.016 (1.3%) 0.006 (0.5%)
5.3.4.3. Sensitivity and specificity of the Tamr-1 antigen.
The frequency distribution of PP values of IgG Tamr-1 ELISA from the
negative (n=188) and positive (n=209) sera is given in Ligure 5.9. Figure 5.10A and
B shows the results of TG-ROC analysis indicating the relationship between cut-off
values and the sensitivity and specificity of the IgG Tamr-1 ELISA.
The mean of duplicate sample PP values was arranged as positive or negative,
using cut-off values of 14 PP and 18 PP on the basis of 95% and 99% specificity of
the test. At a cut-off value of 14 PP, sensitivity and specificity were 78.5% [73.0-
84.1 with a 95% confidence interval, (CI)] and 95.2% (92.0-98.3, 95% CI),
respectively. At a cut-off value of 18 PP, sensitivity and specificity were 72.7%
(66.7-78.7, 95% CI) and 98.4% (96.7-100, 95% CI), respectively (Table 5.4).
Serum samples from animals immunised with high passage, attenuated cell
lines were used to assess the sensitivity of the Tamr-1 IgG ELISA. The percent
positivity ofmost of these serum samples was under the chosen cut-off points (14 PP
and 18 PP) (Table 5.4). Although the number of sera tested from high passage cell
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Figure 5.9. Distribution of percentage positive (PP) data for sera from T. annulata
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Figure 5.10. TG-ROC analysis of the IgG Tamr-1 ELISA, indicating the
relationship between cut-off values and the sensitivity and specificity of the IgG
Tamr-1 ELISA. A) Serum samples obtained from animals infected either with
sporozoites or with low and high passage cell lines were used to determine sensitivity and
specificity (positive, n=209; negative, n= 188). B) Serum samples obtained from animals
infected either with sporozoites or with low passage cell lines were used to determine

































Table 5.4. Estimates of diagnostic sensitivity (%) with associated 95% confidence
intervals (CI) in brackets for IgG Tamr-1 ELISA calculated for animals infected with
T. annulata sporozoites or immunised with either low passage or high passage cell
lines. Groups with different letters are statistically significant from one another.
Cut-off SporozoiteA Low passageA High passage8 All
(n: 86) (n: 97) (n: 26) (n: 209)
14 PP 83.7 88.7 23.1 78.5
(75.9-91.5) (82.4-95.0) (6.8-39.4) (73.0-84.1)
18 PP 77.9 83.5 15.4 72.7
(69.1-86.7) (76.1-90.9) (1.5-29.3) (66.7-78.7)
line immunised animals was small, exclusion of serum samples obtained from
animals immunised with the high passage cell lines improved the sensitivity of the
test. The sensitivity of the test differed slightly between serum samples from animals
immunised with the low passage cell lines and those from animals infected with
sporozoites. However, results obtained from sporozoite infected animals were not
significantly different from macroschizont infected animals at both given cut-off
values of 14 PP (p = 0.332) and 18 PP (p = 0.337). Some serum samples from
animals immunised with cell lines T. annulata Tova and T. annulata Ode, which do
not have the ability to produce piroplasms in vivo, gave positive antibody response to
the Tamr-1 antigen (data not shown).
If the test specificity was reduced to 90% at 11 PP cut-off value, the
sensitivity of the IgG Tamr-1 ELISA was 85.2% (80.4-90.0, 95% CI) including all
sera (Figure 5.10A). When serum samples from animals immunised with the high
passage cell lines were excluded the sensitivity of the test at 11 PP cut-off value was
90.7% (86.5-94.9, 95% CI) (Figure 5.10B), which is not significantly different from
the sensitivity obtained with the inclusion of the high passage cell line.
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A substantial agreement between the piroplasm antigen IFAT and the IgG
Tamr-1 ELISA was found when all serum samples were included (kappa= 0.73 at 14
PP and 0.7 at 18 PP). The agreement between the two tests was also substantial at
each cut-off value using serum samples from animals infected with sporozoites
(kappa= 0.8 at both 14PP and 18 PP). Almost perfect agreement between the two
tests was observed with samples from animals immunised with the low passage cell
line (kappa= 0.84 at both 14PP and 18 PP).
The results of the cross-reactivity of the IgG Tamr-1 ELISA with serum
samples from experimentally infected calves (or field samples from Sicily) are given
in Table 5.5. Of 15 serum samples from T. parva-infected calves, eight were positive
at 14 PP and five at 18 PP. Of the two T. buffeli positive samples from Australia,
neither was positive at both cut-off values. However, four out of ten T. buffeli
positive serum samples from Sicily were positive at the cut-off value of 18 PP. One
animal infected with B. bovis and one infected with Trypanosoma evansi were
positive at the cut-off value of 14 PP.
Table 5.5. The results of the cross-reactivity of the IgG Tamr-1 ELISA with serum
samples from experimentally infected calves (or field samples from Sicily).
Infection with No. Positive / No. Sample
14 PP cut-off 18 PP cut-off
T. parva 8/15 5/15
T. buffeli 4/12 4/12
T. sergenti 0/2 0/2
Babesia bovis 1/12 0/12
B. bigemina 0/9 0/9
Anaplasma marginale 0/8 0/8
Trypanosoma evansi 1/2 0/2
Ostertagia ostertagi 0/3 0/3
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5.3.4.4 Blind Test
Table 5.6 shows the results of the blind test performed at the CTVM using the
IgG Tamr-1 ELISA in correlation with the results of IFAT using the piroplasm
antigen. At cut-off points of 14 PP and 18 PP, 91.7% (86.2-97.2, 95% CI) and 95.8%
(91.8-99.8, 95% CI) of animals were true negative, respectively. The proportion of
IFA positive animals were 90.3% (85.5-95.1, 95% CI) and 75% (67.9-82.1, 95% CI)
at cut-off points of 14 PP and 18 PP, respectively. Thirteen animals that were
infected with various cell lines, viz. T. anmdata Tova, which does not produce
piroplasms, and T. anmdata Ode, which is an attenuated cell line, were tested. Two
out of three T. anmdata Tova serum samples and five out of six T. annulata Ode
serum samples were above 18 PP. Since the standardisation tests had expected counts
less than five at 18 PP cut-off value, Chi-square test could not be used. Instead, the
Fisher's exact test was used (Instat statistic). At 18 PP cut-off value, there were
significant differences in the sensitivity of the test from the values determined in the
standardisation and optimisation section 5.3.4.3 (p < 0.05). The specificity of the test
was not significantly different at 14 PP cut-off value. There was no significant
difference of both groups of sera. Serum samples from animals infected with T.
buffeli, B. bigemina and B. bovis were negative. Two out of six samples obtained
from animals infected with T. parva were positive, one at 14 PP and another at 18
PP.
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Table 5.6. Results of the IgG Tamr-1 ELISA and the piroplasm IFAT using serum
samples in blind test.

































Totals 144 96 240
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5.4. DISCUSSION
The current study was designed to assess the performance of three
recombinant antigens, Tamr-1, NC10-Sspl3 and Tash-2, in ELISAs with the main
objective of distinguishing animals vaccinated against tropical theileriosis from those
that are naturally infected with T. annulata. Three recombinant antigens expressed in
different life cycle stages of the parasite, Tamr-1 (merozoite/piroplasm), NC10-
Sspl3 (macroschizont) and Tash-2 (macroschizont /piroplasm) were shown to be
antigenic in Western blot analysis with the majority of sera obtained from animals
either infected with sporozoites or immunised with low passage cell lines of various
stocks of T. annulata. Consequently, ELISAs performed with these three
recombinant antigen could be used as diagnostic tools for T. annulata infection in
cattle. Since the primary aim of the study was the development of an ELISA that can
be used to detect only naturally infected animals but not vaccinated ones, detailed
studies were carried out with the IgG Tamr-1 ELISA. Only preliminary
standardisation was performed for the NC10-Sspl3 and Tash-2 ELISAs because of
time constraints.
The indirect ELISA format was selected to detect IgG and IgM antibodies
against T. annulata infection. The same basic protocol was used for each IgG and
IgM ELISA in terms of the incubation times and substrate. However, reagent
dilutions were optimised separately for each ELISA by chequerboard titration. Plate-
to-plate and day-to day variations are major sources of experimental error in ELISA
assays. In order to minimise these variations, large batches of reagents and plates
were obtained and stored at recommended conditions. To obtain upper and lower
control limits, 90th and 10th percentiles were considered to be more appropriate
because the data from repeated assays did not have a normal distribution (Davison et
al., 1999).
Pre-infection serum samples tested in both IgG and IgM NC10-Sspl3
ELISAs gave relatively high background binding. It is necessary to optimise several
parameters such as plate type, the content and pH of the buffer, incubation
temperature and length, as suggested previously (Kemeny, 1992; Venkatesan and
Wakelin, 1993). pH of the buffer probably influences the charge property of the solid
phase leading to non-specific binding of serum immunoglobulins, especially IgM
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(Kuen et al., 1993). High background binding observed with the NC10-Sspl3 ELISA
could also be due to the recombinant antigen itself. The fact that the NC10-Sspl3
recombinant protein used in the current study contains part of the repeat region of the
protein (see Chapter 4) may lead to cross-reactions with other parasites or pathogens
with similar epitopes.
The diagnostic sensitivity and specificity of the IgG Tamr-1 ELISA was
determined using tests performed with 209 positive sera from experimentally
infected or immunised cattle and 188 negative sera from British cattle. Results are
given at two cut-off values, viz. 14 PP and 18 PP. The application of both of these
cut-off values in analysing the data leads to the incorporation of intermediate results
between positive and negative threshold, for example <14 PP: negative; 14-18 PP:
suspect; >18 PP: positive) (Greiner et al., 1995). The interpretation of intermediate
test results depends on the specific diagnostic purpose of the test. Re-testing
individual animals, which may not be feasible in sero-epidemiological studies, was
suggested for clarification of unexpected rather than intermediate test results
(Worthington, 1993). For epidemiological studies, it is appropriate to consider only
one cut-off value and indicate the test parameters for a given cut-off value selected
because of the ambiguity of borderline results.
The overall specificity of the IgG Tamr-1 ELISA was high at both 14 PP
(95.2%) and 18 PP (98.4%) cut-off values. The sensitivity of the test was low, i.e.
78.5% and 72.7% at 14 PP and 18 PP, respectively. However, if the cut-off value
were chosen at 11 PP, rather than 14 PP, which corresponds to 90% specificity, the
sensitivity of the test would be increased to 90.7%.
Both the sensitivity and specificity of serum samples used for IgG Tamr-1
ELISA were 100% in the piroplasm antigen IFAT. Thus, the specificity of the test
was close to that of IFAT, whereas the sensitivity was substantially lower at both 14
and 18 PP cut-off values. Although the IFAT is more reliable then the Tamr-1
ELISA, Tamr-1 ELISA could be very useful in large scale sero-epidemiological
studies as it is less laborious than IFAT.
In a preliminary study using a limited portfolio of control and test sera, the
specificity and sensitivity of the Tamr-1 ELISA was previously reported to be 94%
and 92%, respectively (Matita, 1994). This is in marked contrast to specificity and
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sensitivity levels reported in the present study. Possible causes of differences
between these two studies are i) number of samples tested, ii) the serum dilution used
and iii) different cut-off values chosen.
In order to compensate for various factors that may influence the diagnostic
sensitivity and specificity, the use of at least 300 known positive and 1000 known
negative samples was suggested (Jacobson, 1996). However, it is very difficult to
obtain such high numbers of animals under experimental conditions. In the study
performed by Matita (1994), 33 known negative sera and 33 known positive sera
from experimental calves infected on a single occasion with T. annulata sporozoites
were used. The present study was conducted with significantly larger number of both
positive and negative samples (188 negative, 209 positive).
Another reason for low sensitivity obtained in the current study with the
Tamr-1 ELISA could be the optimisation of the test with a high affinity serum. Since
high sensitivity is favoured by low serum dilutions (Venkatesan and Wakelin, 1993),
this would result in choosing high serum dilutions and low antigen concentrations.
The serum dilution used by Matita (1994) was 1:50 which is ten fold less than the
one used in the present study. Thus, low affinity serum samples could not be
detected.
The cut-off values chosen in the current study were in favour of specificity.
When specificity of the test was 94% at the cut-off value of 13 PP, the sensitivity of
the test was still lower than reported by Matita (1994). A simple reason for this could
be that samples chosen to establish sensitivity and specificity of the test did not
represent the field animal population in both experiments. The test sensitivity and
specificity should not vary between studies if the animals chosen truly represent the
population (Thrusfield, 1995).
The evaluation of the Tamr-1 antigen for cross-reactivity with other species
of Theileria and other haemoprotozoan parasites indicated that cross-reactivity
occurred with sera raised against T. parva as reported in other ELISAs performed
with crude piroplasm antigens (Gray et al., 1980; Kachani et al., 1992). Cross
reactivity between related species of Theileria, especially between T. annulata and T.
parva, and other haemoparasites has been demonstrated in other serological tests
(FAO, 1984) including IFAT (Burridge et al., 1974). These cross-reactions are
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important only where the distribution of the parasites may overlap as in the case of
Southern Sudan where T. annulata and T. parva are both present (Lomuro, 1992).
A small proportion of serum samples obtained from animals infected with T.
buffeli, B. bovis and Tryp. evansi also cross-reacted in the Tamr-1 ELISA. None of
the serum samples from animals experimentally infected with T. buffeli/T. sergenti
were positive. Only serum samples obtained from field infected animals from Sicily
were found to be positive. It is evident from these observations that mixed infection
with T. annulata and T. buffeli is probable. In fact, the presence of both T. annulata
and T. buffeli in Sicily has been reported previously (Purnell, 1978). If the cross-
reactivity between T. annulata and T. buffeli is due to shared epitopes, the use of the
Tamr-1 ELISA in epidemiological studies is problematic, since the distribution of T.
buffeli overlaps quite extensively with T. annulata (Mimioglu et al., 1971; Fujisaki,
1992; Ceci et al., 1997).
PP values of serum samples from animals infected with B. bovis and Tryp.
evansi infected were inconclusive. More serum samples from Trypanosoma spp and
Babesia spp infected animals should be tested to obtain unequivocal results since T.
annulata, Trypanosoma spp and Babesia spp co-exist in many areas.
International standards for diagnostic tests for theileriosisis are lacking
(Dolan, 1989). As a result, each laboratory validates diagnostic tests using "in house"
materials. Since there is no "Gold Standard" test available for T. annulata infection,
it is difficult to compare the results of different studies. To overcome this problem, a
set of serum samples from experimentally infected animals were selected and re-
codedwThese serum samples were then made available to various laboratories to
validate their ELISAs. The results of this blind test were analysed by a third person.
At a cut-off value of 18 PP, the sensitivity of the blind test (75.0%) was very close to
the estimated sensitivity for the standardisation of this test (72.7%) and there was no
significant difference between these values. The blind test was carried out using
Tamsl-1 antigen by Gubbels et al., (unpublished). The sensitivity and specificity of
the Tamsl-1 ELISA using these sera were 69.2% and 96.5% at a cut off value of
12.5 PP, respectively, indicating that the sensitivity obtained by the Tamr-1 ELISA
appears to be better. However, the sensitivity and specificity of the Tamr-1 and
Tamsl-1 ELISAs were not significantly different (p<0.05).
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In conclusion, the evidence provided in the current study indicates that Tamr-
1 ELISA is not sensitive enough to replace the conventional IFAT, which is currently
in use. However, the Tamr-1 ELISA could be a useful tool to study the large-scale
sero-epidemiology of tropical theileriosis, though, it should be noted that the Tamr-1
ELISA is validated using serum samples from animals infected under controlled
conditions that may not represent the actual field situation (Greiner et al., 1997).
In the next chapter, results obtained with the recombinant antigens Tamr-1,
NC10-Sspl3 and Tash-2 using serum samples from experimentally infected animals
(Chapter 3) will be discussed. In these animal experiments, the field situation of both
vaccination and field challenge were simulated to examine whether these stage-
specific antigens could distinguish vaccinated animals from those that are naturally




VALIDATION OF ENZYME LINKED IMMUNO-SORBENT ASSAYS
USING SERA FROM CALVES EXPERIMENTALLY INFECTEDWITH
THEILERIA ANNULATA
6.1. INTRODUCTION
The indirect fluorescent antibody test (IFAT) using both the macroschizont
and piroplasm antigens is currently used as the standard serological assay to detect
vaccinated and animals naturally infected with T. annulata (Pipano, 1974; Anon,
1997). The IFAT has contributed considerably to our understanding of the
prevalence of theileriosis. It has also served as a valuable tool in monitoring
experimental infections. However, the test has several drawbacks. For example, it is
cumbersome to carry out and relies on subjective assessment of fluorescence. In
addition, IFAT does not distinguish naturally infected animals from those that are
vaccinated (Pipano et al., 1969) because of the presence of common antigens in all
life cycle stages of the parasite (Knight et al., 1998). Detection of antibody responses
before and after vaccination is required to determine if animals are exposed to the
disease following vaccination. This is important to assess the efficacy of a vaccine.
However, IFAT is not ideally suited to this purpose.
A natural infection with T. annulata sporozoites initiated by infected ticks
results-in the exposure of the host immune system to sporozoites, macroschizonts and
merozoites/piroplasms. In contrast, animals immunised with an attenuated high
passage schizont-infected cell line, the form of vaccine used widely in the control of
theileriosis, which does not produce piroplasms, will be exposed only to the
macroschizont stage of the parasite. Therefore, serological tests employing proteins
specific to the sporozoite or piroplasm stages of the parasite in principle detect only
animals infected with sporozoites, but not those vaccinated with macroschizonts.
However, studies showed that animals infected with a single dose of sporozoites
could not reliably be detected with a sporozoite surface antigen, SPAG-1, of T.
annulata (Matita, 1994). This could be due to the fact that sporozoites are exposed to
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host immune system for a short time period before they develop into macroschizonts
(Jura et ai, 1983a).
Another approach to distinguish between vaccinated and naturally infected
animals would be to use antigens specific to piroplasm stage of the parasite provided
that the attenuated cell line vaccine does not produce piroplasms. To complement
currently available piroplasm stage-specific antigens Tarns 1 (Shiels et ai, 1995) and
Tamr-1 (Shiels et al., 1994), a recombinant protein specific to the macroschizont
stage of the parasite could be used to detect both animals infected with sporozoites
and those that are vaccinated with an attenuated, high-passage cell line. The use of
these two antigen-specific tests would provide the answers to the major questions
concerning the epidemiology and control of tropical theileriosis viz. the prevalence
of the disease and the effectiveness of attenuated cell line vaccines.
In this chapter, the stage-specific recombinant antigens, Tamr-1, NC10-Sspl3
and Tash-2, were screened against antisera produced as described in Chapter 3. The
objectives of the current study were: i) to determine whether the Tamr-1 ELISA
could detect animals infected with sporozoites but not those immunised with the high
passage cell line vaccine; ii) to establish whether NC10-Sspl3 or Tash-2 antigens
would detect both naturally infected and vaccinated animals; iii) to determine the
period during which antibodies against Tamr-1, NC10-Sspl3 or Tash-2 antigens
could be detected in the presence and absence of challenge; iv) to compare the results
of ELISAs with the standard IFAT; v) to evaluate the Tamr-1 ELISA using serum
samples obtained from Aydin province of Turkey where theileriosis is endemic. The
last objective was also related to the carrier state of the animals as determined by
piroplasm parasitaemia and PCR (Chapters 3 and 7).
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6.2. MATERIAL AND METHODS
6.2.1. Serum Samples for ELISA and IFAT
6.2.1.1. Experimental infection ofcalves with T. annulata
Serum samples from animals that were experimentally infected either with
sporozoites or with low and high passage cell lines were used. Experimental design,
the clinical and haematological responses of animals were described in Chapter 3.
Briefly, 21 calves were divided into three main groups referred to as Groups 1, 2 and
3 (Table 3.1). Calves in Group 1 (n=4) were inoculated with T. annulata Ankara
sporozoites. Calves in Group 2 (Group 2A n=5; Group 2B n=4) were inoculated with
T. annulata Ankara low-passage cell line. Calves in Group 3 (Group 3A n=4; Group
3B n=4) were inoculated with T. annulata Ankara/Pendik high-passage cell line in
two consecutive experiments as described in Chapter 3. Animals in all groups were
challenged with a heterologous T. annulata Gharb sporozoite stabilate either one or
seven month(s) following the primary parasite inoculation.
6.2.1.2. Serum samples used for testing persistence of antibody responses
against antigens representing specific stages ofthe parasite
Two groups of animals, Groups A and B, were tested for antibody responses
against the Tamr-1, NC10-Sspl3 and Tash-2 recombinant antigens. Serum samples
were tested only in IgG ELISAs.
Group A consisted of five calves; two Sahiwal heifers and three Friesian
steers.'These animals were infected with sporozoite stabilates and kept for 3 years
without challenge. The three Friesian steers were then challenged with heterologous
sporozoites. Table 6.1 shows the timing of infection and challenge. The serum
samples that were tested are also given in Table 6.1.
Group B consisted of 11 calves that were infected with different parasite
stocks at various doses of sporozoite stabilates. They were challenged on several
occasions with a larger dose of sporozoites than that used for the initial infection
Calves were monitored for 1 to 2.5 years (Table 6.2).
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Table 6.1. Serum samples (Group A) used for testing the persistence of antibody
responses against the recombinant antigens, Tamr-1, NC10-Sspl3 and Tash-2.
Calf No Day post-infection Parasite inoculation Dose






10A, 12A, 0 Ta. Hissar STAB 50,52,55,62 0.1 t.e.
14A 28
(Friesian) 3 years Ta. Hissar STAB 50,55,62 4.0 t.e.
Challenge 28
Ta: T. annulata\ t.e. tick equivalent; STAB: Stabilate; GUTS: ground up tick
supernate
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Table 6.2. Serum samples (Group B) used for testing the persistence of antibody
responses against the recombinant antigens, Tamr-1 and Tash-2. Days in brackets
indicate the day after challenge(s).
CalfNo Day post-infection Parasite inoculation Dose/t.e.
(challenge)
891,900, 0 (pre-infection) Ta Hissar STAB 26,37,43,46,49 0.1




















































Ta Hissar STAB 26,37,43,46,49 0.001
Ta Gharb STAB 44,45,47 4.0
Ta Ankara STAB 13,22B,23,48 1.6
Ta: T. annulata\ t.e. tick equivalent; STAB: Stabilate; GUTS: ground up tick
supernate
195
6.2.1.3. Field serum samples
A total of 79 serum samples collected from cattle with a history of theileriosis
around the Aydin province of Turkey, where tropical theileriosis is endemic (see
section 7.2.1.5), were tested by IFAT using both piroplasm and macroschizont
antigens and by the IgG Tamr-1 ELISA. These cattle were also examined for the
presence of piroplasms by Giemsa's stained blood smears and PCR as described in
Chapter 7. The results obtained from ELISA, IFAT, blood smear and PCR were
analysed using the Chi-square distribution (Minitab, version 10.2).
6.2.2. ELISA
6.2.2.1. Recombinant antigens
To investigate the diagnostic significance of isotype marker in theileriosis,
levels of specific IgG and IgM were analysed using Tamr-1, NC10-Sspl3 and Tash-2
recombinant antigens.
6.2.2.2. ELISA protocol
The ELISA protocols for both IgG and IgM ELISAs and their standardisation
were described in Chapter 5.
6.2.2.3. Data expression and cut-offvalues
The data obtained from the IgG Tamr-1 ELISA were expressed as percentage
positivity (PP) as described in Chapter 5. The data obtained from the IgM Tamr-1,
IgG and IgM Tash-2 and NC10-Sspl3 ELISAs were expressed as absorbance value.
Cut off values of 14 PP and 18 PP were chosen for the IgG Tamr-1 ELISA
based on the standardisation of this ELISA as described in Chapter 5. For the IgM
Tamr-1 ELISA and the IgG and IgM ELISAs of NC10-Sspl3 and Tash-2, pre-
infection serum samples (day 0) were accepted as reference. The positive/negative
cut-off lines for these ELISAs were set as two times the absorbance value of pre-
infection serum for each calf (de Savigny and Voller, 1980). In order to avoid plate
to plate variations, sequential serum samples obtained from each animal were tested






Antigen slides were prepared from cultures as described previously
(Goddeeris et al., 1982; Minami et al., 1983). Briefly, cells obtained from a 2 day-
old T. annulata culture were centrifuged at 300 x g for 10 minutes at 4°C, the
supernate discarded and cells were washed in cold PBS three times. Before the last
wash, the cell viability and infection rates were assessed. Viability and infection rates
both of 95 % were considered optimal. Cells were resuspended to approximately 5 x
107 cells/ml in cold PBS and an equal volume of cold 1:10 formalin (3.7 %
formaldehyde, Analar, BDH) was added to the cell suspension dropwise while gently
stirring the tube. Cells were fixed on ice for 10 minutes, washed in PBS three times,
and resuspended to 2 x 107 cells/ml in PBS. Antigen slides were prepared by placing
a 20 pi volume of cell suspension onto each well of multiwell slides (ICN
Biomedicals Ltd). Cells were removed immediately using an automatic pipettor to
leave a thin layer of cells on each well. Slides were air-dried at room temperature and
wrapped in tissue paper and stored in self-sealing polythene bags containing silica
gel (BDH) at -20°C.
ii) Piroplasm antigen
Piroplasm antigen slides were prepared as described previously (Burridge,
1971). Approximately 5 ml of blood was collected directly into 150 ml of cold PBS
from the jugular vein of a calf, experimentally infected with T. annulata Hissar,
when the parasitaemia was 82%. The blood sample was centrifuged at 300 x g for 10
minutes at 4°C. The supernatant was discarded along with the buffy coat.
Erythrocytes were washed three times in PBS and centrifuged at 300 x g for 10
minutes at 4°C. The supernatant was discarded along with the buffy coat. Following
the last wash, erythrocytes were resuspended in 5 ml PBS supplemented with 1%
bovine plasma albumin (Sigma) at 1:20 (v/v). Multiwell antigens were prepared as
described above for the macroschizont antigens.
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6.2.3.2. IFATmethod
Serum samples from animals infected experimentally (section 6.2.1.1) and
from animals in the field (see section 6.2.1.3) were tested using both macroschizont
and piroplasm antigens. Antigen slides were thawed at 4°C for 30 minutes in a sealed
bag with silica gel and kept at room temperature for another 30 minutes. Acetone
fixed antigen slides were rinsed in PBS four times (10 minutes each), then air-dried
at room temperature. Formalin fixed slides were ready to use after thawing.
Meanwhile four-fold dilutions of sera from 1:40 to 1:2560 were prepared in PBS.
Ten microlitres of the serum dilutions were placed into wells of antigen
slides. Each antigen slide included the following controls: T. annulata positive and
negative sera diluted at 1:160 in PBS and PBS alone as a conjugate control. Slides
were incubated in a moist chamber for 30 minutes at room temperature, washed in
PBS three times (10 minutes each) and air-dried at room temperature. Rabbit anti-
bovine IgG conjugated to fluorescein isothiocyanate (FITC) (Sigma) at a dilution of
1:80 in PBS was placed onto each well. The PBS contained 0.01% of Evans Blue
(Sigma) which served as counterstain. Slides were incubated in the moist chamber in
the dark for 30 minutes, then washed in PBS three times (10 minutes each). The
slides were air-dried, mounted in 66% (v/v) glycerol in 50 mM Tris-HCl, pH 9.2,
using 22 x 40 mm coverslips. Slides were examined for fluorescence under x 20 or x
40 oil immersion objective using an blue violet incident light fluorescence
microscope (Leitz Orthoplan, Wetzlar). The degree of fluorescence was recorded as
strong fluorescence (+) (positive reaction), weak positive (+/-) or no fluorescence (-)
(negative reaction). Only strong fluorescence (+) was accepted as positive. The
weak positive fluorescence (+/-) and no fluorescence (-) were considered to be




6.3.1. ELISA Results of Calves Immunised against T. annulata by Infection
with Different Parasite Stages
Serum samples from animals that were experimentally infected either with
sporozoites or with low and high passage cell lines (see section 6.2.1.1) were tested
by both the IgG and IgM ELISAs using Tamr-1, NC10-Sspl3 and Tash-2.
6.3.1.1. Immunoglobulin G response ofexperimentally infected animals
Results of IgG ELISAs using Tamr-1, NC10-Sspl3 and Tash-2 are given in
Figures 6.1-6.3 respectively.
i) IgG Tamr-1 ELISA
All the calves had PP values below 14 PP prior to infection with sporozoites
or macroschizont infected cell lines. The profdes of the IgG response of calves in
Group 1 using the Tamr-1 ELISA was not reproducible as two calves had low and
the other two had high antibody titres. The response of calf 21A increased to above
the cut-off points earlier than other calves in this group (Figure 6.1A). The PP value
of calf 21A was above the cut-off points by day 35. It remained as such until
challenge with T. annulata Gharb sporozoites 7 month after primary infection. Calf
23B had the lowest antibody response in Group 1. PP values for this animal were
above the cut-off values by day 85 and fluctuated thereafter around the cut-off values
until challenge (Figure 6.1A). The response of the other two calves in this group was
similar to each other. PP values were detectable between days 42 and 56 and
remained above or very close to cut off values until challenge.
PP values of calves in Group 2A immunised with T. annulata Ankara low
passage cell line were high in the Tamr-1 ELISA (Figure 6.IB). All animals in this
group responded to infection relatively early. IgG antibodies could be detected at 14
or 21 days post-immunisation. Antibody response remained above cut-off values
throughout the monitoring period, with the exception of calf 24B. The IgG response
of calf 24B was detected only on day 21, and its PP values remained below cut-off
values after challenge (Figure 6.IB).
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Figure 6.1. IgG responses of calves infected with T. annulata Ankara sporozoites
or immunised with the high or low passage cell lines detected by Tamr-1
ELISA. Calves were challenged with a heterologous stock of T. annulata Gharb
sporozoite stabilate either 35 days or 7 months following the primary parasite
inoculation.
A. Group 1: Calves infected with T. annulata Ankara sporozoites and
challenged 7 months after primary infection.
B. Group 2A: Calves immunised with T. annulata Ankara low passage cell
line and challenged 7 months after primary infection.
C. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 7 months after primary infection




14 21 28 35 42 56 85 111 140 168 205 225 232 239 253 267
Challenge
Days
B. Group 2A; low passage cell line immunisation
17 —<
24B —3




7 14 21 28 35 42 56 85 111 140 168 205 225 232 239 253 267
Challenge
Days
























14% cut off 18% cut off
32A
■ 891A






D. Group 2B: Calves immunised with T. annulata Ankara low passage cell
line and challenged 35 days after primary infection.
E. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 35 days after primary infection.
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Figure 6.2. IgG responses of calves infected with T. annulata Ankara sporozoites
or immunised with the high or low passage cell lines detected by NC10-Sspl3
ELISA. Calves were challenged with a heterologous stock of T. annulata Gharb
sporozoite stabilate either 35 days or 7 months following the primary parasite
inoculation.
A. Group 1: Calves infected with T. annulata Ankara sporozoites and
challenged 7 months after primary infection.
B. Group 2A: Calves immunised with T. annulata Ankara low passage cell
line and challenged 7 months after primary infection.
C. Group 3A: Calves immunised with T. annulata Ankara/Pendik high










D. Group 2B: Calves immunised with T. annulata Ankara low passage cell
line and challenged 35 days after primary infection.
E. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 35 days after primary infection.
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Figure 6.3. IgG responses of calves infected with T. annulata Ankara sporozoites
or immunised with the high or low passage cell lines detected by Tash-2 ELISA.
Calves were challenged with a heterologous stock of T. annulata Gharb sporozoite
stabilate either 35 days or 7 months following the primary parasite inoculation.
A. Group 1: Calves infected with T. annulata Ankara sporozoites and
challenged 7 months after primary infection.
B. Group 2A: Calves immunised with T. annulata Ankara low passage cell
line and challenged 7 months after primary infection.
C. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 7 months after primary infection
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D. Group 2B: Calves immunised with T. annulata Ankara low passage cell
line and challenged 35 days after primary infection.
E. Group 3A: Calves immunised with T. annulata Ankara/Pendik high






The early antibody response detected in this group was coincident with the
early appearance of piroplasms on day 7 (see Chapter 3). Calves in Group 2A
showed two antibody peaks. The first peak was between days 21 and 35 and the
second peak between days 84 and 112. The second peak coincided with the antibody
peak observed in Group 1. PP values of three out of five animals in Group 2A did not
increase following challenge 7 months after the primary immunisation.
Calves in Group 2B which were immunised with the low passage cell line
and challenged 35 days later had antibody responses similar to that described for
Group 2A. All calves had detectable and peak IgG responses between days 21 and 28
(Figure 6.ID). Following challenge, the antibody level of calf 309 continued to
increase while those of other calves remained relatively similar to pre-challenge
levels.
All calves in Groups 3A and 3B had low antibody responses both before and
after primary immunisation (Fig 6.1C and E respectively). PP values of animals
within these groups were below the cut-off values throughout the infection. All
calves, except calf 308, had detectable levels of antibody by day 42 following
challenge.
ii) IgG NC10-Sspl3 ELISA
The pattern of antibody profiles was very similar in all calves in Group 1. All
calves showed slight, yet continuous, increase in IgG antibody responses during the
course of infection. Antibody levels reached above twice the pre-infection OD levels
between days 85 and 168 following primary infection in all calves (Figure 6.2A).
There were considerable differences in the antibody responses to primary
infection and challenge among calves in Group 2A. In four out of five calves,
antibody levels reached to above twice the pre-infection OD values after
immunisation (Figure 6.2B). The antibody response of these animals fluctuated
before challenge. Following challenge, antibody response in these four calves
increased above twice the pre-infection OD level (Figure 6.2B). One calf (calf 22A)
did not show any antibody response to infection and challenge.
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Antibody response of calves in Group 2B, increased to twice the pre-infection
OD levels within 14 days following the immunisation and steadily increased until
and after challenge (Figure 6.2D).
Calves in Group 3A had similar antibody responses to those in Group 1. IgG
antibody levels were low but steadily increased from 7 or 21 days post-
immunisation until and after challenge. The antibody response in all calves reached
twice the pre-infection OD levels by days 21 or 168 (Figure 6.2C).
Antibody response of two out of four calves in Group 3B increased to twice
the pre-infection OD levels by day 14. Antibody level of the remaining two calves
reached twice the pre-infection OD levels only following challenge (Figure 6.2E).
iii) IgG Tash-2 ELISA
Results obtained from the IgG Tash-2 ELISA are demonstrated in Figure
6.3A-E. Calves in Group 1 showed less variation in their IgG response to Tash-2
than the IgG response to Tamr-1. All calves in Group 1 showed a greater antibody
response to primary infection than that obtained using the Tamr-1 and NC10-Sspl3
antigens. Following infection, the antibody response remained around the base line
until day 56 (calves 21A, 23B and 48C) or day 85 (897A) and then quickly increased
to a very high level (Figure 6.3A). The antibody level remained high throughout the
secondary infection i.e. after challenge.
Groups 2A and 2B had antibody profiles similar to that described for Group 1
except that the antibody response was earlier and at a higher level (Figure 6.3B and
D). Antibody levels increased to a high level by days 21-42 after immunisation and
remained high throughout the primary immunisation and after challenge.
There was only a slight increase in IgG levels to Tash-2 antigen in Groups 3A
and 3B after immunisation (Figure 6.3C and E). The antibody levels of three calves
in group 3A reached twice the pre-infection OD levels by days 111 or 140 (Figure
6.3C). Following challenge, all calves, except 54C and 308A, showed an antibody
response at different levels.
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6.3.1.2. Immunoglobulin M response ofexperimentally infected animals
Results of IgM ELISAs using Tamr-1, NC10-Sspl3 and Tash-2 are given in
Figures 6.4-6.6 respectively.
i) IgM Tamr-1 ELISA
A classic IgM response was obtained following infection with sporozoites in
Group 1 (Figure 6.4A). The IgM response occurred before the IgG response. IgM
levels showed an increase in two calves by day 21 and remained high until day 85.
Antibody levels declined before challenge in all animals except calf 48C. There was
a slight increase in antibody levels in some animals following challenge (Figure
6.4A).
The IgM responses of Group 2A were greater and more rapid than those of
Group 1 (Figure 6.4B). Antibody titres in all calves reached twice the pre-infection
OD values by days 7 and 21 following immunisation. Antibody levels declined
almost to pre-infection levels between days 46 and 168 in three out of five calves
(Figure 6.4B).
Antibody responses of calves in Group 2B were similar to those of Group 2A.
Antibody levels peaked on day 21 or 28. A rapid decline was observed until and
following challenge with the exception of calf 15, which had a peak antibody
response 15 days following challenge (Figure 6.4D).
Calves in Group 3A had only a slight increase in IgM levels after the
immunisation (Figure 6.4C). Following challenge, antibody titres increased rapidly,
reaching a peak on day 28 after challenge and declined afterwards.
The IgM titre increased to twice the pre-infection levels in two calves (303A,
308A) after immunisation in Group 3B. In the remaining calves, the IgM responses
were detected only following challenge (Figure 6.4E).
ii) IgM NC10-Ssp 13 ELISA
Results obtained from the IgM NC10 Ssp-13 ELISA are illustrated in Figure
6.5 A-E. IgM antibody profiles of individual calves in Group 1 were similar to those
observed with the IgG antibody for the same group. Antibody titres reached twice the
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Figure 6.4. IgM responses of calves infected with T. annulata Ankara
sporozoites or immunised with the high or low passage cell lines detected by
Tamr-1 ELISA. Calves were challenged with a heterologous stock of T. annulata
Gharb sporozoite stabilate either 35 days or 7 months following the primary parasite
inoculation.
A. Group 1: Calves infected with T. annulata Ankara sporozoites and
challenged 7 months after primary infection.
B. Group 2A: Calves immunised with T. annulata Ankara low passage cell
line and challenged 7 months after primary infection.
C. Group 3A: Calves immunised with T. annulata Ankara/Pendik high







D. Group 2B: Calves immunised with T. annulata Ankara low passage cell
line and challenged 35 days after primary infection.
E. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 35 days after primary infection.
D. Group 2B; low passage cell line immunisation
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Figure 6.5. IgM responses of calves infected with T. annulata Ankara
sporozoites or immunised with the high or low passage cell lines detected by
NC10-Sspl3 ELISA. Calves were challenged with a heterologous stock of T.
annulata Gharb sporozoite stabilate either 35 days or / months tollowing the primary
parasite inoculation.
A. Group 1: Calves infected with T. annulata Ankara sporozoites and
challenged 7 months after primary infection.
B. Group 2A: Calves immunised with T. annulata Ankara low passage cell
line and challenged 7 months after primary infection.
C. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 7 months after primary infection
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D. Group 2B: Calves immunised with T. annulata Ankara low passage cell
line and challenged 35 days after primary infection.
E. Group 3A: Calves immunised with T. annulata Ankara/Pendik high






Figure 6.6. IgM responses of calves infected with T. annulata Ankara
sporozoites or immunised with the high or low passage cell lines detected by
Tash-2 ELISA. Calves were challenged with a heterologous stock of T. annulata
Gharb sporozoite stabilate either 35 days or 7 months following the primary parasite
inoculation.
A. Group 1: Calves infected with T. annulata Ankara sporozoites and
challenged 7 months after primary infection.
B. Group 2A: Calves immunised with T. annulata Ankara low passage cell
line and challenged 7 months after primary infection.
C. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 7 months after primary infection
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D. Group 2B: Calves immunised with T. annulata Ankara low passage cell
line and challenged 35 days after primary infection.
E. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 35 days after primary infection.
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pre-infection OD values by day 56 or 168 in all calves. Following challenge,
antibody levels continued to increase (Figure 6.5A).
The IgM levels of calves 17 and 32C in Group 2A increased following
immunisation and declined afterwards (Figure 6.5B). Both calves had a peak
antibody response following challenge. In calves 22A, 24B and 892A, the antibody
response remained low but increased slightly before and after challenge (Figure
6.5B).
The antibody response varied during the course of immunisation and
challenge among individual animals in Group 2B (Figure 6.5D). In all calves,
antibody levels were detectable by day 14 or 21 after immunisation. Calf 309A
showed a low antibody response to immunisation and challenge. Calves 302A, 535A
and 15 had two peaks of antibody response, one post-immunisation and another post-
challenge.
The antibody profile of calves in Group 3A was similar to that described for
the IgG antibodies, but with a lower response after the immunisation. Antibody
levels reached twice the pre-infection OD level between days 28 (calves 54C and
891A) and 85 (calves 26A and 32A). There was little or no antibody response after
challenge (Figure 6.5C). IgM levels of all calves in Group 3B remained around the
pre-immunisation OD values following immunisation, except calf 308A (Figure
6.5E). An increase in antibody level was detected in all calves following challenge.
iii) IgM Tash-2 ELISA
-Results of IgM antibody responses of experimentally infected animals in IgM
Tash-2 ELISA are shown in Figure 6.6A-E. In general, high pre-infection OD values
were detected in comparison to OD values obtained with the IgG Tash-2 ELISA.
Calves in Group 1 had detectable Tash-2 specific IgM response by days 28
(calf 897A) or 84 (calves 21A, 23B, 48C) after primary infection (Figure 6.6A).
Antibody levels of calf 21A fluctuated until day 84, and then increased to a very high
level by day 112. In all calves, antibody levels remained high until and after
challenge.
The IgM response was detected earlier than the IgG response in calves in
Group 2A and 2B. The antibody levels started to increase from day 14 onwards,
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reached a very high level by day 85 and remained high throughout the infection and
challenge. A marked fluctuation in IgM antibody levels occurred (Figure 6.6B and
D).
The antibody responses of calves in Group 3A increased from day 56 (calf
54C) or 84 (calves 26A, 32A and 891 A). An increase in antibody level was observed
in three out of 4 calves following challenge (Figure 6.6C). There was either no
difference (calves 532, 528 and 303A) or a slight increase (calf 308A) in IgM levels
following immunisation in Group 3B (Figure 6.6E). IgM antibody responses
increased quickly and to high OD values following challenge except calf 308A.
6.3.2. IFAT Results of Experimentally Infected Animals
The antibody profiles determined by IFAT of two representative calves from
each group are shown in Figures 6.7A-E.
Antibody levels to both macroschizonts and piroplasms rose from negative
pre-infection values to positive values between days 28 and 42 in all calves in Group
1 (sporozoite infection). The antibody levels remained positive and at relatively high
values with only a slight decrease before challenge. Antibody levels for both antigens
increased in all calves after challenge.
Calves in Groups 2A and 2B (low passage cell line infection) showed an
earlier response to both antigens than calves infected with sporozoites. All animals
within this group became positive between day 14 and 21 and remained positive until
and after challenge.
- Anti-macroschizont antibodies could be detected in animals immunised with
the high passage cell line (Groups 3A and 3B) between days 14 and 21. Antibody
levels of all calves in Group 3A declined and became undetectable in two calves by
challenge. Seven out of eight calves became positive for anti-piroplasm antibody by
day 35. Calf 532 did not give a positive response prior to challenge. Anti-piroplasm
antibody levels detected by IFAT were low in these animals and could be detected
for only a relatively short period of time compared to calves infected with
sporozoites and with the low passage line. Following challenge all calves
seroconverted to both antigens. In addition, the antibody response to challenge was
more rapid than that obtained following the primary immunisation.
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Figure 6.7. Antibody responses of two representative calves from each Group,
which were infected with T. annulata Ankara sporozoites or immunised with the
high or low passage cell lines, detected by both the macroschizont and
piroplasm IFAT.
A. Group 1: Calves infected with T. annulata Ankara sporozoites and
challenged 7 months after primary infection.
B. Group 2A: Calves immunised with T. annulata Ankara low passage cell
line and challenged 7 months after primary infection.
C. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
passage cell line and challenged 7 months after primary infection
D. Group 2B: Calves immunised with T. annulata Ankara low passage cell
line and challenged 35 days after primary infection.
E. Group 3A: Calves immunised with T. annulata Ankara/Pendik high
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6.3.3. Persistence of Serological Responses to Recombinant Antigens
The persistence of antibody responses against the three recombinant antigens
(Tamr-1, NC10-Sspl3 and Tash-2) and the antibody response to challenge were
analysed using serum samples obtained from animals in Group A and B (see section
6.2.1.2ii).
6.3.3.1. Serum samplesfrom Group A
Table 6.3 shows the results of the IgG ELISAs using serum samples from
calves in Group A. Antibody responses were detected in both Sahiwal heifers and in
calf 12A using IgG Tamr-1 ELISA. There were no detectable antibody levels
specific to Tamr-1 by the end of the first and the third year. On the other hand,
antibodies were detected in three out of five cattle by ELISA using Tash-2 or NC10-
Sspl3 recombinant antigens 3 years after the primary infection (Table 6.3). In
addition, there was an increase in antibody levels in three of the cattle against both
macroschizont antigens following challenge.
6.3.3.2. Serum samples from Group B
Results of IgG Tamr-1 and Tash-2 ELISAs using serum samples from Group
B are given in Figures 6.8 and 6.9, respectively. Results indicated that all animals
developed antibodies specific to Tamr-1 following primary infection (Figure 6.8).
However, during the course of infection, antibody levels declined to below or around
cut-off values of 14% or 18% positivity in all animals. Antibody response was
detected only in a proportion of animals following challenge.
All animals seroconverted in ELISA using Tash-2 recombinant antigen. In
general, antibodies against the Tash-2 were detected later than those for the Tamr-1
antigen. Antibody levels in all cattle fluctuated but remained distinctly above twice
pre-infection OD values following infection and challenges (Figure 6.9). In contrast
to Tamr-1, antibody response increased in all cattle following heterologous or
homologous challenges. Serum samples in this group could not be tested with NC10-
Sspl3 ELISA because of time constraints.
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Figure 6.8. Persistence of antibody response against the recombinant antigen
Tamr-1 in Group B cattle infected with T. annulata sporozoite stabilates
detected by ELISA. Calves challenged once or several times with homologous or
heterologous T. annulata sporozoite stabilate. Arrows shows day of challenges. (A)
Calves 891, 892, 899 and 900; (B) calves 903, 902 120A and 1219; (C) calves 1052
and 1055; (D) 11434. Infection and challenge(s) of these calves were carried out as



















































































Figure 6.9. Persistence of antibody response against the recombinant antigen
Tash-2 in Group B cattle infected with T. annulata sporozoite stabilates detected
by ELISA. Calves challenged once or several times with homologous or
heterologous T. annulata sporozoite stabilate. Arrows shows day of challenges. (A)
Calves 891, 892, 899 and 900; (B) calves 903, 902 120A and 1219; (C) calves 1052
and 1055; (D) 11434. Infection and challenge(s) of these calves were carried out as




















6.3.4. Field Serum Samples
Point prevalence values of T. annulata infection in cattle around Aydin
province of Turkey which were obtained using the IgG Tamr-1 ELISA and both the
piroplasm and macroschizont IFAT are given in Table 6.4. The presence of
piroplasm parasitaemia and PCR results of these animals are also shown in Table 6.4.
Numbers of cattle found to be positive by the IgG Tamr-1 ELISA, macroschizont
IFAT and PCR were similar at 14 PP cut-off value. However, they did not detect
antibodies in the same animals. For example, nine cattle found to be negative by
Tamr-1 ELISA were positive by the macroschizont IFAT and the 12 Tamr-1 positive
cattle were negative by the macroschizont IFAT. The Tamr-1 ELISA detected
significantly more animals as positive than the piroplasm IFAT (p = 0.046) and the
examination of Giemsa's stained blood smears (p = 0.013). The number of animals
detected by Tamr-1 ELISA was significantly less at 18 PP cut-off value than at 14 PP
cut-off value (p = 0.001), IFAT macroschizont (p = 0.001) and PCR (p = 0.02).
If the PCR results are accepted as 'gold standard', the number of false-
positive animals detected by the IgG Tamr-1 ELISA at 14PP cut-off value (n=12)
and the macroschizont IFAT (n=8) was close to each other. Similarly, the difference
between the number of false-positive animals detected by the IgG Tamr-1 ELISA at
18 PP cut-off value (n= 6) and the piroplasm IFAT (n= 4) was small.
6.4. DISCUSSION
In this study, the stage-specific recombinant antigens, Tamr-1, NC10-Sspl3
and Tash-2, were screened against antisera produced to determine whether the Tamr-
1 ELISA could distinguish vaccinated animals from those naturally infected animals
when it is used together with either the NC10-Sspl3 or Tash-2 ELISAs.
Cut-off values for IgG Tamr-1 ELISA were determined as 14 and 18 PP as
described in Chapter 5. The diagnostic sensitivity and specificity of the NC10-Sspl3
and Tash-2 ELISAs and cut-off values could not be determined because of time
constraints. In order to assess the increase in antibody levels of individual calves
following infection the cut-off values for the IgM Tamr-1 ELISA and the IgG and
IgM ELISAs ofNC10-Sspl3 and Tash-2 were used as twice the absorbance value of
pre-infection serum for each calf (de Savigny and Voller, 1980).
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In most of the animals that were infected with sporozoites (Group 1),
antibody responses to Tamr-1 antigen were detected relatively late, i.e. between days
28 and 56, in comparison to IFAT using the macroschizont and piroplasm antigens
(days 28 and 35). Furthermore, calves in Group 1 had lower PP values than those
infected with the low passage cell line (Group 2A and 2B). This relatively late and
low antibody response might be due to the treatment of animals in Group 1 with
buparvaquone earlier than those in Group 2A and 2B. Calves in Group 1 were treated
with buparvaquone 4 or 5 days after the detection of piroplasms in the blood smears
while calves in Group 2A and 2B exhibited piroplasms for 13 to 15 days before
treatment. This would in effect reduce the time during which the immune system is
exposed to piroplasms in Group 1, leading to a delay in the production of antibodies
against the Tamr-1 antigen. The early antibody response observed in animals
infected with the low passage cell line (Group 2A and 2B) might also be due to the
appearance of piroplasms in circulation as early as day 7 in some of the calves in
contrast to at day 9 in animals infected with sporozoite infection. The early detection
of piroplasms in animals infected with the low passage cell line could be due to fact
that these macroschizont infected cells start differentiating to merozoites soon after
inoculation.
As expected, no antibody responses were detected in calves immunised with
the high passage cell line (Group 3A and 3B) using the Tamr-1 ELISA. The antibody
responses of these animals obtained with the Tamr-1 ELISA were below 14 and 18
PP indicating that this antigen could be used to distinguish vaccinated animals from
naturally infected or challenged animals. No piroplasms were observed in calves in
these groups. It would appear from these observations that macroschizonts from high
passage cell lines did not differentiate to merozoites in vivo as observed in vitro
(Ilhan, 1995), or, if such differentiation occurred, these merozoites did not develop to
produce piroplasms and to stimulate antibodies detectable by the ELISA using Tamr-
1 antigen.
Antibodies against NC10-Sspl3 and Tash-2 antigens could be detected by
IgG ELISAs in animals either infected with sporozoites (Group 1) or immunised
with the low passage cell line (Group 2A and 2B). Antibody responses were also
detected in calves immunised with the high passage cell line (Group 3A). Although
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the antibody levels were around twice the pre-infection values this is not clearly
demonstrated in Figures 6.2 and 6.3. This is simply due to fact that the scale of
figures was adjusted according to antibody levels of animals in Group 1 and 2.
Antibodies against NC10-Sspl3 and Tash-2 were detected later (day 84) than
antibodies against Tamr-1 ELISA (day 35) in Group 1. Similarly, anti-Tash-2
antibodies were detected later than anti-NC10-Sspl3 and anti-Tamr-1 antibodies in
Group 2A and 2B. This relatively late appearance of the antibodies against NC10-
Sspl3 and Tash-2 correlates with some animals being negative in Western blot
analysis as described in Chapter 5. Most of the serum samples, which did not react,
with NC10-Sspl3 and Tash-2 in Western blotting, were obtained at day 28 following
infection.
The OD values obtained by IgG Tash-2 ELISA in calves infected with
sporozoites were close to pre-infection values for the first three months following
infection and reached very high levels afterwards. It is well established that antibody
levels increase with time after immunisation associated with a progressive change in
the quality of antibody (Eisen and Siskind, 1964). Specifically, low affinity
antibodies are produced soon after infection, whereas high affinity antibodies are
produced at later stages of infection. This is referred to as 'affinity maturation'
(Roitt, 1994). Previous observations indicated that the low antigen concentrations
and high serum dilutions favour the detection of high affinity antibodies (Lew,
1984). This could be a reason for not detecting antibodies during the first three
months of infection by the IgG Tash-2 ELISA. Since the IgG Tash-2 ELISA was
established using high serum dilution (1:400) and low antigen concentration
(0.08pg/ml), it is most likely that the Tash-2 ELISA detected high affinity
antibodies. This problem could be eliminated by increasing epitope density, i.e.
increasing antigen concentration to preferentially improve the binding of lower
affinity antibodies (Butler, 1988). In addition, low affinity antibodies might not be
detected due to dissociation from the solid phase antigen during washing steps
(Devey and Steward, 1988).
No antibody response was observed in calves immunised with the high
passage cell line (Group 3A and 3B) by day 111 and antibody levels only reached
twice the pre-infection values by the time of challenge. These low level antibody
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responses could be due to the presence of low affinity antibodies. Alternatively, the
protein encoded by the Tash-2 gene may not be expressed in the high passage cell
line used in the current study (D. Swan, pers. comm.).
The IgM response detected by IgM Tamr-1 ELISA occurred earlier than the
IgG response in calves infected with either sporozoites (Group 1) or the low passage
cell line (Group 2A and 2B). The response declined by day 84 after infection or
immunisation, indicating a classical IgM response. Thereafter, IgM levels fluctuated
during the course of infection and, in some cases, remained above twice the pre-
infection levels until challenge. In contrast to the IgM response to Tamr-1, IgM
responses against NC10-Sspl3 and Tash-2 were similar to IgG responses to the same
antigens. IgM levels for NC10-Sspl3 and Tash-2 fluctuated but remained above the
cut-off values until challenge in most of calves. This is in contrast to previous
observations which indicated that IgM levels increased from day 21 and declined by
day 40 following infection with T. parva (Spooner et al., 1973). On the other hand, it
was shown that high levels of IgM response could be maintained for more than one
year in some trypanosome-infected cattle (Luckins and Mehlitz, 1976). High and
continuous IgM antibody responses following the primary infection could be due to
the development of a carrier state of the parasite. This would result in continuous
stimulation of antibody production. Since the NC10-Sspl3 antigen is expressed
mainly in the macroschizont stage of the parasite and Tash-2 antigen in both the
macroschizont and piroplasm stages, continuous IgM antibody responses against
these two antigens at later stages of infection would indicate that calves infected with
sporozoites or macroschizont infected cell lines are carrier for both macroschizonts
and piroplasms.
Results obtained from ELISAs performed with three recombinant antigens
were compared with the conventional IFAT using both macroschizont and piroplasm
antigens. The IFAT using the macroschizont antigen is currently used as the standard
serological assay for T. annulata to detect both vaccinated and naturally infected
animals (Pipano, 1974; Anon, 1997). All calves used in the current study sero-
converted with IFAT using both macroschizont and piroplasm antigens after
infection or immunisation. Antibodies were detected earlier with the IFAT than with
any of the IgG or IgM ELISAs in calves infected with sporozoites or immunised with
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the low and high passage cell lines. In general, piroplasm antibodies in IFAT were
detected later than macroschizont antibodies fitting in with the normal life cycle
sequence of the parasite. This is probably because the merozoite/piroplasm stage
follows the macroschizont stage in the Theileria vertebrate life cycle. However,
animals infected with the low passage cell line developed antibodies against
piroplasms and macroschizonts simultaneously. The antibody response to piroplasms
was observed earlier in groups of animals that were infected with the low passage
cell line than in animals that were infected with sporozoites. This is explained by the
early appearance of piroplasms in the blood (day 7) in some calves infected with the
low passage cell line (Chapter 3). This correlates with the apparently anomalous
development of merozoites and piroplasms from inoculated macroschizont infected
cells before their transfer to host cells. In contrast, piroplasms did not appear before
day 9 in sporozoite infected animals (Chapter 3).
Anti-piroplasm antibodies could be detected in animals immunised with the
high passage cell line even though piroplasms were not seen. However, the antibody
levels and duration of the responses were lower and shorter than those observed after
infection with the low passage cell line. Although piroplasms were not observed in
Giemsa's stained blood smears, detection of anti-piroplasm antibody by IFAT would
be expected due to the presence of macroschizont antigens common to piroplasms
(Bell-Sakyi and Williamson, 1994; Knight et al., 1998).
The IgG Tamr-1 ELISA detected antibodies for over 7 months following the
primary infection and over a year after challenge. The challenge only slightly
affected the antibody levels against the Tamr-1 antigen. On the other hand, both the
IgG NC10-Sspl3 and Tash-2 ELISAs detected antibodies for three years even in
absence of challenge. All these animals 'naturally' infected with sporozoites were
piroplasm carriers for three years, implying the persistent presence ofmacroschizonts
and their differentiation to merozoites/ piroplasms. However, it should be noted that
no age-matched control serum samples were available for these experiments. Instead,
pre-infection serum samples were used as negative reference. This is important since
antibody levels change with age and increase with bacterial or viral infections. This
may, in turn, enhance non-specific binding (Venkatesan and Wakelin, 1993). For a
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more comprehensive study, therefore, it would be useful to repeat these experiments
after establishing appropriate cut-off values.
The current study demonstrates that, in contrast to the Tamr-1, the antibody
response to the Tash-2 antigen increases following challenge. Data obtained from
this experimental study using serum samples to test the persistence of antibody
responses indicate that immune responses against the macroschizont stage was
highly effective and blocked any significance recrudescence of piroplasms. This
suggests that challenges did not stimulate an antibody response against piroplasms,
but against macroschizonts.
The antibody response of cattle with a history of theileriosis in Aydin
province of Turkey was examined in the current study by the IgG Tamr-1 ELISA and
results were compared with the following diagnostic tests: the macroschizont and
piroplasm IFAT, Giemsa's stained blood smears and PCR. The results obtained from
these studies indicated that the IgG Tamr-1 ELISA is as sensitive as the
macroschizont IFAT and more sensitive than the piroplasm IFAT at 14 PP cut off
value. The IgG Tamr-1 ELISA was also as sensitive as the piroplasm IFAT at 18 PP
cut off value. These results suggest that the IgG Tamr-1 ELISA could be as powerful
a diagnostic tool as the macroschizont and piroplasm IFAT for use in
epidemiological studies of theileriosis. However, the diagnostic value of the Tamr-1
ELISA in the field can only be assessed using a larger number of field samples that
can truly represent the actual field situation.
The present study also indicated that the macroschizont IFAT is more
sensitive than the piroplasm IFAT. A similar observation was previously made by
(Darghouth et al., 1996b). This is expected since serum samples examined in the
current study were obtained during disease season (June-July). As discussed above,
the antibody response to macroschizonts occurs more rapid than the antibody
response to piroplasms in animals newly exposed to theileriosis. These results
indicate that timing of sample collection should be considered in evaluating the
sensitivity of IFAT.
The aim of the current study was to distinguish between vaccinated and
naturally infected animals by combining results of Tamr-1 ELISA with either NC10-
Sspl3 or Tash-2 ELISAs. According to this scheme, if both Tamr-1 ELISA and
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NC10-Sspl3 / Tash-2 are positive, it can be concluded that the animal has been
infected or challenged with sporozoites. On the other hand, a negative result with the
Tamr-1 ELISA and a positive result with NC10-Sspl3 / Tash-2 would indicate that
the animal was only immunised with an attenuated macroschizont infected cell line,
and not yet exposed to field challenge with tick transmitted sporozoites.
The results of this study show that, ELISAs using the Tamr-1, NC10-Sspl3
or Tash-2 recombinant antigens cannot be used to distinguish animals vaccinated
with the attenuated high passage cell line from those that are naturally infected.
Because the sensitivity of the Tamr-1 is insufficient (see Chapter 5) and neither the
NC10-Sspl3 ELISA nor the Tash-2 ELISA detect sensitively antibodies in animals
immunised with high passage cell line. Both IgG Tamr-1 and Tash-2 ELISAs,
however, could serve as powerful diagnostic tools in epidemiological studies of
theileriosis, as ELISA systems permit processing of larger numbers of samples than
IFAT and give objective results. Nevertheless, it should be noted that the sensitivity
of the Tash-2 ELISA was lower during the first three months following infection
with sporozoites. Therefore, antibody responses to the Tash-2 antigen should ideally
be examined three months after the disease season.
In the next chapter, the detection of the carrier-state of T. annulata in cattle
using a nested PCR will be described. The nested PCR distinguishes T. annulata
from T. buffeli in cattle and T. annulata from T. lestoquardi and B. equi in vector
ticks. Such sensitive and specific tests would not only complement the sero-
epidemiological studies of theileriosis but also help targeting the limited amount of
vaccine produced each year to those areas most in need.
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CHAPTER SEVEN
DETECTION OF THEILERIA ANNULATA IN CATTLE BY PCR USING
THE TAMS-1 GENE SEQUENCES
7.1. INTRODUCTION
The purpose of this study was to develop a sensitive and specific diagnostic
test for the detection of the carrier state of tropical theileriosis. To this end, a nested
PCR using primers derived from the gene encoding the 30 kDa major merozoite
surface antigen (Tarns-1) of T. annulata was established.
Animals that are exposed to sporozoites for the first time become infected
and the outcome may be sub-clinical infection or clinical disease leading to death or
survival (Sergent et al., 1945; Neitz, 1957). In many Theileria infected animals,
infection persists after recovery and is maintained by two stages of the parasite's life
cycle: macroschizont and piroplasm (Sergent et al., 1940; Neitz, 1957; Sergent,
1963). The carrier state of Theileria spp is believed to be maintained by the persistent
and slow division of macroschizonts that give rise to piroplasms (Norval et al.,
1992). The division and long-term persistence of T. annulata piroplasms within
erythrocytes have been demonstrated (Conrad, 1983; Conrad et al., 1985). However,
there is no experimental evidence indicating that piroplasms re-invade host
erythrocytes following multiplication.
Vector ticks, which feed on carrier cattle and become infected, have the
potential to transmit the parasite to a susceptible host. Therefore, the carrier state of
T. annulata is of great importance in the epidemiology of the disease. The detection
of carrier animals is needed not only for a better understanding of the epidemiology
of theileriosis but also for effective implementation of control programmes. The
detection of the carrier state of the parasite could also indicate the immune status of
animals in the field since animals that survive the initial infection with sporozoites
are fully protected against homologous and heterologous sporozoite challenge
(Barnett, 1963; Ilhan, 1995; Chapter 3).
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Traditionally, the carrier-state of theileriosis has been determined by
microscopic examination of Giemsa's stained blood smears for the presence of
piroplasms. This method, which requires considerable time and expertise, is not
sensitive since piroplasm parasitaemia is often too low to be detected in many
carriers (Norval et al., 1992). This results in underestimation of the true prevalence
of the carrier state in a population. Another drawback ofmicroscopic examination for
the detection of the carrier state relates to its specificity. Different piroplasm forms,
i.e. rod, oval, comma and rings, predominate in different Theileria species
(Uilenberg, 1981b). Yet, this can vary during the course of infection (Norval et al.,
1992). Therefore, the detection of the carrier state with microscopy can be
ambiguous where the distributions of different Theileria species overlaps.
Another method that can be used to detect the carrier state of theileriosis is
xenodiagnosis. Xenodiagnosis involves the application of vector ticks to test animals,
followed by transfer and transtadial transmission to susceptible hosts (Sergent et al.,
1945). It is sensitive but impractical and expensive.
As described above, the carrier state of theileriosis is maintained by the
macroschizont stage of the parasite. Cell culture methods, which allow the detection
of macroschizonts (Brown, 1987), could be used to examine the carrier state of
theileriosis. Previous studies demonstrated that macroschizont-infected cell lines can
successfully be isolated from animals undergoing clinical disease (Ilhan et al., 1998;
Chapter 3) and during recovery and convalescence (Sharma and Brown, 1981).
However, macroschizont infected cell lines could not be isolated 56 days after
primary infection with sporozoites (Ilhan et al., 1998; Chapter 3), limiting the
diagnostic value of this technique for the detection of carrier animals.
It is evident from the above discussion that none of the techniques mentioned
above can be relied on individually to reveal the true prevalence of theileriosis. The
development of molecular biology has made available tools to detect and identify
microorganisms. The PCR which is a method for enzymatic amplification of specific
DNA sequences (Mullis and Faloona, 1987; Saiki et al., 1988b) is the most
frequently used tool. A PCR-based methodology would offer important advantages
over conventional techniques such as greater sensitivity and specificity. The
diagnostic value of PCR has been demonstrated in a number of studies on a wide
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range of parasites (Figueroa and Buening, 1995; Comes et al., 1996) including T.
annulata (Ilhan, 1995; d'Oliveira et al., 1995; 1997b).
Preliminary experiments aimed to detect the carrier state of the parasite
through PCR utilizing primers from small subunit ribosomal RNA (ssu RNA) (Ilhan,
1995) have failed due to lack of specificity (data not shown). The purpose of the
current study was to develop a sensitive PCR, specific to T. annulata, with a
particular emphasis on the carrier state of the parasite. The PCR described in this
chapter utilises primers complementary to sequences in the Theileria spp. major
merozoite surface antigen gene (Shiels et al., 1995; Katzer et al., 1998b).
7.2. MATERIALS AND METHODS
7.2.1. Parasite Material
7.2.1.1. T. annulata piroplasm-infected blood
Sporozoite stabilates of three stocks of T. annulata, Ankara (Turkey) (Schein
et al., 1975), Gharb (Morocco) (Ouhelli, 1985) and Hisar (India) (Gill et al., 1980),
were thawed and used to infect three cattle. When piroplasm parasitaemia was 1 -
5%, blood was taken into EDTA vacutainer tubes and then serially diluted with
uninfected bovine blood taken from a different animal to give ten-fold dilutions of
piroplasm material from 1% to 10"9%. Care was taken not to use blood from high
parasitaemia (5>) when red blood cells can be infected with several piroplasms.
Blood-samples were used for DNA isolation immediately or 6 months after storage at
-20°C.
7.2.1.2. T. annulata infected cell lines
Peripheral blood mononuclear cells (PBM) were isolated from animals
diagnosed with tropical theileriosis in Aydin province, western Turkey and were
cultured to provide 25 immortal, macroschizont-infected cell lines (see section
7.2.1.4). In addition, previously isolated and cryopreserved cell lines from Morocco
(Gharb), Tunisia (Battan) (Ben Miled, 1993), Spain (Caceres) (de Kok et al., 1993),
Sudan (Soba) (Melrose et al., 1984), Turkey (Ankara), Israel (Tova) (Pipano et al.,
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1974), Iran (Razi) (Hooshmand-Rad and Hashemi-Fesharki, 1968) and India (Hisar)
were resuscitated and grown as described in section 3.2.4.
7.2.1.3. Otherparasites
DNA from several other tick-borne pathogens was used to test for cross-
reactivity with T. annulata primers. Three T. lestoquardi-infecied cell lines from
Iran, namely Lahr, Shiraz and Kemalabad (Hooshmand-Rad et al., 1993), were used
in the current study. T. buffeli (Australia) was provided as a blood stabilate from the
Tick Fever Research Centre, Wacol, Queensland, Australia. A splenectomised calf
was infected with this stabilate. Piroplasm infected blood at a piroplasm parasitaemia
of 1% was collected into EDTA vacutainers and stored at - 20°C until DNA was
extracted. Four stocks of Babesia equi, Kwa Zulu (South Africa) (Zweygarth, pers.
comm.), Onderstepoort (South Africa) (Phipps, pers. comm.) USDA/Florida stock
(U.S.A.) (Knowles et al., 1991), and "North Africa" (Gerstenberg et al., 1998) were
supplied in the form of fresh blood, blood stabilate in DMSO or as isolated
merozoites. B. bigemina (Muguga, Kenya), B. bovis (Nigeria) and B. divergens
(Stormont, Ireland), kept at CTVM as blood stabilates in DMSO were thawed and
the blood used directly to extract DNA.
7.2.1.4. Uninfected samples
Uninfected bovine blood from naive Scottish calves from East Lothian was
collected into lithium-heparin containing vacutainers and DNA was prepared from
200 pi blood using a Qiagen blood kit or 1 ml blood using saponin lysis buffer. In
addition, the PBM isolated from blood according to standard procedures using
Ficoll-Paque (Brown, 1983) and DNA was prepared using a Qiagen blood kit.
7.2.1.5. Field samples
In June-July 1996, a pilot study was carried out in 17 districts of Aydin
province (Figure 7.1) to assess the suitability of the PCR for field samples. Over a
period of five weeks 151 blood samples were collected in EDTA vacutainer tubes
from local exotic cattle which had a history of T. annulata infection. Each blood
sample was used to prepare thin blood smears and also for DNA extraction for PCR
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analysis. Blood smears were fixed in methanol, stained with Giemsa's and examined
for the presence of blood protozoa at 1,000 x magnification under high power light
microscopy. The degree of parasitaemia was recorded as the percentage of infected
red blood cells after counting 1,000 red blood cells. If the parasitaemia was less than
0.1%, the number of piroplasms per 50 fields was assessed. The smear was recorded
as negative if no piroplasms were observed in 50 fields i.e. approximately 25,000 red
blood cells.
For DNA isolation, a 1ml sample of EDTA blood was aliquoted and kept at
-20°C until use. The DNA was extracted following saponin lysis of the blood as
described in section 7.2.2 and DNA samples stored for up to one year at -20°C.
Biopsies taken from enlarged lymph nodes of 39 cattle showing acute
theileriosis symptoms were Giemsa's stained and examined for the presence
macroschizonts.
Jugular blood was taken into EDTA vacutainers in order to isolate T.
annulata macroschizont infected cells from 67 cattle showing patent infection either
before or after treatment for theileriosis with buparvaquone. Blood was processed
either the same day or the following day as described by Brown (1983). Briefly,
blood was centrifuged at 500 x g for 10 minutes and the plasma was discarded. The
buffy coat was removed and placed into a 25 cm2 tissue culture flask containing 4.5
ml cold, RPMI-1640 (Gibco) medium supplemented with 20% heat inactivated
Serum Supreme (Bio-Whittaker), 2mM L-Glutamine, 150 pg/ml streptomycin, 150
iu/ml penicillin and 5 x lO^ M 2-mercapto-ethanol. The flask was placed vertically
in an incubator at 37°C with the cap tight. The medium was changed twice a week by
taking 3 ml of medium without disturbing the cells and replacing it with the same
volume of fresh warm medium. Culture smears were prepared weekly to assess
whether macroschizont infected cells were established. To do this, 0.5 ml of culture
suspension was centrifuged at 300 x g for 10 minutes. A thick smear was prepared
from the pellet and Giemsa's stained. When approximately 50% or more cells in the
smear were infected 2.5 ml of culture suspension was transferred into a new flask
containing 7.5 ml of fresh media and placed horizontally in an incubator.
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7.2.2. DNA Extraction
7.2.2.1. Preparation ofDNA from cell cultures
Standard phenol-chloroform extraction was used to extract DNA from
macroschizont-infected cell lines and uninfected bovine PBM as described
previously (Sambrook et al., 1989) (see section 4.2.18.1).
7.2.2.2. Preparation ofDNA from blood
DNA from blood samples was extracted either using QIAamp Blood Kit
(Qiagen Ltd., UK) or the saponin lysis method (Barker et al., 1992). The extraction
of DNA from both uninfected and infected blood using the QIAamp Blood Kit was
performed according to the manufacturer's instructions. DNA was extracted from
200 pi of blood. Blood samples were mixed with 25 pi Qiagen protease and 200 pi
Buffer AL by vortexing for 15 seconds. The mixture was incubated at 70°C for 10
minutes. The samples were placed in QIAamp spin columns and centrifuged at 6,000
x g for 1 min. The extracted DNA was washed twice with 500 pi of AW buffer
(Qiagen) by centrifugation of columns for 1 minute at 6,000 x g. An extra spin at
13,000 x g was performed to remove residual buffer to prevent the presence of
ethanol from interfering with subsequent reactions. DNA was eluted with 200 pi of
elution buffer (Buffer AE).
The DNA from blood samples collected from cattle in western Turkey as well
as from limit dilution of piroplasms in blood were extracted by the saponin lysis
method as described in section 3.2.5.1. One blood sample of an infected calf was
included as a negative sample for every 11 test samples during DNA extraction as a
control for contamination.
7.2.3. Nested Polymerase Chain Reaction
A nested PCR was carried out to amplify T. annulata DNA in blood samples
(McPherson et al., 1993). Primers were designed from the gene encoding the 30 kDa
merozoite surface antigen of T. annulata (Shiels et al., 1995; Katzer et al., 1998a).
The first amplification of the nested PCR was carried out in a final volume of 50 pi
using primers T3 and T5 amplifying a 924 bp fragment of the gene (Table 7.1). The
reagents for the PCR were 0.5 pM each primer, 0.2mM each dNTP (Pharmacia
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Biotech), 20 mM Tris-HCl (pH 8.55)*, 16 mM (NH4)2 S04*, 2.5 mM MgCl2*, 150
pg/ml Bovine Serum Albumin* (*all contained in the 10X reaction buffer supplied
with the Taq polymerase enzyme), 0.025U/pl Taq Polymerase (Ultrotaq DNA
Polymerase, Thermometric Ltd.) and 2 pi test or control DNA sample in a final
volume of 50 pi. The reaction solution in each tube was covered with sterile mineral
oil (Sigma). Thin walled 200 pi tubes were used in an Omni Gene PCR thermal
cycler (Hybaid). Cycling conditions were 94°C for 5 minutes followed by 40 cycles
at 94°C for 1 min, 60°C for 1 min and 72°C for 1 min. A final extension step of 72°C
for 10 min was also used. In addition to test DNA samples, a positive control (DNA
from a T. annulcitci infected cell line), a negative sample control (containing bovine
DNA only) and a DNA negative control (5 pi Milli-Q water substituted for DNA)
were included in the PCR reaction.
Primers TamslF and TspmslR were used in the second amplification of the
nested PCR, amplifying a 785 bp fragment of the gene (Table 7.1). The reagents for
the PCR were at the same final concentration as the first amplification in a 20 pi final
volume. Two pi ofDNA from the first amplification were used as template. Cycling
conditions were identical to those described earlier for the first amplification.
Table 7.1. PCR primers from the 30 kDa merozoite surface antigen gene.
Primer Sequence Specificity
T5 5' ATT TAA ATC GCT CAC TAG TCT GC 3' Theileria spp
T3 5' GAT AAG TTG TTA CGA ACAT GGG TTT 3' Theileria spp
Tarns IF 5' ATG CTG CAA ATG AGG AT 3'
T. annulata
Tspms 1R 5' GGA CTG ATG AGA AGA CGA TGA G 3' Theileria spp
The PCR products (10 pi) were separated on a 1.5% agarose gel containing
0.5 pg/ml ethidium bromide and then used for Southern blotting (see section 3.2.5.3).
In order to demonstrate that the PCR products were specific to the 30 kDa gene, a
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20-mer sequence (5' ATC TGH CTG TGA CAT TTG HA3') from within the Tams-
1 gene was used as a probe. The 20-mer oligonucleotide probe was labelled with
DIG 3' End Labelling Kit according to the manufacturer's instruction (Boehringer
Mannheim) and used in Southern blot hybridisation. For labelling, 100 pmoles of
probe was mixed with 4 pi Tailing buffer (Vial 1; 1M potassium cacodylate, 125
mM Tris-HCl, 1.125 mg/ml BSA pH 6.6), 4pl CoCl2 (25 mM), 1 pi DIG dd-UTP (1
mM Digoxigenin-11-dUTP), 1 pi terminal transferase (50 units/pl) and 80 mQ water
to 20 pi. The mixture was incubated at 37°C for 15 minutes and stored at -20°C until
use.
Nylon blots were prehybridised in DIG Easy Hyb buffer (Boehringer
Mannheim) at 40°C for 4 hours. Hybridisation was carried out overnight at 40°C in
fresh buffer containing 30 pmoles DIG labelled DNA probe previously denatured by
boiling for 10 minutes. DIG labelled DNA molecular weight marker XIV (100 base
pair ladder, Boehringer Mannheim) was also added to the hybridisation buffer.
Washes were performed twice in 2 x SSC, 0.1% SDS at room temperature for five
minutes and twice in 0.5 x SSC, 0.1% SDS at 45°C. The detection of hybridised
product was visualised with an immunological detection system using the DIG DNA
Labelling and Detection kit (Boehringer Mannheim) according to the manufacturer's
instructions as described in section 3.2.5.3.
7.2.4. Statistical analysis
The results obtained from field samples by the nested PCR, microscopic
examination of Giemsa's stained blood and lymph node biopsy smears and isolation




7.3.1. Detection of T. annulata in Bovine Blood
T. annulata Gharb piroplasm infected blood with parasitaemia ranging from
1% at ten fold dilution steps to 10"9% was used to test the sensitivity of the PCR.
Figure 7.2 shows the results of the nested PCR and Southern blot hybridisation. The
lowest concentration of piroplasms that could be detected was 10"5% i.e. 1 piroplasm
per 107 red blood cells, by both PCR (Figure 7.2A) and Southern blot hybridisation
(Figure 7.2B) with DNA prepared using QIAamp Blood Kit. Sensitivity of the PCR
was reduced to 10"4% i.e. 1 piroplasm per 106 red blood cells, when Saponin lysis
buffer was used to isolate DNA. A similar level of sensitivity was obtained using the
Ankara stock of T. annulata (data not shown). This experiment was repeated with
blood kept at -20°C after 6 months and the same result was obtained (data not
shown).
7.3.2. Detection of Different Stocks of T. annulata
The nested PCR was performed using T. annulata stocks from different
geographical areas in the range of the parasite and other stocks from one province in
Turkey. Figure 7.3A indicates that the PCR detected all stocks tested. These results
were confirmed by Southern blot hybridisation (Figure 7.3B).
7.3.3. Cross-Reactions
DNA from parasites related to T. annulata was not amplified by this nested
PCR. However, non-specific amplification occasionally occurred, possibly due to the
prolonged number of cycles. These PCR products were shown to be non-specific by
Southern blotting (Figure 7.4).
7.3.4. Field Survey around Aydin, Turkey
Figure 7.5 shows the PCR results in conjunction with the results of
microscopic examination of blood smears, lymph node biopsy and isolation of
macroschizont infected cells by cell culture. Blood smear examinations of 151 cattle
from the province ofAydin revealed that 100 (66%) of cattle were positive for
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Figure 7.2. Ethidium bromide-stained gel (A) and Southern blot (B) of the PCR
to determine the level of sensitivity of the test using DNA extracted from T.
annulata Gharb infected blood, serially diluted with uninfected bovine blood.
DNA was extracted by both Qiagen kit and saponin lysis buffer. Lane 1: XIV
Marker; lanes 2-11 show the DNA extraction by Qiagen blood kit; lanes 12-21 show
the DNA extraction by saponin lysis buffer. Lanes 2-10 and 12-20: 1% piroplasm
parasitaemia, decreasing in 10 fold dilution steps to 10"8%; lane 11 and 21:
uninfected bovine blood; Lane 22-23: DNA from T. annulata Ankara and Gharb cell
lines; Lane 24: No DNA control.
785 bp-





Figure 7.3. Ethidium bromide stained agarose gel (A) and Southern blot (b) of
the PCR demonstrating the specificity of the test with cell lines of 28 different
stocks of T. annulata across its geographical range. Top line: Lane 1 and 21: XIV
Marker (Boehringer Mannheim); lanes 2 to 9: Caceres (Spain), Gharb (Morocco),
Battan (Tunisia), Soba (Sudan), Tova (Israel), Ankara (Turkey), Razi (Iran), Hisar
(India). The remaining lanes between 10 and 30 on the gel are isolates from different
villages around Aydin, Turkey.
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Figure 7. 4. Ethidium bromide stained agarose gel (A) and Southern blot (B) of
the PCR demonstrating lack of cross-reactivity with closely related parasites.
Lane 1: Marker, lane 2: T. annulata Gharb cell line, lane 3: T. annulata Razi cell
line, lane 4: T. hirci - Lahr cell line, lane 5: T. lestoquardi Shiraz cell line, lane 6: B.
bigemina (Kenya), lane 7: B. bovis (Mexico), lane 8: B. divergens (Stormont), lane 9:
B. equi USDA, lane 10: B. equi Onderstepoort, lane 11:5. equi Kwa Zulu, lane 12:
T. buffeli Australia, lane 13: Bovine PBM, lane 14: Sheep PBM, lane 15: Horse
whole blood, lane 16: Adult tick, lane 17: No DNA.
1 3 5 7 9 11 13 15 17 18
785 bp—►
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Figure 7.5. Results of microscopic examination of thin blood, lymph node
biopsy smears for the detection of the presence of piroplasms and
macroschizont respectively, and establishment of macroschizont infected cells













piroplasms, which based on morphology of the piroplasms and clinical symptoms of
the cattle, were assumed to be T. annulata. There was a concurrent clinical infection
of Anaplasma marginale in one animal. Two animals were infected with A.
marginale alone and another two with Babesia spp. alone. These animals were
negative for T. annulata using the PCR. In total 121 of 151 animal tested were
positive in the T. annulata PCR. T. annulata piroplasms were seen in only 100 of
these 151 cattle. Three of the 21 PCR positive, blood smear negative animals were
positive by lymph node biopsy. Macroschizonts were detected in 20 out of 39 cattle
sampled by lymph node biopsy, 34 of these 39 cattle were positive by PCR (Figure
7.5).
Sixty-seven blood samples from animals showing symptoms of theileriosis
were used to establish T. annulata macroschizont-infected cell lines. Several
problems occurred at the beginning of the experiment. During the first two weeks,
flasks with the cap loose were placed into a sandwich box and 5% CO2 was supplied
using a fire extinguisher. Bacterial contamination was found in many of the cell
cultures and fifteen cell cultures were discarded because of bacterial contamination.
Subsequently 5% C02 was omitted and the flask caps were tightened. A total of 26
macroschizont infected cell lines were isolated from 7 different districts of Aydin.
Two of these cultures showed mixed infections with Trypanosoma theilerv, another
was infected with Try. theileri only. One of the cultures co-infected with Try. theileri
was successfully treated with amphotericin-B (Fungizon, Gibco)at a dose of 2.5
pl/ml for two days in the RPMI-1640 medium while the trypanosomes disappeared
from the second cell line during the course of passage. Because of these problems, it
was not possible to compare the results of the cell culture isolation and PCR, but all
Theileria positive cell cultures were positive for PCR.
Statistical analysis using X2 indicated that PCR was significantly more
sensitive than all other diagnostic tests performed in the current study, i.e.
microscopic examination of piroplasms (p = 0.006), lymph node biopsy (p = 0.000)
and cell culture (p= 0.000).
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7.4. DISCUSSION
The aim of the current study was to develop a sensitive and specific PCR that
can be used as a diagnostic tool to detect the carrier state of theileriosis. The nested
PCR using primers derived from the gene encoding the 30 kDa merozoite surface
antigen (Tarns-1) of T. annulata is demonstrated to amplify parasite DNA using
blood samples from animals exhibiting low piroplasm parasitaemia.
The nested PCR method has proved to be 100 times more sensitive than
searching 200 fields in high power light microscopy assuming that cattle have 107
red blood cells per pi of blood, detecting piroplasms at 10"5 % i.e. 1 piroplasm in 107
red blood cells. This is equivalent to the detection of 1 piroplasm in 1 pi of blood.
200 fields of light microscopy at 1000 x magnification corresponds approximately to
105 red blood cells. In the present study, 50 fields ofmicroscopy were examined as a
result of which the comparative sensitivity of the nested PCR is increased a further 4
times.
Experiments performed with samples collected from the field also
demonstrated that the sensitivity of the nested PCR was significantly higher both in
detecting the carrier state and in clinical diagnosis of the disease than that obtained
by conventional diagnostic tests (microscopic examination ofGiemsa's stained blood
and lymph node biopsy smears or isolation of macroschizont infected cell lines). It
should be noted that PCR performed with DNA extracted using the QIAamp blood
kit was more sensitive than that using saponin lysis buffer indicating that the
sensitivity of the PCR is affected by the method of DNA extraction. In any case,
these results would strongly suggest that the carrier state of animals infected with T.
annulata could be diagnosed using the PCR with a greater degree of sensitivity.
The sensitivity of the PCR was first tested with a number of different stocks
of T. annulata of widely diverse geographical origin since it was previously
demonstrated that the Tarns-1 protein is very polymorphic (Katzer et al., 1998a).
Over 30 stocks of the parasite collected from ten countries across a wide range of T.
annulata distribution and from Aydin province of Turkey could be detected with the
nested PCR. All these parasites have been shown to be phenotypically diverse by
glucose phosphate isomerase polymorphism (Melrose et al., 1980); E. Kirvar pers.
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comm.). It appears from these observations that the nested PCR can detect T.
annulata across its geographical range.
A PCR-based methodology using primers N516 and N517, also derived from
the Tarns-1 gene, was previously developed by d'Oliveira et al. (1995; 1997b). The
sensitivity of the PCR developed by d'Oliveira et al. (1995) was 2-3 piroplasms per
pi (107 red blood cells). However, the same level of sensitivity could not be obtained
in our laboratory and the sensitivity of PCR obtained using primers N516 and N517
was only 1 piroplasm in 105 cells (data not shown). Additionally, the amplification of
DNA from some of the T. annulata stocks isolated from Aydin province of Turkey
using the primers N516 and N517 was inconsistent (data not shown). This substantial
differences in observed sensitivity and specificity of PCRs described here and by
d'Oliveira et al. (1995, 1997) might be ascribed to differences in the primers used in
the respective methods.
Microscopic examination of Giemsa's stained blood smears is the traditional
method used for the detection of T. annulata piroplasms. Nevertheless, it is not
possible to distinguish between T. annulata species on the bases of morphological
differences, e.g. proportion of annular vs. pyriform piroplasms (T. annulata vs. T.
parva), and presence of 'bars' and 'veils' (71 buffeli) (Norval et al., 1992). The
results showed that the nested PCR described in the current study could distinguish
T. annulata from other bovine Theileria species tested. This is important for
epidemiological studies in areas where the distribution of these parasites overlaps.
The nested PCR could also distinguish T. annulata from Babesia spp. and
Anapldsma spp. Since mixed infections with these parasites occur very often in
cattle, the nested PCR should prove useful for differential diagnosis.
Additionally, and most importantly, the nested PCR also distinguished the
closely related parasites of sheep, T. lestoquardi (=hirci) and of horses, Babesia
(=Theileria) equi, from T. annulata. All three parasites, T. annulata, T. lestoquardi
and Babesia equi are all transmitted by Hyalomma ticks (Hooshmand-Rad and
Hawa, 1973; Robinson, 1982; Friedhoff, 1988). Although it was previously
demonstrated that T. lestoquardi cannot infect cattle (Brown et al., 1998a; Leemans
et al., 1999b), the accurate identification of these species in ticks is important to
assess the potential threat of T. annulata in a particular area and to gather
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epidemiological data on tick infection rates. The presence of Theileria in ticks is
traditionally determined by staining dissected salivary glands with methyl green
pyronin (Walker and McKellar, 1983). Despite of its relative simplicity, however,
this method can only be performed on live ticks and does not allow differentiation of
these parasites (Walker and McKellar, 1983; Kirvar et al., 1998). The inner set of
primers used in the current study was also demonstrated to be effective in detecting
T. annulata using DNA from infected vector ticks (Kirvar et al., 1999).
Taken together, the nested PCR described in the current study is shown to be
both sensitive and specific and would be valuable in epidemiological studies of T.
annulata for both carrier animals and vector ticks. Such studies are needed for an
accurate assessment of theileriosis in risk areas, a prerequisite for effectively




Tropical theileriosis, a disease of cattle caused by infection with the
protozoan parasite T. annulata, presents an important constraint to livestock
development in Asia, north Africa and southern Europe (Purnell, 1978). The control
of tropical theileriosis in many countries has primarily been carried out by
vaccination with attenuated macroschizont infected high passage cell lines (Pipano,
1976; Hashemi-Fesharki, 1988; Onar, 1989; Ouhelli, 1991; Singh, 1991; Zablotsky,
1991). Targeting the available vaccine where it is most needed and monitoring to
determine whether vaccinated animals are withstanding sporozoite challenge through
infected tick in the field requires comprehensive epidemiological disease surveys.
Highly sensitive and specific diagnostic techniques are necessary to detect the
presence of parasite or antibodies which recognise parasite antigens. To date the
most common method used to monitor the response to theilerial vaccines and natural
infection is the IFAT using both macroschizont and piroplasm antigens (Pipano and
Cahana, 1969; Anon, 1997). However, IFAT does not give any indication of which
animals have been vaccinated or which animals are naturally infected through
infected ticks. This is because the presence of common antigens is present in
different life cycle stages of the parasite in the vertebrate host.
"The primary objective of this study was to develop sensitive and specific
diagnostic tests for T. annulata infection in particular to distinguish animals
vaccinated with attenuated macroschizont infected cells from naturally infected
animals and to detect sensitively and specifically the carrier state in cattle. The work
was carried out in the following stages: (i) design and conduct animal experiments to
produce material for development and evaluation of stage specific ELISAs and
highly sensitive and specific PCR, (ii) clone a macroschizont gene of T. annulata and
express it as recombinant protein to use in ELISA, (iii) establish the diagnostic
sensitivity and specificity of the Tamr-1 and macroschizont ELISAs for detection of
antibodies against T. annulata, (iv) assess the ability of Tamr-1 and macroschizont
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ELISAs to distinguish vaccinated animals from those naturally infected, (v) develop
a highly sensitive and specific PCR methodology using T. annulata specific primers
from the gene encoding 30 kDa merozoite surface antigen (Tarns 1) to detect low
level infections in carrier animals (vi) evaluate PCR on experimental material raised
in (i).
Three main groups of calves were infected with T. annulata Ankara at
different parasite stages and at different levels of attenuation, i.e. sporozoites (Group
1), a non attenuated low passage cell line (Groups 2A and 2B), an attenuated high
passage cell line (Ankara/Pendik) (Groups 3A and 3B). The calves were challenged
one or seven months after primary infection with a heterologous sporozoite stabilate,
T. annulata Gharb. The severity of reaction to infection and challenge were
categorised as severe, moderate and mild according to the results obtained from
clinical, parasitological and haematological parameters (Anon, 1989). Reaction to
primary infection was different in each group. All calves in Group 1 underwent a
severe reaction to primary infection. Calves in Groups 2A and 2B showed a wide
range of reactions from severe to mild to primary infection. In contrast, all calves in
Groups 3A and 3B underwent only mild reactions. Following challenge all animals
in Groups 1, 2A and 2B exhibited solid immunity to challenge response 1 month or 7
months after primary infection. Following challenge, these calves, underwent a
transient temperature reaction with no or only slight decrease in WBC. Only one calf
in Group 2B showed a long period of pyrexia, but haematological and parasitological
results suggested that this temperature response might not have been related to the
challenge. However, calves in Group 3A and 3B showed moderate or severe
reactions to challenge. In sum, immunity stimulated by the Ankara/Pendik cell line
protected three out of four animals one month following vaccination (Group 3B) and
two out of four 7 months following vaccination (Group 3A). The sporozoite
challenge infection of the control group was lethal and despite chemotherapy two
calves died.
The carrier state of animals was determined by microscopic detection of
piroplasms, cell culture isolation of macroschizonts infected cells from peripheral
blood and a PCR method (Ilhan, 1995) using primers from ssu rRNA (Allsopp et al.,
1993). Animals infected with sporozoites or the low passage cell line were shown to
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be persistent carriers following infection by PCR and the presence of piroplasms in
blood smears. In addition, cell cultures could be established more frequently from
these animals than animals immunised with the high passage cell line. Animals
infected with the high passage cell line were rarely positive by PCR, or cell culture
and only very rare piroplasm-like organisms were detected infrequently in these
animals before challenge.
Antibody responses of these animals were monitored by the IFAT using
macroschizont and piroplasm antigens as a conventional test and by the IgG and IgM
ELISAs using three recombinant antigens, Tamr-1 (merozoite rhoptry), NC10-Sspl3
(macroschizont) and Tash-2 (macroschizont and piroplasm). All calves sero-
converted with IFAT using both macroschizont and piroplasm antigens. The
macroschizont IFAT result showed a relatively similar pattern in all calves.
Differences in antibody responses were revealed by the piroplasm IFAT and the
Tamr-1 and Tash-2 ELISAs. Anti-piroplasm antibodies were detected by IFAT even
though piroplasms were not seen in the calves immunised with the high passage cell
line. However, the antibody levels and duration of responses was lower and shorter
than those after infection with the sporozoites and the low passage cell line.
Similarly, no antibody response or very slight increase in the antibody levels were
observed using the Tamr-1 and Tash-2 ELISAs in animals immunised with the high
passage cell line.
Taken together these observations indicate a correlation between the primary
infection, the immune response to challenge, the carrier status and antibody
responses of these animals. Calves which showed solid immunity to challenge (i)
exhibited a moderate to severe clinical reactions to primary infection, (ii) were
persistent carriers and (iii) showed a significant increase in antibody levels in the IgG
Tamr-1 and Tash-2 ELISAs. In contrast, where protection against challenge was poor
or moderate, calves (i) exhibited inapparent or mild clinical and parasitological
reactions to primary infection, (ii) were intermittent carriers of the parasite, and (iii)
showed a low level and short duration of antibody responses to piroplasm IFAT and
no or slight increase of antibody levels in the Tamr-1 and Tash-2 ELISAs.
The reason why animals immunised with attenuated cell lines were not well
protected from challenge is of considerable interest and potential relevance as such
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cell lines are used as vaccines in Turkey. Several factors are considered to be
involved in the induction of immunity by macroschizont-infected cell cultures. These
factors include (i) the level of attenuation of a cell culture, (ii) transfer of
macroschizonts from inoculated cells into recipient's cells with establishment,
multiplication and dissemination, (iii) induction of a carrier state with resultant
premunity.
The aim of attenuation of the parasite is to reduce its virulence while
maintaining its immunogenicity and infectivity (Pipano, 1977; Pipano, 1989b).
Complete attenuation is accompanied by the loss of ability to produce merozoites
thus piroplasms (Pipano, 1977). Different field isolates of T. annulata require
different periods in culture before reaching complete attenuation (Hooshmand-Rad,
1973). However, prolonged passages appear to reduce infectivity and
immunogenicity (Brown, 1990). Therefore, the Ankara/Pendik vaccine cell line was
subcultured more than 300 times over 3 years.
Attenuated macroschizonts grown in culture may undergo only a limited
number of replication cycles when inoculated into cattle (Pipano, 1977) which may
result in the poor transfer of the parasite into the recipient's reticulo-endothelial cells.
It has been demonstrated that attenuated T. annulata Ode cells disseminate very
poorly compared to virulent parent cell lines in scid mice (Somerville et al., 1998a).
The degree of dissemination was correlated with a marked reduction in matrix
metalloproteinases (MMP) which are known to play an important role in metastasis
(Sier et al., 1996). It is believed that to achieve immunity with macroschizont
infected cell culture, the parasite must establish and replicate within the recipient's
mononuclear cells (Brown et al., 1978a; Brown and Gray, 1981). Therefore,
excessively attenuated macroschizont infected cells may not reach a sufficient
quantity needed to induce immunity and may not induce a carrier state with resultant
premunity or co-infectious immunity as defined by Sergent (1963).
Although the antibody detected by a serological test is not necessarily an
indication of the immunity that has developed against infection, the presence of
antibody may indicate either multiplication of macroschizonts with or without the
presence of piroplasms. In another experiment, calves that were infected with
sporozoites were immune to a heterologous challenge three years after primary
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infection (Preston and Brown, unpublished). These animals were consistent
piroplasm carriers until the challenge and antibodies could be detected 3 years
following primary infection with the Tash-2 ELISA. The presence of piroplasms and
detection of anti-macroschizont antibodies would indicate that calves infected with
sporozoites are carriers of both macroschizonts and piroplasms. This is contrast to
the classical definition of a carrier of T. annulata that is the ability of an infected and
recovered animal to serve as a reservoir of infection for vector ticks which are able to
transmit the parasite to susceptible hosts (Young et al., 1986). Currently the carrier
status is thought to be maintained by the persistent and slow division of
macroschizonts giving rise to piroplasms (Norval et al., 1992).
In the current study, immunity stimulated by the Ankara/Pendik vaccine cell
line protected three out of four animals one month following vaccination which was
only marginally better than the protection observed (2/4) 7 months following
immunisation. Cattle immunised in the field where the prevalence of disease is high
are likely to be exposed to field, i.e. tick/sporozoite challenge during the first disease
season and become immune for long periods. However, if animals pass the first
disease season without challenge, they may become susceptible to disease in
following years. Therefore, whether repeated vaccination may be required will
depend on the level of field challenge and endemic stability in the region. However,
re-immunisation with the same cell line may not boost immunity because of a graft
rejection type response (Nichani et al., 1997a; Nichani et al., 1997b).
Several approaches were tested in order to obtain a macroschizont stage
specific antigen for use in an ELISA to detect anti-theilerial antibodies even in
vaccinated animals. Screening of a cDNA library of T. annulata with the QP gene,
(Baylis et al., 1993) which is equivalent to PIM, a polymorphic immunodominant
macroschizont gene of T. parva (Toye et al., 1991; 1995a; 1995b), resulted in
isolation of three genes, NCI, NC2 and NC10. Only the NCI and NC10 genes were
sequenced and the sequence analysis showed that there is not high homology
between the QP gene and gene represented by the cDNA clones. The region of
similarity between the predicted amino acid sequences of cDNA clones and the
QP/PIM gene was found to be over the Gin-Pro and Glu-Pro regions. However, the
NC10 gene shows tetrapeptide repeats with QP repeats in its central region and these
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repeats are similar to the repeats observed in the PIM gene sequence (Baylis et al.,
1993; Toye et al., 1995b). Similar motifs were also demonstrated for the pl50 gene
of T. parva (Skilton et al., 1998). Therefore, these motifs and sequence homologies
may represent a common ancestry for NC10, PIM and pl50 genes.
Northern blot analysis of the cDNA clones demonstrated that genes
represented by clones NCI, NC2 and NC10 were differentially expressed by
different life cycle stages of the parasite. The NCI and NC2 were expressed mainly
by the sporozoite stage and clearly down-regulated at the piroplasm stage. In
contrast, the NC10 gene was expressed mainly at the macroschizont stage of the
parasite life cycle. The QP probe, however, detected at least three mRNA species of
T. annulata. At the stringency used a higher level of homology would be expected
for detection of the same RNA species by these probes. Additionally, both QP and
NC2 probes do not detect the same RFLP's on Southern blots at 60°C stringency.
Thus, it is most likely that the mRNA species detected by the NCI, NC2 and NC10
genes is not the same mRNA species that is detected by QP protein.
The results of sequence, Southern and northern blot analyses suggest that
none of the genes isolated from the T. annulata cDNA library have real homology to
the QP/PIM gene. There is a possibility that there is a gene(s) in the T. annulata
genome with a higher homology to the QP/PIM gene. On the other hand, the NC10
gene is QP/PIM-like in terms of the tetrapeptide repeats with QP motifs and thus the
encoded protein could be a functional homologue of the QP/PIM gene. Additionally,
since the QP/PIM gene is highly polymorphic among T. parva stocks (Toye et al.,
1995apl 995b), the presence of selection for diversity in this antigen in one or both
species may have resulted in the low level of homology displayed between PIM and
the T. annulata cDNA clones.
Since both NCI and NC10 genes were expressed by the macroschizont stage
of the parasite, attempts were made to produce recombinant proteins from these
genes. The expression ofNCI gene fragments was toxic to the strains of E. coli used.
However, a 1.2 kb fragment ofNC10 gene, NC10-Sspl3, was successfully expressed
as a His-tagged fusion protein using both pGex and pQE vector systems and the
expression product was immunogenic as it reacted with immune bovine sera. Results
of western blot analysis demonstrated that several polypeptides from macroschizont
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infected cells of different T. annulata stocks reacted with the rabbit anti-NC10-Sspl3
serum. The detection of several polypeptides could be due to fact that: (i) the NC10-
Sspl3 fusion protein contains repeated amino acid motifs and therefore, it is possible
that some of the bands detected were due to cross reactivity of the anti-serum with
similar repeats within different proteins as shown for other parasites (Anders, 1986;
Skilton et ai, 1998); or (ii) there could be more than one related gene for NC10 gene
in the T. annulata genome as two mRNA species were detected by the NC10 cDNA
probe in northern blot analysis and the anti-NCIO sera detected proteins on both
macroschizont and nucleus of the host cells.
The results of IFAT using anti-NC10-Sspl3 sera against macroschizont
infected cells were very interesting. The immunofluorescence reactivity was detected
against both macroschizonts and the host cell nucleus. Host nuclear reactivity was
scattered over the region of nuclear envelope. The staining of the host nucleus was
specific to cells in interphase as no staining was observed in cells undergoing mitotic
division. These results indicate that the protein detected on the host nucleus may be
related to infection and immortalisation of the host cell by the parasite. At present,
identification of mechanisms related to induction of host cell proliferation by
Theileria is limited and not fully understood (reviewed by Chaussepied and
Langsley, 1996; Dobbelaere and Heussler, 1999). Recently, it was reported that a
parasite molecule, TashAT, is transported to the host cell nucleus and could be
involved in regulating proliferation and/or host cell gene expression (Swan et al.,
1999). The staining pattern of macroschizont infected cells obtained by the TashAT
gene was similar to that obtained by NC10 gene but not identical. Staining with anti-
TashAT antibody has also been observed in cells during mitosis (Shiels, Stern and
Swan, unpublished). Therefore, while the TashAT and NC10 genes may both be
involved in the control of host cell proliferation it is possibly they perform distinct
complementary functions related to a location either within or on the surface of the
host nucleus.
Further studies that would clarify several aspects of the results obtained here
include (i) complete the sequence of the 5' end of the NCI and NC10 genes, (ii) carry
out further Southern blot analysis of NCI0 gene at high stringency to confirm the
gene is single copy, (iii) investigate the fate of the protein during mitosis using
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electron microscopic examination (iv) carry out transfection studies to confirm
whether the NC10 antigen is responsible for the fluorescence pattern described in the
current study or if is this due to a related parasite antigen or cross recognition of a
host polypeptide.
Three recombinant antigens expressed in different life cycle stages of the
parasite, Tamr-1 (merozoite/piroplasm), NC10-Sspl3 (macroschizont) and Tash-2
(macroschizont/piroplasm) were demonstrated to be antigenic by western blot
analysis using serum from the majority of animals infected with T. annulata
sporozoites and low passage cell lines. Subsequently, these antigens were used in
indirect ELISAs. According to this scheme, if the Tamr-1 ELISA and either the
NC10-Sspl3 or the Tash-2 ELISA are positive, it can be concluded that the animal
has been infected or challenged with sporozoites regardless of whether it had been
immunised. On the other hand, a negative result with the Tamr-1 ELISA and a
positive result with the NC10-Sspl3 or Tash-2 ELISA would indicate that the animal
was only immunised with an attenuated macroschizont infected cell line, and not yet
exposed to field challenge with tick transmitted sporozoites.
The indirect ELISA format was selected to detect both IgG and IgM
antibodies against T. annulata infection. International guidelines were adapted for
the IgG Tamr-1 ELISA (Wright et al., 1993). In particular, ODs were expressed as a
positivity index (percent positivity, PP) of the high positive control (C++) on each
ELISA plate to minimise the effects of plate to plate and day to day variation. In
addition control limits were determined for four controls (C++, C+, C- and Cc) and
used to accept and reject each plate. Recently, computer software packages such as
Shewhard-CUSUM (Blacksell et al., 1996) have been increasingly used to monitor
ELISA performance. It was suggested by Blacksell et al. (1996) that at least ten tests
should be conducted to provide reference control data. In the current study for the
IgG Tamr-1 ELISA, six replicate tests were conducted to establish control limits to
accept or reject a plate. Quality control limits are an essential feature of ELISAs
because of their inherent variability. Various measures have been recommended to
minimise such variations for example: 1) the use of large reagent batches stored
under optimal conditions, 2) technical training of operators, 3) good laboratory
management (Kemeny, 1991).
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The categorisation of animals as positive and negative by ELISA is
dependent on the cut-off value chosen. The cut-off value for the Tamr-1 ELISA was
established using a frequency distribution of results from positive and negative
animals (Wright et al., 1993), and a method of two graphs receiver operating
characteristic (TG-ROC) analysis (Greiner et al., 1995) which graphically represents
the effect of different cut-off values on sensitivity and specificity. The TG-ROC
analysis could be carried out using a computer programme, which is public domain
software (Greiner, 1995). In many studies, TG-ROC was used in evaluation of
sensitivity and specificity of ELISA (Greiner et al., 1997; Gubbels et al., 1999a;
Mboloi et al., 1999). However, in the current study TG-ROC were empirically
prepared using the cumulative frequency distribution of negative (CFDneg) and the
inverse positive (CFDpos) sample (Greiner et al., 1995) using cut-off values of 0 - 100
PP at 1 PP intervals. Cut-off values of 14 and 18 PP were chosen as the values that
gave the best estimates of sensitivity and specificity for the IgG Tamr-1 ELISA.
By using 209 calves experimentally infected with T. annulata the diagnostic
sensitivity of the IgG Tamr-1 ELISA was 78.5% and 72.7% at 14 PP and 18 PP cut¬
off values, respectively. Both of the values were substantially lower than the
sensitivity obtained with these serum samples using the IFAT piroplasm antigen
(100%). However, the specificity of the test determined using 188 negative cattle
was 95.2% and 98.4% at 14 PP and 18 PP cut-off values, respectively which is very
close to that obtained by IFAT (100%). Here, only T. annulata positive and negative
animals were used which did not pick up on the non-specificity of the IFAT for
example. Although the IFAT is more reliable than the Tamr-1 ELISA, the IgG Tamr-
1 ELISA could be very useful in large-scale sero-epidemiological studies, as it is less
laborious than IFAT.
In order to assess the increase in antibody levels of individual calves infected
with either T. annulata Ankara sporozoites or the low passage cell line or immunised
with the high passage cell line the cut-off values for the NC10-Sspl3 and Tash-2
ELISAs were used as twice the absorbance value of pre-infection serum for each calf
(de Savigny and Voller, 1980). The IgG and IgM ELISAs using the three
recombinant antigens, Tamr-1, NC10-Sspi3 and Tash2, were analysed to assess their
ability to distinguish vaccinated animals from those naturally infected and to
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determine their value as diagnostic tools for epidemiological studies. Results were
compared with the macroschizont and piroplasm IFAT. All three recombinant
antigens detected antibody responses in calves infected with either sporozoites or the
low passage cell line. The earliest antibody detection was observed with IFAT
(between days 28-35), then the Tamrl (between days 28-56), NC10-Sspl3 (day 84)
and Tash2 (by day 84) antigens. The IgG Tamr-1 ELISA detected antibodies for over
7 months following the primary infection and over a year after challenge. On the
other hand, both the IgG NC10-Sspl3 and Tash-2 ELISAs detected antibodies for
three years even in absence of challenge. All the animals 'naturally' infected with
sporozoites were piroplasm carriers for three years, implying the persistent presence
ofmacroschizonts and their differentiation to merozoites/ piroplasms.
Effectively, no piroplasms were detected by examination of Giemsa's stained
blood smears from animals immunised with the high passage cell line. These results
confirmed the previous reports that Ankara/Pendik vaccine cell line does not produce
piroplasm in vivo (Ozkoc and Pipano, 1981; Onar, 1989). As expected, no antibody
responses were detected in these animals using the Tamr-1 ELISA indicating that
this antigen could be used to distinguish vaccinated animals from naturally infected
or challenged animals. Antibody responses were detected in calves immunised with
the high passage cell line (Group 3A) with the both the IgG NC10-Sspl3 and Tash-2
ELISAs. However, antibody levels were very low and detected even later (day 111)
than those in animals infected with sporozoites (day 84).
Taken together, the results indicated that ELISAs using the Tamr-1, NC10-
Sspl3~or Tash-2 recombinant antigens cannot be used to distinguish animals
vaccinated with the attenuated high passage cell line from those that are naturally
infected under the standardised conditions described here. Firstly, the sensitivity
obtained with the Tamr-1 ELISA is insufficient. Secondly, although the antibody
responses of animals were readily detected three months after infection with
sporozoites with the IgG NC10-Sspl3 and especially Tash-2 ELISAs the antibody
levels were very close to pre-infection OD values in animals vaccinated with the high
passage cell line.
Late detection of antibody in animals infected with sporozoites or immunised
with the high passage cell line could be due to the fact that antibodies against T.
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annulata may have low affinity to the Tash-2 antigen. The detection of low affinity
antibodies could be improve by changing antigen concentrations, serum dilutions and
washing conditions (Butler, 1988; Devey and Steward, 1988).
Another approach to discriminate vaccinated animals from naturally infected
animals would be to label the cell line vaccines with a marker as described for the
rinderpest virus (Baron and Barrett, 1997) and Salmonella live vaccine strains (Beyer
and Bohm, 1996). In this way, it would be possible to monitor whether an animal has
been vaccinated effectively i.e. the vaccine 'take'. The infection or challenge of
animals with sporozoites could be then monitored by either the Tamr-1 or Tash-2
ELISAs.
Another aspect of the current study was to develop a sensitive and specific
PCR method to detect low level infections in carrier animals. The nested PCR using
primers derived from the gene encoding the 30 kDa merozoite surface antigen
(Tarns 1) of T. annulata was able to amplify parasite DNA from blood exhibiting 10"
5% parasitaemia, i.e. 1 piroplasm in 1 pi blood. This is 100 x more sensitive than
examining 200 fields by light microscopy at 1000 x magnification. The nested PCR
was also more sensitive in detecting acute infections than isolation of macroschizont
infected cells from peripheral blood of infected animals by cell culture and than the
examination of Giemsa's stained lymph node biopsy smears. Additionally, the nested
PCR is proven to be a specifically detected T. annulata DNA making it a better test
than other diagnostic tests such as IFAT, ELISA which cross-react with related
parasites.
~In conclusion, even though the ELISAs developed here failed to distinguish
vaccinated animals from naturally infected animals both Tamr-1 and Tash-2 ELISA
could be powerful diagnostic tools. Both the Tamr-1 and Tash-2 ELISAs have the
potential for use in epidemiological studies. However, further modification of the
ELISAs is required to improve their sensitivities. The nested PCR is very sensitive
and specific and would be valuable in epidemiological studies of T. annulata for both
carrier animals and vector ticks. Such studies are not only needed for an accurate
assessment of theileriosis in risk areas, but are also a prerequisite for effectively
targeting of vaccines for the control of tropical theileriosis.
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